cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
115405,Pyridine-2-carboxylic acid,202-719-7,98-98-6,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,152,H319:142;H302:140;H318:8;H315:94;H332:69;H335:92;H301:5
115407,"Ethane-1,2-disulphonic acid, compound with 5-(2-chloroethyl)-4-methylthiazole (1:2)",217-483-0,1867-58-9,Acute Tox. 4;Eye Irrit. 2;STOT SE 3;STOT SE 3;Aquatic Chronic 3,Notified C&L,3,H319:3;H302:3;H335:3;H412:3
115409,Proxan-potassium,205-441-4,140-92-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H302:40;H335:39;H315:40
115410,"(1S)-1,2,3,4-tetrahydro-1-phenylisoquinoline",445-640-5,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H302:1;H411:1
115415,"1-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]ethan-1-one",278-549-2,76784-40-2,Acute Tox. 4,REACH registration C&L,4,H302:3;Not classified:1
115416,"Cocoa, ext.",283-480-6,84649-99-0,Not Classified,REACH registration C&L,1458,Not classified:1441;H226:10;H225:7;H319:1
115422,"Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-, (2E)-2-butenedioate (salt)",618-161-6,88407-82-3,Repr. 2;Lact.,Notified C&L,1,H361:1;H362:1
115423,Ethylphosphonic acid,229-839-2,6779-09-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43,H318:38;H314:43;H290:1
115427,"1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride",217-111-7,1743-01-7,,Notified C&L,1,H319:1;H335:1;H315:1
115428,"polyphosphoric acids, esters with ethoxylated castor oil",614-325-6,68153-27-5,,Notified C&L,3,H302:2;H318:2;H315:2;H314:1
115430,"Distillates (coal tar), benzole fraction, distn. residues;Wash Oil;[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150°C to 300°C (302°F to 572°F) or a semi-solid or solid with a melting point up to 70°C (158°F). It is composed primarily of naphthalene and alkyl naphthalenes.]",310-165-3,121620-46-0,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
115432,Tribenzylchlorosilane,242-549-0,18740-59-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
115437,2-bromopentane,203-521-3,107-81-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,64,H319:64;H226:20;H315:64;H225:44;H335:44
115438,"(S)-(+)-1,1'-Bi-2-naphthol bis(trifluoromethanesulfonate)",603-279-2,128544-05-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:39;H314:39;H290:1
115439,Aluminium rubidium bis(sulphate),236-877-3,13530-57-9,Not Classified,Notified C&L,26,Not classified:26
115442,"α,α,α,α',α',α'-hexafluoro-3,5-xylenol",206-488-3,349-58-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46;H226:1
115444,Betahistine dihydrochloride,226-966-5,5579-84-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,52,H319:49;H335:47;H413:43;H315:50;Not classified:1;H302:1
115447,Ammonium 2-ethylhexyl hydrogen phosphate,286-349-1,85222-97-5,Not Classified,Notified C&L,2,Not classified:1;H302:1
115448,"Elder, Sambucus canadensis, ext.",294-458-0,91722-58-6,Not Classified,Notified C&L,89,Not classified:89
115449,n-hexane,203-777-6,110-54-3,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;STOT RE 2;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H361:0;H225:0;H373:0;H411:0;H315:0;H336:0;H304:0
115453,"D-Gluconic acid, calcium salt (2:1)",605-881-0,18016-24-5,Not Classified,Notified C&L,2,Not classified:2
115456,"10-hydroxy-3,6,10-trimethylundec-3-en-2-one",268-841-8,68141-19-5,Skin Sens. 1;Eye Irrit. 2A,Notified C&L,25,H317:25;H319:25
115458,"4,4,12,12-tetraethoxy-3,13-dioxa-8-thia-4,12-disilapentadecane",612-019-7,60764-86-5,Not Classified,Notified C&L,6,Not classified:5;H402:1;H320:1;H412:1;H227:1;H226:1;H315:1;H319:1;H335:1
115460,Mesaconic acid,207-859-2,498-24-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
115461,"2,7-dimethylocta-3,5-diyne-2,7-diol",227-670-9,5929-72-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
115463,"(1E)-1-(methoxyimino)-1-(2,5,5-trimethyl-1,3-dioxan-2-yl)acetone",607-917-0,263355-39-1,Not Classified,Notified C&L,83,Not classified:83
115469,"Hydrocarbons, C4, butane conc., n-butene-contg.",306-006-2,95465-91-1,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,1,H220:1;H280:1
115474,"1H-indole-2,3-dione 3-[(4-nitrophenyl)hydrazone]",250-469-2,31107-06-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H317:38;H319:38;H335:38;H315:38
115475,"Butanedioic acid, 2-(2-oxopropyl)-, 1,4-diethyl ester",601-564-6,1187-74-2,,Notified C&L,1,H319:1;H335:1;H315:1
115476,"Sulfonic acids, C10-14-alkane",271-775-2,68608-16-2,Not Classified,Notified C&L,5,Not classified:5
115477,"[4-[bis[4-(diethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]diethylammonium tetrachlorozincate",265-470-3,65121-93-9,Skin Corr. 1A;Aquatic Chronic 2,Notified C&L,2,H411:2;H314:2
115484,"Rifamycin, 3-amino-1,4-dideoxy-1,4-dihydro-4-imino-1-oxo-",612-936-2,62041-01-4,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1,H319:1;H412:1
115485,"Alcohols, C16-18 and C18-unsatd., ethoxylated",500-236-9,68920-66-1,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1616,H411:269;H315:1431;H302:326;H318:280;H412:183;H400:174;H319:87;Not classified:23;H335:23;H410:13;H336:1
115487,2-[(methylthio)methyl]furan,215-874-0,1438-91-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1448,H319:1412;H302:1287;H335:1411;H315:1412;Not classified:36
115489,"(1R,2S,4R)-born-2-ylamine",251-076-9,32511-34-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
115496,"3,3'-[carbonylbis[imino(2-methyl-4,1-phenylene)azo]]bisnaphthalene-1,5-disulphonic acid",247-220-5,25738-24-3,Not Classified,Notified C&L,2,Not classified:2
115502,"4,4'-carbonimidoylbis[N,N-dimethylaniline]",207-762-5,492-80-8,Acute Tox. 4;Eye Irrit. 2;Carc. 2;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H302:0;H411:0;H351:0
115504,N-(α-Cyano-2-thenyl)-4-ethyl-2-(ethylamino)-5-thiazolecarboxamide,605-299-7,162650-77-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H410:89;H400:89
115508,"1,5-Bis(4-allyldimethylammoniumphenyl)pentan-3-one dibromide",609-798-0,402-40-4,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,39,H330:39;H310:39;H300:39
115511,3-bromopropan-1-ol,210-986-6,627-18-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,51,H302:40;H318:40;H319:11;H335:8;H315:11;Not classified:2;H411:1
115512,Sodium 4-sec-dodecylbenzenesulphonate,271-912-6,68628-60-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H302:1;H318:1;H315:1
115514,Palladium diiodide,232-203-7,7790-38-7,,Notified C&L,4,H319:4;H335:4;H315:4
115515,"Fatty acids, C18-unsatd., dimers, sodium salts",614-107-0,67701-20-6,Not Classified,Notified C&L,17,Not classified:17
115518,"Ilex aquifolium, ext.",289-948-6,90045-83-3,Flam. Liq. 2,Notified C&L,1,H225:1
115520,1-(isopropylamino)-3-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]propan-2-ol hydrochloride,264-384-3,63659-19-8,Acute Tox. 4,Notified C&L,49,H302:48;H361:5;H412:2;Not classified:1
115522,N-hydroxymethaniminium chloride,222-440-4,3473-11-8,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H300:38;H315:38
115524,α-bromo-4-nitro-o-cresol,212-248-9,772-33-8,Skin Corr. 1B,Notified C&L,40,H314:40;H302:2;H318:2;H332:2;H312:2
115525,2-chloro-6-(ethylamino)-4-nitrophenol,411-440-1,131657-78-8,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H302:0;H411:0
115529,2-methyl-2-azabicyclo[2.2.1]heptane,404-810-9,4524-95-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;STOT RE 2,Harmonised C&L,0,H302:0;H314:0;H373:0;H226:0;H312:0
115538,"Pyridine, 2-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-, trans-, ethanedioate (1:1)",610-657-0,51366-19-9,Not Classified,Notified C&L,1,Not classified:1
115540,"Oils, Anthoxanthum odoratum",614-783-7,68916-09-6,Acute Tox. 4,Notified C&L,99,H302:98;H411:1
115541,L-anserine nitrate,233-079-7,10030-52-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
115543,"3,3,10,10-tetramethoxy-2,11-dioxa-3,10-disiladodecane",617-969-6,87135-01-1,STOT RE 1,Notified C&L,40,H372:38;Not classified:1;H319:1;H315:1
115546,N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl] butanamide; 2-hydroxybenzoate,922-246-6,,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,2,H317:2;H302:2;H318:2
115547,"dalapon-sodium;sodium 2,2-dichloropropionate",204-828-5,127-20-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H412:0;H315:0
115548,"Phenol, 3,4-difluoro-",424-300-1,2713-33-9,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H228:1;H312:1
115549,"Cyclopenta[c]pyrrole-1-carboxylic acid, (2S)-2-cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyloctahydro-, (1S,3aR,6aS)-",609-815-1,402958-98-9,Not Classified,Notified C&L,1,Not classified:1
115550,Methyl tetrahydro-4-oxo-3-thenoate,220-256-9,2689-68-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:1;H315:2;H319:2;H332:1;H335:2;H312:1
115554,"2,6-dimethylpyrimidin-4-ylamine",207-320-1,461-98-3,,Notified C&L,6,H319:6;H335:5;H315:6
115555,Tris(pentyloxy)silane,241-853-0,17907-97-0,Aquatic Chronic 4,Notified C&L,38,H413:38
115556,"1-bromo-1,1,2,2,3,3,3-heptafluoropropane",207-023-7,422-85-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H312:1
115557,[3-(trifluoromethyl)phenyl]urea,236-040-2,13114-87-9,,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H335:1
115559,"1,3-Difluor-2-difluormethoxy-5-(4-trans-pentyl-[1,1-bicyclohexyl]-4-trans-yl)-benzene",604-117-3,139215-89-7,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
115563,"(S)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole",600-715-3,106092-09-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H335:39;H315:40;H302:3
115571,"D-gluconic acid, compound with 2,2',2''-nitrilotrisethanol (1:1)",255-922-8,42728-79-0,Not Classified,Notified C&L,32,Not classified:32
115572,"2,6-bis[(2-hydroxy-5-methylphenyl)methyl]p-cresol",216-587-3,1620-68-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
115574,4-(chloromethyl)benzonitrile,212-869-5,874-86-2,Acute Tox. 4;Skin Corr. 1B,Notified C&L,44,H302:43;H314:44;H332:4;H312:4;H301:1;H318:1
115575,"gases (petroleum), C3-4, isobutane-rich;Petroleum gas;[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]",270-724-1,68477-33-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;H220:0;H340:0;Not classified:0
115577,p-methyl-α-propylbenzyl alcohol,228-496-6,6282-37-7,Acute Tox. 4,Notified C&L,38,H302:38
115578,4-amino-2-chlorobenzonitrile,244-114-0,20925-27-3,Skin Sens. 1,Notified C&L,44,H317:39;H335:4;H315:5;H319:5;H332:4;H301:5;H312:4;H311:1;H331:1
115579,"2,2'-(cyclohexylimino)bisethanol",224-809-5,4500-29-2,Acute Tox. 4;Skin Corr. 1C;STOT RE 2,REACH registration C&L,113,H373:58;H302:60;H314:83;H319:22;H315:22;H318:3;Not classified:5
115580,8-fluoro-3-iodoquinoline,617-904-1,866782-59-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
115581,2-(4-methylbenzyl)succinic acid,613-164-9,6315-21-5,Not Classified,Notified C&L,22,Not classified:20;H319:2;H315:2;H302:1;H335:1
115583,"α,2,2,6-tetramethylcyclohexene-1-butyraldehyde",265-747-9,65405-84-7,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1411,H410:70;H400:70;H315:14;H317:56;Not classified:1341
115585,"Distillates (petroleum), light thermal cracked;Cracked gasoil;[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C",265-084-5,64741-82-8,Carc. 1B,Harmonised C&L,0,H350:0
115587,"2-thenoic acid, compound with 2-aminoethanol (1:1)",285-310-6,85068-50-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
115588,Cerium tetrahydroxide,234-599-7,12014-56-1,Aquatic Chronic 4,Notified C&L,162,H413:83;H319:39;Not classified:34;H314:6
115595,"Dehydrogenase, glucose",232-836-9,9028-53-9,Resp. Sens. 1,Notified C&L,11,H334:8;Not classified:3
115597,Dl-lactic acid,209-954-4,598-82-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1469,H318:1464;H315:1414;H314:55;H319:5;H335:5
115600,"2,4,5-tribromoimidazole",217-997-5,2034-22-2,Acute Tox. 2;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,45,H311:39;H331:39;H300:43;H315:44;H319:44;H335:43;H330:1;H310:1;H301:2
115601,2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methylpropan-1-one,600-777-1,106797-53-9,Aquatic Chronic 3,Notified C&L,2140,H412:2140
115605,Chloromethyl chlorosulphate,256-442-1,49715-04-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 2;Carc. 1A;Aquatic Chronic 3,REACH registration C&L,55,H302:53;H314:55;H412:4;H330:10;H318:8;H350:6;H312:7;H272:41;H290:1;H311:1
115615,"α,β,2,2,6-pentamethylcyclohexanepropanol",262-117-5,60241-53-4,Aquatic Chronic 2,Notified C&L,1578,H411:1578
115618,trichloroacetonitrile,208-885-7,545-06-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0,H311:0;H411:0;H301:0;H331:0
115621,N-(2-hydroxypropyl)octanamide,245-400-8,23054-60-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
115622,Tetrasodium 5-(4-(7-Amino-1-Hydroxy-3-Sulphonato-2-Naphthylazo-)-6-Sulphonato-1-Naphthylazo) Isophthalate,603-263-5,128226-83-5,Skin Sens. 1,Notified C&L,1,H317:1
115623,"Trichloro(1,2-dibromoethyl)silane",224-031-6,4170-50-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H335:38;H318:38;H315:38
115631,"Dichloro-5,12-dihydroquino[2,3-b]acridine-7,14-dione",254-100-6,38720-66-0,Not Classified,Notified C&L,38,Not classified:38
115633,4-benzhydrylpyridine,222-955-4,3678-72-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
115634,"Naphtha (petroleum), hydrotreated light;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-151-9,64742-49-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
115635,Didysprosium tricarbonate,225-770-7,5066-34-2,Not Classified,Notified C&L,5,Not classified:5
115636,"3,5-Difluoroanisole",618-922-2,93343-10-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H226:45;H335:42;H315:44
115641,"2,2,2-trifluoro-1-(trifluoromethyl)ethyl methacrylate",221-309-9,3063-94-3,Flam. Liq. 2,REACH registration C&L,50,H225:46;H302:41;H315:47;H319:47;H332:41;H335:45;H312:41;H224:4
115648,"(2E)-3,7-dimethylocta-2,6-dien-1-ol; (2E)-3,7-dimethylocta-2,6-dienal; 1,2-dimethoxy-4-(prop-2-en-1-yl)benzene; 1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol; 3,7-dimethylocta-1,6-diene",616-903-3,8007-02-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,233,H317:155;H319:187;H411:129;H315:188;H335:39;H304:39;Not classified:5;H226:1;H412:1;H318:1
115650,"Disodium 8-((3,3'-dimethyl-4'-(4-(4-methylphenylsulphonyloxy)phenylazo)(1,1'-biphenyl)-4-yl)azo)-7-hydroxynaphthalene-1,3-disulphonate",229-272-0,6459-94-5,Carc. 1B,Notified C&L,53,H350:38;Not classified:10;H351:3;H413:2;H411:1
115656,Gemeprost,264-775-9,64318-79-2,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4;Repr. 1B,Notified C&L,16,H332:16;H301:16;H360:16;H312:16
115657,sulphur dioxide,231-195-2,7446-09-5,Press. Gas;Skin Corr. 1B;Acute Tox. 3,Harmonised C&L,0,H331:0;H314:0;Not classified:0
115660,"Alcohols, tallow, ethoxylated",612-400-8,61791-28-4,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1,Notified C&L,560,H302:519;H318:535;H400:450;H319:13;Not classified:6;H315:6;H411:1
115661,"Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined;Low boiling point modified naphtha;[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94°C to 99°C (201°F to 210°F).]",295-436-3,92045-55-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
115662,"5-[[(2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furfurylamine",266-330-4,66356-53-4,Skin Sens. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,41,H334:39;H317:39;H335:38;H302:2;H314:1;H319:1;H315:1
115663,"2,2,2-trichloroacetamide",209-849-3,594-65-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,48,H319:48;H302:9;H335:9;H315:10;H332:1;H312:1
115666,Sodium sulphite,231-821-4,7757-83-7,Not Classified,REACH registration C&L,2428,Not classified:554;H314:1286;H319:518;H302:454;H315:478;H335:64;H412:6;H031:1;H334:2;H317:1
115667,11-phenylundecanoic acid,222-087-6,3343-24-6,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38
115669,"1,4,7,10-tetraazacyclododecane",425-450-9,294-90-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H314:0;H400:0;H312:0
115670,"1,3,5-Triazine-2,4,6-triamine, N2,N2,N4,N4,N6-pentakis(methoxymethyl)-",608-661-2,3169-30-0,Not Classified,Notified C&L,1,Not classified:1
115671,"4-Ethyl-2',3'-difluor-4''-propyl-1,1':4',1''-terphenyl",605-092-1,157248-25-4,Not Classified,REACH registration C&L,2,Not classified:2
115674,"(3β,5β)-3,5,14,19-tetrahydroxycard-20(22)-enolide",209-211-4,560-54-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H311:38;H301:38;H331:38
115682,Tetrahydroxytitanium,243-744-3,20338-08-3,Not Classified,Notified C&L,162,Not classified:162
115685,"2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-imine",229-014-7,6401-97-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2,H302:1;H318:1;H412:1;H315:1;Not classified:1
115690,"3,4-dichlorobenzenesulphonyl chloride",202-656-5,98-31-7,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,48,H226:40;H314:48;H290:1;H318:1;H227:1
115691,Methyl tetrahydro-3-oxo-2-thenoate,220-257-4,2689-69-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:42;H302:38;H335:4;H315:4
115692,"Naphthalenesulfonic acid, reaction products with formaldehyde and urea, ammonium salts",291-648-5,90459-07-7,Not Classified,Notified C&L,55,Not classified:55
115694,2-(4-isobutylphenyl)propiononitrile,261-365-1,58609-73-7,,Notified C&L,1,H302:1
115697,"Octahydro-7,7,8,8-tetramethyl-2,3b-methano-3bH-cyclopenta[1,3]cyclopropa[1,2]benzene-4-methyl formate",261-582-1,59056-70-1,Not Classified,Notified C&L,93,Not classified:93
115698,"Hydrogen bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-), compound with 2-ethylhexylamine (1:1)",275-864-7,71701-15-0,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2042,H410:2;H400:2;Not classified:2040
115704,butyl prop-2-enoate;styrene,607-806-7,25767-47-9,Not Classified,Notified C&L,493,Not classified:492;H319:1
115708,Methoxyacetonitrile,217-092-5,1738-36-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:41;H226:43;H332:41;H312:41;H335:1;H311:1;H331:1;H315:1;H319:1;H301:1
115709,"(6R,7R,14S)-17-cyano-7,8-dihydro-7-[(1S)-1-hydroxy-1,2,2-trimethylpropyl]-3,6-O-dimethyl-6,14-ethano-17-normorphine",921-415-1,,Not Classified,Notified C&L,1,Not classified:1
115710,(chlorothio)formyl chloride,220-415-2,2757-23-5,Skin Corr. 1B,Notified C&L,47,H314:47;H302:1;H332:1;H312:1;H290:1;H318:1
115712,o-phenylene phosphorochloridate,216-106-7,1499-17-8,Skin Corr. 1B,Notified C&L,38,H314:38
115715,"N,N'-[iminobis(ethyleneiminoethylene)]distearamide",257-537-0,51946-06-6,Not Classified,Notified C&L,34,Not classified:34
115716,"Benzenesulfonyl chloride, 3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxy-",604-161-3,139756-22-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,REACH registration C&L,3,H319:2;H335:3;H413:2;H315:2;H314:1
115718,"Octane-2,4-dione",237-937-1,14090-87-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
115723,"Bis(1,1-dimethylethyl) malonate",208-769-6,541-16-2,,Notified C&L,6,H317:6
115724,"3,3-diethoxypropene",221-276-0,3054-95-3,Flam. Liq. 2,Notified C&L,184,H225:184;H319:48;H335:3;H315:4
115729,"reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate;disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate",422-970-8,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
115733,"2,6-Dichloroquinoxaline",606-094-5,18671-97-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,55,H302:38;H335:38;H318:38;H315:39;H317:16;H319:17;H411:16
115735,Canthaxanthin,208-187-2,514-78-3,Not Classified,Notified C&L,90,Not classified:89;H412:1
115736,4-morpholinecarbaldehyde,224-518-3,4394-85-8,Skin Sens. 1B,REACH registration C&L,193,H317:127;H319:66;H335:25;H315:5
115737,Nitrotoluene,215-311-9,1321-12-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Notified C&L,86,H311:86;H373:86;H411:86;H331:85;H301:86;H361:3;H340:3;H350:3;H330:1
115739,"2,5-dimethyl-p-benzoquinone",205-283-6,137-18-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H301:39;H315:40;H302:1
115741,Diethyl phenylmalonate,201-456-5,83-13-6,Not Classified,REACH registration C&L,3,Not classified:3
115742,Nicopholine,207-763-0,492-85-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
115744,"2,5-Furandione, polymer with ethenylbenzene, ammonium salt",607-847-0,26022-09-3,Not Classified,Notified C&L,37,Not classified:37
115756,[3-(dihexylamino)allylidene]malononitrile,262-865-2,61600-15-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1;H312:1
115762,4-hydroxyphenylglycolic acid,214-839-7,1198-84-1,,Notified C&L,1,H319:1;H335:1;H315:1
115765,"Fatty acids, C6-24 and C6-24-unsatd., Me esters, distn. residues",310-083-8,102242-52-4,Not Classified,REACH registration C&L,130,Not classified:130
115771,"3,6-Bis(4-tert-butylphenyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione",416-250-2,,Not Classified,REACH registration C&L,91,Not classified:91
115772,Thymidine,200-070-4,50-89-5,Not Classified,REACH registration C&L,18,Not classified:17;H341:1;H302:1
115777,C.I. Reactive Yellow 37,602-668-4,12237-16-0,,Notified C&L,7,Not classified:7
115778,Brightener 0503E,476-900-6,,Not Classified,Notified C&L,37,Not classified:37
115779,"Resin acids and Rosin acids, hydrogenated, esters with triethylene glycol",271-996-4,68648-53-3,Not Classified,REACH registration C&L,111,Not classified:111
115788,Tungsten carbide,235-123-0,12070-12-1,Not Classified,REACH registration C&L,97,Not classified:91;H228:6
115789,Ethylene dilaurate,210-827-0,624-04-4,Not Classified,Notified C&L,2,Not classified:2
115792,Mercury disilver tetraiodide,232-045-9,7784-03-4,,Notified C&L,5,H410:5;H373:5;H330:5;H310:5;H300:5;H400:5
115794,"2,6-dimethyl-2-octyl acetate",270-884-2,68480-08-0,Not Classified,Notified C&L,36,Not classified:36
115795,2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride,205-676-2,146-68-9,,Notified C&L,12,H319:7;H302:9;H335:6;H315:7;Not classified:3;H332:4;H312:4;H228:1;H371:1;H351:1
115798,"5-Methyl-1,3-benzenediacetonitrile",601-716-1,120511-74-2,Acute Tox. 3;Skin Sens. 1,Notified C&L,4,H317:3;H301:4;H311:1;H331:1;H315:1;H319:1
115799,3-β-hydroxy-5-α-spirostan-12-one,207-392-4,467-55-0,Eye Irrit. 2,Notified C&L,1,H319:1
115800,methacrylic acid;2-methylpropenoic acid,201-204-4,79-41-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A,Harmonised C&L,0,H302:0;H314:0;H312:0
115801,"6-ethyl-2,10,10-trimethyl-1-oxaspiro[4.5]deca-3,6-diene",279-344-0,79893-63-3,Not Classified,Notified C&L,38,Not classified:25;H315:13
115805,"sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate",400-030-8,94612-91-6,Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;STOT SE 3;STOT RE 1,Harmonised C&L,0,H302:0;H317:0;H331:0;H372:0;H319:0;H335:0
115807,2-(7-ethyl-1H-indol-3-yl)ethanol,609-910-8,41340-36-7,Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Notified C&L,2,H373:1;H302:2;H411:1;H410:1
115809,"Hexanoic acid,2-ethyl-, neodymium(3+) salt (3:1)",679-516-9,73227-23-3,Skin Irrit. 2,Notified C&L,23,H315:18;Not classified:5
115810,Choline chloride O-(disodium phosphate),240-953-1,16904-96-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
115812,"Disodium 7-hydroxy-8-[[4-[1-[4-[(4-hydroxyphenyl)azo]phenyl]cyclohexyl]phenyl]azo]naphthalene-1,3-disulphonate",229-396-5,6507-77-3,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,147,H319:137;H411:105;H412:35;Not classified:7;H317:2;H410:2
115815,"Allylamine, hydrochloride, homopolymer",615-303-9,71550-12-4,Acute Tox. 4;Skin Sens. 1,Notified C&L,45,H317:45;H302:45
115821,p-propylanisole,203-203-4,104-45-0,Not Classified,REACH registration C&L,1555,Not classified:1555
115823,8-aminonaphthalene-2-sulphonic acid,204-311-4,119-28-8,Not Classified,REACH registration C&L,49,Not classified:2;H314:43;H319:4;H315:4
115825,"[[bis[(9,10-dihydro-9,10-dioxo-1-anthryl)amino]-8,16-dihydro-8,16-dioxopyranthrenediyl]diimino]bisviolanthrone",288-346-0,85711-83-7,Not Classified,Notified C&L,5,Not classified:5
115827,bis(hydroxylammonium) sulfate;hydroxylamine sulfate (2:1),233-118-8,10039-54-0,Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Carc. 2;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H302:0;H290:0;H351:0;H317:0;H373:0;H315:0;H319:0;H400:0;H312:0
115833,Hexyl 2-butenoate,242-808-8,19089-92-0,Not Classified,Notified C&L,1415,Not classified:1376;H319:39;H335:39;H315:39
115835,"Tar, coal, low-temp.;Coal oil;[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 °C (1292 °F)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.]",266-025-6,65996-90-9,Carc. 1A,Harmonised C&L,0,H350:0
115837,Elastase (pig pancreas),254-453-6,39445-21-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
115842,17 beta-Hydroxy-5(10)-estren-3-one,600-891-1,1089-78-7,Carc. 2;Repr. 1A;Lact.,REACH registration C&L,2,H362:2;H351:2;H360:2
115843,2-dodecylhexadecan-1-ol,276-627-0,72388-18-2,Not Classified,REACH registration C&L,2,Not classified:2
115846,"1,3-dibromo-2,2-dimethylpropane",226-598-5,5434-27-5,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H227:1;H319:1;H335:1;H315:1
115848,Methyl laurate,203-911-3,111-82-0,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,385,H411:230;H400:261;Not classified:68;H319:1;H335:1;H315:1
115850,"Methyl 5-[1-[(allyloxy)imino]butyl]-2,2-dimethyl-4,6-dioxocyclohexanecarboxylate, sodium salt",259-733-1,55635-13-7,Acute Tox. 4,Notified C&L,38,H332:38
115852,4-methylcyclohexanecarboxylic acid,224-369-4,4331-54-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:38;H315:1
115853,"Extract oils (coal), naphthalene oils;Acid Extract;[The aqueous extract produced by an acidic wash of alkali-washed naphthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]",292-623-1,90641-00-2,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
115857,3-(benzothiazol-2-yl)-7-(diethylamino)-2-benzopyrone,253-830-2,38215-36-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;H302:1;H332:1;H335:1;H312:1;Not classified:1
115858,p-chlorophenylhydrazine hydrochloride,214-030-9,1073-70-7,Acute Tox. 3,REACH registration C&L,60,H301:10;H350:9;H302:50;H332:46;H312:46;H315:9;H319:9;H335:8
115859,"glutaral;glutaraldehyde;1,5-pentanedial",203-856-5,111-30-8,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1A;Acute Tox. 2;STOT SE 3;Resp. Sens. 1;Aquatic Acute 1;Aquatic Chronic 2,Harmonised C&L,0,H410:0;H335:0;H314:0;H317:0;H330:0;H334:0;H411:0;H301:0;H400:0
115864,"2,3,5,6-tetrafluoroterephthalic acid",211-489-7,652-36-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
115868,3-ethylpiperidine,851-348-2,13603-10-6,Flam. Liq. 3;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H226:1;H335:1;H314:1
115872,Bismuth Strontium Calcium Copper oxide,601-335-0,114901-61-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H302:39;H315:39;H319:39;H335:39;H312:39;H332:1
115873,"Polycarboxylate, sodium salt",921-226-4,,Not Classified,Notified C&L,37,Not classified:37
115874,"Dodecene, hydroformylation products, low-boiling",271-240-3,68526-92-1,Asp. Tox. 1;Aquatic Chronic 4,Notified C&L,1,H304:1;H413:1
115876,Tripotassium nitrilotriacetate,219-270-8,2399-85-1,Acute Tox. 4;Eye Irrit. 2;Carc. 2,Notified C&L,154,H319:154;H302:154;H351:99;H315:55
115877,aniline,200-539-3,62-53-3,Acute Tox. 3;Acute Tox. 3;Eye Dam. 1;Skin Sens. 1;Acute Tox. 3;Muta. 2;Carc. 2;STOT RE 1;Aquatic Acute 1,Harmonised C&L,0,H311:0;H351:0;H341:0;H317:0;H331:0;H318:0;H372:0;H301:0;H400:0
115883,4-methoxyacridin-9(10H)-one,252-505-2,35308-00-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
115886,Isopropyl undec-10-enoate,226-735-9,5459-98-3,Not Classified,Notified C&L,1,Not classified:1
115893,Tridecanal,234-004-0,10486-19-8,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,134,H319:110;H411:54;H335:40;H315:55;H318:24;H314:24
115896,(E)-1-[bis(4-fluorophenyl)methyl]-4-cinnamylpiperazine dihydrochloride,250-216-6,30484-77-6,Acute Tox. 4,Notified C&L,97,H302:96;H361:1;Not classified:1;H410:1
115898,Citraconic acid,207-858-7,498-23-7,Acute Tox. 4,Notified C&L,65,H302:65
115899,"Phosphoric acid, mono- and di-C12-18-alkyl esters",291-937-6,90506-72-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
115900,Aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate,620-094-2,136618-51-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1
115902,2-phenethyl crotonate,268-842-3,68141-20-8,Not Classified,Notified C&L,89,Not classified:89
115907,"1,1,1-trimethoxypentane",237-496-5,13820-09-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,51,H319:50;H226:51;H315:50;H335:8
115909,"Fatty acids, tallow, hydrogenated, lithium salts",266-107-1,66071-82-7,Not Classified,Notified C&L,8,Not classified:8
115910,Ketamine hydrochloride,217-484-6,1867-66-9,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,88,H302:85;H332:2;H319:84;H335:47;H315:83;H361:37;H373:37;H301:2;Not classified:1;H351:1
115914,Pyrazine-2-carboxylic acid,202-718-1,98-97-5,Not Classified,REACH registration C&L,19,Not classified:16;H319:3;H335:3;H315:3;H302:1
115915,"Sulfonic acids, alkane, sodium salts",271-774-7,68608-15-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,154,H318:103;H315:107;H302:47;H319:4
115916,Ferric nitrate nonahydrate,616-509-1,7782-61-8,Ox. Sol. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,59,H272:59;H319:54;H335:46;H315:54;H318:4;H314:4
115918,"Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides",270-331-5,68424-95-3,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,228,H314:215;H411:22;H318:22;H301:2;H400:215;H302:213;H312:107;H335:20;H311:13;Not classified:12;H410:2;H226:1
115919,Nonane,203-913-4,111-84-2,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 1,REACH registration C&L,1182,H410:360;H226:725;H315:582;H336:587;H304:719;H319:715;H411:181;H332:254;H400:141;H413:62;H331:30;H335:29;H302:8;Not classified:11;H311:8
115920,Propyl butyrate,203-320-0,105-66-8,Flam. Liq. 3,Notified C&L,1498,H226:1498;H319:56;H335:56;H315:56
115922,"Chrysanthemum parthenium, ext.",289-701-2,89997-65-9,Not Classified,Notified C&L,38,Not classified:37;H317:1;H371:1;H226:1;H411:1
115923,"2,3,4,5,6-pentafluorobenzamide",211-488-1,652-31-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
115924,"Pentaerythritol, ethoxylated, phosphates",500-237-4,68936-81-2,Not Classified,Notified C&L,61,Not classified:61
115926,Sodium O-ethyl dithiocarbonate,205-440-9,140-90-9,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,36,H302:11;H314:4;H311:4;H411:3;H318:3;H372:3;H332:4;H228:5;H319:32;H335:27;H315:32;H312:2;H410:1;H317:1;H400:1;H251:1;H261:1
115927,Dirhenium heptaoxide,215-241-9,1314-68-7,Not Classified,Notified C&L,110,Not classified:62;H314:48;H272:4;H318:1
115928,1-[(2S)-1-ethylpyrrolidin-2-yl]methanamine,607-160-6,22795-99-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:40;H226:42;H335:41;H315:40;H318:3;H314:3;H302:1;H312:1
115930,4-(methylthio)phenol,214-031-4,1073-72-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:47;H335:46;H315:47;Not classified:1;H302:1;H412:1;H332:1;H312:1;H320:1
115932,dimethylzinc,208-884-1,544-97-8,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H250:0;H314:0;H260:0;H400:0
115935,Sodium nonan-1-oate,237-887-0,14047-60-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58,H319:38;H335:38;H315:38;H318:20
115937,[(3-Oxo-butyryl)-phenyl-amino]-acetic acid ethyl ester,919-276-7,,Not Classified,Notified C&L,1,Not classified:1
115938,5-[(2-amino-4-sulphophenyl)sulphonyl]salicylic acid,229-173-2,6421-84-7,Not Classified,Notified C&L,3,Not classified:3
115940,Isopropyl butyrate,211-320-7,638-11-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,202,H319:189;H226:202;H335:189;H315:189
115941,"Lauric acid, monoester with glycerol",248-337-4,27215-38-9,Not Classified,Notified C&L,5,Not classified:5
115942,(S)-(-)-3-Methylamino-1-(thiophen-2-yl)-propan-1-ol hydrochloride,928-946-8,,Not Classified,Notified C&L,1,Not classified:1
115943,4-[[1-hydroxy-6-(phenylamino)-3-sulpho-2-naphthyl]azo]naphthalenesulphonic acid,287-283-6,85455-47-6,Not Classified,Notified C&L,2,Not classified:2
115945,Bis(2-hydroxyethyl)ammonium dihydrogen phosphate,249-913-8,29870-32-4,Not Classified,Notified C&L,2,Not classified:2
115946,Octahydrocyclopenta[c]pyrrole,227-114-5,5661-03-0,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H302:1;H318:1;H314:2;H412:1
115948,"Extract residues (coal), naphthalene oil, alk.;Naphthalene Oil Extract Residue;[A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.]",310-166-9,121620-47-1,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
115952,5-(trifluoromethyl)-m-anisidine,206-487-8,349-55-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,132,H302:132;H315:132;H319:132;H332:132;H335:127;H312:128;H311:4
115954,[(dimethylamino)methyl]ferrocene,215-044-8,1271-86-9,,Notified C&L,6,H319:6;H315:6;H335:1
115955,"1H-1-Benzazepine-1-acetic acid, 3-amino-2,3,4,5-tetrahydro-2-oxo-, 1,1-dimethylethyl ester, (3S)-",600-892-7,109010-60-8,Not Classified,Notified C&L,1,Not classified:1
115960,"[(2,2,3,3-tetrafluoropropoxy)methyl]oxirane",243-431-1,19932-26-4,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H335:1;H315:1
115961,Chloro(phenyl)acetic acid,225-284-5,4755-72-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
115963,2-Fluoro-5-iodobenzoic Acid,603-004-6,124700-41-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47;H302:1
115967,Rhenium,231-124-5,7440-15-5,Not Classified,REACH registration C&L,380,Not classified:146;H228:229;H413:3;H272:2
115969,Cyclopropyl 4-fluorophenyl ketone,212-247-3,772-31-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,4,H302:4;H318:3;H315:4;H319:1;H335:1
115972,"Hydrocarbons, C4, n-butene conc.",306-005-7,95465-90-0,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,1,H220:1;H280:1
115978,reaction mass of: 2-ethylhexyl mono-D-glucopyranoside;2-ethylhexyl di-D-glucopyranoside,414-420-0,,Eye Dam. 1,Harmonised C&L,0,H318:0
115984,"2,3,5,6-tetrafluorobenzene-1,4-diamine",214-837-6,1198-64-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H302:1;H332:1;H335:1;H312:1
115986,"Silicic acid, potassium salt",215-199-1,1312-76-1,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,1423,H318:1165;H315:568;H290:195;H335:883;H314:780;Not classified:75;H319:167;H302:3
115987,"1,3,7,9-tetranitro-6H-benzotriazolo[2,1-a]benzotriazol-5-ium--ate",246-752-5,25243-36-1,Expl. 1.4,Notified C&L,21,H204:20;H201:1
115989,"Ferrate(2-), [2-[[4-[[2,6-dihydroxy-3-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]phenyl]amino]-5-nitrobenzenesulfonato(3-)][4-[(2-hydroxy-3,5-dinitrophenyl)azo]-1,3-benzenediolato(2-)]-, ammonium sodium",277-767-5,74204-29-8,Not Classified,Notified C&L,17,Not classified:16;H411:1
115990,"2,2'-[[4-[(6-methoxybenzothiazol-2-yl)azo]phenyl]imino]bisethanol",228-923-6,6373-93-9,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38
115997,Giemsa's stain,257-438-2,51811-82-6,Eye Irrit. 2,Notified C&L,4,H319:4
115998,"2,3-dimethyl-2H-indazol-6-amine",610-188-1,444731-72-0,Acute Tox. 4,Notified C&L,3,H302:3;H319:1;H335:1;H315:1;H341:1
115999,"4-aminonaphthalene-1,8-dicarboximide",217-110-1,1742-95-6,Skin Sens. 1,REACH registration C&L,73,H317:33;H319:39;H335:39;H315:39;Not classified:1
116003,Fluorobenzene,207-321-7,462-06-6,Flam. Liq. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,262,H225:259;H411:140;H318:164;H319:87;H412:73;H373:19;Not classified:2;H315:2;H335:1;H226:1;H402:1
116004,4-aminophenylmercury acetate,228-497-1,6283-24-5,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:39;H373:38;H330:39;H310:39;H300:39;H400:38;Not classified:1
116007,Platinum diiodide,232-204-2,7790-39-8,,Notified C&L,4,H317:4;H319:4;H335:4;H315:4
116008,"3,7,7-trimethylbicyclo[4.1.0]hept-3-ene",236-719-3,13466-78-9,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1609,H412:1326;H317:1605;H226:1606;H315:1527;H304:1605;H411:52;H410:43;H400:43;H332:25;Not classified:3;H305:1
116011,O-isobutylbenzoin,245-039-6,22499-12-3,Not Classified,Notified C&L,2,Not classified:2
116012,"3-((R)-amino-1,2,3,4-tetrahydrocarbazol-9-yl)propanoic acid",923-144-4,1182722-58-2,Not Classified,REACH registration C&L,2,Not classified:2
116014,"1,3-dibromobutane",203-520-8,107-80-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
116016,Ethyl 2-methylcyclopropanecarboxylate,244-113-5,20913-25-1,Flam. Liq. 3,Notified C&L,38,H226:38
116020,"Thyme, Thymus serpyllum, ext.",284-023-3,84776-98-7,Flam. Liq. 3;Asp. Tox. 1;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1,Notified C&L,288,H314:250;H317:251;H226:251;H318:188;H304:251;H412:62;Not classified:38;H302:3;H411:4;H315:1
116021,"1-{3-chloro-4-[[]1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]phenyl}-3-(2,6-difluorobenzoyl)urea",601-443-8,116714-46-6,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,91,H410:91;H400:91
116022,p-nitrostilbene,223-653-5,4003-94-5,Acute Tox. 4,Notified C&L,38,H302:38
116023,"Impatiens noli-tangere, ext.",289-949-1,90045-84-4,Not Classified,Notified C&L,1,Not classified:1
116024,2-(3-methylbenzyl)succinic acid,613-163-3,6315-20-4,Not Classified,Notified C&L,22,Not classified:20;H319:2;H315:2;H302:1;H335:1
116028,1-ethyl-1-methylpyrrolidinium bromide,418-200-5,69227-51-6,Muta. 2,Harmonised C&L,0,H341:0
116031,"Lithium 9,10-dihydroxyoctadecanoate",262-087-3,60154-91-8,Not Classified,Notified C&L,2,Not classified:2
116033,"Methyl-2,3-dibromo-2-methylpropionate",437-260-3,,Acute Tox. 2;STOT SE 3;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H410:1;H341:1;H330:1;H335:1;H400:1
116036,"3,7-bis(diethylamino)phenoxazin-5-ium hydroxide",301-023-1,93966-70-2,Acute Tox. 3;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46,H410:44;H330:34;H318:45;H301:45;H400:35;H331:9;H411:1;Not classified:1
116041,"Sulfuric acid, copper(2+) salt, basic",215-568-7,1332-14-5,Acute Tox. 4,Notified C&L,1,H302:1
116046,"Butanedioic acid, 1,4-bis[2-[2-(1-methylethyl)-3-oxazolidinyl]ethyl] ester",618-314-7,89911-10-4,Not Classified,Notified C&L,27,Not classified:27
116048,"Naphtha (petroleum), heavy thermal cracked;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C",265-085-0,64741-83-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
116054,"1,3-dichlorotetrafluoroacetone",204-829-0,127-21-9,Acute Tox. 3,Notified C&L,40,H301:40;H335:1;H311:1;H330:1;H315:2;H319:2;H310:1;H332:1
116056,"2,2,2',2'-tetrakis(hydroxymethyl)-3,3'-oxydipropan-1-ol",204-794-1,126-58-9,Not Classified,REACH registration C&L,553,Not classified:551;H319:2;H335:2
116057,"Copper chloride (CuCl2), dihydrate",600-176-4,10125-13-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,179,H302:177;H410:104;H315:173;H319:101;H400:150;H290:41;H411:72;H318:72;H312:73;H314:6;H335:8;H332:2;H412:1;H373:1;H301:2
116059,"Benzene-1,2,4,5-tetracarboxylic acid, compound with 4,5-dihydro-2-phenyl-1H-imidazole (1:2)",259-226-5,54553-91-2,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,120,H302:120;H411:103;H318:16;H315:17;H412:1
116060,"Sulphuric acid, chromium potassium salt",233-627-5,10279-63-7,Not Classified,Notified C&L,4,Not classified:3;H319:1;H335:1;H315:1
116067,"1,2-dimethylnaphtho[1,2-d]thiazolium toluene-p-sulphonate",261-283-6,58480-17-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
116072,"Distillates (petroleum), C",270-725-7,68477-34-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
116075,[µ-[carbonato(2-)-O:O’]] dihydroxy trinickel,265-748-4,65405-96-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H302:0;H410:0;H341:0;H334:0;H317:0;H372:0;H315:0;H350:0;H332:0;H360:0;H400:0
116076,"Corn oil, nonsaponifiable fraction",266-416-1,66587-54-0,Not Classified,Notified C&L,52,Not classified:52
116078,"(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino]-3-[(E)-[(3'R)-2-oxo-[1,3'-bipyrrolidin]-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",606-675-3,209467-52-7,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1;H302:1
116080,"3-methyl-5-(1,1,3,3-tetramethylbutyl)pyrocatechol",219-886-7,2563-08-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38
116081,Bentonite,215-108-5,1302-78-9,Not Classified,Notified C&L,4431,Not classified:2962;H319:1455;H335:1408;H315:1408;H371:11;H332:2;H370:1;H351:1;H372:1;H373:2;H302:1;H317:1;H334:1
116084,"N,N'-[fluoranthene-3,8-diylbis[imino(9,10-dihydro-9,10-dioxoanthracene-4,1-diyl)]]bis(benzamide)",299-921-0,93918-41-3,Not Classified,Notified C&L,1,Not classified:1
116085,"[[(phosphonomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonic acid",239-931-4,15827-60-8,Met. Corr. 1;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,337,H290:158;H318:248;H315:194;H314:87;H319:38;Not classified:25;H302:20;H312:20;H335:5
116086,"2,3-dimethylbutan-2-ol",209-847-2,594-60-5,Flam. Liq. 2,Notified C&L,127,H225:88;H226:39
116088,"Carbamic acid, (2-hydroxyethyl)-, compd. with 2-aminoethanol (1:1)",613-011-6,62350-25-8,Eye Irrit. 2,Notified C&L,26,H319:26;H302:1
116092,3-Iodo-4-methoxyaniline,616-118-6,74587-12-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H312:1
116096,Testosterone 3-cyclohexylpropionate,217-998-0,2034-94-8,,Notified C&L,1,H204:1
116103,"fatty acids, C",294-302-1,91697-41-5,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H410:0;H341:0;H334:0;H317:0;H372:0;H350:0;H360:0;H400:0
116104,Sodium dihydrogen 2-sulphonatosuccinate,249-639-9,29454-16-8,Not Classified,Notified C&L,1,Not classified:1
116107,"Shale oils, light",923-592-0,,Flam. Liq. 2;Acute Tox. 3;Asp. Tox. 1;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Muta. 1B;Carc. 1B;Repr. 1B;Aquatic Chronic 1,REACH registration C&L,3,H410:3;H335:3;H314:3;H340:3;H360:3;H225:3;H301:3;H311:3;H317:3;H318:3;H350:3;H332:3;H304:3
116108,3-(allyloxy)oxetane,229-838-7,6777-00-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H226:2;H315:2;H335:1
116109,Decanenitrile,217-830-6,1975-78-6,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1467,H410:1298;H400:1381;H315:1382;Not classified:80;H302:6;H332:1;H312:1;H319:1
116111,"Heptanoic acid, ester with 2,2-dimethyl-1,3-propanediol",272-469-1,68855-18-5,Not Classified,REACH registration C&L,90,Not classified:90
116116,Dipropyl trisulphide,227-903-4,6028-61-1,Acute Tox. 4,Notified C&L,1438,H302:1428;H319:77;H335:77;H315:77;Not classified:10
116117,6-methyl-2-pyridylamine,217-360-1,1824-81-3,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58,H301:58;H310:55;H315:58;H319:58;H335:57;Not classified:2;H311:3;H331:1
116122,(3-[(3-Cholamidopropyl)dimethylammonio]propanesulfonate,616-246-2,75621-03-3,Skin Irrit. 2;STOT SE 3,Notified C&L,175,H335:171;H315:174;H319:58;H334:1;H317:1;H302:1;H341:1;H332:1;H360:1
116125,"Triisooctyl 4,4',4''-[(octylstannylidyne)tris(oxy)]tris[4-oxoisocrotonate]",281-731-4,84029-63-0,Repr. 2;STOT RE 2;STOT RE 2;Aquatic Chronic 4,Notified C&L,1,H361:1;H373:1;H413:1
116130,Zirconium(4+) oleate,255-637-9,42040-79-9,Aquatic Chronic 4,Notified C&L,2,H413:2
116140,2-ethoxy-4-methylphenol,607-762-9,2563-07-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,258,H317:253;H302:253;H318:253;H315:257;H319:4;H335:4;Not classified:1
116142,"N,N'-(2-chloro-1,4-phenylene)bis[4-[(2,5-dichlorophenyl)azo]-3-hydroxynaphthalene-2-carboxamide]",226-106-9,5280-78-4,Not Classified,REACH registration C&L,323,Not classified:315;H413:8
116145,5'-amino-2'-methylacetanilide,226-599-0,5434-30-0,,Notified C&L,2,H302:1;H315:2;H319:2;H332:1;H335:1
116146,"Reaction product of 4,4'-methylenediphenyle diisocyanate (202-966-0) and cyclohexylamine (203-629-0) and amines, coco alkyl (262-977-1)",922-523-1,,,Notified C&L,3,H413:3
116148,Selenium dioxide,231-194-7,7446-08-4,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,241,H410:241;H314:6;H330:6;H373:241;H318:6;H301:241;H400:115;H331:234;H362:3;H372:2;H370:1;H319:1
116151,"Zinc 3,5,5-trimethylhexanoate",283-563-7,84682-03-1,Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H400:2
116152,Afghan rose oil,616-902-8,8007-01-0,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Carc. 2;Aquatic Chronic 2,Notified C&L,223,H351:144;H317:159;H411:145;H318:147;H315:172;H226:52;H319:13;H412:14;H341:3
116156,"2,5-dimethylhexan-3-ol",243-152-5,19550-07-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H335:42;H318:38;H315:42;H319:4;H226:1
116157,8-(sec-butyl)quinoline,266-809-8,67634-06-4,Acute Tox. 4,Notified C&L,1011,H302:1011
116162,5-(4-Methylphenyl)-1H-tetrazole,607-480-6,24994-04-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H303:1
116167,Phenylacetaldehyde oxime,230-309-8,7028-48-0,Acute Tox. 4,Notified C&L,87,H302:87
116168,"9H-pyrido[3,4-b]indole",205-959-0,244-63-3,Acute Tox. 4,Notified C&L,1,H302:1
116171,"2,2,3-trimethylbutyric acid",256-441-6,49714-52-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H335:1;H318:1;H315:1
116172,2-methyl-5-phenylpentanol,405-890-8,25634-93-9,Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0,H319:0;H315:0
116174,2-hydroxy-2-methylpropionic acid,209-848-8,594-61-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,113,H335:55;H318:51;H315:56;H302:56;H319:5;H311:1;H332:1
116178,"3-(anthraquinon-1-ylamino)anthra[2,1,9-mna]naphth[2,3-h]acridine-5,10,15(16H)-trione",224-519-9,4395-53-3,Not Classified,Notified C&L,32,Not classified:32
116181,"(2E)-3-[(1R,4S,7R,7aR)-1-Acetoxy-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylacrylic acid",617-228-7,81397-67-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,196,H410:194;H400:194;Not classified:2
116183,"607-571-0 Formaldehyde, polymer with phenol and furfuryl alcohol",607-571-0,25153-36-0,Skin Sens. 1B,Notified C&L,11,H317:11
116186,(±)-3-[(1-methyl-2-phenylethyl)amino]propiononitrile hydrochloride,242-191-5,18305-29-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:38;H332:38;H312:38;H301:1
116191,"1,1,1-trifluoro-N-((trifluoromethyl)sulfonyl)-methanesulfonamide",435-300-4,82113-65-3,Skin Corr. 1B,Notified C&L,2,H314:1;H301:1;H318:1
116192,Tetrahexylammonium iodide,218-382-4,2138-24-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
116197,3-benzhydrylpyridine,222-954-9,3678-71-5,Eye Irrit. 2,Notified C&L,38,H319:38
116201,3-amino-4-hydroxybenzenesulphonamide,202-657-0,98-32-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,90,H319:47;H315:47;Not classified:43;H335:42
116204,"(S,S)-2,6-Bis(4-isopropyl-2-oxazolin-2-yl)pyridine",601-576-1,118949-61-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
116205,Vinylcyclohexane,211-779-3,695-12-5,Flam. Liq. 2;Asp. Tox. 1;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,48,H410:4;H314:4;H225:48;H318:4;H304:8;H400:4;H319:1;H335:1;H315:1;H302:1;H332:1;H312:1
116207,"Benzenesulfonic acid, dodecyl-, branched, sodium salt",614-939-4,69227-09-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,84,H302:61;H411:69;H318:61;H315:61;H410:17;H400:17;H312:16;Not classified:14
116209,"Dogwood, Cornus sanguinea, ext.",289-798-1,90028-10-7,Flam. Liq. 3,Notified C&L,1,H226:1
116211,"Ethane-1,2-diyl palmitate",210-826-5,624-03-3,Not Classified,REACH registration C&L,6,Not classified:6
116212,Diphenylphosphinic chloride,216-107-2,1499-21-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,68,H226:49;H314:67;H335:19;H318:2;Not classified:1
116216,Adipohydrazide,213-999-5,1071-93-8,Aquatic Chronic 2,REACH registration C&L,2831,H411:2359;H317:449;Not classified:119;H318:31;H319:36;H335:32;H315:33;H302:2
116217,5-[(2-hydroxyethyl)amino]-o-cresol,259-583-7,55302-96-0,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,127,H319:127;H411:19;H335:105;H315:101;H332:5;H312:5;H302:1
116226,"N-(tetrahydro-2,6-dioxo-2H-pyran-3-yl)phthalimide",222-088-1,3343-28-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,39,H302:38;H351:38;H315:39;H319:39;H332:38;H335:38;H312:38
116227,SUBSTANCE SC116510,422-140-5,,Skin Sens. 1,Notified C&L,1,H317:1
116228,Lithium myristate,243-743-8,20336-96-3,Eye Irrit. 2,REACH registration C&L,10,H319:9;Not classified:1
116231,Dipotassium hexaiodoplatinate,240-954-7,16905-14-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
116233,9-cis-retinal,208-188-8,514-85-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,38,H315:38;H302:38;H332:38;H312:38
116234,(R)-(3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide,208-768-0,541-15-1,Not Classified,REACH registration C&L,1537,Not classified:137;H319:1400;H315:1400;H335:60
116235,Iodo-tris(triphenylphosphine)copper(I),454-330-9,,Aquatic Chronic 4,REACH registration C&L,1,H413:1
116241,2-(4-tert-butylphenoxy)ethanol,211-929-8,713-46-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
116242,"5-carboxy-4-hexylcyclohex-2-ene-1-octanoic acid, compound with 2,2',2''-nitrilotriethanol (1:2)",267-425-3,67859-77-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
116245,Sodium sulphate,231-820-9,7757-82-6,Not Classified,REACH registration C&L,4195,Not classified:4047;H317:57;H412:38;H319:41;H315:48;H411:1
116249,Diammonium dihydrogen [[(2-hydroxyethyl)imino]bis(methylene)]bisphosphonate,283-705-8,84696-97-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
116250,"dimethenamid-P (ISO);2-chloro-N-(2,4-dimethyl-3-thienyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide",605-329-9,163515-14-8,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H302:0;H410:0;H400:0
116252,"2-ethylhexyl 14-ethyl-6,6-dioctyl-4,8,11-trioxo-5,7,12-trioxa-6-stannaoctadeca-2,9-dienoate",233-117-2,10039-33-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Repr. 2;STOT RE 1;Aquatic Chronic 4,REACH registration C&L,61,H361:3;H413:58;H317:2;H372:3;H315:61;H319:60;H373:58;H412:2;H410:1;H400:1
116254,"5-hydroxy-1,4-naphthoquinone",207-567-5,481-39-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,138,H301:138;H315:138;H319:138;H335:135;H400:128;H311:1;H331:1;H410:1;H413:1
116255,"Fatty acids, C6-24 and C6-24-unsatd., distn. residues",310-082-2,102242-51-3,Not Classified,Notified C&L,8,Not classified:8
116257,4-chloromandelic acid,207-764-6,492-86-4,,Notified C&L,6,H319:6;H335:6;H315:6;H302:1
116260,"3,4,5,6-tetrachloropyridine-2-carbonitrile",241-784-6,17824-83-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H301:38;H315:38
116263,"Tar, coal, high-temp.;Coal tar;[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 °C (1292 °F)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]",266-024-0,65996-89-6,Carc. 1A,Harmonised C&L,0,H350:0
116264,"N,N'-p-phenylenedimaleimide",221-910-6,3278-31-7,Acute Tox. 4,Notified C&L,39,H302:39
116269,"Nona-1,8-diene",225-527-5,4900-30-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:39;H226:41;H335:38;H315:39
116270,Zinc chromate,236-878-9,13530-65-9,Acute Tox. 4;Skin Sens. 1;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,73,H302:68;H410:68;H317:68;H350:68;H400:58;Not classified:5;H411:1
116271,"1,4-dichlorobutane",203-778-1,110-56-5,Flam. Liq. 3,Notified C&L,103,H226:102;H319:39;H335:39;H315:39;H412:8;Not classified:1
116274,2-(2-methylphenoxy)aniline,223-329-3,3840-18-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H335:39;H315:40;Not classified:1
116278,(±)-isomenthone,253-295-5,36977-92-1,Skin Irrit. 2;Skin Sens. 1B,Notified C&L,33,H317:33;H315:33
116279,"3,5-Dimethoxy-4-methylbenzoic acid",612-068-4,61040-81-1,,Notified C&L,6,H319:5;H335:5;H315:5;H302:1;H332:1;H312:1
116282,"Extract oils (coal), light oil;Acid Extract;[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]",292-622-6,90640-99-6,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
116289,"Phosphoric acid, mixed C12-16-alkyl and Ph triesters",605-170-5,159002-22-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,129,H410:126;H400:126;Not classified:3
116290,Alimemazine tartrate,224-368-9,4330-99-8,Acute Tox. 3,Notified C&L,76,H301:75;H317:37;H411:35;H318:35;H311:11;H302:1;H331:1;H319:1;H315:1
116291,Rhodium,231-125-0,7440-16-6,Not Classified,REACH registration C&L,242,Not classified:187;H228:45;H335:5;H302:2;H318:2;H334:2;H251:1;H250:1;H319:1;H315:1;H252:1
116296,"Tar acids, ethylphenol fraction;Distillate Phenols;[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]",284-891-3,84989-03-7,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
116298,"reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate;N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate",410-650-0,,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0;H318:0
116305,"β,4-dimethylcyclohex-3-ene-1-ethyl acetate",249-266-1,28839-13-6,Not Classified,Notified C&L,88,Not classified:88
116307,"(-)-BETA-D-FRUCTOPYRANOS-[(3AS,5AR,8AR,8BS)-2,2,7,7-TETRAMETHYLTETRAHYDRO-3AH-BIS[1,3]DIOXOLO[4,5-B:4',5'-D]PYRAN-3A-YL]METHYL SULFAMATE",619-263-3,97240-79-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,113,H319:97;H335:96;H315:96;H361:16;H360:1;H302:1
116309,Potassium p-[(p-aminophenyl)azo]benzenesulphonate,286-112-2,85187-24-2,Not Classified,Notified C&L,1,Not classified:1
116310,4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide monohydrochloride,230-634-5,7232-21-5,Acute Tox. 4,Notified C&L,99,H302:98;H319:1;H335:1;H315:1
116311,O-Allyl-N-(9-anthracenylmethyl)cinchonidinium bromide,606-421-1,200132-54-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
116312,"N-(2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)acetamide",201-457-0,83-15-8,,Notified C&L,1,H302:1
116313,"4,6-dichlororesorcinol",205-284-1,137-19-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H311:1;H331:1;H301:1;H302:1
116319,p-dodecylphenol,203-202-9,104-43-8,Skin Corr. 1C;Eye Dam. 1;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,32,H410:26;H314:24;H318:19;H360:17;H400:31;H361:15;H315:8;H319:6
116320,"2,4-dinitroanisole",204-310-9,119-27-7,Acute Tox. 4,REACH registration C&L,75,H302:49;H351:23;H341:6;H242:1;H301:2;H201:1
116326,"2,3-diphenylacrylonitrile",219-726-6,2510-95-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H302:42;H315:38;H319:38;H332:42;H335:38;H312:42
116331,"Disodium hydrogen 3,5-disulphonatobenzoate",242-807-2,19089-55-5,Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H311:1;H301:1
116337,"Proteinase, Bacillus neutral",278-547-1,76774-43-1,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,13,H334:13;H319:10;H335:10;H315:10
116338,2-bromo-4'-methylacetophenone,210-595-0,619-41-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:43;H315:44;H311:1;H331:1;H318:1;H301:1;H317:1;H302:1
116342,"(±)-(1α,2β,5α)-2-(isopropyl)-5-methylcyclohexyl benzoate",254-061-5,38649-18-2,Not Classified,REACH registration C&L,2,Not classified:2
116343,"2,4-xylenol",203-321-6,105-67-9,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H311:0;H411:0;H301:0;H314:0
116345,"(1S)-1,2,3,4-tetrahydro-1-phenyl-Isoquinoline",601-570-9,118864-75-8,Eye Irrit. 2,Notified C&L,16,H319:12;H335:3;H315:3;H302:3;Not classified:1;H413:1;H332:1;H312:1
116346,1-bromooctane,203-912-9,111-83-1,Aquatic Acute 1,REACH registration C&L,57,H400:55;H410:50;H319:7;H315:7;H335:4;H302:2;H332:1;H227:1;H312:1
116348,"Reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative,mixed potassium/sodium salt",424-250-9,,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H412:0
116350,"Fatty acids, coco, ethoxylated",612-401-3,61791-29-5,Not Classified,Notified C&L,135,Not classified:134;H319:1;H315:1
116352,"[tetrachloro-29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]copper",248-573-8,27614-71-7,Not Classified,REACH registration C&L,119,Not classified:119
116353,Vanadium carbide,235-122-5,12070-10-9,Not Classified,REACH registration C&L,47,Not classified:5;H302:38;H332:38;H312:38;H319:4;H335:4;H228:4;H315:4
116355,"Fatty acids, palm-oil, Me esters",293-086-6,91051-34-2,Not Classified,Notified C&L,12,Not classified:12
116357,6-chloro-9-[[3-[(2-chloroethyl)ethylamino]propyl]amino]-2-methoxyacridine dihydrochloride,205-675-7,146-59-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H335:38;H311:38;H331:38;H315:38;H319:38;H301:38
116358,2-[2-(2-methoxyethoxy)ethoxy]-2-methylpropane,258-182-4,52788-79-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
116360,D-90,427-620-8,,Not Classified,Notified C&L,4,Not classified:4
116362,Ipratropium bromide,244-873-8,22254-24-6,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,5,H319:3;H302:5;H332:5;H334:1;H317:1
116363,N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxyadenosine,264-776-4,64325-78-6,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H319:2;H410:2;H400:2
116364,"4-acetamido-2,5-dimethoxybenzenesulphonyl chloride",236-279-2,13279-58-8,Skin Corr. 1A,Notified C&L,31,H314:31
116365,".alpha.1,.alpha.1,.alpha.3,.alpha.3-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile",601-715-6,120511-73-1,Acute Tox. 4;Repr. 1B,Notified C&L,71,H302:42;H360:67;H351:30;H301:28;H410:5;H331:3;H372:4;H332:2;H361:2;H373:2;H312:1;H413:1;H341:1
116370,(E)-undec-2-enal,258-559-3,53448-07-0,Not Classified,Notified C&L,135,Not classified:92;H400:38;H319:5;H315:5
116372,"4,4-dimethyl-1-phenyl-3-pyrazolidone",220-181-1,2654-58-2,Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H317:43;H300:45;H315:39;H319:39;H335:39;H412:1;H312:1
116373,Dithiooxamide,201-203-9,79-40-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:46;H302:48;H335:45;H315:46
116377,"Hydrogen [4-[4-(diethylamino)-2',4'-disulphonatobenzhydrylidene]cyclohexa-2,5-dien-1-ylidene]diethylammonium, sodium salt",204-934-1,129-17-9,Acute Tox. 4;Resp. Sens. 1;Aquatic Chronic 3,REACH registration C&L,2177,H334:35;H412:35;H312:35;Not classified:2100;H319:41;H315:41;H335:1;H341:1
116378,dichloroacetic acid,201-207-0,79-43-6,Skin Corr. 1A;Aquatic Acute 1,Harmonised C&L,0,H314:0;H400:0
116380,"thiacloprid (ISO);(Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide;{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide",601-147-9,111988-49-9,Acute Tox. 3;Acute Tox. 4;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H410:0;H360:0;H351:0;H336:0;H332:0;H301:0;H400:0
116383,N-[4-(1-oxopropyl)phenyl]acetamide,241-032-7,16960-49-9,Acute Tox. 4,Notified C&L,38,H302:38
116385,2-(Methylsulfonyl)-4-(trifluoromethyl)benzoic acid,604-325-4,142994-06-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,157,H319:157;H315:157
116389,"1,2-Hydrazinedicarboxylic acid, 1-[(6aS,10S,10aS,11aR)-8-(aminocarbonyl)-10-(dimethylamino)-5,6a,7,10,10a,11,11a,12-octahydro-4,6,6a,9-tetrahydroxy-5,7-dioxo-1-naphthacenyl]-, 1,2-bis(phenylmethyl) ester",606-958-1,22229-68-1,Lact.,REACH registration C&L,3,H362:3
116391,"N,N-diethylaniline",202-088-8,91-66-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H311:0;H373:0;H411:0;H331:0;H301:0
116392,"Cuprate(4-), [[]µ-[[][[]3,3'-methylenebis[[]6-[[]2-[[]5-[[]2-(2,4-disulfophenyl)diazenyl]-2-(hydroxy-[?]O)-4-hydroxyphenyl]diazenyl-[?]N1]benzoato-[?]O]](8-)]]di-, sodium (1:4)",600-312-2,102424-25-9,Not Classified,Notified C&L,83,Not classified:83
116403,"Distillates (coal tar), benzole fraction;Light Oil;[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C",283-482-7,84650-02-2,Carc. 1B,Harmonised C&L,0,H350:0
116406,proxan-sodium (ISO);sodium O-isopropyldithiocarbonate,205-443-5,140-93-2,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0;H315:0
116408,p-tolylthiourea,210-740-8,622-52-6,,Notified C&L,8,H301:7;H311:1;H331:1;H319:1;H335:1;H315:1
116409,"N,N-diethyl-4-[(2-methoxy-4-nitrophenyl)azo]aniline",228-924-1,6373-95-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H319:38;H335:38;H413:38;H315:38
116410,"Tar acids, methylphenol fraction;Distillate Phenols;[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]",284-892-9,84989-04-8,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
116411,"Toadflax, Linaria vulgaris, ext.",290-374-3,90131-62-7,,Notified C&L,1,Not classified:1
116413,"Siloxanes and Silicones, di-Me, methoxy-terminated",614-835-9,68951-97-3,,Notified C&L,3,H319:3;H226:3;H335:3;H315:3
116414,Sodium 3-mercaptopropanesulphonate,241-620-3,17636-10-1,Not Classified,REACH registration C&L,2138,Not classified:2041;H302:55;H319:42;H335:41;H315:42
116415,(Z)-oct-3-ene,238-912-8,14850-22-7,Flam. Liq. 2,Notified C&L,2,H225:2
116420,Pyrazinamide,202-717-6,98-96-4,Acute Tox. 1;Skin Irrit. 2;Acute Tox. 1,Notified C&L,54,H330:52;H310:52;H315:52;Not classified:2
116425,"N,N-dimethylacetamide",204-826-4,127-19-5,Acute Tox. 4;Acute Tox. 4;Repr. 1B,Harmonised C&L,0,H332:0;H360:0;H312:0
116427,"3-bromopiperidine-2,6-dione",613-059-8,62595-74-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
116428,"Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based, contg. solvent deasphalted residual oil",615-785-0,72623-84-8,Not Classified,Notified C&L,88,Not classified:84;H361:2;H350:3;H372:2;H304:2
116430,1-amino-2-methyl-2-propanethiol hydrochloride,434-480-1,32047-53-3,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H302:0;H314:0;H412:0
116433,"Cis-1-acetyl-5,6,7,8-tetrahydronaphthalene-6,7-diol",619-329-1,98235-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
116434,γ-ethoxybenzenebutyronitrile,275-229-4,71172-39-9,Acute Tox. 4,Notified C&L,38,H302:38
116438,"1,4-dibromobutane",203-775-5,110-52-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,68,H317:6;H302:7;H411:6;H412:39;H301:50;H318:52;H315:60;H335:56;H319:9;Not classified:2;H341:2;H311:1;H330:1
116439,"Pelargonium roseum, ext.",290-144-2,90082-55-6,Not Classified,Notified C&L,116,Not classified:89;H317:27;H318:26;H315:27;H411:1;H302:1;H410:1;H226:1;H304:1
116442,Aluminium tris(dihydrogen phosphate),236-875-2,13530-50-2,Eye Dam. 1,REACH registration C&L,196,H318:143;Not classified:47;H319:4;H315:4;H362:1;H360:1;H314:1
116445,"Distillates (petroleum), C3-6, piperylene-rich;Petroleum gas;[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]",270-726-2,68477-35-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;H220:0;H340:0;Not classified:0
116448,"Paraffins (petroleum), normal C5-20",265-233-4,64771-72-8,Asp. Tox. 1,Notified C&L,1023,H304:808;Not classified:184;H302:141;H413:162;H336:79;H411:15
116450,"Gelsemine, monohydrochloride",252-504-7,35306-33-3,Acute Tox. 2;Acute Tox. 2,Notified C&L,3,H330:2;H300:2;H301:1;H331:1
116452,"beflubutamid (ISO);(RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide",601-267-1,113614-08-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
116455,Dimethyl 2-(2-methoxyphenoxy)malonate,604-747-9,150726-89-9,Not Classified,Notified C&L,3,Not classified:1;H319:2;H335:1;H315:1
116456,"1-(2,4,5-triethoxyphenyl)ethan-1-one",263-999-4,63213-29-6,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,194,H302:194;H412:156
116457,Gallium phosphide,235-057-2,12063-98-8,Eye Irrit. 2;STOT SE 3,Notified C&L,98,H319:98;H335:98;H315:4
116458,"1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate",429-300-3,155601-30-2,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0;H318:0
116462,"2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R,3R)-",619-254-4,970-74-1,Not Classified,Notified C&L,2,Not classified:2
116464,Methylsuccinic acid,207-857-1,498-21-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
116466,Promethium,231-121-9,7440-12-2,Not Classified,Notified C&L,1,Not classified:1
116469,2-chloropropionic acid,209-952-3,598-78-7,Acute Tox. 4;Skin Corr. 1A,Harmonised C&L,0,H302:0;H314:0
116472,diphosphorus pentasulphide,215-242-4,1314-80-3,Flam. Sol. 1;Water-react. 1;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H302:0;H260:0;H332:0;H228:0;H400:0
116474,Trichloromethanesulphinyl chloride,246-558-0,25004-95-9,Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Acute Tox. 2,Notified C&L,38,H330:38;H310:38;H300:38;H314:38
116475,Aluminate Dyprosium Europium Oxydanlydene Strontium,416-840-1,201426-52-0,Aquatic Chronic 2,REACH registration C&L,13,H411:13
116477,"2,4,5,6-tetrafluorobenzene-1,3-diamine",214-836-0,1198-63-6,,Notified C&L,3,H302:2;H332:2;H312:2;H315:2;H319:2;H335:1
116478,4-chloro-6-methoxypyrimidine,435-030-7,,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H312:1
116480,Pentachromium triboride,234-510-1,12007-38-4,Not Classified,Notified C&L,2,Not classified:2
116481,thiram (ISO);tetramethylthiuram disulphide,205-286-2,137-26-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H317:0;H373:0;H315:0;H319:0;H332:0;H400:0
116483,"Extract residues (coal), light oil alk., distn. overheads;Light Oil Extract Residues, low boiling;[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145°C (293°F). Composed primarily of C",292-625-2,90641-02-4,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
116484,"Rosin, oligomeric reaction products with phenol",500-192-0,68083-03-4,Not Classified,Notified C&L,79,Not classified:79
116490,(-)-N-methylhyoscinium nitrate,228-065-2,6106-46-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2,Notified C&L,41,H330:40;H310:40;H300:40;H302:1
116492,reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate,442-300-8,,Skin Sens. 1,Harmonised C&L,0,H317:0
116501,2-[2-(dodecyloxy)ethoxy]ethanol,221-279-7,3055-93-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1375,H318:1337;H400:1337;H315:1287;H319:38
116504,1-phenylpiperazine dihydrochloride,223-654-0,4004-95-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
116508,"2H-Pyran-4-carboxylic acid, tetrahydro-, methyl ester",600-952-2,110238-91-0,Eye Irrit. 2,Notified C&L,1,H319:1
116511,4-(6-HYDROXYHEXYLOXY)BENZOIC ACID,617-498-6,83883-25-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 2;STOT SE 2,REACH registration C&L,3,H371:2;H302:2;H341:2;H332:2;H312:2;H319:1;H315:1
116512,(Z)-pent-2-ene,210-988-7,627-20-3,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,70,H225:69;H304:45;H315:40;H319:40;H335:39;H310:22;H300:22;H330:22;Not classified:1
116515,HYPERFORM TM HPN-20E,473-820-3,,Not Classified,REACH registration C&L,1,Not classified:1
116516,"(Z)-tetrahydro-2,2-dimethyl-5-(1-methyl-1-propenyl)furan",259-975-8,56058-70-9,Flam. Liq. 3,Notified C&L,1,H226:1
116519,"Phosphoric acid, mono- and di-C16-18-alkyl esters",291-938-1,90506-73-3,Eye Irrit. 2,Notified C&L,8,H319:4;Not classified:4
116523,2-chloro-2-methylpropionic acid,209-846-7,594-58-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H302:1;H412:1;H318:1;H315:1;H332:1
116526,"Carbamic acid, N-butyl-, 2-propyn-1-yl ester",616-291-8,76114-73-3,Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,53,H317:53;H302:53;H332:52;H412:52;H335:16
116527,Galactosamine hydrochloride,217-198-1,1772-03-8,Not Classified,Notified C&L,8,Not classified:8
116528,N-tert-butylbenzothiazole-2-sulphenamide,202-409-1,95-31-8,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,234,H317:233;H410:216;H400:169;H413:16;H412:1
116530,"5-ethyl-5,4'-tolylbarbituric acid",258-023-9,52584-39-1,Eye Irrit. 2,Notified C&L,38,H319:38
116538,"5-α-pregnane-3,20-dione",209-297-3,566-65-4,Not Classified,Notified C&L,2,Not classified:1;H361:1;H302:1;H351:1;H332:1;H312:1
116541,Methyl β-D-galactopyranoside,217-361-7,1824-94-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
116542,"O,O,O-triethyl phosphorothioate",204-797-8,126-68-1,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 1,Notified C&L,41,H319:38;H330:38;H302:38;Not classified:3
116543,Honey,617-041-0,8028-66-8,Not Classified,Notified C&L,53,Not classified:53
116545,3-chloro-4-isocyanatotoluene,254-906-8,40398-00-3,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H334:38;H319:38;H335:38;H315:38
116547,"Pentanedioic acid, compd. with (1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol",606-819-5,216699-04-6,Skin Sens. 1;Eye Dam. 1;Muta. 2;Carc. 1B,Notified C&L,1,H341:1;H317:1;H350:1;H318:1
116557,Gnetol,617-839-9,86361-55-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
116564,"Alcohols, C7-9",266-417-7,66587-56-2,Eye Irrit. 2,Notified C&L,1,H319:1
116566,(2R)-2-hydroxy-3-methylbutanoic acid,605-705-2,17407-56-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
116569,Aldioxa,226-964-4,5579-81-7,Not Classified,Notified C&L,1,Not classified:1
116575,L-2-hydroxy-4-methylvaleric acid,237-329-6,13748-90-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;Not classified:1
116576,"2,6-dichloro-3-(trifluoromethyl)pyridine",259-585-8,55304-75-1,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:45;H300:39;H315:45;H302:5;H332:5;H312:5;H311:1;H301:2;H331:1
116577,4-Ethoxybenzoyl Chloride,605-323-6,16331-46-7,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,40,H335:39;H318:39;H314:40;H319:1;H290:1
116578,"6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione",412-480-2,72453-58-8,Aquatic Chronic 2,Harmonised C&L,0,H411:0
116579,"Fatty acids, C6-24 and C16-18-unsatd., esters with sucrose",297-409-1,93571-82-5,Not Classified,Notified C&L,54,Not classified:54
116581,"1-(4,6-dimethoxypyrimidin-2-yl)-3-[methyl(methylsulfonyl)sulfamoyl]urea",601-744-4,120923-37-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,306,H410:256;H400:256;H332:39;H412:50
116584,"Apple, Malus pumila, ext.",289-567-5,89957-48-2,Flam. Liq. 2,Notified C&L,1287,H225:1286;Not classified:1
116586,"tert-butyl α,α-dimethylbenzyl peroxide",222-389-8,3457-61-2,Org. Perox. E;Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H242:0;H411:0;H315:0
116587,Dialuminium trisulphide,215-109-0,1302-81-4,Water-react. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,212,H319:212;H335:212;H260:174;H315:212
116590,"Naphtha (petroleum), solvent-refined light;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C",265-086-6,64741-84-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
116592,"Resin acids and Rosin acids, hydrogenated, esters with pentaerythritol",264-848-5,64365-17-9,Not Classified,REACH registration C&L,183,Not classified:183
116594,"TALLOW AMINE, MALEIC ANHYDRIDE ESTER",927-973-2,,Not Classified,Notified C&L,8,Not classified:8
116595,Tris(2-hydroxyethyl)ammonium palmitate,256-444-2,49719-60-0,Not Classified,Notified C&L,3,Not classified:3
116596,C.I. Direct Red 243,617-877-6,86543-85-3,Not Classified,Notified C&L,4,Not classified:3;H334:1;H317:1;H412:1
116599,Estriol succinate,208-185-1,514-68-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,1,H361:1;H302:1;H351:1;H332:1;H312:1
116601,"1,1-dimethylethyl trimethylsilylacetate",255-222-2,41108-81-0,Flam. Liq. 3,Notified C&L,38,H226:38
116602,"Alcohols, C12-14, ethoxylated, sulfates, sodium salts",500-234-8,68891-38-3,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1383,H318:1195;H412:563;H315:1374;H319:181;Not classified:8;H411:2;H317:1
116603,Niflumic acid,224-516-2,4394-00-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H302:42;H315:43;H319:43;H332:42;H335:42;H312:42;H412:1;H301:3;H311:1;H331:1;H413:1
116605,Isopropyl N-benzoyl-N-(3-chloro-4-fluorophenyl)-L-alaninate,261-051-4,57973-67-8,Acute Tox. 4;Aquatic Acute 1,Notified C&L,41,H400:41;H312:38;H410:3
116607,N-phenylpiperidin-4-amine,245-402-9,23056-29-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
116609,Phenyl cinnamate,220-413-1,2757-04-2,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H317:38;H302:38
116611,"3,9-dicyclohex-3-enyl-2,4,8,10-tetraoxaspiro[5.5]undecane",229-542-8,6600-31-3,Aquatic Chronic 1,REACH registration C&L,40,H410:2;H302:38
116612,2-acetylphenyl p-anisate,226-655-4,5445-86-3,Skin Sens. 1;Aquatic Acute 1,Notified C&L,38,H317:38;H400:38
116613,Valnoctamide,224-033-7,4171-13-5,Acute Tox. 4,Notified C&L,39,H302:39
116618,"Benzenepropanoic acid, 2-chloro-β-oxo-, ethyl ester",606-229-8,19112-35-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
116624,Diacetoxydiphenylsilane,219-889-3,2565-07-3,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;STOT SE 3,Notified C&L,1,H302:1;H335:1;H318:1;H312:1
116625,"Fatty acids, C16-22 and C18-22-unsatd.",306-078-5,95912-82-6,Not Classified,Notified C&L,15,Not classified:15
116626,"Poly(oxy-1,2-ethanediyl), a,a'-[[[3-(decyloxy)propyl]methyliminio]di-2,1-ethanediyl]bis[w-hydroxy-,branched,chlorides",614-533-7,68478-94-4,Skin Corr. 1B,Notified C&L,89,H314:89;H317:34;H335:34;H318:18
116631,"isobutyl 3,4-epoxybutyrate",401-920-9,100181-71-3,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H400:0;H315:0
116635,Hexan-4-olide,211-778-8,695-06-7,Skin Irrit. 2,REACH registration C&L,1776,H315:7;Not classified:1636;H319:135;H335:1
116637,1-(2-bromoethoxy)-4-chlorobenzene,217-994-9,2033-76-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
116639,"(Dibenz[b,e]oxepin-2-acetic acid, 11-[3-(dimethylamino)propylidene]-6,11-",604-185-4,140462-76-6,Acute Tox. 3;Aquatic Acute 1,Notified C&L,45,H301:39;H400:39;Not classified:2;H361:3;H315:2;H302:3;H332:2;H362:1;H319:1;H312:1;H341:1
116642,"Manganese, isooctanoate naphthenate complexes",285-613-3,85117-62-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H335:1;H312:1
116643,"11β,17-dihydroxy-21,21-diiodo-6α-methylpregna-1,4-diene-3,20-dione",302-866-8,94134-96-0,Self-react. B;STOT RE 2,REACH registration C&L,2,H341:2;H373:2;H241:2
116645,"Methyl 2,5-dihydroxybenzoate",218-427-8,2150-46-1,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,129,H317:84;H318:1;H400:84;H319:44;H335:43;H315:44;Not classified:1
116646,Antimony triiodide,232-205-8,7790-44-5,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,43,H302:43;H332:43;H411:43
116648,2-chloroadenosinehemihydrate,205-678-3,146-77-0,Repr. 2,Notified C&L,3,H361:2;H302:1;H332:1;H360:1;H312:1
116649,Pentafluoropropionic acid,207-021-6,422-64-0,Skin Corr. 1B;Acute Tox. 4,Notified C&L,47,H332:46;H314:47;H302:3;H290:1;H318:1;H335:1;H312:2;H227:1
116650,Zirconium carbide,235-125-1,12070-14-3,Not Classified,REACH registration C&L,216,Not classified:2;H228:214;H302:39;H332:39;H312:39
116653,5-mesyl-2-[(2-nitrophenyl)thio]aniline,298-153-3,93778-19-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H302:2;H332:2;H312:2
116656,"4,11-Triphenodioxazinedisulfonic acid, 3,10-diamino-6,13-dic hloro-",619-326-5,98210-99-2,Skin Corr. 1A,REACH registration C&L,38,H314:38
116657,"dinickel(2+) sodium bis(3-carboxy-5-[[](E)-2-(7-oxido-2,6-disulfonaphthalen-1-yl)diazen-1-yl]-1H-1,2,4-triazol-1-ide)",443-510-2,738587-10-5,Not Classified,Notified C&L,1,Not classified:1
116659,"Thyme, Thymus zygis, ext.",285-397-0,85085-75-2,Flam. Liq. 4;Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1438,H302:91;H314:116;H227:14;H317:1402;H411:116;H318:42;H304:1391;H226:1386;H412:1286;Not classified:36;H401:2;H371:1;H361:1
116661,"3,6,10-trimethylundeca-3,9-dien-2-one",270-886-3,68480-10-4,Not Classified,Notified C&L,88,Not classified:88
116662,"N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine",413-810-8,65181-78-4,Aquatic Chronic 2,Harmonised C&L,0,H411:0
116663,Triphenylphosphine hydrobromide,229-012-6,6399-81-1,Acute Tox. 4;Skin Corr. 1B,Notified C&L,43,H302:38;H314:43
116666,"Furan-2,5-dicarbonitrile",261-287-8,58491-62-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H311:1;H331:1;H315:1;H319:1;H301:1
116673,6-chlorohexan-2-one,233-546-5,10226-30-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,19,H319:18;H335:17;H315:18;Not classified:1;H302:1;H332:1;H312:1
116678,"Amides, from 2-[(2-aminoethyl)amino]ethanol and hydrogenated tallow fatty acids",268-941-1,68155-12-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,10,H317:9;H319:9;H411:9;H315:9;Not classified:1
116683,"1,3,5-triisopropyl-2,4-dinitrobenzene",286-111-7,85187-23-1,Not Classified,REACH registration C&L,2,Not classified:2
116684,Dioctyl sulphide,220-259-5,2690-08-6,Eye Dam. 1,Notified C&L,53,H318:38;H319:13;H412:8;H335:4;H315:5;Not classified:2
116685,Anethole,203-205-5,104-46-1,Skin Sens. 1,Notified C&L,184,H317:165;Not classified:19;H411:2
116688,Bis(trimethylsilyl) sulphate,242-192-0,18306-29-1,Flam. Sol. 1;Skin Corr. 1B,Notified C&L,43,H228:43;H314:43;H318:1
116690,3-isopropylpyrocatechol,218-385-0,2138-48-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1;H335:1;H315:1
116693,Sulfuric acid monododecyl ester sodium salt (1:1),616-937-9,8012-56-4,Acute Tox. 4,Notified C&L,4,H302:4
116694,Tellurium dioxide,231-193-1,7446-07-3,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 4;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,69,H302:11;H314:10;H317:15;H411:16;H318:10;H372:11;H350:11;H332:15;H360:17;H400:10;Not classified:51;H315:2;H319:2;H361:1;H373:2;H413:1
116695,Iron silicide,234-670-2,12022-95-6,Not Classified,Notified C&L,49,Not classified:44;H319:5;H315:5
116697,(2S)-(-)-2-Acetoxypropanoyl chloride,609-239-0,36394-75-9,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,39,H317:38;H302:39;H314:39;H332:1;H312:1
116699,"3,3'-[(2,5-dimethyl-p-phenylene)bis[imino(1-acetyl-2-oxoethylene)azo]]bis[4-chloro-N-(5-chloro-o-tolyl)benzamide]",226-107-4,5280-80-8,Not Classified,REACH registration C&L,189,Not classified:189
116702,O-benzylglycine toluene-p-sulphonate,217-094-6,1738-76-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,7,H302:3;H332:3;H312:3;Not classified:3;H319:1
116703,"Distillates (coal tar);Heavy Anthracene Oil;[The distillate from coal tar having an approximate distillation range of 100 °C to 450 °C (212 °F to 842 °F). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.]",266-027-7,65996-92-1,Carc. 1B,Harmonised C&L,0,H350:0
116704,(2H10)-p-xylene,255-193-6,41051-88-1,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,45,H315:45;H226:45;H332:45;H312:45
116705,3-methoxy-2-pyridone,244-116-1,20928-63-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H302:38;H335:44;H315:44
116714,"Oleic acid, compound with dicyclohexylamine (1:1)",244-876-4,22256-71-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2B,REACH registration C&L,32,H319:2;H302:8;H315:8;Not classified:24;H318:6
116715,4-butoxybenzoic acid,216-104-6,1498-96-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
116717,"12'-hydroxy-2',5'α-diisopropylergotaman-3',6',18-trione phosphate",227-906-0,6030-85-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,1,H361:1;H302:1;H332:1;H312:1
116719,4-methoxybutan-1-ol,203-858-6,111-32-0,,Notified C&L,1,H319:1;H226:1;H335:1;H315:1
116720,"2,3-Difluoro-4-[4-(4-trans-propylcyclohexyl)-cyclohexen-1-yl] -toluene",922-337-0,,Not Classified,Notified C&L,1,Not classified:1
116725,Dodecene,246-922-9,25378-22-7,,Notified C&L,56,Not classified:33;H400:22;H410:1;H304:1
116727,Barium bis(dihydrogenorthophosphate),236-715-1,13466-20-1,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,48,H302:43;H332:43;H318:3;Not classified:5
116731,"1,6-Bis(methoxybenzoyloxy)hexane",433-470-4,,Not Classified,REACH registration C&L,1,Not classified:1
116732,"Bis(hydrogenated Tallow Alkyl)amines, Oxidized",604-386-7,143925-92-2,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,124,H317:124;H413:124;H412:55
116733,"Carrageen, ext.",607-369-2,244023-79-8,Flam. Liq. 3,Notified C&L,1,H226:1
116734,2-hydroxyethyl oleate,224-806-9,4500-01-0,Not Classified,Notified C&L,20,Not classified:19;H412:1
116738,"2,5-dimethyl-1-phenyl-1H-pyrrole-3-carbaldehyde",201-458-6,83-18-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Muta. 2;Carc. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H361:2;H302:3;H410:2;H351:2;H341:2;H317:3;H315:3;H319:3;H335:3;H400:2;H412:1
116740,"(-)-3,7-dimethyloct-7-enyl benzoate",234-001-4,10486-12-1,Not Classified,Notified C&L,88,Not classified:88
116746,3-ethoxysalicylaldehyde,207-765-1,492-88-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H302:2
116747,5-bromo-4'-chlorosalicylanilide,222-957-5,3679-64-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
116748,"2,5-diethoxy-4-[(4-methylphenyl)thio]benzenediazonium tetrachlorozincate (2:1)",254-062-0,38656-51-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1
116750,"[2R-(2α,3Z,5α)]-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, compound with tert-butylamine (1:1)",266-104-5,66069-34-9,Flam. Sol. 1;Self-heat. 1,REACH registration C&L,6,H228:6;H251:5;H334:1;H317:1
116751,Sodium 2-[methyloleoylamino]ethane-1-sulphonate,205-285-7,137-20-2,Eye Irrit. 2,Notified C&L,497,H319:343;H318:108;H302:103;H315:40;Not classified:39
116752,"Tricarbonyl[(1,2,3,4,5,6-η)-o-toluidine]chromium",235-149-2,12083-33-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H315:38;H319:38;H332:38;H335:38;H312:38
116754,Methyl 4-nitronaphthyl ether,225-528-0,4900-63-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
116759,"1,2,4(or 1,3,5)-trimethylcyclohex-3-ene-1-methanol",276-861-3,72812-40-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,233,H319:233;H315:233
116760,"3,7-dihydro-1-methyl-1H-purine-2,6-dione",228-108-5,6136-37-4,,Notified C&L,2,H302:1;H319:1;H335:1;H315:1
116765,Magnesium L-glutamate,242-413-0,18543-68-5,Not Classified,Notified C&L,6,Not classified:6
116766,p-(trifluoromethoxy)benzaldehyde,211-531-4,659-28-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:46;H315:48;H302:2;H227:1
116767,"N-(2,2-diethoxyethyl)pyridine-4-methylamine",252-739-5,35822-55-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
116770,"2,4-dimethoxyphenyl isocyanate",282-747-4,84370-87-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,42,H302:42;H334:42;H315:42;H319:42;H332:42;H335:42;H312:38
116771,Bis(2-ethoxyethyl) sebacate,210-829-1,624-10-2,Eye Irrit. 2,Notified C&L,1,H319:1
116775,"5,6-dihydro-2,4,6-trimethyl-1,3,5-dithiazine",211-323-3,638-17-5,STOT SE 3,Notified C&L,1380,H335:1289;Not classified:90;H319:2;H228:1;H315:2;H311:1
116777,Silver chromate,232-043-8,7784-01-2,Ox. Sol. 2;Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H410:44;H272:44;H317:44;H350:44;H400:42
116778,"Naphtha (petroleum), hydrodesulfurized light, dearomatized;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C",295-434-2,92045-53-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
116780,"Benzenamine, 4,4'-methylenebis-, reaction products with glycidyl Ph ether",290-534-2,90170-96-0,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H317:1;H411:1;H332:1;H312:1
116786,"2,2'-(5-Methyl-1,3-phenylene)di(2-methylpropionitrile)",601-714-0,120511-72-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;H302:1;H360:1
116789,Aqueous Extract of Beef Tissue,923-285-1,,Not Classified,Notified C&L,2,Not classified:2
116791,Nimorazole,229-394-4,6506-37-2,Acute Tox. 4;Muta. 2;Repr. 2;Lact.,Notified C&L,30,H341:30;H302:30;H361:30;H362:30
116792,"Paraffins (petroleum), normal C>10",265-232-9,64771-71-7,Asp. Tox. 1,REACH registration C&L,796,H304:708;H413:83;Not classified:88;H319:17;H336:2;H226:2;H335:1;H315:1;H312:1
116793,Magnesium hydrogenorthophosphate,231-823-5,7757-86-0,Not Classified,REACH registration C&L,103,Not classified:103
116799,Iron hydroxide oxide,243-746-4,20344-49-4,Not Classified,Notified C&L,1288,Not classified:1288
116801,"Disodium 4-amino-3,6-bis[(4-aminophenyl)azo]-5-hydroxynaphthalene-2,7-disulphonate",277-004-6,72906-46-8,Not Classified,Notified C&L,1,Not classified:1
116803,Tetrachlorothiophene,227-866-4,6012-97-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,43,H311:43;H301:43;H331:43;H410:4;H400:4
116807,Butorphanol,255-808-8,42408-82-2,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,17,H334:16;H317:16;H302:17;H332:17;H361:1;H312:1
116809,"L-Glutamine, L-alanyl-",609-717-9,39537-23-0,Not Classified,Notified C&L,2,Not classified:2
116810,5-iodosalicylic acid,204-313-5,119-30-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,57,H319:56;H335:55;H315:56;H317:1;H302:1;H410:1;H400:1
116812,Germanium tetrachloride,233-116-7,10038-98-9,Met. Corr. 1;Skin Corr. 1A;STOT SE 3,REACH registration C&L,141,H290:3;H335:20;H314:141;H330:39;H318:15;Not classified:1
116814,Oxolamine dihydrogen citrate,217-760-6,1949-20-8,Acute Tox. 4,Notified C&L,41,H302:41
116815,"Pitch, coal tar, high-temp., heat-treated;[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 °C to 180 °C (176 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]",310-162-7,121575-60-8,Carc. 1B,Harmonised C&L,0,H350:0
116817,2-amino-4-(methylsulphonyl)phenol,202-654-4,98-30-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,3,H319:3;H315:3;H335:1
116820,Ethyl 2-methylpent-2-en-1-oate,261-367-2,58625-96-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,10,H317:10;H319:10;H315:10
116825,1-cyclohexylpropan-1-one,214-380-2,1123-86-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:1;H302:1;H335:1;H315:1;Not classified:1
116828,3-(3-tert-butyl-4-hydroxyphenyl)propionic acid,403-920-4,107551-67-7,Acute Tox. 4;Eye Irrit. 2,Harmonised C&L,0,H319:0;H302:0
116829,Methyl 4-bromobenzoate,210-596-6,619-42-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:40;H335:40;H315:40;Not classified:2
116832,"Methyl 3,5-bis-tert-butyl-4-hydroxybenzoate",219-729-2,2511-22-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,42,H319:42;H335:42;H413:38;H315:42
116834,2-ethoxypropanol,242-806-7,19089-47-5,Flam. Liq. 3,Notified C&L,194,H226:191;Not classified:3;H336:1
116838,D-cystine,206-486-2,349-46-2,,Notified C&L,1,Not classified:1
116840,"Distillates (coal tar), light oils; Carbolic Oil;[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150°C to 210°C (302°F to 410°F).]",283-483-2,84650-03-3,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
116842,Lutetium tribromide,238-446-5,14456-53-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
116844,"Ethylene bis[3,3-bis(3-tert-butyl-4-hydroxyphenyl)butyrate]",251-073-2,32509-66-3,Not Classified,REACH registration C&L,59,Not classified:59
116847,"(2-formamido-1,3-thiazol-4-yl)(oxo)acetic acid",426-680-2,,Skin Sens. 1,Notified C&L,2,H317:2
116849,Tributyl-2-thiourea,219-350-2,2422-88-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H302:1;H410:1;H400:1
116854,"1,4-butanediyl bis(mercaptoacetate)",233-479-1,10193-95-0,Acute Tox. 4,Notified C&L,1,H302:1
116856,"2,3-dihydroxypropyl (dihydrogen phosphate), sodium salt",241-577-0,17603-42-8,Not Classified,Notified C&L,47,Not classified:47
116857,Thulium trinitrate,239-069-9,14985-19-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,3,H411:1;H318:1;H315:2;Not classified:1;H272:1;H319:1;H335:1
116859,Choline,200-535-1,62-49-7,Flam. Liq. 2;Skin Corr. 1;Eye Dam. 1;Repr. 1B;STOT SE 1,REACH registration C&L,44,H314:42;H225:1;H318:1;H370:1;H360:1;Not classified:2
116862,Chloromethanesulphonyl chloride,222-526-1,3518-65-8,Acute Tox. 4;Skin Corr. 1B,Notified C&L,46,H302:42;H314:46;H332:2;H312:1;H290:1;H318:1
116866,"Fatty acids, coco, mixed esters with 1,3-butanediol, montan-wax fatty acids and trimethylolpropane",297-073-6,93334-01-1,Not Classified,Notified C&L,31,Not classified:31
116870,Methacholine chloride,200-537-2,62-51-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H302:42;H335:41;H315:42
116871,Merbromin,204-933-6,129-16-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H410:42;H373:42;H330:42;H310:42;H300:42;H400:42;Not classified:1;H362:1
116878,"Fatty acids, C9-13-neo-, sodium salts",297-071-5,93333-99-4,Not Classified,Notified C&L,5,Not classified:5
116880,Dialuminium tris(hydrogen phosphate),236-876-8,13530-54-6,Not Classified,Notified C&L,33,Not classified:33
116881,1-ethylpiperidin-4-ol,222-528-2,3518-83-0,Skin Irrit. 2,Notified C&L,39,H315:39
116882,2-mercaptopropionic acid,201-206-5,79-42-5,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,1458,H302:41;H314:172;H290:26;H317:2;H318:41;H311:1286;H301:1301;H330:1286;H331:14;H332:4
116885,1-bromopentane,203-776-0,110-53-2,Flam. Liq. 3;Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,65,H226:65;H411:11;H315:65;H319:60;H335:59;H302:5
116886,N-acetyl-α-D-glucosamine,233-115-1,10036-64-3,Not Classified,Notified C&L,44,Not classified:44
116887,Gadolinium tribromide,237-494-4,13818-75-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
116891,Methacrylic anhydride,212-084-8,760-93-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,79,H302:30;H317:36;H318:68;H315:67;H332:28;H335:67;H331:40;Not classified:5;H314:6
116893,Potassium iodide,231-659-4,7681-11-0,Not Classified,REACH registration C&L,582,Not classified:101;H372:156;H319:272;H334:83;H317:128;H315:201;H335:67;H302:111;H411:80;H360:39;H373:39;H312:10;H351:1;H361:2;H370:1
116895,Tetrasodium N-(3-carboxylato-1-oxo-3-sulphonatopropyl)-N-octadecyl-DL-aspartate,254-187-0,38916-42-6,Not Classified,Notified C&L,238,Not classified:140;H411:60;H319:45;H315:7
116897,"Coffee, Coffea arabica, ext.",283-481-1,84650-00-0,Flam. Liq. 3,Notified C&L,1511,H226:1402;Not classified:96;H302:11;H225:2
116901,"Tomato, ext.",290-375-9,90131-63-8,Not Classified,Notified C&L,62,Not classified:37;H412:25
116906,2-iodo-5-methylbenzoic acid,610-860-4,52548-14-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
116909,"Tar acids, polyalkylphenol fraction;Distillate Phenols;[The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225°C to 320°C (437°F to 608°F). Composed primarily of polyalkylphenols.]",284-893-4,84989-05-9,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
116910,"Butoxy-2,3-difluorbenzol",603-949-4,136239-66-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1;Not classified:1
116916,nitrobenzene,202-716-0,98-95-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2;STOT RE 1;Aquatic Chronic 3;Repr. 1B,Harmonised C&L,0,H360:0;H311:0;H351:0;H412:0;H331:0;H372:0;H301:0
116917,"2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate",433-910-5,145153-52-2,Skin Sens. 1,Harmonised C&L,0,H317:0
116918,"Alcohols, C10-16, ethoxylated, phosphates",500-235-3,68909-65-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,196,H318:192;H314:135;H315:60;Not classified:1;H400:1
116920,"Siloxanes and Silicones, di-Me, Me 3,3,3-trifluoropropyl, vinyl group-terminated",614-836-4,68951-98-4,Not Classified,Notified C&L,12,Not classified:12
116924,"Benzene-1,2,4,5-tetracarboxylic acid, compound with 4,5-dihydro-2-phenyl-1H-imidazole (1:1)",259-224-4,54553-90-1,Aquatic Chronic 2,Notified C&L,261,H411:190;Not classified:27;H412:44;H317:19;H302:18;H315:19;H319:16;H335:16
116931,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with tall-oil fatty acids and triethylenetetramine",500-191-5,68082-29-1,Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,434,H317:315;H411:181;H318:242;H315:352;H319:119;H334:55;H332:55;H312:55;H412:47;Not classified:68;H290:5;H413:5;H314:4;H410:2;H400:1
116935,"Alpinia officinarum, ext.",291-068-2,90320-42-6,Flam. Liq. 3;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,995,H317:995;H226:912;H411:994;H304:98;H412:1;H315:2;H319:1
116936,2-methoxyethyl hydrogen maleate,241-787-2,17831-64-0,Not Classified,Notified C&L,9,Not classified:9
116937,"[1S-(1α,2α,5α)]-2,6,6-trimethylbicyclo[3.1.1]heptane",233-629-6,10281-53-5,Flam. Liq. 3,Notified C&L,38,H226:38
116942,"Oxydiethane-2,1-diyl dipalmitate",272-394-4,68818-39-3,Not Classified,Notified C&L,1,Not classified:1
116943,Calcium tetraborate,234-511-7,12007-56-6,Repr. 2,REACH registration C&L,99,H361:3;Not classified:90;H360:6
116944,8-bromoinosine,259-730-5,55627-73-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H301:38;H315:38
116946,"tris(η5-cyclopenta-2,4-dien-1-yl)gadolinium",215-046-9,1272-21-5,Flam. Sol. 2;Water-react. 2,Notified C&L,42,H261:38;H228:42
116947,"Distillates (petroleum), cracked steam-cracked petroleum distillates;Cracked gasoil;[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C",270-727-8,68477-38-3,Carc. 1B,Harmonised C&L,0,H350:0
116949,"Poly(oxy-1,2-ethanediyl), α-sulfo-ω-(hexyloxy)-, ammonium salt (1:1)",613-219-7,63428-86-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,21,H319:20;H315:20;Not classified:1
116956,Dipotassium dodecyl phosphate,242-780-7,19045-77-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,13,H318:13;H315:13
116957,"Ethyl 2,3-Dicyanopropionate",609-836-6,40497-11-8,,Notified C&L,2,H302:2;H332:2;H312:2;H315:1;H319:1
116958,(3-nitrophenoxy)acetic acid,217-528-4,1878-88-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
116961,"N,N-diethyl-m-toluidine",202-089-3,91-67-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,116,H302:77;H332:77;H412:76;H312:77;H311:39;H411:39;H301:39;H331:39;H315:1;H319:1
116962,Tetracosactide,241-031-1,16960-16-0,Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,17,H334:17;H317:17;H332:17
116965,Docosyltrimethylammonium methyl sulphate,279-791-1,81646-13-1,Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,142,H373:112;H411:97;H318:112;H315:142;H400:118;H319:30;H410:21;H412:14
116967,"5'-Guanylic acid, monoanhydride with phosphorothioic acid, trilithium salt",308-328-9,97952-36-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
116969,2-chloro-3-ethylbenzoxazolium tetrafluoroborate,263-998-9,63212-53-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H311:1;H301:1;H315:1;H319:1;H335:1;H302:1;H318:1;H314:1
116972,3-methoxybutyl chloroformate,278-058-3,75032-87-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
116973,S-[1-methyl-1-(4-methyl-2-oxocyclohexyl)ethyl] ethanethioate,304-949-4,94293-57-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,114,H319:103;H315:103;Not classified:11
116974,"1,3-dichloro-2,4,5,6-tetrafluorobenzene",214-835-5,1198-61-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
116982,"Docosanoic acid, reaction products with 3-[[2-[(2-aminoethyl)amino]ethyl]amino]propanenitrile, eicosanoic acid and stearic acid, acetates",302-217-9,94095-13-3,Not Classified,Notified C&L,1,Not classified:1
116984,"3,7-dimethyloct-6-enyl isovalerate",272-982-0,68922-10-1,Not Classified,Notified C&L,122,Not classified:121;H317:1;H411:1;H315:1
116987,"tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate",405-170-3,116340-05-7,Acute Tox. 3;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H301:0;H412:0
116989,"[7(S)-(1α,2β,4β,5α,7β)]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate N-oxide hydrobromide",228-066-8,6106-81-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,40,H311:39;H301:39;H331:39;H302:1
116990,"(1S,3AR,6AS)-2-[(2S)-2-({(2S)-2-CYCLOHEXYL-2-[(2-PYRAZINYLCARBONYL)AMINO]ACETYL}AMINO)-3,3-DIMETHYLBUTANOYL]-N-[(3S)-1-(CYCLOPROPYLAMINO)-1,2-DIOXO-3-HEXANYL]OCTAHYDROCYCLOPENTA[C]PYRROLE-1-CARBOXAMIDE",609-814-6,402957-28-2,Acute Tox. 4,Notified C&L,11,H302:10;Not classified:1
116996,Copper bis(dimethyldithiocarbamate),205-287-8,137-29-1,Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,457,H330:454;H411:1;H400:446;H331:1;H410:1;Not classified:1;H319:1
117000,4-(4-Nitrophenyl)morpholin-3-one,610-199-1,446292-04-2,Not Classified,REACH registration C&L,5,Not classified:4;H302:1;H332:1;H312:1
117001,"Disodium [μ-[[7,7'-iminobis[4-hydroxy-3-[[2-hydroxy-5-(N-methylsulphamoyl)phenyl]azo]naphthalene-2-sulphonato]](6-)]]dicuprate(2-)",253-441-8,37279-54-2,,Notified C&L,9,H319:8;H315:8;Not classified:1
117006,"Hydrocotyle vulgaris, ext.",289-947-0,90045-82-2,Not Classified,Notified C&L,1,Not classified:1
117008,2-(p-tolyloxy)aniline,244-115-6,20927-98-4,,Notified C&L,1,H302:1;H332:1;H312:1
117011,Reactive Yellow F00-0155,439-150-0,,Not Classified,Notified C&L,1,Not classified:1
117012,N-(hydroxymethyl)benzamide,228-495-0,6282-02-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,43,H319:42;H302:38;H335:4;H315:4;Not classified:1
117013,Cyclohexyl(ethyl)amine,226-733-8,5459-93-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,102,H302:102;H314:102;H311:102;H412:34;H226:102;H332:80;H318:34
117026,"2-Propanol, reaction products with boron trifluoride and 5-ethylidenebicyclo[2.2.1]hept-2-ene",292-041-8,90530-04-4,Not Classified,Notified C&L,233,Not classified:233
117030,"Sulfuric acid, iron(2+) salt (1:1), heptahydrate",616-510-7,7782-63-0,Eye Irrit. 2,Notified C&L,2617,H319:2611;H302:2615;H315:2611;H412:33;H290:3;Not classified:2;H335:1
117035,4-oxo-2-thioxothiazolidine-3-propionic acid,230-307-7,7025-19-6,Eye Irrit. 2,Notified C&L,40,H319:40;H311:1;H301:1;H315:2;H335:1
117041,Dibutylnaphthalenesulphonic acid,246-921-3,25377-92-8,Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,Notified C&L,3,H290:2;H318:3;H314:2;H302:1;H332:1;H315:1
117042,2-chloroacrylic acid,209-953-9,598-79-8,,Notified C&L,6,H314:6
117043,nonadecafluorodecanoic acid,206-400-3,335-76-2,Carc. 2;Lact.;Repr. 1B,Harmonised C&L,0,H362:0;H351:0;H360:0
117044,Lead uranate pigment,287-565-9,85536-79-4,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H302:1;H410:1;H373:1;H332:1;H360:1;H400:1
117047,1-bromo-5-chloropentane,259-193-7,54512-75-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,6,H319:5;H411:2;H335:3;H315:5;H302:2;H316:1
117048,"[2,2-bis[(3,7-dimethyl-6-octenyl)oxy]ethyl]benzene",266-807-7,67634-04-2,Not Classified,Notified C&L,88,Not classified:88
117049,Norvaline,229-543-3,6600-40-4,Not Classified,REACH registration C&L,8,Not classified:7;H319:1;H335:1;H315:1
117050,1-(4-chlorophenyl)-3-methyl-1H-pyrazol-5-amine,254-907-3,40401-39-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
117052,Terlipressin,238-680-8,14636-12-5,Acute Tox. 4,Notified C&L,1,H332:1
117053,"3-β,14,16-β-trihydroxy-5-β,14-β-card-20(22)-enolide",208-886-2,545-26-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H311:38;H301:38;H331:38
117055,Linalyl benzoate,204-796-2,126-64-7,Eye Irrit. 2,Notified C&L,1657,H319:1345;Not classified:312
117066,"5-ethyl-2,3,4,5-tetramethylcyclohexen-1-one",241-403-3,17369-60-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1375,H319:1375;H335:1375;H315:1375
117069,3-phenoxypropiononitrile,221-278-1,3055-86-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:39;H332:39;H312:39;H315:1;H319:1
117071,7-butyloxepan-2-one,226-963-9,5579-78-2,Not Classified,Notified C&L,126,Not classified:88;H319:38;H335:38;H315:38
117072,Pent-1-yne,210-987-1,627-19-0,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H225:43;H304:42;H315:43;H319:43;H335:43
117074,(2S)-(+)-2-Hydroxy-3-methylbutanoic acid,605-704-7,17407-55-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:41;H315:41
117075,α-(4-pyridyl)benzhydryl alcohol,216-584-7,1620-30-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
117080,"Hexane-1,3,6-tricarbonitrile",217-199-7,1772-25-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:38;H332:38;H311:1;H331:1;H315:1;H319:1;H301:1
117082,"Siloxanes and Silicones, Me hydrogen, Me group-terminated",615-752-0,72319-10-9,Water-react. 2;Aquatic Chronic 3,Notified C&L,1,H261:1;H412:1
117083,"N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide",412-920-3,16695-22-0,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
117084,"Bauxite (Al2O3.xH2O), calcined",296-578-9,92797-42-7,Not Classified,Notified C&L,11,Not classified:9;H335:2;H372:1;H332:1
117089,"4,4'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)imino[6-[bis(2-hydroxyethyl)amino]-1,3,5-triazine-4,2-diyl]imino]]bisarenoate sodium salt",,,Not Classified,Notified C&L,1,Not classified:1
117091,"Formaldehyde, polymer with benzenamine, hydrogenated",603-894-6,135108-88-2,Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,410,H314:404;H412:40;H317:41;H373:40;H318:38;H301:4;H302:401;H332:27;H312:28;Not classified:5
117093,N-methylaniline,202-870-9,100-61-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H311:0;H373:0;H331:0;H301:0;H400:0
117094,"2,3,3-trimethylbut-1-ene",209-845-1,594-56-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H225:40;H319:40;H335:39;H315:39
117098,Di-p-tolylethanedione,222-388-2,3457-48-5,Not Classified,Notified C&L,1,Not classified:1
117099,"2,2,6,6-tetramethylpiperidinooxy",219-888-8,2564-83-2,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,284,H318:69;H314:256;H412:60;H319:22;H335:22;H315:22;H332:12;Not classified:5;H310:1;H411:1
117100,4-(Octyloxy)benzonitrile,618-154-8,88374-55-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H302:42;H332:42;H312:42
117102,Dithiazanine iodide,208-186-7,514-73-8,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H335:42;H300:42;H315:42;Not classified:1
117104,o-nitrophenyl selenocyanate,257-350-4,51694-22-5,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H410:44;H373:44;H331:44;H301:44;H400:44
117107,Uranium dioxide,215-700-3,1344-57-6,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,38,H410:38;H330:38;H373:38;H411:38;H300:38;H400:38
117109,trans-oct-4-ene,238-913-3,14850-23-8,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,43,H225:43;H304:39
117111,Ethyl pentadecanoate,255-223-8,41114-00-5,Not Classified,Notified C&L,88,Not classified:88
117114,"Amides, from 2-[(2-aminoethyl)amino]ethanol, C18-24 fatty acids, and hydrogenated tallow fatty acids, compds. with di-Me sulfate",292-508-6,90623-02-2,Aquatic Chronic 2,Notified C&L,1,H411:1
117116,Lithium vanadium oxyde,600-755-1,106605-60-1,Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H301:1;H411:1;H331:1;H319:1;H335:1
117118,"(E,E,E)-2,6,10-trimethyldodeca-2,6,9,11-tetraen-1-al",241-854-6,17909-77-2,Not Classified,Notified C&L,261,Not classified:261
117120,"1,3-Difluor-2-difluormethoxy-5-(4'-trans-ethyl-[1,1'-bicyclohexyl]-4-trans-yl)-benzene",604-116-8,139215-88-6,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
117123,"ethyl 4-methyl-1,3-thiazole-5-carboxylate",606-584-9,20582-55-2,,Notified C&L,2,H319:2;H335:2;H315:2
117131,"Benzenesulfonic acid, 2-[2-[5-amino-3-methyl-1-(3-sulfophenyl)-1H-pyrazol-4-yl]diazenyl]-4,5-dichloro-, calcium salt (1:1)",601-038-6,111071-53-5,,Notified C&L,33,Not classified:33
117132,"deltamethrin (ISO);(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate",258-256-6,52918-63-5,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H301:0;H331:0;H400:0
117135,Octyltriphenylphosphonium bromide,255-635-8,42036-78-2,,Notified C&L,4,H319:4;H335:4;H315:4
117137,"Cyclohexanol, 2-(1,1-dimethylethyl)-4-methyl-, 1-acetate",601-383-2,115724-27-1,Aquatic Chronic 2,Notified C&L,233,H411:233
117140,(S)-(-)-1-(4-chlorophenyl)ethylamine,609-965-8,4187-56-8,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 2,Notified C&L,128,H317:122;H411:128;H331:83;H318:124;H315:122;H301:87;H302:41;H330:41;H314:6;H335:1
117141,"Raffinates (petroleum), sorption process",265-087-1,64741-85-1,,Notified C&L,1,H304:1
117142,"Benzenesulfonic acid, 2-amino-4-[(2,3-dibromo-1-oxopropyl)amino]-",608-126-3,27685-88-7,Not Classified,Notified C&L,1,Not classified:1
117147,"tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilbene-2,2'-disulfonate",429-230-3,371921-41-4,Eye Dam. 1,Harmonised C&L,0,H318:0
117152,3-Methoxybutyl 3-Mercaptopropionate,608-098-2,27431-40-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
117153,"Fatty acids, C6-24, distn. residues",310-084-3,102242-53-5,Not Classified,Notified C&L,1,Not classified:1
117154,(2H8)toluene,218-009-5,2037-26-5,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;STOT SE 3;Repr. 2;STOT RE 2;STOT RE 2,Notified C&L,549,H361:513;H225:512;H373:513;H315:513;H336:513;H304:513;Not classified:37;H412:23;H319:23
117155,Iridium tetraiodide,232-206-3,7790-45-6,,Notified C&L,4,H319:4;H335:4;H315:4
117158,"1,4-bis[(vinyloxy)methyl]cyclohexane",413-370-7,17351-75-6,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
117160,"Methyl 2,4-dihydroxybenzoate",218-428-3,2150-47-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
117162,"3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium sulfate",925-768-2,,Not Classified,REACH registration C&L,1,Not classified:1
117169,2-methyl-3-phenylpropionaldehyde,226-654-9,5445-77-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H335:1;H312:1
117178,"Octanoic acid, branched, zirconium salt (2:1)",305-520-4,94581-21-2,Repr. 2,Notified C&L,2,H361:1;Not classified:1
117180,"Boric acid, zinc salt",215-566-6,1332-07-6,Eye Irrit. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,328,H361:55;H319:9;H411:31;H400:250;H410:225;Not classified:8;H315:5;H335:3;H412:2
117187,Lomifylline,233-547-0,10226-54-7,Acute Tox. 4,Notified C&L,2,H302:1;Not classified:1
117188,2'-Fluoro-4'-hydroxyacetophenone,619-366-3,98619-07-9,,Notified C&L,8,H319:8;H335:7;H315:8
117193,"Naphthalenesulfonic acid, tripropylene-, methylated, sodium salts",291-649-0,90459-08-8,Eye Irrit. 2,Notified C&L,1,H319:1
117198,4-isopropylpyrocatechol,218-384-5,2138-43-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,2,H319:2;H411:2;H335:2;H315:2
117205,Iron disilicide,234-671-8,12022-99-0,,Notified C&L,6,H319:4;H335:4;H315:4;Not classified:2
117209,"N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane",410-060-3,130728-76-6,Skin Sens. 1;Muta. 2;Aquatic Chronic 2,Harmonised C&L,0,H341:0;H317:0;H411:0
117211,"3,4-dimethoxyphenol",217-995-4,2033-89-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43;H302:1
117213,2-ethylhexyl (4-chloro-2-methylphenoxy)acetate,249-636-2,29450-45-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,218,H302:185;H410:184;H332:184;H400:184;H312:184;H317:1;H411:1;Not classified:33
117214,1-methylpyridine-2-one,211-777-2,694-85-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H302:44;H335:43;H315:44
117218,"9,10-diphenylanthracene",216-105-1,1499-10-1,Not Classified,Notified C&L,6,Not classified:5;H319:1;H335:1;H315:1
117220,"2,2,3,3,3-pentafluoropropane-1,1-diol",207-020-0,422-63-9,,Notified C&L,5,H319:5;H302:5;H335:5;H315:5;H332:1;H312:1
117221,T001378,423-080-2,,Eye Dam. 1,Notified C&L,1,H318:1
117224,"N,N-diethyl-3-(trimethoxysilyl)propylamine",255-192-0,41051-80-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,57,H335:52;H318:42;H315:43;H319:11;Not classified:4
117226,Rubidium dichlorobromate(1-),289-320-1,87520-11-4,Not Classified,Notified C&L,25,Not classified:25
117230,"Decahydrospiro[furan-2(3H),5'-[4,7]methano[5H]indene]",270-887-9,68480-11-5,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,224,H317:1;H410:1;H400:1;H315:1;Not classified:223
117232,N-ethylheptadecafluorooctanesulphonamide,223-980-3,4151-50-2,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,127,H302:127;H411:127;H312:127
117233,Hexane-1-thiol,203-857-0,111-31-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4,Notified C&L,164,H225:86;H332:79;H312:78;H302:86;H226:68;H331:85;H315:22;H319:22;H335:22;H336:8;H371:1
117237,"3',5'-dimethoxycinnamic acid",240-956-8,16909-11-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
117239,2-chloro-3-methyl-5-nitropyridine,244-889-5,22280-56-4,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,135,H335:133;H301:129;H318:127;H315:134;H319:7;H302:4;H311:2;H331:2
117241,3-methyl-5-phenylpentanol,259-461-3,55066-48-3,Acute Tox. 4;STOT RE 2,REACH registration C&L,1751,H373:56;H302:1521;H318:229;Not classified:2
117242,Dibarium diphosphate,236-716-7,13466-21-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:38;H332:38;Not classified:1
117244,"Disodium 4-hydroxy-3-[(2-methoxyphenyl)azo]-5-[[(p-tolyl)sulphonyl]amino]naphthalene-2,7-disulphonate",229-393-9,6505-96-0,Not Classified,Notified C&L,1,Not classified:1
117246,(2R)-(2-chlorophenyl)(hydroxy)ethanoic acid,610-917-3,52950-18-2,Skin Sens. 1;Eye Dam. 1,Notified C&L,45,H317:43;H318:43;H319:2;H335:1;H315:2
117248,"methyl (4-butanoyl-2,3-dichlorophenoxy)acetate",608-516-3,30720-99-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,2,H317:2;H319:2;H315:2
117250,3-ethyl-1-methyl-1H-Imidazolium chloride (1:1),613-739-4,65039-09-0,Acute Tox. 4;Eye Irrit. 2B,REACH registration C&L,131,H319:131;H302:85;H315:46;H413:1;H335:1
117256,OXONOLROT 536 PINA,418-910-5,,Aquatic Chronic 3,Notified C&L,1,H412:1
117258,"pyroxsulam (ISO); N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-methoxy-4-(trifluoromethyl) pyridine-3-sulfonamide",610-007-6,422556-08-9,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H400:0
117259,Ethyl 9-oxo-9H-thioxanthene-2-carboxylate,280-960-7,83817-60-1,Not Classified,REACH registration C&L,2,Not classified:2
117260,"1-Hexanol, 2-ethenyl-",610-948-2,53045-66-2,,Notified C&L,2,H302:1;H226:1;H314:1;Not classified:1
117265,Gallium antimonide,235-058-8,12064-03-8,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,95,H302:95;H332:95;H411:95
117268,(4-vinylphenyl)methyl-2-[(1Z)-1-aza-3-methyl-2-(4-methylthiophenyl)-3-morpholin-4-ylbut-1-enyloxy]acetate,453-050-4,,Aquatic Chronic 4,Notified C&L,1,H413:1
117270,"5-hydroxy-2-methyl-1,4-naphthoquinone",207-569-6,481-42-5,Acute Tox. 3;Skin Corr. 1B,Notified C&L,129,H301:129;H314:128;H319:1;H335:1;H315:1;H318:1
117271,2-mercaptoethyl oleate,261-609-7,59118-78-4,Not Classified,Notified C&L,55,Not classified:55
117272,"(1S)-3,7,7-trimethylbicyclo[4.1.0]hept-3-ene",207-856-6,498-15-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,61,H317:61;H226:61;H411:22;H315:23;H304:23;H400:61;H410:39;H332:1
117276,p-tert-butylcinnamaldehyde,282-823-7,84434-23-1,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,1,H317:1;H315:1
117278,(Methylbenzene)tricarbonylchromium,235-148-7,12083-24-8,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H228:38;H312:38
117280,"Fatty acids, coco, compds. with ethanolamine",266-105-0,66071-80-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,26,H319:22;H315:22;H318:2;Not classified:2
117285,"N-[[4-(2-Dimethylaminoethoxy)phenyl]methyl]-3,4-dimethoxybenzamide hydrochloride",602-905-1,122892-31-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H410:38;H400:39;H302:1;H332:1;H312:1
117294,trizinc diphosphide;zinc phosphide,215-244-5,1314-84-7,Water-react. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H300:0;H260:0
117298,"Distillates (coal tar), upper;Heavy Anthracene Oil;[The distillate from coal tar having an approximate distillation range of 220 °C to 450 °C (428 °F to 842 °F). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.]",266-026-1,65996-91-0,Carc. 1B,Harmonised C&L,0,H350:0
117301,"1,3,5-tris-[6-({[(N,N-dibutylamino]carbonyl}amino)hexyl]-1,3,5-triazinane-2,4,6-trione",919-402-0,,Not Classified,Notified C&L,83,Not classified:83
117303,"Citric acid, copper sodium salt",253-831-8,38218-87-0,Acute Tox. 4;Aquatic Acute 1,Notified C&L,1,H302:1;H400:1
117304,"2-[(2E)-2-(6-Methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethyl]-2-methylcyclopentane-1,3-dione",618-321-5,899-79-6,Skin Sens. 1B;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H411:1;H401:1
117307,Pentyl dihydrogen phosphate,219-188-2,2382-76-5,Skin Corr. 1C;Eye Dam. 1,Notified C&L,509,H318:449;H314:503;H412:7;Not classified:6
117309,Methylidynetri-p-phenylene triisocyanate,219-351-8,2422-91-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,43,H302:24;H317:27;H330:24;H334:43;H315:27;H319:24;H335:24
117312,"17-(cyclobutylmethyl)morphinan-3,14-diyl [S-(R*,R*)]-2,3-dihydroxysuccinate",261-443-5,58786-99-5,Acute Tox. 4;Repr. 2,Notified C&L,91,H361:90;H302:91;H412:51;H372:52;H370:51;H315:1;H319:1;H335:1;H332:1;H312:1
117314,Honeyol,447-760-3,,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Muta. 2,Notified C&L,1,H341:1;H317:1;H302:1;H314:1
117318,"Extract residues (coal), light oil alk., acid ext.;Carbolic Oil Extract Residue;[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.]",292-624-7,90641-01-3,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
117319,"1,3,5-triazine-2,4,6(1H,3H,5H)-trithione",211-322-8,638-16-4,Acute Tox. 4,REACH registration C&L,63,H302:34;Not classified:12;H319:16;H335:16;H315:16;H317:1;H410:1;H400:1
117320,5-(3-methylbenzothiazol-2(3H)-ylidene)-4-oxo-2-thioxothiazolidin-3-acetic acid,255-416-7,41504-19-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
117321,Nonene,248-339-5,27215-95-8,Flam. Liq. 3;Asp. Tox. 1;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,458,H319:441;H226:441;H304:458;H413:441;H225:17;H410:17;H411:1;H400:1
117322,"Tallow, reaction products with diethylenetriamine",287-099-6,85409-31-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H314:1
117323,3-ethoxypropyl isothiocyanate,303-898-5,94231-77-3,Flam. Liq. 4;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H314:1;H227:1;H332:1;H335:1;H312:1
117324,Cerium tribromide,238-447-0,14457-87-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
117329,"tris(η5-cyclopenta-2,4-dien-1-yl)holmium",215-047-4,1272-22-6,Flam. Sol. 2;Water-react. 2,Notified C&L,42,H261:38;H228:42
117330,Octadecylbenzenesulphonic acid,249-268-2,28855-17-6,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 4,REACH registration C&L,31,H413:1;H318:31;H314:31;H412:30
117335,6-chloro-3-nitropyridin-2-ylamine,248-188-5,27048-04-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,19,H319:18;H335:17;H315:18;H302:4;H332:4;H312:4;Not classified:1;H341:1
117337,4-(diethoxyphosphinyl)-2-methyl-2-butenoic acid ethyl ester,601-818-6,122009-11-4,Eye Dam. 1,REACH registration C&L,1,H318:1
117338,"2-Methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane",601-623-6,1195-66-0,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,44,H319:38;H226:44
117339,"Phosphorous acid, sodium salt; Phosphorous acid, sodium salt",604-975-9,15475-67-9,Acute Tox. 4;Skin Corr. 1A,Notified C&L,39,H302:39;H314:39
117341,Pheniramine hydrogen maleate,205-051-4,132-20-7,Acute Tox. 4,Notified C&L,63,H302:57;H317:13;H332:2;H312:2;H336:2;H301:2
117343,"disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate",412-530-3,157627-98-0,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
117344,"(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide",615-206-1,709031-45-8,,Notified C&L,2,H371:1;H319:1
117351,"Disodium 4-amino-5-hydroxy-3-[[4-[5-[(4-hydroxyphenyl)azo]-1H-benzimidazol-2-yl]phenyl]azo]-6-(phenylazo)naphthalene-2,7-disulphonate",298-308-5,93803-37-3,Not Classified,Notified C&L,1,Not classified:1
117356,"Paraffin waxes (petroleum), hydrotreated",265-154-5,64742-51-4,Not Classified,REACH registration C&L,1096,Not classified:1040;H413:56
117358,Rubidium hydrogen carbonate,242-805-1,19088-74-5,Not Classified,Notified C&L,26,Not classified:26
117361,"1,1,1,3,3,5,5,7,7,7-decachloro-(1-lambda-5, 3-lambda-5, 5-lambda-5)-tetraphosphaza-1,3,5-trieniumhexa-chlorophosphate",419-940-1,21246-63-9,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H317:1;H318:1;H314:1
117365,Methyl undec-10-enoate,203-910-8,111-81-9,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1473,H412:2;H302:1466;H332:1466;H400:99;H411:1367;H410:97;Not classified:7
117367,Methyl 4-iodobenzoate,210-597-1,619-44-3,,Notified C&L,12,H319:11;H335:10;H315:11;H411:2
117369,2-(4-chlorophenoxy)-5-(trifluoromethyl)aniline,206-485-7,349-20-2,Acute Tox. 4,REACH registration C&L,2,H302:1;Not classified:1
117374,Pentamethylphosphonic diamide,219-728-7,2511-17-3,,Notified C&L,4,H302:4;H332:4;H312:4
117375,Calcium magnesium tetrahydroxide,254-454-1,39445-23-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,136,H335:121;H318:121;H315:121;Not classified:15
117376,"Cuprate(1-), [4-[[dihydroxy[(2-hydroxy-3,5- dinitrophenyl)azo]phenyl]azo]benzenesulfonato(3-)]-, hydrogen",615-958-0,73297-36-6,Aquatic Chronic 3,Notified C&L,83,H412:83
117383,"12-hydroxyoleic acid, compound with 2-aminoethanol (1:1)",242-546-4,18738-11-9,Not Classified,Notified C&L,9,Not classified:9
117384,"pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate",414-910-4,,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
117386,Ditungsten carbide,235-124-6,12070-13-2,,Notified C&L,7,H228:4;Not classified:3
117392,2-methyl-1-nitroanthraquinone,204-932-0,129-15-7,Carc. 2,Notified C&L,38,H351:38
117393,"3-Aminopropyl(methyl) silsesquioxanes, ethoxy-terminated",603-274-5,128446-60-6,Flam. Liq. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,Notified C&L,47,H317:30;H226:47;H318:30;H314:30;H319:17;H315:17
117394,Ethyl methanesulphonate,200-536-7,62-50-0,Acute Tox. 4;Muta. 1B;Carc. 2,Notified C&L,50,H302:50;H340:42;H351:45;H361:5;H332:4;H312:4;H315:3;H350:2;H319:3;H335:3
117397,Pentamethyldisiloxane,215-873-5,1438-82-0,Flam. Liq. 2,Notified C&L,44,H225:44
117399,N-pentylaniline,220-183-2,2655-27-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H312:1
117400,"Fatty acids, palm kernel-oil, Me esters",293-084-5,91051-32-0,Not Classified,Notified C&L,6,Not classified:6
117402,2-(2-Vinyloxyethoxy)ethyl acrylate,451-690-9,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,2,H317:2;H302:2;H412:2
117405,"N,N-diethyl-4[(2,4-dinitrophenyl)azo]aniline",228-925-7,6373-96-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
117408,"3,4-dicyanoaniline",260-370-6,56765-79-8,Acute Tox. 3,REACH registration C&L,9,H301:9;H311:7;H331:2;H315:2;H319:2;H335:1
117411,"2,2'-(1,3-phenylene)bis(4,5-dihydro-1,3-oxazole)",421-510-3,34052-90-9,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,6,H319:5;H302:5;H317:1
117418,"5,6-epoxyhex-1-ene",233-771-9,10353-53-4,Flam. Liq. 2;Acute Tox. 3,Notified C&L,52,H225:52;H301:51;H302:1;H315:1;H319:1;H332:1;H312:1;H340:1;H311:1;H373:1;H331:1;H350:1
117419,formetanate (ISO);3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate,244-879-0,22259-30-9,Acute Tox. 2;Skin Sens. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H330:0;H300:0;H400:0
117421,Methan(2H)ol,215-933-0,1455-13-6,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT SE 1,Notified C&L,46,H225:46;H311:46;H331:42;H370:46;H301:46;H330:4;Not classified:1
117425,(S)-(-)-1-Phenylpropylamine,609-485-9,3789-59-1,Acute Tox. 4;Skin Corr. 1B,Notified C&L,43,H302:42;H314:43;H411:4;H318:1
117427,"2-(2-aminopropan-2-yl)-4-[(4-fluorobenzyl)carbamoyl]-1-methyl-6-oxo-1,6-dihydropyrimidin-5-yl pivalate",620-134-9,1172131-64-4,Not Classified,REACH registration C&L,4,Not classified:4
117437,Butyl cyanoacetate,226-730-1,5459-58-5,Not Classified,REACH registration C&L,54,Not classified:15;H315:39;H319:39;H332:38;H335:38;H312:38
117440,"Copper, 2,2'-[carbonylbis[imino(1-hydroxy-3-sulfo-6,2-naphthalenediyl)azo]]bis[benzoic acid] complex",253-440-2,37279-47-3,Not Classified,Notified C&L,1,Not classified:1
117443,Diethyl 2-Propynylmalonate,605-851-7,17920-23-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
117444,"Phenanthrene, distn. residues;Heavy Anthracene Oil Redistillate;[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 °C to 420 °C (644 °F to 788 °F). It consists predominantly of phenanthrene, anthracene and carbazole.]",310-169-5,122070-78-4,Carc. 1B,Harmonised C&L,0,H350:0
117450,"Fucus vesiculosus, ext.",283-633-7,84696-13-9,Not Classified,Notified C&L,194,Not classified:191;H226:2;H373:1
117451,Lead selenate,231-199-4,7446-15-3,,Notified C&L,5,H410:5;H360:4;H330:4;H373:5;H301:5;H400:5;H331:1
117454,"N,N-dimethyl-2-[(4-methyl-1,3,2-dioxaborinan-2-yl)oxy]ethylamine",230-306-1,7024-33-1,Eye Irrit. 2,Notified C&L,38,H319:38
117455,Triisodecyl phosphite,246-998-3,25448-25-3,Skin Sens. 1,REACH registration C&L,318,H317:150;H319:97;H315:147;H340:41;H360:41;H335:39;Not classified:14;H336:1
117459,Alpha-cyclopropylbenzyl alcohol,213-749-5,1007-03-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
117460,"1,2,3-Propanetriol, acetate",215-637-1,1335-58-6,Not Classified,Notified C&L,1,Not classified:1
117461,Gold alumina pink corundum,287-564-3,85536-78-3,Not Classified,Notified C&L,1,Not classified:1
117465,Zinc diheptanoate,226-069-9,5261-20-1,Not Classified,Notified C&L,1,Not classified:1
117467,Cyclohexyldimethylamine,202-715-5,98-94-2,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,422,H314:351;H311:263;H226:353;H318:211;H331:217;H411:176;H301:240;Not classified:68;H302:112;H332:69;H400:107;H312:68;H330:66;H412:20;H310:20;H410:14;H335:3;H290:3
117473,Dipropyl carbonate,210-822-3,623-96-1,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H302:38;H226:41;H315:38;H319:38;H332:38;H335:38;H312:38
117475,(2-nitrophenoxy)acetic acid,217-527-9,1878-87-1,,Notified C&L,5,H319:5;H335:4;H315:5
117476,Dipotassium tetrakis(nitrito-N)platinate,237-491-8,13815-39-9,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,3,H334:1;H317:1;H302:3;H332:1;H318:1;H290:1
117479,"Fatty acids, C8-10, compds. with 2,2'-[[3-[(2-hydroxyethyl)amino]propyl]imino]bis[ethanol] N-(C14-18 and C16-18-unsatd. alkyl) derivs.",306-002-0,95465-87-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,9,H319:9;H315:9
117482,Sodium dibenzyldithiocarbamate,259-587-9,55310-46-8,Eye Dam. 1;Aquatic Chronic 1,REACH registration C&L,74,H410:3;H318:3;H302:38;H319:33
117483,3-aminocrotononitrile,214-266-2,1118-61-2,Acute Tox. 2;Acute Tox. 3;Skin Sens. 1,Notified C&L,79,H311:38;H317:78;H300:62;H314:24;H312:24;H319:16;H302:17;H315:1
117488,4'-mercaptoacetanilide,214-427-7,1126-81-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
117489,"Benzenesulfonamide, 4-methyl-, reaction products with formaldehyde and melamine",307-988-5,97808-67-8,Not Classified,REACH registration C&L,3,Not classified:3
117491,1-methoxyhexane-3-thiol,304-874-7,94291-50-6,Not Classified,Notified C&L,89,Not classified:89
117495,"4-[4-(2-chlorophenyl)-2-phenyloxazol-5-yl]-N,N-diethylaniline",259-804-7,55766-52-4,Aquatic Chronic 2,Notified C&L,3,H411:3
117496,"parathion - methyl (ISO);O,O-dimethyl O-4-nitrophenyl phosphorothioate",206-050-1,298-00-0,Flam. Liq. 3;Acute Tox. 2;Acute Tox. 3;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H311:0;H373:0;H330:0;H226:0;H300:0;H400:0
117501,"Cola nitida, ext.",283-621-1,84696-01-5,Flam. Liq. 3,Notified C&L,3,H226:1;Not classified:1;H302:1
117503,"leptophos (ISO);O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate",244-472-8,21609-90-5,Acute Tox. 3;Acute Tox. 4;STOT SE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H370:0;H301:0;H400:0;H312:0
117507,Methyl[3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]ammonium chloride,260-101-2,56296-78-7,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1,Notified C&L,125,H302:122;H318:103;H400:117;H361:21;H332:17;H312:16;H410:9;H330:4;H373:3;H315:10;H336:5;H411:1;H301:2;Not classified:1;H331:1;H362:1
117508,"(3α,7α)-3,7,15-trihydroxy-12,13-epoxytrichothec-9-en-8-one",610-668-0,51481-10-8,Acute Tox. 2,Notified C&L,44,H300:44;H330:2
117509,1-bromo-2-phenylethane,203-130-8,103-63-9,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,83,H319:64;H302:82;H315:26;H335:6;H332:1;H312:1
117510,4-(isopropyl)-β-methylcyclohexaneethanol,266-806-1,67634-03-1,Not Classified,Notified C&L,88,Not classified:78;H319:10
117511,"1-isopropyl-N,N,2,-trimethylpropylamine",259-229-1,54561-96-5,Flam. Liq. 3;Skin Irrit. 2,Notified C&L,38,H226:38;H315:38
117512,"2,4-dichloro-6-morpholino-1,3,5-triazine",229-544-9,6601-22-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,41,H302:40;H335:40;H318:40;H315:41;H319:1
117514,Methyl 4-methoxysalicylate,226-657-5,5446-02-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
117517,17-β-hydroxy-17-α-methyloestr-4-en-3-one,208-183-0,514-61-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,16,H302:16;H360:16;H351:16;H331:16;H332:16;H301:16;H312:16
117520,Iridium tetrahydroxide,215-196-5,1312-46-5,Not Classified,Notified C&L,6,Not classified:5;H302:1;H413:1;H315:1;H319:1;H332:1;H312:1
117522,"Tetrasodium 6,6'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[4-amino-5-hydroxynaphthalene-1,3-disulphonate]",220-026-8,2610-05-1,Carc. 1B,Notified C&L,48,H350:44;H319:5;H361:1
117523,"Oils, Alpinia zerumbet",454-840-1,,Not Classified,Notified C&L,52,Not classified:52
117529,"Alcohols, C10-16, ethoxylated, sulfosuccinates, disodium salts",500-232-7,68815-56-5,Self-heat. 1;Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,626,H302:2;H314:2;H290:2;H317:2;H251:2;H318:54;H319:554;H315:516;Not classified:2
117530,"bronopol (INN);2-bromo-2-nitropropane-1,3-diol",200-143-0,52-51-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Harmonised C&L,0,H302:0;H318:0;H315:0;H335:0;H400:0;H312:0
117533,"1,1'-dibenzyl-4,4'-bipyridinium dichloride",214-158-5,1102-19-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H302:39;H315:39;H319:39;H332:39;H335:38;H312:39
117535,4-HYDROXYPHENYLACETONE,616-432-3,770-39-8,,Notified C&L,6,H319:6;H335:5;H315:6
117536,"[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C",425-520-9,197179-61-6,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H318:0;H400:0
117540,"(5-tert-butyl-2-dimethylcarbamoyl-2H-[1,2,4]triazol-3-ylsulfanyl)-acetic acid ethyl ester",601-165-7,112143-82-5,Acute Tox. 3;Eye Irrit. 2;Acute Tox. 2;Aquatic Acute 1,Notified C&L,127,H330:127;H319:127;H301:127;H400:127
117543,Benzyltrimethylammonium fluoride hydrate,603-205-9,127582-36-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
117544,OO-tert-butyl monoperoxymaleate,217-691-1,1931-62-0,Org. Perox. C;Acute Tox. 3;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,10,H317:5;H242:4;H301:10;H318:10;H241:6
117550,Methyl (R)-aminophenylacetate hydrochloride,243-399-9,19883-41-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,40,H319:40;H335:2;H315:2;H302:1
117551,"Butanedioic acid, sulfo-, C-(2-coco amidoethyl) esters, disodium salts",272-219-1,68784-08-7,,Notified C&L,73,H318:66;H315:37;H319:7
117554,Secnidazole,222-134-0,3366-95-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,8,H302:6;H332:3;Not classified:2
117555,2-nitropropane,201-209-1,79-46-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Carc. 1B,Harmonised C&L,0,H350:0;H302:0;H226:0;H332:0
117558,Trypsin inhibitor,232-906-9,9035-81-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,45,H334:44;H317:44;Not classified:1;H315:1;H319:1;H335:1
117560,Diindium tris(sulphate),236-689-1,13464-82-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,70,H319:56;H335:56;H315:56;Not classified:10;H412:2;H334:2;H317:2;H301:2
117561,1-[[](2'-METHOXYETHYL)AMINO]-2-NITRO-4-[[]DI-(2'-HYDROXYETHYL)AMINO]BENZENE,607-292-4,23920-15-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,12,H319:12;H302:12;H315:6;H332:6;H335:6
117563,"Castor oil, ester with sorbitol",307-007-0,97488-70-5,Not Classified,REACH registration C&L,2,Not classified:2
117570,2-(3-phenylpropyl)pyridine,218-300-7,2110-18-1,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,Notified C&L,1606,H317:1364;H319:1606;H315:1606;H335:42;H373:1;H411:1;H318:1
117573,Pyruvic acid,204-824-3,127-17-3,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,1683,H318:1366;H314:1683;H290:1
117575,1-methylheptyl acetate,218-123-5,2051-50-5,Not Classified,Notified C&L,89,Not classified:89
117576,3-β-hydroxy-5-α-androstan-17-one,207-563-3,481-29-8,Repr. 1B;Lact.,REACH registration C&L,43,H362:2;H360:2;H361:41;H302:17;H351:17;H332:17;H312:17
117577,5-hydroxybenzofuran-2-one,220-252-7,2688-48-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
117579,"Di(isooctadecanoic) acid, diester with glycerol",273-368-5,68958-48-5,Not Classified,Notified C&L,49,Not classified:49
117583,S-methyl hexanethioate,219-410-8,2432-77-1,Flam. Liq. 2;Acute Tox. 4,Notified C&L,91,H225:88;H302:78;H226:2;H319:1;H315:1;Not classified:1
117584,Coke (petroleum),265-080-3,64741-79-3,Not Classified,Notified C&L,28,Not classified:27;H317:1;H350:1;H373:1
117587,Methyl 2-methoxypropionate,241-622-4,17639-76-8,,Notified C&L,4,H319:4;H226:4;H335:4;H315:4
117591,N-ethyl-p-toluidine,210-742-9,622-57-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,Notified C&L,15,H311:13;H412:14;H373:13;H331:13;H301:13;H330:2;H310:2;H300:2;H315:2;H319:2;H335:1
117592,"Naphthenic acids, reaction products with diethylenetriamine",268-610-1,68131-13-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,76,H410:41;H317:61;H315:63;H319:61;H400:41;H411:21;H314:10;H302:4;Not classified:5
117595,"Extract oils (coal), tar base;Acid Extract;[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.]",266-020-9,65996-86-3,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
117602,"Charcoal, activated",264-846-4,64365-11-3,Not Classified,Notified C&L,74,Not classified:72;H319:2;H335:2;H315:2
117603,({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid,604-571-2,147127-20-6,Eye Dam. 1,REACH registration C&L,2,H318:2
117611,3-bromophenetole,220-186-9,2655-84-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
117616,"Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C",270-728-3,68477-39-4,Asp. Tox. 1,Harmonised C&L,0,H304:0
117620,"(E)-[(3,7-dimethyl-2,6-octadienyl)oxy]acetaldehyde",265-743-7,65405-73-4,Not Classified,Notified C&L,88,Not classified:88
117621,"3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene",224-778-8,4488-57-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,89,H302:1;H226:89;H331:1;H411:1;H315:1;H319:1;H335:1
117622,Oxodiphenylstannane,218-883-8,2273-51-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H302:42;H315:42;H319:42;H332:42;H335:42;H312:42;Not classified:1
117624,Dotriacontane,208-881-5,544-85-4,Not Classified,Notified C&L,7,Not classified:7
117628,"2,2-dioxo-1,2λ*6*-benzoxathiin-4-one",610-468-3,49670-47-5,Not Classified,REACH registration C&L,2,Not classified:2
117629,Thulium tribromide,238-444-4,14456-51-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
117632,Calcium di(octanoate),228-067-3,6107-56-8,Aquatic Chronic 3,REACH registration C&L,9,H412:2;Not classified:6;H319:1;H315:1
117633,"Isostearic acid, ethoxylated",611-343-6,56002-14-3,Not Classified,Notified C&L,441,Not classified:441
117635,Poly(ethylene-co-methyl acrylate),607-546-4,25103-74-6,Not Classified,Notified C&L,127,Not classified:89;H319:38;H335:38;H315:38
117636,"Tetrasodium 4,4'-bis[[4-chloro-6-[(4-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate",253-360-8,37138-26-4,Not Classified,Notified C&L,1,Not classified:1
117638,Bis(p-nitrophenyl) carbonate,225-775-4,5070-13-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,46,H319:46;H315:46;H302:2
117640,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctyl acrylate",206-212-1,307-98-2,,Notified C&L,8,H319:8;H335:7;H315:8
117644,hexan-1-ol,203-852-3,111-27-3,Acute Tox. 4,Harmonised C&L,0,H302:0
117645,"3-[5-chloro-2-phenoxyphenyl]-1-methyl-2,4-pyrrolidinon",921-770-2,,Muta. 2,Notified C&L,16,H341:16
117646,"Almond, ext., hydrolyzed",309-327-6,100209-19-6,Not Classified,Notified C&L,83,Not classified:83
117651,Tetrahydroxysilane,233-477-0,10193-36-9,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,3,H318:2;H314:2;Not classified:1
117652,Potassium hydroxyacetate,247-326-1,25904-89-6,Not Classified,Notified C&L,59,Not classified:59
117653,"Methyl 2,3-O-(1-methylethylidene)-5-O-[(4-methylphenyl)sulfonyl]-ß-D-ribofuranoside",609-920-2,4137-56-8,Self-react. E,REACH registration C&L,2,H242:2
117655,2-Bromo-4'-(trifluoromethyl)acetophenone,609-544-9,383-53-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:38;H335:38;H315:38;H314:3;H302:1;H290:1;H318:1;H332:1;H312:1
117656,2-heptylidenecyclopentan-1-one,254-339-6,39189-74-7,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,250,H317:50;H315:250
117657,Octylamine,203-916-0,111-86-4,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,720,H335:89;H314:719;H311:111;H226:688;H318:651;H411:42;H332:213;H301:537;H400:216;H410:47;H302:183;H312:124;H412:33;H310:4
117658,"Pyrimidine-4,5,6-triamine sulphate (1:1)",256-446-3,49721-45-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
117659,Tetrafluorophthalic anhydride,211-485-5,652-12-0,,Notified C&L,8,H319:8;H335:7;H315:8
117662,Diiodine pentaoxide,234-740-2,12029-98-0,Ox. Sol. 2;Skin Corr. 1B;Eye Dam. 1,Notified C&L,48,H272:48;H318:40;H314:47;Not classified:1;H319:1;H315:1
117665,indium phosphide,244-959-5,22398-80-7,Carc. 1B;STOT RE 1;Repr. 2,Harmonised C&L,0,H361:0;H350:0;H372:0
117666,Potassium isononanoate,282-991-1,84501-71-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H302:2;H315:3;Not classified:1
117668,"1-chloro-9,10-bis(phenylethynyl)anthracene",255-220-1,41105-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
117672,Carzenide,205-327-4,138-41-0,,Notified C&L,6,H319:6;H335:6;H315:6;H302:2;H332:1;H312:1
117673,"2-hydroxyethanesulphonic acid, compound with 4,4'-[hexane-1,6-diylbis(oxy)]bis[benzenecarboxamidine] (2:1)",211-533-5,659-40-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,120,H302:64;H410:1;H400:1;Not classified:56;H319:23;H411:23;H332:1
117676,"2,2-dimethyl-1,3-dioxane-4,6-dione",217-992-8,2033-24-1,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,46,H411:10;H400:10;H315:17;H319:24;Not classified:12;H335:7
117677,tetraphosphorus trisulphide;phosphorus sesquisulphid,215-245-0,1314-85-8,Flam. Sol. 2;Water-react. 1;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H302:0;H228:0;H400:0;H260:0
117684,"2,6-bis[2-(dimethylamino)ethoxy]pyridine",249-633-6,29449-91-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
117686,"Methyl 2,3-dimethoxybenzoate",218-425-7,2150-42-7,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H335:1;H315:1
117688,"5-[(4-chloro-2-nitrophenyl)azo]-1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-2-oxonicotinonitrile",274-660-5,70528-90-4,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,28,H410:5;H400:4;Not classified:23
117689,Molybdophosphoric acid,610-660-7,51429-74-4,Ox. Sol. 3;Skin Corr. 1B,Notified C&L,49,H272:41;H314:49;H224:4;H318:4;H413:1
117691,"Polysulfides, di-tert-dodecyl",270-335-7,68425-15-0,Skin Sens. 1B,REACH registration C&L,235,H317:2;H413:200;Not classified:33
117692,Lithium propionate,229-429-3,6531-45-9,Not Classified,Notified C&L,4,Not classified:3;H411:1;H412:1;H315:1
117693,"Distillates (petroleum), hydrotreated heavy naphthenic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-155-0,64742-52-5,Carc. 1B,Harmonised C&L,0,H350:0
117695,Triisononylamine,254-104-8,38725-13-2,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H317:2;H410:2;H400:2;H315:2
117699,reaction mass of: ethyl exo-tricyclo[5.2.1.0,407-520-0,80657-64-3,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
117703,Diammonium tetraborate,234-513-8,12007-58-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H335:3;H315:3
117704,2-bromobutyryl bromide,247-441-7,26074-52-2,Skin Corr. 1B;STOT SE 3,Notified C&L,41,H335:38;H314:41;H290:2;H318:2;H317:1;H302:1
117705,"2,8-diphenylanthra[2,1-d:6,5-d']bisthiazole-6,12-dione",204-931-5,129-09-9,Not Classified,Notified C&L,27,Not classified:16;H319:11;H315:6
117708,[No public or meaningful name is available],448-660-2,,Not Classified,Notified C&L,83,Not classified:83
117713,Calcium succinate,205-445-6,140-99-8,Not Classified,Notified C&L,1,Not classified:1
117715,Cacotheline,209-215-6,561-20-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H311:1;H301:1;H331:1
117716,1-[(4-chloro-2-nitrophenyl)azo]-2-naphthol,229-094-3,6410-13-5,Not Classified,Notified C&L,5,Not classified:5
117719,"Disodium 1,2-dihydroxyethane-1,2-disulphonate",208-233-1,517-21-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,36,H319:36;H335:35;H315:36
117720,"Naphthenic acids, reaction products with polyethylenepolyamines",265-230-8,64755-04-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:3;H335:3;H315:3;Not classified:1
117721,"1,3-dihydro-1,3-dioxo-2H-isoindole-2-propionic acid",222-083-4,3339-73-9,,Notified C&L,8,H319:8;H335:7;H315:8
117724,copper hydroxide nitrate,601-793-1,12158-75-7,Ox. Sol. 3;Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H302:1;H410:1;H272:1;H318:1;H400:1
117725,2-ethoxynaphthalene-1-carbonyl chloride,259-502-5,55150-29-3,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,12,H319:4;H315:4;H302:3;H332:3;H314:8;H290:1;H318:1
117729,"1,3-Dioxolan-2-one polymer with 1,6-hexanediol and 1,5-pentanediol",603-596-6,132459-81-5,Not Classified,Notified C&L,2,Not classified:1;H319:1;H332:1;H315:1
117730,5-hydroxypentan-2-one,213-994-8,1071-73-4,Not Classified,Notified C&L,74,Not classified:72;H319:2;H335:2;H315:2
117731,Isodecyl phenyl hydrogen phosphite,269-745-9,68311-09-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,7,H410:5;H400:5;Not classified:1;H319:1;H315:1
117732,"1,4-Bis(hexafluoro-alpha-hydroxyisopropyl)benzene Hydrate",606-403-3,1992-15-0,,Notified C&L,5,H319:5;H335:4;H315:5
117735,Chlorophyllins,287-483-3,85536-03-4,,Notified C&L,1,Not classified:1
117736,"Naphtha (petroleum), heavy steam-cracked, hydrogenated;Low boiling point hydrogen treated naphtha",295-432-1,92045-51-7,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
117737,Chloro(dicyclohexyl)phosphane,605-396-4,16523-54-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,47,H318:42;H314:47;H290:1
117738,Phenylphosphine,211-325-4,638-21-1,Pyr. Liq. 1;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,42,H250:42;H335:42;H311:38;H331:38;H315:42;H319:42;H301:38;H252:4;H332:4
117739,"3-[4-[[4-(dimethylcarbamoylamino)phenyl]methyl]phenyl]-1,1-dimethylurea",619-979-6,10097-09-3,Aquatic Chronic 3,Notified C&L,108,H412:69;H410:38;H400:38;Not classified:1
117742,4-Aminobenzylamine,610-164-0,4403-71-8,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1
117747,"3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctanesulphonyl chloride",248-576-4,27619-89-2,Not Classified,REACH registration C&L,34,Not classified:33;H334:1;H317:1
117748,ethyl 2-oxo-4-phenylpyrrolidine-3-carboxylate,610-841-0,52450-32-5,Acute Tox. 4,REACH registration C&L,40,H302:40
117752,"2-(allyloxy)-1,3,5-tribromobenzene",221-913-2,3278-89-5,Not Classified,Notified C&L,17,Not classified:17
117754,"6,7-dimethoxy-2-quinolone",226-101-1,5278-38-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
117756,METHYL BROMO(PHENYL)ACETATE,608-480-9,3042-81-7,Skin Corr. 1B,Notified C&L,51,H314:51;H290:1;H318:1
117757,Sodium acetate,204-823-8,127-09-3,Not Classified,REACH registration C&L,1308,Not classified:1250;H319:53;H371:4;H332:4;H302:1;H315:1
117764,"N-a-Fmoc-a-aminoisobutyric acid, N-Fmoc-C-a-methylalanine",619-072-5,94744-50-0,Not Classified,Notified C&L,4,Not classified:3;H319:1;H302:1;H332:1;H312:1
117766,"1-Hexanol, 2-ethyl-, manuf. of, by-products from, distn. residues",271-832-1,68609-68-7,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,218,H412:161;H315:135;H319:57;H411:57
117772,1-CYCLOPROPYLMETHYL-4-METHOXYBENZENE,444-110-0,16510-27-3,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1289,H317:1289;H319:1287;H411:1289;H318:2
117773,cis-propenylphosphonic acid,246-928-1,25383-06-6,Skin Corr. 1A,Notified C&L,2,H314:2
117776,Phenacetin,200-533-0,62-44-2,Acute Tox. 4;Carc. 1B,Notified C&L,158,H350:154;H302:158;H332:3;H312:3;H341:2
117777,"1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate",925-259-5,,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,2,H317:2;H412:1
117779,"Lithium 4-[(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)azo]-2,5-dichlorobenzenesulphonate",257-768-7,52236-73-4,Not Classified,REACH registration C&L,4,Not classified:4
117780,N-aminorhodanine,215-870-9,1438-16-0,Acute Tox. 2;Acute Tox. 2,Notified C&L,39,H310:38;H300:39;H311:1
117783,"Sulfonic acids, petroleum, potassium salts",271-779-4,68608-24-2,Eye Irrit. 2,Notified C&L,8,H319:8
117787,2-bromoethyltrimethylammonium bromide,220-419-4,2758-06-7,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,43,H311:38;H331:38;H301:43;H314:38;H335:4;H318:4;H315:5;H319:1
117788,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 4,4'-methylenedianiline",500-194-1,68130-79-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,26,H317:16;H319:16;H411:16;H315:16;Not classified:10
117790,Aluminum barium magnesium oxide,264-456-4,63774-55-0,Not Classified,Notified C&L,8,Not classified:8
117798,Phenyl vinyl sulphone,226-890-2,5535-48-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,48,H302:40;H317:44;H318:39;H315:47;H335:46;H319:8;H341:2;Not classified:1
117800,Tris(p-isocyanatophenyl) thiophosphate,223-981-9,4151-51-3,Acute Tox. 4,REACH registration C&L,114,H302:10;H334:96;Not classified:8
117802,"2,4,5,6(1H,3H)-Pyrimidinetetrone, monohydrate",607-078-0,2244-11-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:42;H332:42;H312:42;H319:2;H315:1;H335:1
117804,Essential oil Schinus Terebinthifolius (Anacardiaceae) obtained from red berries by supercritical carbon dioxide extraction (indicative),481-880-7,949495-68-5,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,100,H317:75;H226:75;H304:75;H411:49;H302:12;H315:51;H319:50;H410:26;H400:26;H412:25
117807,Platinum tetraiodide,232-207-9,7790-46-7,,Notified C&L,4,H314:4
117809,Amorpohous Alimina Silicate,618-970-4,93763-70-3,Not Classified,Notified C&L,253,Not classified:212;H319:41;H335:41;H315:39
117812,Indan-5-carbaldehyde,250-036-8,30084-91-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H302:3;H315:3;H319:3;H332:3;H335:3;H312:3;H412:1
117817,"1,4-diethyl 2,3-bis(propan-2-ylidene)butanedioate",607-155-9,22769-97-7,Not Classified,REACH registration C&L,2,Not classified:1;H411:1
117821,"Hexasodium 7,7'-(carbonyldiimino)bis[4-hydroxy-3-[[2-sulphonato-4-[(4-sulphonatophenyl)azo]phenyl]azo]naphthalene-2-sulphonate]",220-027-3,2610-10-8,Aquatic Chronic 3,REACH registration C&L,94,H412:30;H411:42;H319:20;Not classified:16;H315:6
117822,Methyl pivalate,209-959-1,598-98-1,Flam. Liq. 2,Notified C&L,55,H225:54;H302:14;H411:2;H319:1;H335:1
117825,"Starch, 2-hydroxypropyl ether, polymer with 2-(chloromethyl)oxirane",614-462-1,68412-87-3,Not Classified,Notified C&L,81,Not classified:81
117826,Pyridin-3-ol 1-oxide,229-545-4,6602-28-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,39,H302:38;H351:38;H315:39;H319:39;H332:38;H335:38;H312:38
117833,"1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate",431-010-7,154486-26-7,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0;H318:0
117835,Diethyl sulphide,206-526-9,352-93-2,Flam. Liq. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1471,H225:1471;H319:48;H412:1;H315:46;H302:22;H331:22;H335:4;H371:1
117837,"Disodium 4,5-dihydro-5-oxo-1-(4-sulphonatophenyl)-1H-pyrazole-3-carboxylate",222-444-6,3473-75-4,Skin Sens. 1,REACH registration C&L,2,H317:2
117839,Tetraethylammonium benzoate,240-957-3,16909-22-1,Acute Tox. 4,REACH registration C&L,55,H302:1;H319:54;H335:54;H315:54
117846,Euterpe precatoria extract,472-120-5,906655-61-6,Skin Sens. 1B,Notified C&L,25,H317:25
117847,"Fatty acids, tall-oil, mixed with naphthenic acids, reaction products with diethylenetriamine",293-125-7,91051-71-7,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,56,H302:56;H411:56;H318:55;H314:56
117850,2-isopropoxyethyl salicylate,279-348-2,79915-74-5,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,249,H317:16;H302:34;Not classified:215
117853,6-nitropiperonal,211-926-1,712-97-0,,Notified C&L,5,H319:5;H335:5;H315:5
117854,"3,6,9,12,15,18,21,24-octaoxahexacosane-1,26-diol",222-206-1,3386-18-3,Eye Irrit. 2,Notified C&L,2,H319:2;H335:1;H315:1
117855,(+)-3-methylcyclopentanone,229-711-6,6672-30-6,Flam. Liq. 3,Notified C&L,38,H226:38
117857,N-(2-chloroethyl)acetamide,230-884-5,7355-58-0,,Notified C&L,8,H319:7;H335:6;H315:7;H373:2;H302:1
117859,"10,11-dihydro-5H-dibenz[b,f]azepine",207-787-1,494-19-9,Skin Sens. 1,REACH registration C&L,64,H317:22;H319:41;H410:1;H400:1;Not classified:1;H315:2;H335:1
117861,"5-amino-4-chloro-2-methyl-2,3-dihydropyridazin-3-one",605-639-4,17254-80-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 1,Notified C&L,1,H319:1;H410:1;H335:1;H315:1
117863,"Tris(2,3-dibromopropyl) phosphate",204-799-9,126-72-7,Acute Tox. 4;Skin Irrit. 2;Carc. 1B;Aquatic Acute 1,Notified C&L,41,H350:38;H302:41;H400:38;H315:38
117864,4-isothiocyanatobenzonitrile,220-323-2,2719-32-6,Skin Corr. 1B,Notified C&L,45,H314:43;H302:5;H332:4;H312:5;H335:3;H311:2;H331:3;H315:2;H319:2;H301:2
117865,2-tert-butyl-6-methylaniline,236-044-4,13117-94-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
117866,"Hydrocarbon waxes (petroleum), oxidized, Me esters, barium salts",271-637-1,68603-10-1,Not Classified,REACH registration C&L,443,Not classified:2;H302:441;H332:441
117868,"p,p',p''-tris(dimethylamino)trityl alcohol",207-396-6,467-63-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,44,H302:43;H410:4;H400:4;Not classified:1
117869,"(2S,5R,6R)-6-[[(2R)-2-Amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate.",615-347-9,7177-48-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,1426,H334:1425;H317:1398;H315:1389;H319:1389;H335:1388;H351:1;H362:1;H302:1
117870,Ammonium bis[4-[(5-chloro-2-hydroxy-phenyl)azo]-3-hydroxy-N-phenyl-2-naphthalenecarboxamidato(2-)]ferrate (1-),403-590-1,,Not Classified,REACH registration C&L,4,Not classified:4
117872,"2,5-cyclohexadien-1-one, 4-[[4-(phenylamino)phenyl]imino]-, reaction products with sodium sulfide (Na2(Sx)), leuco derivatives",235-518-8,12262-26-9,Not Classified,REACH registration C&L,38,Not classified:38
117877,"Hawthorn, Crataegus oxyacantha, ext.",283-262-0,84603-61-2,Not Classified,Notified C&L,5,Not classified:3;H319:1;H226:2
117879,"Lead 2,4-dihydroxybenzoate",244-118-2,20936-32-7,Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H302:1;H410:1;H373:1;H332:1;H360:1;H400:1
117880,Copper oxide,215-706-6,1344-70-3,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,170,H302:170;H410:170;H400:170
117881,"Benzenemethanol, 2-[2-phenyl-4-(phenylmethyl)-1-piperazinyl]-, (2E)-2-butenedioate (salt)",605-121-8,157994-99-5,,Notified C&L,1,H302:1;H332:1;H312:1
117882,sodium;2-hexadecylsulfanyl-1H-benzimidazole-5-sulfonate,616-081-6,743423-33-8,Eye Dam. 1;Aquatic Chronic 4,REACH registration C&L,1,H318:1;H413:1;H360:1
117883,"Proteinase, Tritirachium album serine",254-457-8,39450-01-6,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,184,H334:183;H319:183;H315:183;H317:47;H335:62
117885,"Potassium sodium 5-(5-(4-chloro-6-(4-sulfonatophenylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinemethanesulfonate",402-480-0,111850-26-1,Not Classified,REACH registration C&L,1,Not classified:1
117890,"1,1'-[propane-1,3-diylbis(oxy)]bis(2-bromo-4-tert-butylbenzene)",925-064-5,,Not Classified,Notified C&L,1,Not classified:1
117891,"1,4-dioxan-2-one",608-477-2,3041-16-5,Eye Dam. 1,REACH registration C&L,2,H318:1;H319:1;H315:1
117892,3-methyl-5-phenylpent-2-enenitrile,299-682-2,93893-89-1,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1A;Aquatic Chronic 3,REACH registration C&L,321,H317:283;H302:321;H412:283;H332:38;H312:38
117893,"[nitrilotris(methylene)]trisphosphonic acid, compound with 2,2',2''-nitrilotris[ethanol]",276-623-9,72379-89-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
117894,5-{5-chloro-3-[4-(methylsulfonyl)phenyl]pyridin-2-yl}-2-methylpyridinium 4-methylbenzenesulfonate,619-811-1,287930-71-6,Acute Tox. 4;Lact.;STOT RE 2,REACH registration C&L,37,H362:1;H373:37;H302:37;H319:36;H412:36
117899,9-methylenenonadecane,482-350-8,,Acute Tox. 4,Notified C&L,1,H332:1
117901,1-amino-4-[(4-methoxyphenyl)amino]anthraquinone,245-405-5,23060-42-6,Aquatic Chronic 4,Notified C&L,38,H413:38
117904,N-(carbamoylmethyl)taurine,230-908-4,7365-82-4,Not Classified,REACH registration C&L,30,Not classified:28;H319:2;H335:2;H315:2
117906,4-isopropylcyclohexanol,225-035-0,4621-04-9,Eye Irrit. 2,REACH registration C&L,1595,H319:37;H318:1557;H315:1
117909,"1,3-Propanediol, 2,2-dimethyl-, C5-9 carboxylates",288-342-9,85711-80-4,Not Classified,REACH registration C&L,1,Not classified:1
117910,"Benzenesulfonic acid, 4-C10-14-alkyl derivs., sodium salts",294-224-8,91696-66-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,38,H302:37;H318:37;H315:37;Not classified:1
117915,N-decyl-4-nitrobenzamide,445-880-0,64026-19-3,Aquatic Chronic 4,Harmonised C&L,0,H413:0
117916,2-methoxyphenetole,241-571-8,17600-72-5,Eye Dam. 1,Notified C&L,39,H318:38;H302:1;H332:1;H312:1
117922,4-amino-N-[3-(diethylamino)propyl]benzamide,700-444-1,106595-73-7,,Notified C&L,1,Not classified:1
117925,"Slags, nickel smelting",920-632-9,,,REACH registration C&L,1,Not classified:1
117930,3-methylbenzo[b]thiophene,215-934-6,1455-18-1,Acute Tox. 4,Notified C&L,39,H302:39
117931,"reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate;hexasodium phosphonobutane-1,2,3,4-tetracarboxylate",410-800-5,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
117932,"1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, (2a, 6a, 8a, 9ab)-, monomethanesulfonate monohydrate",601-404-5,115956-13-3,Acute Tox. 4,Notified C&L,2,H302:2;H318:1
117939,"4-poly(propyl), benzene sulfonic acid",919-274-6,,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H314:1;H317:1;H411:1;H318:1;H335:1
117940,"3-methyl-7-propylpurine-2,6-dione",611-243-2,55242-64-3,Acute Tox. 4,REACH registration C&L,7,H302:7
117942,"4'-[2-(4-Chlorphenyl)ethyl]-4-ethyl-2-fluor-1,1'-biphenyl",603-506-5,131739-14-5,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
117943,"1,3-bis(3-chloropropyl)-1,1,3,3-tetramethyldisiloxane",242-018-3,18132-72-4,,Notified C&L,1,H319:1;H335:1;H315:1
117944,4-isopropylbenzonitrile,237-492-3,13816-33-6,Aquatic Chronic 2,REACH registration C&L,1453,H411:1335;Not classified:110;H319:6;H335:6;H315:7;H317:1
117948,"2-methylprop-1-ene, pentamer",610-010-2,42278-27-3,Asp. Tox. 1,REACH registration C&L,1,H304:1
117949,Diiron zinc tetraoxide,235-052-5,12063-19-3,Not Classified,Notified C&L,35,Not classified:31;H410:4;H318:4;H372:4;H315:4;H370:4
117955,"Methyl 2,2-dimethylacetoacetate",254-189-1,38923-57-8,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H227:1;H319:1;H335:1;H315:1
117957,Heptadecan-1-ol,215-932-5,1454-85-9,Not Classified,Notified C&L,95,Not classified:91;H319:4;H335:4;H315:4
117958,"Ethyl 2,4-dichloropyrimidine-5-carboxylate",257-531-8,51940-64-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
117963,POLYOXYETHYLENE DIOLEATE,618-407-2,9005-07-6,Not Classified,Notified C&L,646,Not classified:625;H319:21
117967,"Pelargonium odoratissimum, ext.",290-141-6,90082-52-3,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,109,H412:106;H317:109;H318:104;H315:109;H304:109;H411:2;H319:4;H302:1;H410:1;H226:1;H400:1;H312:1
117972,"Gardenia jasminoides, ext.",296-280-9,92457-01-7,Not Classified,Notified C&L,1,Not classified:1
117976,Trioleyl phosphate,221-983-4,3305-68-8,Not Classified,Notified C&L,1,Not classified:1
117981,Yellow JGW 743 REG,437-960-9,,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,37,H318:37;H412:37
117982,"[2,2-bis[(3,7-dimethyl-2,6-octadienyl)oxy]ethyl]benzene",266-805-6,67634-02-0,Not Classified,Notified C&L,88,Not classified:88
117983,2-mercaptoethyl acetate,227-509-2,5862-40-8,Acute Tox. 4,Notified C&L,38,H302:38
117985,"(1,2-dichloroethyl)benzene",214-035-6,1074-11-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Carc. 2,Notified C&L,38,H302:38;H351:38;H318:38;H331:38;H315:38;H335:38
117986,(Meta)acrylic ester co-polymer,607-492-1,25035-69-2,Not Classified,Notified C&L,141,Not classified:140;H319:10;H335:9;H315:10;H371:1;H334:1
117987,4-(Isopropoxycarbonyl)benzeneboronic acid,608-957-1,342002-82-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
117988,Lead sulphate,231-198-9,7446-14-2,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,87,H302:87;H410:87;H373:87;H332:87;H360:87;H400:86
117990,"Sebacic acid, compound with hexane-1,6-diamine (1:1)",229-177-4,6422-99-7,Not Classified,REACH registration C&L,59,Not classified:59
117993,2-methyl-3-(p-tolyl)propionaldehyde,255-410-4,41496-43-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1634,H319:1551;H315:1634;H411:83
117994,Diisooctyl sebacate,248-333-2,27214-90-0,Not Classified,Notified C&L,1,Not classified:1
117997,"Cyclopentanol, 1,2-dimethyl-3-(1-methylethenyl)-, 1-acetate",619-014-9,94346-09-5,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,10,H411:10;H315:10
117999,Silver(1+) perfluorooctanoate,206-402-4,335-93-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
118000,5-methylpyrimidine,218-006-9,2036-41-1,Flam. Sol. 2;Acute Tox. 4,Notified C&L,44,H302:38;H228:42;H319:6;H335:6;H315:6;H226:1
118005,"2,3-dimethoxybenzylamine",224-515-7,4393-09-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:40;H335:40;H315:40;H318:2;H314:2
118006,2-isopropenyl-5-methylhex-4-enyl acetate,247-327-7,25905-14-0,Not Classified,Notified C&L,89,Not classified:89
118007,Trihexyphenidyl hydrochloride,200-142-5,52-49-3,Acute Tox. 4,Notified C&L,9,H302:7;H332:2;H312:2;H360:2;H301:2;H317:2;H315:2;H350:2;H319:2;H335:2;Not classified:1
118008,"1,2,3,7,8,9-hexahydro-2,8-dithioxo-6H-purin-6-one",240-120-2,15986-32-0,,Notified C&L,4,H319:4;H335:4;H315:4
118009,"Alcohols, C8-10, ethoxylated, sulfates, ammonium salts",500-233-2,68891-29-2,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,535,H318:93;H315:534;H319:442;H317:1
118010,[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium] methyl sulphate,238-129-1,14254-17-2,Eye Dam. 1,Notified C&L,8,H318:7;H412:2;Not classified:1
118011,"5-(Acetylamino)-2-((4-Amino-(2,5-Bis(2-Acetyloxy)Ethoxy)phenyl)Diazenyl)Benzene Sulfonic Acid, Sodium salt",917-522-8,,Not Classified,Notified C&L,1,Not classified:1
118013,Octan-1-ol,203-917-6,111-87-5,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,3353,H319:3316;H412:628;H302:498;H312:498;H410:28;H225:28;H318:28;H336:29;H335:56;H400:28;H315:756;H226:22;Not classified:9;H411:4;H341:3
118020,(2-methoxyphenoxy)acetic acid,217-526-3,1878-85-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,44,H319:44;H302:38;H315:44;H335:5
118023,"3,5-diisopropylpyrocatechol",218-386-6,2138-49-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
118024,"Zeolite, silica rich, without aluminium, crystalline, synthetic, non fibrous",930-986-6,,Not Classified,REACH registration C&L,1,Not classified:1
118025,"Cyclohexanecarboxaldehyde, 4-propyl-",606-681-6,209735-40-0,Not Classified,Notified C&L,1,Not classified:1
118026,Tetrasodium [2-[[1-hydroxy-3-sulpho-6-[[3-sulpho-4-[2-[2-sulpho-4-[[4-[(4-sulphophenyl)azo]phenyl]-ONN-azoxy]phenyl]vinyl]phenyl]-NNO-azoxy]-2-naphthyl]azo]benzoato(6-)]cuprate(4-),277-494-1,73507-19-4,Not Classified,Notified C&L,15,Not classified:15
118028,Oct-2-enal,219-115-4,2363-89-5,,Notified C&L,1544,H319:1286;H315:1286;Not classified:258
118030,"Sodium [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino]methanesulphonate",200-694-7,68-89-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,67,H334:47;H317:47;H302:11;H351:9;H412:5;Not classified:4;H341:1
118035,Praseodymium,231-120-3,7440-10-0,Not Classified,REACH registration C&L,140,Not classified:45;H413:26;H251:26;H315:28;H319:28;H228:26;H250:67;H260:4;H252:4;H335:2
118042,Ethyl pent-2-yn-1-oate,259-588-4,55314-57-3,Flam. Liq. 3;Eye Dam. 1;Resp. Sens. 1,Notified C&L,39,H334:38;H226:39;H318:38;H319:1;H335:1;H315:1
118046,"1,2-Ethanediamine, N-(2-aminoethyl)-, reaction products with epichlorohydrin",615-730-0,72207-68-2,Acute Tox. 4,Notified C&L,1,H302:1
118053,Pent-2-yne,210-989-2,627-21-4,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H225:44;H319:44;H335:43;H315:44;H304:5
118055,Dihydrazinium sulphate,236-688-6,13464-80-7,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,70,H410:70;H311:70;H317:70;H331:70;H350:70;H301:70;H400:70
118057,Dimethyldioctadecylammonium bromide,223-037-6,3700-67-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,59,H319:55;H335:58;H315:59;H410:4;H318:4;H400:4;H317:2
118062,"2,3,3-TRIMETHYLINDAN-1-ONE",459-090-9,54440-17-4,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,1291,H412:1291;H315:1291
118066,"3-[(6-deoxy-α-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-benzopyran-4-one",241-856-7,17912-87-7,,Notified C&L,2,Not classified:2
118067,β-bromostyrene,203-131-3,103-64-0,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,138,H317:1;H302:138;H412:1
118072,(E)-2-methyl-4-phenylpent-2-enal,618-755-5,91495-55-5,Not Classified,REACH registration C&L,2,Not classified:2
118073,"Charcoal, plant, ext.",307-008-6,97488-71-6,Not Classified,Notified C&L,1,Not classified:1
118077,"2-heptyl-3,4-bis(9-isocyanatononyl)-1-pentylcyclohexane",269-419-6,68239-06-5,Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1;STOT SE 3,Notified C&L,70,H334:67;H319:36;H335:69;H331:33;H315:4;H317:2;H302:3
118080,"Hydrogen 3,6-bis(diethylamino)-9-(2,4-disulphonatophenyl)xanthylium",220-025-2,2609-88-3,Not Classified,Notified C&L,1,Not classified:1
118081,"Tetrasodium [[[[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-2-sulphophenyl]amino]sulphonyl]-29H,31H-phthalocyaninetrisulphonato(6-)-N29,N30,N31,N32]cuprate(4-)",235-429-4,12225-39-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,59,H319:46;H335:59;H315:59;H320:13
118082,"fenazaquin (ISO);4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline",410-580-0,120928-09-8,Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H332:0;H301:0;H400:0
118087,3-ethyl-2-methylbenzoxazolium iodide,226-068-3,5260-37-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
118089,6-(methylthio)-1H-purin-2-amine,214-833-4,1198-47-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H335:38;H318:38;H315:38
118096,"Methyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate",263-308-6,61898-95-1,,Notified C&L,1,H315:1
118097,"Benzenesulfonic acid, 4-amino-, diazotized, coupled with diazotized xylidine and resorcinol",305-459-3,94552-14-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
118103,"transfluthrin (ISO);2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate",405-060-5,118712-89-3,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H315:0
118107,"Residues (petroleum), thermal cracked;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C",265-081-9,64741-80-6,Carc. 1B,Harmonised C&L,0,H350:0
118108,Trisilver orthophosphate,232-049-0,7784-09-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:46;H335:46;H315:46;H410:2;H318:2;H400:2
118109,"Oils, guaiac wood",616-975-6,8016-23-7,Not Classified,Notified C&L,119,Not classified:80;H315:39
118111,"9,9-bis(4-hydroxyphenyl)fluorene",406-950-6,3236-71-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H410:0;H400:0;H315:0
118113,dimethylcarbamoyl chloride,201-208-6,79-44-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 1B,Harmonised C&L,0,H302:0;H331:0;H315:0;H350:0;H319:0;H335:0
118114,5-methyl-2-phenyl-1H-imidazole-4-carboxylic acid,249-261-4,28824-94-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
118123,Methyl 2-hydroxy-2-methylpropionate,218-301-2,2110-78-3,Flam. Liq. 3,REACH registration C&L,115,H226:115;H318:16
118129,tetrachloroethylene,204-825-9,127-18-4,Carc. 2;Aquatic Chronic 2,Harmonised C&L,0,H351:0;H411:0
118130,"Decanoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",261-445-6,58793-73-0,Not Classified,Notified C&L,1,Not classified:1
118131,"Alcohols, C12-13, ethoxylated, phosphates",500-193-6,68130-45-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,8,H318:7;H314:7;H315:1;Not classified:1
118140,"Tris[[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthyl]methylene]cyclohexa-2,5-dien-1-ylidene]diethylammonium] [29H,31H-phthalocyaninetrisulphonato(5-)-N29,N30,N31,N32]cuprate(3-)",277-087-9,72928-62-2,Not Classified,Notified C&L,2,Not classified:2
118143,Tartaric anhydride dibenzoate,241-621-9,17637-11-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,39,H319:39;H335:39;H315:39
118146,"Lecithins, hydroxylated",232-440-6,8029-76-3,Not Classified,Notified C&L,148,Not classified:148
118149,"2-Pyrrolidinone,1-ethenyl-,polymer with N,N,N-trimethyl-3-[(2-methyl-1-oxo-2-propenyl)amino]-1-propanaminium chloride",603-542-1,131954-48-8,Not Classified,Notified C&L,57,Not classified:36;H411:21;H315:21
118153,"Tris(oxiranylmethyl) benzene-1,2,4-tricarboxylate",230-638-7,7237-83-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,497,H317:496;H319:496;H411:318;H315:496;H410:1
118155,"8-(1-methoxyethoxy)-2,6-dimethyloct-2-ene",268-243-7,68039-24-7,Not Classified,Notified C&L,126,Not classified:88;H413:38
118156,Zinc bis[12-hydroxyoctadecanoate],252-669-5,35674-68-1,Not Classified,REACH registration C&L,14,Not classified:14
118170,4-[(2-chlorophenyl)azo]-3-hydroxy-N-phenylnaphthalene-2-carboxamide,229-096-4,6410-26-0,Not Classified,Notified C&L,26,Not classified:26
118171,(Z)-hex-3-enyl anthranilate,265-744-2,65405-76-7,Not Classified,Notified C&L,88,Not classified:88
118172,"Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C",270-729-9,68477-40-7,Asp. Tox. 1,Harmonised C&L,0,H304:0
118177,Hexylamine,203-851-8,111-26-2,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,257,H314:257;H311:166;H412:88;H226:256;H318:123;H301:131;H330:1;H310:1;H302:126;H312:90;H411:71;H332:5;H317:1
118179,"reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;1-octane-N,N,N-trimethylammonium di-octylphosphate;1-octane-N,N,N-trimethylammonium octylphosphate",407-490-9,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Harmonised C&L,0,H302:0;H314:0;H312:0
118180,Phallacidin from Amanita phalloides,607-975-7,26645-35-2,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,38,H330:38;H310:38;H300:38
118182,"Ginger, ext.",283-634-2,84696-15-1,Skin Sens. 1,REACH registration C&L,1643,H317:1429;H319:1516;H411:1358;H304:1451;H315:172;Not classified:50;H412:53;H225:26;H335:5;H226:4;H318:1;H302:1;H227:2;H316:2;H402:1
118184,"methyl 3-amino-2,2,3-trimethylbutyrate",431-720-7,90886-53-6,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H314:0;H412:0
118189,"N,N-dimethyl-3-nitroaniline",210-590-3,619-31-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,43,H302:43;H315:39;H319:39;H332:43;H312:43
118193,"3,5-dioxo-cyclohex-3-enecarboxylic acid ethyl ester",618-213-8,88805-65-6,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,156,H317:156;H318:156;H315:156
118194,"Cyclohex-4-ene-1,2-dicarboxylic anhydride",229-399-1,6508-04-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2;H311:1;H331:1;H301:1
118197,"3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-, methanesulfonate, hydrate (1:1:1)",607-003-1,223652-90-2,STOT RE 2;Aquatic Acute 1,Notified C&L,12,H373:11;H400:11;Not classified:1
118198,Butyl triglycol phosphate,610-567-1,50769-39-6,Skin Corr. 1A;Eye Dam. 1,Notified C&L,124,H318:89;H314:124
118201,"2,5-anhydro-D-mannitol",255-221-7,41107-82-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
118203,Diisobutyl succinate,213-113-7,925-06-4,Not Classified,Notified C&L,71,Not classified:71
118205,"Distillates (coal tar), naphthalene oils;Naphthalene Oil;[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200°C to 250°C (392°F to 482°F).]",283-484-8,84650-04-4,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
118206,"Manganese, 4-[(5-chloro-4-methyl-2-sulfophenyl)azo]-3-hydroxy-2-naphthalenecarboxylic acid complex",226-102-7,5280-66-0,Not Classified,REACH registration C&L,317,Not classified:317
118207,"Tetrasodium 7-[[4-[[4,6-bis[(3-sulfonatopropyl)thio]-1,3,5-triazin-2-yl]amino]-3-methoxyphenyl]azo]naphthalene-1,3-disulfonate",428-480-0,,Not Classified,REACH registration C&L,2043,Not classified:2043
118210,Acetamidinium chloride,204-700-9,124-42-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:45;H315:48
118211,"Benzenepropanoic acid, β-amino-, ethyl ester, hydrochloride (1:1)",608-411-2,29754-04-9,Flam. Sol. 1,Notified C&L,33,H228:33
118216,Lead sulphide,215-246-6,1314-87-0,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,67,H302:67;H410:67;H373:53;H332:67;H360:67;H400:63;H362:14;H372:14;H224:1
118217,Benzothiazol-5-amine,214-381-8,1123-93-9,,Notified C&L,8,H302:8;H315:8;H319:8;H332:8;H335:8;H312:7
118218,3-aminophthalic acid,226-595-9,5434-20-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
118220,"Methyl 3,5-dihydroxybenzoate",218-426-2,2150-44-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H302:1
118223,"Dehydrogenase, 3-hydroxybutyrate",232-830-6,9028-38-0,Resp. Sens. 1,Notified C&L,5,H334:5
118224,"Chromate(1-), [N-[7-hydroxy-8-[(2-hydroxy-5-nitrophenyl)azo]-1-naphthalenyl]acetamidato(2-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-, hydrogen, compd. with N-cyclohexylcyclohexanamine (1:1)",275-861-0,71701-12-7,Repr. 1B,Notified C&L,83,H360:83
118227,2-(tert-butylamino)ethanol,225-034-5,4620-70-6,Acute Tox. 4;Skin Corr. 1B,Notified C&L,40,H314:40;H312:38;H311:2;H302:2;H318:1
118228,Dilithium tetraborate,234-514-3,12007-60-2,Acute Tox. 4;Eye Dam. 1;Repr. 2,REACH registration C&L,161,H361:13;H302:56;H318:12;Not classified:39;H319:81;H335:69;H315:69;H317:2
118229,1-decyl-2-methyl-1H-imidazole,255-633-7,42032-30-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
118236,"tris(η5-cyclopenta-2,4-dien-1-yl)lanthanum",215-049-5,1272-23-7,Flam. Sol. 2;Water-react. 2,Notified C&L,42,H261:38;H228:42
118240,Aminoacetonitrile hydrochloride,227-865-9,6011-14-9,Acute Tox. 4,REACH registration C&L,54,H302:48;H315:49;H319:49;H332:44;H335:48;H312:45;H301:6;H336:1;H311:1;H330:1
118246,2-ethylhexyl [(oxan-2-yl)sulfanyl]acetate,439-810-8,,Aquatic Chronic 1,Notified C&L,55,H410:55
118247,"3,3'-(3,3'-dimethoxy-4,4'-biphenylene)bis(2,5-diphenyl-2H-tetrazolium) chloride",217-488-8,1871-22-3,Carc. 1B,Notified C&L,40,H350:40
118251,"1,3-bis(hydroxymethyl)urea",205-444-0,140-95-4,Eye Irrit. 2,REACH registration C&L,194,H319:6;Not classified:132;H302:56;H334:56;H317:56;H332:56;H312:56;H315:2;H335:1
118253,"D-Glucopyranose, oligomers, monosulfosuccinate, coco alkyl glycosides, sodium salts",500-331-5,151911-53-4,Eye Irrit. 2,Notified C&L,1,H319:1
118255,C.I. Solvent Yellow 135,604-404-3,144246-02-6,Not Classified,Notified C&L,2,Not classified:2
118256,"Reaction product of 4,4'-methylenediphenyl diisocyanate (MDI) (101-68-8), Cyclohexylamine (108-91-8) and p-Toluidine (106-49-0)",921-900-8,,Not Classified,Notified C&L,1,Not classified:1
118260,"Naphtha (petroleum), hydrodesulfurized full-range;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",295-433-7,92045-52-8,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
118261,2-diisopropylaminoethyl methacrylate,240-772-8,16715-83-6,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,38,H317:38;H335:38;H318:38;H315:38
118263,"[8,20-dihydro-8,20-diphenyl-5,24:12,17-diimino-7,10:22,19-dinitrilodibenz[f,p][1,2,4,9,11,12,14,19]octaazacycloicosinato(2-)-N25,N26,N27,N28]iron",256-526-8,50293-39-5,,Notified C&L,33,Not classified:33
118264,3-(3-methylpent-3-yl)isoxazol-5-ylamine,401-460-9,82560-06-3,Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H301:0;H331:0;H318:0
118266,"Benzenemethanamine, 3-amino-",610-163-5,4403-70-7,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,39,H302:39;H411:39;H314:39;H318:1
118267,"2-Propenoic acid, 2-cyano-3,3-diphenyl-2,2-bis(((2-cyano-1-oxo-3,3-diphenyl-2-propenyl)oxy)methyl)-1,3-propanediyl ester",429-160-3,178671-58-4,Not Classified,REACH registration C&L,91,Not classified:91
118269,[(2-chloroethyl)thio]benzene,226-891-8,5535-49-9,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Carc. 1A,Notified C&L,45,H311:39;H350:39;H331:38;H314:45;H302:6;H332:6;H312:6;H318:3;H330:1
118272,Dehydrogenase,232-907-4,9035-82-9,Resp. Sens. 1,Notified C&L,9,H334:9
118273,[2-(methylthio)ethyl]amine,242-412-5,18542-42-2,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,43,H226:43;H314:43;H302:1;H319:1;H335:1
118276,"Disodium 2-(2,4,5,7-tetrabromo-6-oxido-3-oxoxanthen-9-yl)benzoate",241-409-6,17372-87-1,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,639,H317:7;H319:557;Not classified:43;H318:22;H412:14;H302:2;H332:4;H312:3;H311:1;H301:1;H314:1
118277,"(1R)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one",242-195-7,18309-32-5,Not Classified,Notified C&L,114,Not classified:114
118278,"Propane-1,2,3-trithiol",225-288-7,4756-13-2,Acute Tox. 3;Eye Irrit. 2,Notified C&L,9,H319:9;H301:9;H317:1;H315:1;H335:1
118280,20-[(6-O-α-L-arabinofuranosyl-β-D-glucopyranosyl)oxy]-12β-hydroxydammar-24-en-3β-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside,234-253-5,11021-14-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:43;H332:42;H312:42
118281,"Polysulfides, di-tert-nonyl",270-336-2,68425-16-1,Not Classified,REACH registration C&L,59,Not classified:1;H319:45;H335:38;H315:38;H413:20
118283,"3-Azetidinol, 1-(1,1-dimethylethyl)- hydrochloride",603-494-1,13156-04-2,Not Classified,REACH registration C&L,2,Not classified:2
118285,"Diisononylnaphthalenesulphonic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",278-316-5,75800-63-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,49,H318:25;H315:25;Not classified:24
118286,"Hydrocarbons, C10-C13, aromatics, >1% naphthalene",926-273-4,,Asp. Tox. 1;Carc. 2;Aquatic Chronic 2,REACH registration C&L,25,H351:25;H411:25;H304:25
118287,"1-[3-[[(2,5-dioxopyrrolidinyl)oxy]carbonyl]phenyl]-1H-pyrrole-2,5-dione",261-368-8,58626-38-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
118292,"Distillates (petroleum), hydrotreated light naphthenic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-156-6,64742-53-6,Carc. 1B,Harmonised C&L,0,H350:0
118293,"isobutyl 5-chloro-2,2-dimethylpentanoate",600-906-1,109232-37-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
118294,(methylsulphonyl)ethylene,222-958-0,3680-02-2,Acute Tox. 4;Acute Tox. 2;Eye Dam. 1,Notified C&L,46,H302:45;H318:45;H310:45;H335:1;H311:1;H330:1;H315:1;H301:1;H319:1
118297,4-isopropenylcyclohex-1-enecarbaldehyde,218-302-8,2111-75-3,Skin Sens. 1B,Notified C&L,1681,H317:1679;H319:274;H315:289;H335:1;H302:1;H341:1
118298,2-bromo-2-ethylbutyryl bromide,247-442-2,26074-53-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,1,H302:1;H314:1
118301,"5-(1,2-dithiolan-3-yl)valeric acid",200-534-6,62-46-4,Not Classified,Notified C&L,122,Not classified:52;H319:38;H302:70;H335:38;H315:38;H412:24;H332:1;H312:1
118306,"benzyl (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25-pentaazatriacontan-30-yl)carbamate",609-812-5,402913-84-2,Not Classified,Notified C&L,1,Not classified:1
118307,(Z)-(3-hexenyloxy)acetaldehyde,268-699-7,68133-72-2,Not Classified,Notified C&L,88,Not classified:88
118313,2-((4-amino-2-nitrophenyl)amino)benzoic acid,411-260-3,117907-43-4,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H318:0;H412:0
118314,1H-benzotriazolecarboxylic acid,262-527-4,60932-58-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,80,H319:57;H335:57;H315:57;H311:22;H302:22;Not classified:1
118315,Methyl hydrogen maleate,221-271-3,3052-50-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45,H319:35;H315:34;Not classified:9;H314:1
118322,Diammonium aquapentachlororhodate,264-455-9,63771-33-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42;H302:4
118325,"Hydrocarbon waxes (petroleum), oxidized, calcium salts",271-636-6,68603-09-8,Not Classified,REACH registration C&L,2,Not classified:2
118326,"2,3-Dihydro-benzo[1,4]dioxine-2-carbonitrile",600-140-8,1008-92-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H335:1;H312:1
118327,7-isopropyl-5-methylbicyclo[2.2.2]oct-5-ene-2-carbonitrile,269-744-3,68311-05-7,Not Classified,Notified C&L,93,Not classified:93
118332,"(Z,E)-undeca-1,3,5-triene",243-397-8,19883-27-3,Asp. Tox. 1,Notified C&L,13,H304:13
118334,[(1-3 Dichlopropan-2-yl)oxy]methyl acetate,618-260-4,89281-73-2,,Notified C&L,2,H351:2;H301:2;H312:2
118335,"Hexamethylene diisocyanate, oligomers, blocked with diethyl malonate",919-560-0,,Not Classified,Notified C&L,83,Not classified:83
118340,Zirconium tetrabutanolate,213-995-3,1071-76-7,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT SE 3,REACH registration C&L,649,H226:501;H318:13;H315:22;H336:13;H335:13;H317:542;H319:542;Not classified:58;H314:6;H302:1;H370:1;H332:1
118342,"Fatty acids, palm kernel-oil",309-936-7,101403-98-9,Not Classified,Notified C&L,102,Not classified:71;H319:25;H315:31;H318:6
118343,[No public or meaningful name is available],469-900-2,,Eye Dam. 1,Notified C&L,1,H318:1
118344,1-chloro-3-methoxypropan-2-ol,223-982-4,4151-97-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:38;H315:39;H302:5;H332:1;H312:1
118346,"Amides, rape-oil, N-[3-(dimethylamino)propyl]",287-003-2,85408-42-0,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,25,H302:22;H318:23;H314:23;H400:23;H319:2;H315:2;H317:1
118347,Propylammonium chloride,209-129-9,556-53-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H302:39;H335:39;H315:40
118348,o-chlorophenylhydrazine hydrochloride,255-194-1,41052-75-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1,Notified C&L,48,H302:48;H332:43;H400:42;H312:43;H319:7;H335:6;H315:7
118355,Tin tetraiodide,232-208-4,7790-47-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,45,H302:39;H314:45;H317:39;H334:39;H332:39;H312:39;H318:1;H335:1
118356,Disodium terephthalate,233-075-5,10028-70-3,Not Classified,Notified C&L,2,Not classified:2
118359,"8-hydroxy-5,7-dinitronaphthalene-2-sulphonic acid",207-600-3,483-84-1,Skin Corr. 1B;Eye Dam. 1;Carc. 2,Notified C&L,39,H351:38;H318:39;H314:39;H290:1
118364,Phenyl (4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)carbamate,606-021-7,184177-81-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,11,H410:11;H400:10
118367,4-tert-butyl-2-nitrophenol,221-914-8,3279-07-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
118368,Barium 4-[(4-chloro-5-methyl-2-sulphonatophenyl)azo]-3-hydroxy-2-naphthoate,241-780-4,17814-20-9,Not Classified,Notified C&L,31,Not classified:31
118373,N-butyl phenyl ether,214-426-1,1126-79-0,Eye Irrit. 2,REACH registration C&L,5,H319:5;H335:1;H315:1
118374,"Amines, C12-14-tert-alkyl, mixed sec-Bu and iso-Bu phosphates",306-227-4,96690-34-5,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,42,H302:42;H411:42;H318:16;H314:16;H319:26;H315:26;H332:1
118382,"1,2,3-Propanetriol, C1-5 carboxylates",288-343-4,85711-81-5,Not Classified,Notified C&L,1,Not classified:1
118383,"3,7-bis(diethylamino)phenoxazin-5-ium acetate",279-349-8,79916-07-7,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,26,H319:22;H302:22;H410:25;H400:25;H301:3;H318:3;Not classified:1
118386,Barium hexaboride,234-965-6,12046-08-1,Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H302:42;H332:42
118387,1-chlorooctadecane,222-207-7,3386-33-2,Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,121,H317:2;H315:116;H319:78;H335:78;H413:34;Not classified:5
118388,"2-Butenedioic acid (2E)-, polymer with α,α'-[(1-methylethylidene)di-4,1-phenylene]bis[ω-hydroxypoly[oxy(methyl-1,2-ethanediyl)]]",609-663-6,39382-25-7,Not Classified,Notified C&L,2108,Not classified:2107;H317:1;H319:1;H315:1
118390,Ammonium hexafluorotantalate(5),251-488-9,33380-11-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:4;H335:4;H315:4;Not classified:1
118398,Triisobutyl phosphate,204-798-3,126-71-6,Skin Sens. 1B,REACH registration C&L,469,H317:376;H412:190;Not classified:54;H334:38;H319:34;H315:47
118400,"1,2,2,3-tetrachloropropane",236-043-9,13116-53-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H312:1
118401,"4,4',4''-triaminotrityl alcohol",207-395-0,467-62-9,Not Classified,REACH registration C&L,42,Not classified:2;H351:40;H302:2;H332:2;H312:2
118403,"dimethomorph (ISO);4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine",404-200-2,110488-70-5,Aquatic Chronic 2,Harmonised C&L,0,H411:0
118407,"N,N,N’,N’-TETRAKIS(2-HYDROXYETHYL)ADIPAMIDE",613-204-5,6334-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,335,H319:177;H335:177;H315:177;Not classified:158
118411,"1,3-benzenediamine, 4-methyl-, reaction products with sulfur, leuco derivatives",235-519-3,12262-27-0,Not Classified,Notified C&L,32,Not classified:32
118412,phenylhydrazine,202-873-5,100-63-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 1;Aquatic Acute 1,Harmonised C&L,0,H311:0;H341:0;H317:0;H331:0;H372:0;H315:0;H350:0;H319:0;H301:0;H400:0
118413,2-[1-(hydroxymethyl)cyclopropyl]acetic acid,617-934-5,869066-83-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H302:1;H335:1;H318:1;H315:1
118414,"2,4-decadienal",219-114-9,2363-88-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1605,H315:1604;H319:1602;H312:1603;H318:1;H314:1
118415,"Golden seal, Hydrastis canadensis, ext.",283-261-5,84603-60-1,Not Classified,Notified C&L,52,Not classified:52
118427,Dioleyl maleate,203-325-8,105-73-7,Not Classified,Notified C&L,22,Not classified:22
118429,"Ferrate(1-), bis[2-[(4-amino-2-hydroxyphenyl)azo]-4-chlorophenolato(2-)]-, (OC-6-22')-, N,N,N',N'-tetrakis[mixed 3-butoxy-2-hydroxypropyl and 2-hydroxy-3-(octyloxy)propyl] derivs., hydrogen, compds. with N-butyl-1-butanamine (1:1)",601-103-9,111559-76-3,Not Classified,Notified C&L,1,Not classified:1
118432,p-fluorobenzylamine hydrochloride,211-534-0,659-41-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H302:38;H335:38;H315:39
118435,Bis(α-methoxy-p-tolyl) ether,219-722-4,2509-26-4,Not Classified,Notified C&L,1,Not classified:1
118440,"[4-[Difluor(3,4,5-trifluorphenoxy)methyl]-3,5-difluorphenyl] -boronacid",614-617-3,685563-69-3,Not Classified,REACH registration C&L,2,Not classified:2
118442,5-Methyl-4-sulfamoyl-thiophene-3-carboxylic acid methyl ester,619-493-4,317815-81-9,Aquatic Chronic 2,Notified C&L,44,H411:44
118443,"Fatty acids, tall-oil, reaction products with polyethylenepolyamines, ethoxylated",500-566-3,161133-68-2,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H411:1;H318:1;H315:1;H319:1;H335:1;H400:1
118444,2-methyl-p-phenylenediamine sulphate,210-431-8,615-50-9,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0;H332:0;H301:0;H312:0
118447,Dipraseodymium trisulphate,233-622-8,10277-44-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:39;H315:39;Not classified:1
118449,"Card-20(22)-enolide, 3-[(O-4-O-acetyl-2,6-dideoxy-β-d-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-d-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-d-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3β,5β,12β)-",226-337-5,5355-48-6,Acute Tox. 2;Skin Corr. 1A;Acute Tox. 2,Notified C&L,1,H330:1;H300:1;H314:1
118457,"Thioperoxydicarbonic diamide ([(H2N)C(S)]2S2), tetracoco alkyl derivs.",292-278-7,90583-75-8,Not Classified,Notified C&L,1,Not classified:1
118458,"(2R,3R)-2,3-bis(acetyloxy)butanedioic acid - 3-(2-methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine (1:1)",920-610-9,,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H317:2;H302:2;H410:2;H400:2
118461,"1,1,3,3,5-pentamethyl-4,6-dinitroindan",204-149-4,116-66-5,Not Classified,Notified C&L,148,Not classified:138;H228:10
118462,CNPU,471-110-8,,Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H373:1;H302:1;H411:1
118465,"Carbonic acid disodium salt, reaction products with aniline, 4-nitrobenzenamine, p-phenylenediamine, sodium sulfide, sulfur and p-toluidine",290-904-3,90268-98-7,Not Classified,REACH registration C&L,38,Not classified:38
118466,Cyclohexanecarbonyl chloride,220-322-7,2719-27-9,Skin Corr. 1B,REACH registration C&L,58,H314:58;H302:10;H335:4;H318:4;H290:1
118467,Pentan-2-ol,227-907-6,6032-29-7,Flam. Liq. 3;Acute Tox. 4;STOT SE 3,Notified C&L,1731,H226:1730;H335:1731;H332:1731;Not classified:2;H302:1;H315:1;H319:1;H224:1
118468,"(2E,6E)-2,6-octadienal",260-372-7,56767-18-1,Skin Irrit. 2,Notified C&L,1373,H315:1363;Not classified:10
118470,"Fatty acids, C6-12, Me esters",267-017-5,67762-39-4,Not Classified,Notified C&L,75,Not classified:42;H319:20;H226:33;H315:20
118474,"1,3-Cyclohexanedimethanamine",219-941-5,2579-20-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,377,H302:370;H314:348;H412:237;H318:163;H312:292;H317:56;H332:55;H315:22;Not classified:7
118475,"tebufenozide (ISO);N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide",412-850-3,112410-23-8,Aquatic Chronic 2,Harmonised C&L,0,H411:0
118484,Iron chloride sulphate,235-649-0,12410-14-9,Met. Corr. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,61,H290:61;H302:61;H318:58;H315:25;H317:13;H314:36
118486,"Fatty acids, coco, stearyl esters",293-002-8,91031-96-8,Not Classified,Notified C&L,1,Not classified:1
118487,CITRUS AURANTIUM DULCIS OIL,600-006-9,8008-57-9,Not Classified,Notified C&L,28,Not classified:25;H226:2;H315:2;H304:1
118490,Urethane Resin M2001,930-384-3,,Not Classified,Notified C&L,1,Not classified:1
118492,Formamidine monoacetate,222-442-5,3473-63-0,Skin Sens. 1,REACH registration C&L,101,H317:100;H319:12;H335:10;H315:12;H360:1;Not classified:1
118493,"Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-hydro-.omega.-hydroxy-, polymer with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane",609-647-9,39323-37-0,Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,83,H334:59;H317:60;H411:25;H332:25;H335:25;Not classified:23;H412:17
118501,"Butanedioic acid, 1-[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl] ester",616-452-2,77341-67-4,Eye Dam. 1,Notified C&L,10,H318:10
118502,"5-bromo-2,4-dihydroxybenzoic acid",230-881-9,7355-22-8,Eye Irrit. 2,Notified C&L,42,H319:42;H335:4;H315:4
118503,"Tobacco, ext.",284-656-5,84961-66-0,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 2;Aquatic Chronic 3,REACH registration C&L,93,H310:45;H226:2;H301:3;H412:45;H312:37;H302:43;Not classified:10;H317:1;H411:1;H330:1;H300:1;H225:1
118504,2-nitrophloroglucinol,240-656-7,16600-92-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
118506,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, reaction products with ethanolamine",285-617-5,85117-66-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,13,H319:13;H315:13
118507,tert-butylchlorodiphenylsilane,261-282-0,58479-61-1,Skin Corr. 1B,Notified C&L,51,H314:51;H335:4;H290:1;H318:1;Not classified:1
118508,"β-Alanine, N-[4-[2-(2-chloro-4-nitrophenyl)diazenyl]phenyl]-N-(2-cyanoethyl)-, methyl ester",601-914-8,12217-86-6,Not Classified,Notified C&L,1,Not classified:1
118511,"Echinacea angustifolia, ext.",283-631-6,84696-11-7,Not Classified,Notified C&L,2,Not classified:2
118513,2-phenoxyaniline,220-254-8,2688-84-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,49,H302:47;H315:43;H319:43;H332:42;H335:42;H312:45;Not classified:1
118514,Bis(2-ethylhexyl) terephthalate,229-176-9,6422-86-2,Not Classified,REACH registration C&L,302,Not classified:301;H361:1;H413:1
118516,"2-bromo-N,N-dimethylbenzylamine",217-831-1,1976-04-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
118518,"Extract residues (coal), naphthalene oil, alk., naphthalene-low;Naphthalene Oil Extract Residue;[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.]",310-167-4,121620-48-2,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
118523,Nicotinamide,202-713-4,98-92-0,Eye Irrit. 2,REACH registration C&L,1048,H319:1043;H335:295;H315:297;H336:32;H317:3;Not classified:3;H302:2
118524,Methyl 2-chloropropionate,241-624-5,17639-93-9,Flam. Liq. 3;Eye Irrit. 2;STOT RE 2,REACH registration C&L,85,H373:5;H319:81;H226:85;H335:74;H315:76;H314:4;H302:1
118525,L-lysine (S)-maleate,275-617-3,71555-10-7,Not Classified,Notified C&L,1,Not classified:1
118528,"spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate",604-636-5,148477-71-8,Skin Sens. 1B;Carc. 1B;STOT RE 2;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H410:0;H317:0;H373:0;H350:0
118534,1H-purine-6-carbonitrile,218-005-3,2036-13-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H315:38;H319:38;H332:38;H335:38;H312:38
118535,"[(8R,9S,10R,13S,14S,17R)-3-ethoxy-17-ethynyl-13-methyl-2,7,8,9,10,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",610-565-0,50717-99-2,Not Classified,REACH registration C&L,2,Not classified:2
118536,N-(p-acetylphenyl)acetamide,220-320-6,2719-21-3,Skin Sens. 1,Notified C&L,43,H317:38;H319:5;H335:4;H315:5
118538,"Exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl isobutyrate",287-872-8,85586-67-0,Not Classified,Notified C&L,1409,Not classified:1409
118544,"2,2,6,6-tetramethylheptane-3,5-dione",214-268-3,1118-71-4,Acute Tox. 4,Notified C&L,43,H302:40;H319:5;H335:5;H315:5;H332:1;H312:1
118547,"Benzo[b]thiophene-3(2H)-one 1,1-dioxide",214-429-8,1127-35-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
118549,3-chloro-2-(chloromethyl)-2-methylpropan-1-ol,226-338-0,5355-54-4,Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H300:38;H315:38
118551,"Oils, reclaimed, sulfated, sodium salts",273-818-0,69029-76-1,Not Classified,Notified C&L,40,Not classified:40
118554,Pentairon triyttrium dodecaoxide,235-053-0,12063-56-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
118556,"Hydrocarbons, C9-C11, n-alkanes, isoalkanes, cyclics, < 2% aromatics",919-857-5,64742-48-9,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3,REACH registration C&L,485,H336:485;H226:485;H304:485
118560,4-hydroxyphenoxyacetic acid,217-525-8,1878-84-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H302:1
118561,2-chloro-5-nitroaniline,228-498-7,6283-25-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,47,H373:44;H330:45;H310:45;H411:43;H300:44;H319:2;H315:2;H272:1;H410:1
118563,"Tetrahydro-2-hydroxy-4H-1,3,6,2-dioxazaborocine",255-920-7,42727-95-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H302:2;H315:2
118568,3-dimethylaminopropiononitrile,217-090-4,1738-25-6,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2B;STOT RE 2,REACH registration C&L,132,H319:132;H373:85;H302:131;H312:132;H334:8
118569,Titanium diboride,234-961-4,12045-63-5,Not Classified,REACH registration C&L,220,Not classified:11;H302:209;H332:209;H312:209
118572,Ethylenebis[chlorodimethylsilane],236-871-0,13528-93-3,Skin Corr. 1B,Notified C&L,45,H314:45;H290:1;H318:1;H335:2
118574,"Poly(oxy-1,2-ethanediyl), a-(1-oxooctadecyl)-[?]-[[](1-oxooctadecyl)oxy]-",618-408-8,9005-08-7,Not Classified,Notified C&L,358,Not classified:352;H317:6;H319:6;H315:6
118576,"Pelargonium graveolens, ext.",290-140-0,90082-51-2,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1641,H317:1605;H319:105;H315:1605;H412:1388;H318:1500;H304:1469;H411:111;Not classified:37;H400:2;H410:1
118580,Benzoylformaldehyde,214-036-1,1074-12-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H302:38;H335:38;H315:39
118584,o-phenoxybenzaldehyde,243-061-0,19434-34-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,200,H319:200;H302:194;H335:200;H315:200
118586,Allyl (2-methylbutoxy)acetate,266-804-0,67634-01-9,Acute Tox. 4;Skin Irrit. 2,Notified C&L,128,H302:127;H315:114;H332:25;H373:13;H400:13;H312:13;Not classified:1
118589,Diisooctyl hydrogen phosphate,248-334-8,27215-10-7,Not Classified,Notified C&L,5,Not classified:5
118594,"ethoprophos (ISO);ethyl-S,S-dipropyl phosphorodithioate",236-152-1,13194-48-4,Acute Tox. 3;Acute Tox. 1;Skin Sens. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H310:0;H330:0;H301:0;H400:0
118596,"1,3-Dimethoxyphthalan",607-367-1,24388-70-3,Acute Tox. 3,REACH registration C&L,2,H301:2
118599,Tin oxide,215-569-2,1332-29-2,Not Classified,Notified C&L,69,Not classified:50;H413:19
118600,"2-methyl-1,4-phenylene bis(4-hydroxybenzoate)",601-643-5,119959-84-1,Not Classified,Notified C&L,84,Not classified:84
118602,"1,2-dichloro-1,2-difluoroethylene",209-956-5,598-88-9,,Notified C&L,1,H280:1;H330:1;H315:1;H319:1;H335:1
118603,"2,4-dimethylquinoline",214-832-9,1198-37-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:38;H315:43
118605,Trisilver arsenite,232-048-5,7784-08-9,Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 1,Notified C&L,1,H410:1;H301:1;H331:1
118610,"prosulfuron (ISO);1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea",619-000-2,94125-34-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0
118612,"7,7'-(carbonyldiimino)bis[4-hydroxy-3-(phenylazo)naphthalene-2-sulphonic] acid, sodium salt",280-235-5,83221-56-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
118613,Ethoxyacetyl chloride,237-930-3,14077-58-8,,Notified C&L,5,H226:5;H314:5;H332:5
118621,2-amino-5-(aminomethyl)naphthalene-1-sulphonic acid,257-650-5,52084-84-1,Not Classified,Notified C&L,10,Not classified:10
118622,N-propylphthalimide,226-189-1,5323-50-2,Not Classified,Notified C&L,42,Not classified:37;H319:5;H315:5
118625,"Propanamide, 3-amino-2,2-dimethyl-",454-190-9,324763-51-1,Eye Dam. 1,REACH registration C&L,85,H318:85
118629,2-bromobenzamide,223-650-9,4001-73-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
118635,"Naphtha (petroleum), C",295-430-0,92045-49-3,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
118646,"5,6,12,13-tetrahydroquino[2,3-b]acridine-7,14-dione",227-508-7,5862-38-4,Not Classified,Notified C&L,83,Not classified:83
118648,Hexanoic anhydride,218-121-4,2051-49-2,Skin Sens. 1A,REACH registration C&L,59,H317:2;H314:57;H290:1;H318:2
118650,"(2,3,5,6-tetrafluorophenyl)methanol",443-840-7,4084-38-2,Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0;H302:0
118651,"2-(2-butoxyethoxy)ethyl dihydrogen phosphate, compound with N,N-dimethylcyclohexylamine",303-499-6,94200-24-5,,Notified C&L,28,H302:23;Not classified:5
118653,"O,O'-diacetylmorphine",209-217-7,561-27-3,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,REACH registration C&L,57,H330:39;H310:39;H300:39;H334:18;H317:18;H302:17;H332:17;H361:1;H362:1;H331:1;H301:1
118654,"Maple-sap products, syrups",232-441-1,8029-81-0,Not Classified,Notified C&L,8,Not classified:8
118655,ethyl 3-(4-fluorophenyl)-3-oxopropanoate,606-415-9,1999-00-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
118658,"Sulfite liquors and Cooking liquors, green",268-612-2,68131-30-6,Met. Corr. 1;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Aquatic Acute 1,REACH registration C&L,393,H314:392;H290:392;H311:224;H301:168;H400:280;H302:168;H312:56;H319:1
118659,"Disodium 3,3'-[cyclohexylidenebis[(2-methyl-4,1-phenylene)azo]]bis(4,6-dihydroxynaphthalene-2-sulphonate)",229-398-6,6507-79-5,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,82,H319:35;H412:34;Not classified:47
118660,(4-tert-butylphenyl)boronic acid,602-928-7,123324-71-0,,Notified C&L,9,H319:9;H335:8;H315:9;H302:3
118663,"Ethanaminium, 2-hydroxy-N-(2-hydroxyethyl)-N,N-dimethyl-, esters with C16-18 and C18-unsatd. fatty acids, chlorides",620-174-7,1079184-43-2,Aquatic Chronic 3,REACH registration C&L,16,H412:14;Not classified:2
118664,Tetrahydro-2-methylquinoline,246-996-2,25448-05-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H301:38;H315:38
118665,"1,1-dichloro-2,2-diethoxyethane",210-591-9,619-33-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H226:42;H335:41;H315:39
118672,"1,2,3-Propanetriol, homopolymer, dioctadecanoate",612-361-7,61725-93-7,Not Classified,Notified C&L,31,Not classified:31
118680,"Distillates (petroleum), heavy thermal cracked;Heavy Fuel oil;[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C",265-082-4,64741-81-7,Carc. 1B,Harmonised C&L,0,H350:0
118681,"Alcohols, C6-10",264-844-3,64365-05-5,,Notified C&L,96,H412:83;H315:83;H319:13;H302:13
118684,S-(tricyclo(5.2.1.0,401-850-9,255881-94-8,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
118686,"Hydrocarbons, C4, 1,3-butadiene- and isobutene-free;Petroleum gas",306-004-1,95465-89-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H350:0;H220:0;H340:0;Not classified:0
118687,"Alkenes, C12-24, chloro",271-247-1,68527-02-6,Not Classified,Notified C&L,49,Not classified:49
118693,Dimethyloxostannane,218-881-7,2273-45-2,Acute Tox. 4;Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,Notified C&L,98,H373:55;H302:59;H412:55;H312:59;H301:39;H318:38;H315:5;H319:5;H332:4;H335:4;H311:1;H331:1
118696,Zirconium dicarbonate,253-113-4,36577-48-7,Not Classified,Notified C&L,1,Not classified:1
118697,(Z)-3-hexenyl salicylate,265-745-8,65405-77-8,Aquatic Acute 1,REACH registration C&L,1664,H400:197;H317:1373;H410:1457;H411:115;H319:38;H335:38;H315:47;H412:20;Not classified:5
118701,2-fluorobenzothiazole,214-384-4,1123-98-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:40;H315:44;H302:6;H311:4;H332:6;H312:2
118703,"Phenoxazin-5-ium, 3,7-bis(diethylamino)-, formate (1:1)",601-264-5,113534-44-4,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,18,H410:18;H314:18;H331:18;H318:18;H301:18;H400:18
118706,propylbenzene,203-132-9,103-65-1,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H226:0;H304:0;H411:0;H335:0
118711,Terbium tribromide,238-442-3,14456-47-4,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
118713,"Distillates (petroleum), hydrotreated light paraffinic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-158-7,64742-55-8,Carc. 1B,Harmonised C&L,0,H350:0
118715,C.I. Acid Brown 311,602-529-8,12234-86-5,Not Classified,Notified C&L,1,Not classified:1
118716,"(2,4-dichlorophenyl)hydrazine monohydrochloride",226-659-6,5446-18-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,88,H319:88;H335:56;H315:88;H311:31;H351:32;H317:31;H331:31;H301:31;H302:7;H332:2;H312:2
118719,Tripotassium trihydrogen [nitrilotris(methylene)]trisphosphonate,301-417-3,94021-24-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
118722,"α-ethyl-2,2,6-trimethylcyclohexanepropanol",262-115-4,60241-52-3,Aquatic Chronic 2,Notified C&L,36,H411:36
118726,Copper cyanide,208-883-6,544-92-3,Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,389,H373:6;H302:12;H410:388;H400:384;H330:377;H310:382;H300:382;H332:5;H317:1
118730,Disodium 2-[4-[(1-hydroxy-4-sulphonato-2-naphthyl)azo]phenyl]-6-methylbenzothiazole-7-sulphonate,218-422-0,2150-33-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,40,H302:38;H318:38;Not classified:1;H319:1;H335:1;H315:1
118732,Diindium trisulphide,234-742-3,12030-24-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,266,H302:265;H315:265;H319:265;H332:265;H335:265;H312:260;Not classified:1
118734,"2',3',4',5',6'-pentafluoroacetophenone",211-487-6,652-29-9,,Notified C&L,6,H319:6;H335:5;H315:6
118736,4-Ethylphenylmagnesium bromide,607-174-2,22873-28-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
118737,"Diethyl 2,2'-thiodiacetate",213-117-9,925-47-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
118743,isopentyl propionate,203-322-1,105-68-0,Flam. Liq. 3,Harmonised C&L,0,H226:0
118745,Iridium dioxide,234-743-9,12030-49-8,Ox. Sol. 3;Aquatic Chronic 4,Notified C&L,16,H272:16;H413:13;H319:3;H315:3
118747,"Pitch, brown-coal tar",309-604-1,100403-58-5,Not Classified,Notified C&L,1,Not classified:1
118755,Butyl hydrogen maleate,213-116-3,925-21-3,Skin Corr. 1B;Eye Dam. 1;STOT RE 2,REACH registration C&L,135,H373:5;H318:43;H314:23;Not classified:73;H335:39;H315:39;H317:2;H334:1
118757,"1,3,5-tri(tert-butyl)-2-nitrosobenzene",246-553-3,24973-59-9,Aquatic Chronic 4,Notified C&L,38,H413:38
118758,aminocarb (ISO);4-dimethylamino-3-tolyl methylcarbamate,217-990-7,2032-59-9,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H311:0;H410:0;H301:0;H400:0
118759,"4-amino-2,3,5,6-tetrafluorobenzonitrile",241-783-0,17823-38-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H315:38;H319:38;H332:38;H335:38;H312:38
118763,Strontium tetraborate,234-515-9,12007-66-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Chronic 1,Notified C&L,2,H302:2;H410:1;H373:1;H332:2;H360:2
118765,"3,3'-((2,5-dimethylbenzene-1,4-diyl)bis(imino(1,3-dioxobutane-1,2-diyl)diazene-2,1-diyl))bis(4-chlorobenzoic acid)",616-083-7,74351-78-3,Not Classified,REACH registration C&L,85,Not classified:85
118766,3-Bromo-4-methylpyridine,608-967-6,3430-22-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:41;H315:46;H302:4;H332:4;H312:4
118767,"Siloxanes and Silicones, di-Me, Me Ph",613-149-7,63148-52-7,Not Classified,Notified C&L,80,Not classified:80
118769,Hafnium tetrafluoride,237-258-0,13709-52-9,Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 3,Notified C&L,44,H335:39;H318:39;H331:39;H315:39;H311:4;H301:4;H314:4;H330:4;Not classified:1
118771,"Distillates (petroleum), hydrotreated heavy paraffinic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-157-1,64742-54-7,Carc. 1B,Harmonised C&L,0,H350:0
118777,"5,7-dichloro-1H-indole-2,3-dione",228-928-3,6374-92-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H302:39;H318:39
118778,9-decenyl propionate,270-882-1,68480-06-8,Skin Irrit. 2,Notified C&L,87,H315:77;Not classified:10
118779,Iopydone,226-969-1,5579-93-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
118780,Iron(II) fumarate,205-447-7,141-01-5,Not Classified,REACH registration C&L,68,Not classified:68
118781,"Tetrasodium N-(1,2-Dicarboxyethyl)-N-Octadecenyl sulfosuccinamate",617-265-9,81869-18-3,Aquatic Chronic 2,Notified C&L,161,H411:123;Not classified:38
118782,3-chloro-2-(chloromethyl)propene,217-489-3,1871-57-4,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,41,H335:39;H226:41;H315:40;H319:41;H301:41;H400:41;H330:2;H332:1
118796,"Hydrocarbons, C9-unsatd., polymd.",615-276-3,71302-83-5,Not Classified,Notified C&L,272,Not classified:198;H317:74;H412:87
118801,"N-(4-chloro-2,5-dimethoxyphenyl)-3-hydroxy-4-[[2-methoxy-5-[(phenylamino)carbonyl]phenyl]azo]naphthalene-2-carboxamide",226-103-2,5280-68-2,Not Classified,REACH registration C&L,555,Not classified:529;H317:26
118802,"1,1,2,2,3-pentachlorocyclopropane",613-064-5,6262-51-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
118808,4-aminophthalic acid,226-596-4,5434-21-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
118809,Ethyl chloroglyoxylate,225-285-0,4755-77-5,Flam. Liq. 3;Met. Corr. 1;Skin Corr. 1;Eye Dam. 1;STOT SE 3,REACH registration C&L,62,H314:61;H290:10;H226:60;H318:10;H335:16;H302:7;H225:2
118811,"trans-2,3-dichlorobut-2-ene",203-779-7,110-57-6,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 1,Notified C&L,75,H314:71;H330:72;H226:43;H301:72;H312:38;H410:33;H311:33;H350:33;H400:33;H361:1;H340:1;H318:1;H372:1;H370:1;H335:1;H315:1;H319:1
118814,"Benzol forerunnings (coal);Light Oil Redistillate, low boiling;[The distillate from coke oven light oil having an approximate distillation range below 100°C (212°F). Composed primarily of C",266-023-5,65996-88-5,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
118818,Potassium butyl hydrogen phosphate,246-750-4,25238-99-7,Eye Irrit. 2,Notified C&L,11,H319:11
118823,"Sebacic acid, compound with 2,2',2''-nitrilotriethanol",274-316-4,70103-35-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
118825,D-glutamic acid,230-000-8,6893-26-1,Not Classified,Notified C&L,5,Not classified:5
118826,hydroxycarbamide,204-821-7,127-07-1,Muta. 1B;Repr. 2,Notified C&L,55,H361:45;H340:47;H360:10;H311:1;H301:1;H331:1;H336:1;H341:2;H351:2
118833,"(Z)-3,7-dimethylocta-1,3,6,-triene",222-081-3,3338-55-4,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,415,H226:414;H304:413;H410:48;H411:49;H315:50;H400:49;H319:1;H335:1
118834,4-dodecylaniline,203-201-3,104-42-7,Acute Tox. 4;Aquatic Acute 1,Notified C&L,40,H302:39;H400:40;H319:1;H410:1;H315:1
118837,Ammonium 8-anilinonaphthalene-1-sulphonate,249-265-6,28836-03-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:39;H315:41
118840,2-ethyl-3-methylbutyraldehyde,247-551-5,26254-92-2,Skin Sens. 1,Notified C&L,38,H317:38
118845,"4-bromo-2,2-diphenylbutanenitrile",254-337-5,39186-58-8,Repr. 2;Aquatic Chronic 2,REACH registration C&L,50,H361:2;H411:2;H413:2;H302:48;H332:47;H312:47;H315:2;H319:2;H335:1
118847,Tetrahydro-α-(1-naphthylmethyl)furan-2-propionic acid,246-926-0,25379-26-4,Not Classified,REACH registration C&L,2,Not classified:2
118848,"2-Oxiranemethanamine, N,N'-(methylenedi-4,1-phenylene)bis[N-(2-oxiranylmethyl)-, polymer with 4,4'-methylenebis[2-methylcyclohexanamine]",603-300-5,128795-76-6,Not Classified,Notified C&L,9,Not classified:9
118850,"Pentane-1,5-diol",203-854-4,111-29-5,Not Classified,REACH registration C&L,327,Not classified:283;H302:44;H319:5;H335:5;H315:5
118851,Methyltriphenylarsonium iodide,216-108-8,1499-33-8,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H410:43;H301:43;H331:43;H400:39;H373:4;H350:1
118855,"Formaldehyde, oligomeric reaction products with 2-amino-2-(hydroxymethyl)-1,3-propanediol",500-196-2,68134-42-9,Not Classified,Notified C&L,1,Not classified:1
118856,"Aromtic hydrocarbons, C",292-621-0,90640-98-5,Asp. Tox. 1,Harmonised C&L,0,H304:0
118858,2-deoxydi(p-toluoyl)-α-D-erythro-pentofuranosyl chloride,224-367-3,4330-21-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
118863,Isopropyl m-tolylcarbamate,220-029-4,2610-63-1,Acute Tox. 4,Notified C&L,38,H302:38
118867,Sodium pentadecafluorooctanoate,206-404-5,335-95-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
118869,"1,1-dimethylurea",209-957-0,598-94-7,Not Classified,REACH registration C&L,47,Not classified:2;H319:45;H335:44;H315:45
118870,Lead telluride,215-247-1,1314-91-6,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,95,H302:95;H410:95;H351:53;H373:95;H332:95;H360:95;H400:95
118871,Mafenide hydrochloride,205-325-3,138-37-4,Skin Sens. 1,Notified C&L,38,H317:38
118874,4-nitrosoaniline,211-535-6,659-49-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H332:0;H312:0
118876,Allobarbital,200-140-4,52-43-7,Acute Tox. 3,Notified C&L,43,H301:42;H302:1
118877,"(6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carboxylic acid, 1-butylammonium salt",439-350-8,,Self-react. E;Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3,Notified C&L,1,H334:1;H317:1;H242:1;H412:1
118882,"Ethyl 2,2-dichloroacetoacetate",228-104-3,6134-66-3,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H227:1;H315:1;H319:1;H335:1
118883,Sodium D-glycero-D-ido-heptonate,250-034-7,30080-50-3,Not Classified,Notified C&L,1,Not classified:1
118885,Sodium N-lauroylsarcosinate,205-281-5,137-16-6,Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2,REACH registration C&L,726,H330:542;H318:547;H315:554;H319:144;Not classified:34;H311:1;H301:1;H331:2;H332:1
118889,Ethyl methylnitrosocarbamate,210-432-3,615-53-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2;Carc. 2,Notified C&L,1,H301:1;H351:1;H341:1;H315:1;H319:1;H335:1
118895,2-bromopyridin-3-ol,229-547-5,6602-32-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
118896,"8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione monohydrochloride",251-489-4,33386-08-2,Acute Tox. 3,Notified C&L,46,H301:46;H335:1;H311:1;H331:1;H372:1;H315:1;H319:1
118898,"3,3'-(ethylenedioxy)dipropiononitrile",222-208-2,3386-87-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,18,H319:10;H315:10;H335:8;H314:8;H225:8;H311:8;H317:8;H411:8;H318:8;H331:8;H350:8;H301:9
118901,"1,8-diazabicyclo[5.4.0]undec-7-ene",229-713-7,6674-22-2,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,645,H301:383;H314:608;H318:444;H302:215;H412:303;H312:77;H290:61;Not classified:38;H311:10;H331:10;H300:10;H341:1;H350:1;H319:1;H315:1
118902,"Honeysuckle, Lonicera japonica, ext.",607-042-4,223749-79-9,Not Classified,Notified C&L,32,Not classified:32
118903,"Sodium 2-fluoro-α-methyl[1,1'-biphenyl]-4-acetate",260-373-2,56767-76-1,Acute Tox. 4,Notified C&L,2,H302:2
118906,3-(dimethoxymethyl)heptane,238-126-5,14250-95-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,93,H319:93;H226:93;H335:93;H315:93
118907,6-Bromo-2-naphtalenecarboxylic acid,611-572-1,5773-80-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:48;H335:47;H315:48;H410:1;H302:1;H332:1;H312:1
118913,Hyaluronic acid sodium salt,618-620-0,9067-32-7,Not Classified,Notified C&L,181,Not classified:169;H302:7;H319:4;H335:1;H315:1;H317:1
118914,"Amines, alkyldimethyl, N-oxides",608-529-4,308062-30-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,5,H318:5;H400:5;H315:5
118915,"Pentasodium bis[3-[[2,4-diamino-5-[(4-sulphophenyl)azo]phenyl]azo]-2-hydroxy-5-nitrobenzenesulphonato(4-)]chromate(5-)",277-760-7,74196-17-1,Not Classified,Notified C&L,22,Not classified:22
118917,(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate,407-880-9,117549-13-0,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
118919,N-[2-[[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]amino]ethyl]palmitamide monoacetate,300-567-7,93942-17-7,Not Classified,Notified C&L,7,Not classified:7
118920,(m-aminophenyl)metaboric acid,250-189-0,30418-59-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:43;H315:44;H302:1;H332:1;H312:1
118923,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecanesulphonyl chloride",248-578-5,27619-90-5,,Notified C&L,47,Not classified:47
118926,Allyl acetoacetate,214-269-9,1118-84-9,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,120,H319:6;H311:88;H302:70;H315:87;H301:50
118929,Sulphur trioxide,231-197-3,7446-11-9,Skin Corr. 1A;STOT SE 3,REACH registration C&L,446,H335:400;H314:426;H318:184;H351:45;H330:69;H411:45;H350:22;H271:21;Not classified:21;H331:9;H311:3;H301:3
118932,Phenylpropiolaldehyde,219-942-0,2579-22-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40
118936,Carbocisteine,211-327-5,638-23-3,Not Classified,Notified C&L,17,Not classified:16;H314:1
118937,"Poly(oxy-1,2-ethanediyl), a-[tris[1-(methylphenyl)ethyl]phenyl]-w-hydroxy-",615-957-5,73297-33-3,,Notified C&L,65,Not classified:64;H412:1
118943,5-methylpyridine-2-carbonitrile,216-589-4,1620-77-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,5,H302:3;H315:5;H319:5;H332:3;H335:4;H312:3;H301:1
118946,Methyl dichlorophosphite,221-915-3,3279-26-3,Flam. Liq. 3;Skin Corr. 1B;STOT SE 3,Notified C&L,43,H226:43;H335:38;H314:43;H318:1
118947,"Mytilus edulis, ext.",305-363-1,94465-78-8,Not Classified,Notified C&L,1,Not classified:1
118948,Phenanthrene-9-carbonitrile,219-725-0,2510-55-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H302:39;H315:39;H319:39;H332:39;H335:38;H312:39
118951,Copper chloride,215-704-5,1344-67-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,29,H319:26;H335:26;H301:25;H315:26;H410:3;H400:3;H302:1
118953,"Bellis perennis, ext.",283-935-9,84776-11-4,Not Classified,Notified C&L,1,Not classified:1
118955,"Phosphoric acid, mono- and dinonyl esters, branched",308-441-3,97999-44-5,Skin Corr. 1B,Notified C&L,9,H314:9
118957,"2,9-dimethyl-1,10-phenanthroline",207-601-9,484-11-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,133,H319:132;H335:131;H315:132;Not classified:1
118958,"Hydrogen [3,4-bis[[(2-hydroxy-1-naphthyl)methylene]amino]benzoato(3-)-N3,N4,O3,O4]nickelate(1-)",262-703-0,61300-98-9,Not Classified,Notified C&L,2040,Not classified:2040
118961,"Octahydro-7,7,8,8-tetramethyl-2,3b-methano-3bH-cyclopenta[1,3]cyclopropa[1,2]benzene-4-methanol",261-580-0,59056-64-3,Not Classified,Notified C&L,90,Not classified:89;H411:1
118962,tin tetrachloride;stannic chloride,231-588-9,7646-78-8,Skin Corr. 1B;Aquatic Chronic 3,Harmonised C&L,0,H314:0;H412:0
118964,"Benzenesulfonic acid, C14-44-branched alkyl derivs., calcium salts",294-226-9,91696-68-3,,Notified C&L,1,Not classified:1
118965,Spinel (Mg(AlO2)2),215-105-9,1302-67-6,Not Classified,REACH registration C&L,35,Not classified:35
118968,"Trans-esterification product of castor oil and 2-ethyl-2-(hydroxymethyl)propane-1,3-diol",614-585-0,68551-65-5,Not Classified,REACH registration C&L,11,Not classified:11
118969,2-[[[4-cloro-3-metil-2-piridinil]metil]sulfinil]-1H-bencimidazol,605-506-0,168167-42-8,,Notified C&L,2,H302:2;H319:1;H332:1;H335:1;H312:1
118970,3-methylsulphanilic acid,202-658-6,98-33-9,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,142,H317:8;H319:57;H412:6;Not classified:84;H315:51;H335:6;H314:1;H350:1
118972,(Z)-hex-3-enyl acetoacetate,282-820-0,84434-20-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,88,H319:88;H335:78;H315:88
118973,Erythromycin glucoheptonate,245-407-6,23067-13-2,Not Classified,Notified C&L,1,Not classified:1
118981,4-Methyl-N-(3-triethoxysilylpropyl)pentan-2-imine,467-100-8,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,3,H319:3;H317:3;H302:3;H315:3
118982,S-(2-methyl-3-furyl) ethanethioate,259-801-0,55764-25-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1440,H319:1377;H335:1349;H315:1439;H302:63;H226:40;H318:62;Not classified:1
118984,"Tetrasodium 2-[4-[2-[4-[[2-methyl-4-(7-sulphonato-2H-naphtho[1,2-d]triazol-2-yl)phenyl]azo]-2-sulphonatophenyl]vinyl]-3-sulphonatophenyl]-2H-naphtho[1,2-d]triazole-5-sulphonate",240-655-1,16596-97-7,Not Classified,Notified C&L,4,Not classified:4
118985,"demeton-O (ISO);O,O-diethyl-O-2-ethylthioethyl phosphorothioate",206-053-8,298-03-3,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1,Harmonised C&L,0,H310:0;H300:0;H400:0
118986,[[4-[butyl(2-phenylethyl)amino]-2-methylphenyl]mEthylene],417-510-8,106794-63-2,Aquatic Chronic 4,Notified C&L,4,H413:4
118987,"Sulfuric acid diammonium salt, reaction products with ammonia, cyanoguanidine and formaldehyde",308-025-1,97809-01-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
118990,"1,4-Benzenedicarboxylic acid, 1,4-dimethyl ester, polymer with 1,4-butanediol",608-561-9,30965-26-5,Not Classified,Notified C&L,35,Not classified:35
118995,ethyl 2-carboxy-3-(2-thienyl)propionate,415-680-8,143468-96-6,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0;H315:0
118997,Henicosanoic acid,219-113-3,2363-71-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:39;H315:39;Not classified:1
118998,4-[[4-(aminocarbonyl)phenyl]azo]-3-hydroxy-N-(2-methoxyphenyl)naphthalene-2-carboxamide,253-292-9,36968-27-1,Not Classified,Notified C&L,128,Not classified:127;H341:1;H412:1;H312:1
119000,Cyclohexanone oxime,202-874-0,100-64-1,Acute Tox. 4,Notified C&L,289,H302:201;H373:118;H412:35;H319:35;H228:35;Not classified:5
119001,"2-Octyne, 1-bromo-",606-041-6,18495-27-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
119003,2-[[2-(dimethylamino)ethyl]methylamino]ethanol,218-658-4,2212-32-0,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,194,H318:154;H314:120;H319:40;H335:72;H315:74;H302:31
119006,"Fatty acids, C8-10, octyl esters",293-003-3,91031-98-0,Not Classified,REACH registration C&L,86,Not classified:86
119009,"Fatty acids, C10-16, Me esters",267-018-0,67762-40-7,Aquatic Acute 1,Notified C&L,98,H400:42;Not classified:56
119010,N-octadecylstearamide,236-276-6,13276-08-9,Aquatic Chronic 4,REACH registration C&L,47,H413:4;Not classified:42;H319:1;H335:1;H315:1
119011,"reaction mass of: mono- and di-glycerols of canola oil;canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];N,N-diorgano dithiocarbamate molybdenum complex",434-240-6,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
119014,Pinanyl hydroperoxide,248-969-0,28324-52-9,,Notified C&L,33,Not classified:33
119017,Nonadecan-1-ol,215-930-4,1454-84-8,Not Classified,Notified C&L,3,Not classified:3
119024,"Benzenesulfonic acid, C15-36-branched alkyl derivs., calcium salts",294-227-4,91696-69-4,Eye Irrit. 2,Notified C&L,441,H319:441
119026,"trans-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexanol Hydrobromide",926-606-3,,Aquatic Chronic 2,Notified C&L,1,H411:1
119031,C.I. Acid Brown 101,612-234-6,61724-09-2,Not Classified,Notified C&L,36,Not classified:36
119033,2-methylnonan-1-oic acid,246-162-8,24323-21-5,,Notified C&L,4,H314:4
119036,N-[3-[(2-cyanoethyl)ethylamino]-4-methoxyphenyl]acetamide,243-060-5,19433-94-4,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,9,H302:9;H412:9
119039,Diamminebis(nitrito-N)palladium,238-388-0,14409-60-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H302:1;H272:1
119042,Decyl isooctadecanoate,283-388-6,84605-08-3,Not Classified,REACH registration C&L,3,Not classified:3
119044,2-(2-isopropoxyethyl)pyridine,274-820-4,70715-19-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119045,"Verbena officinalis, ext.",284-657-0,84961-67-1,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1376,H317:1376;H411:1376;H304:1340;H315:1376;H319:390;H226:89
119046,2-furaldehyde-diethylacetal,236-872-6,13529-27-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,42,H319:42;H335:42;H315:42
119047,Methyl 3-[(dimethoxyphosphinyl)oxy]crotonate,206-051-7,298-01-1,Acute Tox. 2;Acute Tox. 2;Aquatic Acute 1,Notified C&L,38,H310:38;H300:38;H400:38
119048,"1,1'-(4-methyl-1,3-phenylene)bis-1H-pyrrole-2,5-dione",229-175-3,6422-83-9,Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,56,H410:18;H317:18;H330:56;H318:4;H400:18;H319:52;H335:38;H315:52
119051,Sodium 2-(4-methoxyphenyl)hydrazinosulphonate,226-658-0,5446-07-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,40,H319:40;H335:40;H315:40
119052,"Dodecylbenzenesulphonic acid, compound with triethylamine (1:1)",249-400-9,29061-63-0,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,22,H302:20;H314:20;H412:20;H318:20;H335:20;Not classified:2
119054,crotonaldehyde;2-butenal,224-030-0,4170-30-3,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Muta. 2;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H335:0;H225:0;H311:0;H341:0;H330:0;H373:0;H318:0;H315:0;H301:0;H400:0
119056,3-(Isopropoxycarbonyl)benzeneboronic acid,608-956-6,342002-80-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
119057,2-propyltoluene,214-037-7,1074-17-5,Skin Sens. 1;Eye Dam. 1,Notified C&L,46,H317:38;H318:38;H226:5;Not classified:3;H304:1
119061,"[R-(R*,S*)]-trimethyl(α-methylphenacyl)ammonium bromide",259-619-1,55380-59-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119064,"Fatty acids, C18-unsatd., dimers, hydrogenated",500-231-1,68783-41-5,Not Classified,REACH registration C&L,137,Not classified:137
119068,Thiobenzoic acid,202-712-9,98-91-9,Met. Corr. 1;Skin Corr. 1B,REACH registration C&L,57,H290:11;H314:15;H319:42;H335:41;H315:42
119069,Isopentyl octanoate,218-004-8,2035-99-6,Not Classified,Notified C&L,210,Not classified:159;H319:51;H335:39;H315:51
119070,p-hydrazinobenzenesulphonamide,224-513-6,4392-54-5,Acute Tox. 4,Notified C&L,32,H302:31;H319:1;H335:1;H315:1
119074,Isocyclocitral,215-638-7,1335-66-6,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1707,H317:1704;H319:1704;H412:1704;H315:1326;Not classified:3
119075,"triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate",432-270-4,221354-37-6,STOT RE 2;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H361:0;H373:0;H411:0
119076,Diphenyliodonium iodide,218-716-9,2217-79-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H301:4
119077,"4,5-bis[(2-cyanoethoxy)methyl]-2-phenyl-1H-imidazole-1-propiononitrile",265-864-5,65652-67-7,Acute Tox. 4,Notified C&L,28,H302:28
119078,Minaprine,247-329-8,25905-77-5,Acute Tox. 4,Notified C&L,38,H302:38
119089,"N,N''-propane-1,3-diylbis[N'-octadecylurea]",252-667-4,35674-65-8,Not Classified,REACH registration C&L,4,Not classified:4
119090,"N,N-dimethylglycine",214-267-8,1118-68-9,Acute Tox. 4,REACH registration C&L,108,H302:50;Not classified:58;H332:1;H312:1
119091,1-(isopropyl)-4-piperidone,226-339-6,5355-68-0,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,43,H317:38;H335:42;H318:38;H315:43;H319:5
119093,(p-acetylphenoxy)acetic acid,217-524-2,1878-81-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
119099,4-FENILBUTIRATO DE SODIO,605-612-7,1716-12-7,Eye Irrit. 2,Notified C&L,43,H319:41;Not classified:1;H361:1;H335:2;H315:2
119101,"2,6,10,15,19,23-hexamethyltetracosene",271-913-1,68629-07-2,Not Classified,Notified C&L,1,Not classified:1
119102,Zeanyne salt,618-777-5,91662-51-0,Acute Tox. 4,REACH registration C&L,1,H302:1
119105,Methyl O-tetraacetyl-β-D-glucopyranuronate,230-880-3,7355-18-2,Not Classified,Notified C&L,1,Not classified:1
119106,"metoxuron (ISO);3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea",243-433-2,19937-59-8,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
119107,"Amylase, bacterial",232-560-9,9000-85-5,Resp. Sens. 1,Notified C&L,44,H334:44
119108,Sodium isononanoate,282-992-7,84501-72-4,Not Classified,Notified C&L,2,Not classified:2
119110,"Eleutherococcus senticosus, ext.",283-632-1,84696-12-8,Not Classified,Notified C&L,4,Not classified:2;H319:1;H226:2
119111,"2-Thiophenecarboxylic acid, 3-amino-2,5-dihydro-4-methyl-, methyl ester, 1-oxide",603-029-2,125088-75-7,Not Classified,REACH registration C&L,2,Not classified:2
119115,Oxolinic acid,238-750-8,14698-29-4,Acute Tox. 4,Notified C&L,153,H302:152;H371:1;H373:1;H411:1;H332:1;H301:1
119117,(1-methyl-2-oxo-2-phenylethyl)triphenylphosphonium bromide,220-255-3,2689-63-6,,Notified C&L,4,H319:4;H335:4;H315:4
119121,Octaverine hydrochloride,229-836-6,6775-26-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119122,"Sulfite liquors and Cooking liquors, spent, alkali-treated",268-613-8,68131-31-7,Not Classified,Notified C&L,3,Not classified:3
119128,8-amino-5-[(p-aminophenyl)azo]naphthalene-2-sulphonic acid,201-621-1,85-67-6,Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H360:1;H400:1
119131,dipotassium sulphide,215-197-0,1312-73-8,Skin Corr. 1B;Aquatic Acute 1,Harmonised C&L,0,H314:0;H400:0
119133,2-Methoxy-5-(trifluoromethoxy)benzaldehyde,604-489-7,145742-65-0,,Notified C&L,7,H319:7;H315:7;H335:2
119145,(RS)-2-[4-(5-Trifluoromethyl-2-pyridyloxy)phenoxy]propionic,614-949-9,69335-91-7,Aquatic Acute 1,Notified C&L,199,H361:196;H410:158;H400:195;Not classified:3
119147,3-chlorobenzylamine,223-985-0,4152-90-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,47,H318:39;H314:47;H302:2;H332:2;H312:2
119148,"1H-Pyrazolo[4,3-d]pyrimidine, 7-chloro-5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1-methyl-3-propyl-",600-429-9,1033861-39-0,Not Classified,Notified C&L,1,Not classified:1
119155,"2-Butenedioic acid (2Z)-, polymer with chloroethene and ethenyl acetate",618-409-3,9005-09-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,673,H319:549;H335:549;H315:549;Not classified:124
119159,1-benzylpiperazine dihydrochloride,226-188-6,5321-63-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119163,"Bis(2,5-dioxopyrrolidin-1-yl) octanedioate",614-576-1,68528-80-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
119171,"Nitriles, C16-18",268-079-6,68002-65-3,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,36,H410:36;H400:3;H315:36
119172,5-Chloro-3-methylbenzo[b]thiophene-2-sulfonyl chloride,605-457-5,166964-33-6,Skin Corr. 1B,Notified C&L,2,H335:1;H314:2
119174,[3-[[[5-(dimethylamino)-1-naphthyl]sulphonyl]amino]phenyl]metaboric acid,278-319-1,75806-94-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119178,4-(trans-4-Propylcyclohexyl)-1-bromobenzene,485-340-1,,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,4,H335:4;H318:4;H315:4
119180,"Naphtha (petroleum), heavy catalytic cracked, sweetened;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",295-431-6,92045-50-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
119182,"Tetrahydro-2,2,6-trimethyl-6-vinyl-2H-pyran-3-ol",237-889-1,14049-11-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
119186,Dysprosium tribromide,238-443-9,14456-48-5,,Notified C&L,6,H319:6;H335:6;H315:6
119191,Benzyl isooctyl phthalate,248-335-3,27215-22-1,Eye Irrit. 2,Notified C&L,1,H319:1
119192,"N,N-bis(2-hydroxyethyl)undec-10-enamide",262-114-9,60239-68-1,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,27,H318:27;H315:27
119194,Allyl (3-methylbutoxy)acetate,266-803-5,67634-00-8,Acute Tox. 4;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1747,H330:13;H302:1703;H410:3;H400:3;H315:1740;H319:40;H335:39;H332:25;Not classified:4;H311:1;H317:1;H301:1
119196,"Extract residues (coal), tar oil alk.;Carbolic Oil Extract Residue;[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]",266-021-4,65996-87-4,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
119198,Isotridecanoic acid,246-997-8,25448-24-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H413:1;H315:1
119199,5-Amino-2-methylbenzoic Acid,608-202-6,2840-04-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H302:38;H335:38;H315:39
119200,"Tallow, hydrogenated",232-442-7,8030-12-4,Not Classified,Notified C&L,167,Not classified:167
119201,Calcium 4-[(5-chloro-4-methyl-2-sulphonatophenyl)azo]-3-hydroxy-2-naphthoate,230-303-5,7023-61-2,Not Classified,REACH registration C&L,1077,Not classified:1076;H412:1
119205,Isopropyl N-lauroyl sarcosinate,440-990-5,,Not Classified,REACH registration C&L,37,Not classified:37
119207,"Bis[N-(3-ammoniopropyl)-N,N'-butan-1,4-diyldiammonio] trihydrogen triphosphate",256-447-9,49721-50-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
119208,"ammonium 2,2,3 trifluor-3-(1,1,2,2,3,3-hexafluoro-3-trifluormethoxypropoxy), propionate",480-310-4,,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H302:1
119210,"Carboxylic acids, C1-5",273-079-4,68937-68-8,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H226:1;H318:1;H314:1
119211,"Rosin, distn. overheads",270-333-6,68425-08-1,Not Classified,Notified C&L,12,Not classified:12
119214,1-chlorooctane,203-915-5,111-85-3,Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,175,H410:92;H304:89;H411:87;H400:149;H319:1;H315:1
119219,2-ethoxybenzenecarboximidamide hydrochloride,606-080-9,18637-00-8,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,3,H302:3;H412:3
119223,Ethyl (2R)-2-(methylsulfonyloxy)-4-phenylbutyrate,603-326-7,129277-08-3,Not Classified,REACH registration C&L,2,Not classified:2
119225,"1-butoxy-2,3-difluorobenzene",446-810-1,,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H410:1;H400:1
119229,(Z)-3-hexenyl crotonate,265-746-3,65405-80-3,Not Classified,Notified C&L,90,Not classified:89;H319:1;H315:1
119230,Bromchlorenone,226-967-0,5579-85-1,Acute Tox. 4,Notified C&L,38,H302:38
119232,"2,5-Furandione, telomer with ethenylbenzene and (1-methylethyl)benzene, 2-butoxyethyl ester",605-216-4,160611-50-7,Not Classified,Notified C&L,5,Not classified:5
119233,"2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium hydrogen sulphate",286-623-0,85283-95-0,Acute Tox. 2;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H410:2;H330:2;H318:2;H300:2;H400:2;Not classified:1
119236,Butylhydroxyoxostannane,218-880-1,2273-43-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,590,H319:386;H412:329;H315:386;H410:90;H400:19;H360:10;Not classified:164;H302:4;H332:4;H335:5;H312:4;H311:1;H331:1;H301:1;H373:1;H411:1;H318:1
119238,"Triammonium 4-[2,7-dihydro-3-methyl-2,7-dioxo-1-(3-sulfonatobenzoyl)-3H-naphtho[1,2,3-de]quinoline-6-ylamino]benzene-1,3-disulfonate",461-280-1,,Not Classified,Notified C&L,1,Not classified:1
119239,"Propanediamide, 2-(2,6-diethyl-4-methylphenyl)-",608-615-1,314020-40-1,Acute Tox. 4;Repr. 2,Notified C&L,156,H361:156;H302:156
119241,3-(trifluoromethyl)benzylic alcohol,206-489-9,349-75-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:45;H315:47
119246,"Distillates (petroleum), solvent-dewaxed light paraffinic;Baseoil - unspecified;[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",265-159-2,64742-56-9,Carc. 1B,Harmonised C&L,0,H350:0
119252,Benzyl(methyl)amine,203-133-4,103-67-3,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,2133,H302:2078;H314:2127;H412:2037;H226:2037;H332:2037;H312:2040;H334:41;H317:42;H318:38;Not classified:5;H301:8;H290:2;H319:1;H335:3;H315:1;H311:1
119253,Exo-bornyl butyrate,261-281-5,58479-55-3,Not Classified,Notified C&L,1,Not classified:1
119254,1-benzylpiperidine,220-809-4,2905-56-8,,Notified C&L,5,H319:5;H335:4;H315:5
119256,Tetrapotassium dihydrogen [nitrilotris(methylene)]trisphosphonate,301-418-9,94021-25-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
119260,(+)-3-methylcyclohexanone,236-438-6,13368-65-5,Flam. Liq. 3,Notified C&L,39,H226:39
119261,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluorononyl acrylate",206-211-6,307-87-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
119265,Hydrogen bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(1-),251-079-5,32517-36-5,Not Classified,Notified C&L,25,Not classified:25
119268,"[1S-(1α,4α,7α)]-1,2,3,4,5,6,7,8-octahydro-1,4,9,9-tetramethyl-4,7-methanoazulene",208-182-5,514-51-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,87,H319:87;H315:87
119269,"Potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate",606-100-6,187026-95-5,Eye Dam. 1,Notified C&L,1,H318:1
119270,p-tolyl isocyanate,210-743-4,622-58-2,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,70,H302:69;H410:1;H314:26;H317:26;H330:30;H411:26;H318:26;H335:70;H400:26;H334:44;H315:44;H319:44;H332:38;H312:38;H311:1;H331:2;H301:1
119273,Indium sulphide,234-741-8,12030-14-7,Not Classified,Notified C&L,2,Not classified:2
119279,"Ethanaminium, 2-hydroxy-N,N-bis(2-hydroxyethyl)-N-methyl-, monoesters with lanolin fatty acids, Me sulfates (salts)",305-917-2,95370-55-1,Not Classified,Notified C&L,6,Not classified:6
119281,"Cyclohexanamine, 4,4'-methylenebis[2-methyl-, reaction products with glycidyl Ph ether",291-114-1,90341-82-5,Not Classified,Notified C&L,1,Not classified:1
119284,"Fatty acids, C14-18 and C16-18-unsatd., reaction products with diethylenetriamine",283-486-9,84650-06-6,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,3,H317:3;H410:3;H314:3
119293,(4-carboxybutyl)triphenylphosphonium bromide,241-782-5,17814-85-6,Flam. Sol. 2,REACH registration C&L,49,H228:1;H319:42;H335:41;H315:42;H302:6;H332:1;H312:1;Not classified:1
119294,"Alcohols, C6-24, distn. residues",310-080-1,102242-49-9,Not Classified,REACH registration C&L,128,Not classified:128
119296,Guanidinoacetic acid,206-529-5,352-97-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:44;H315:45;Not classified:1
119297,Potassium acetate,204-822-2,127-08-2,Not Classified,REACH registration C&L,470,Not classified:412;H319:58;H335:52;H315:52;H302:6
119299,"2,4,6-tribromo-m-cresol",225-032-4,4619-74-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,42,H302:42;H413:38;H315:42;H319:42;H335:42
119302,2-amino-3-bromo-5-nitrobenzonitrile,241-574-4,17601-94-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,53,H302:40;H315:53;H319:53;H332:44;H335:52;H312:44;H301:4
119306,Cadmium succinate,205-446-1,141-00-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H302:38;H410:38;H332:38;H400:38;H312:38
119313,Phenylhydroxylamine,202-875-6,100-65-2,Acute Tox. 3,Notified C&L,38,H301:38
119316,(3-fluorophenyl)boronic acid,616-400-9,768-35-4,Acute Tox. 4,Notified C&L,22,H302:13;H319:11;H335:10;H315:11;Not classified:2;H332:1;H312:1
119321,"Alcohols, C12-15, ethoxylated",500-195-7,68131-39-5,Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,2227,H412:354;H400:1846;H318:1828;H315:606;H302:452;H410:343;Not classified:65;H319:119;H411:4
119323,3-(dodecylthio)propylamine,249-919-0,29873-33-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38
119326,2-chloropropyl(diethyl)amine,212-089-5,761-21-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2,H319:2;H302:2;H315:2
119327,"2',4'-dimethoxyacetoacetanilide",240-770-7,16715-79-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
119331,Dimethyl (2-oxoheptyl)phosphonate,253-293-4,36969-89-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Muta. 2;Aquatic Chronic 4,Notified C&L,2,H302:1;H413:1;H341:1;H315:2;H319:2;H332:1;H335:1
119333,"mercaptodimethur (ISO);methiocarb (ISO);3,5-dimethyl-4-methylthiophenyl N-methylcarbamate",217-991-2,2032-65-7,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H301:0;H400:0
119336,"(1S)-1,5-anhydro-1-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol hemihydrate",620-201-2,928672-86-0,Aquatic Chronic 2,Notified C&L,2,H411:2;H319:1;H302:1
119340,(2-hydroxytrimethylene)bis(trimethylammonium) dichloride,259-734-7,55636-09-4,Not Classified,Notified C&L,79,Not classified:79
119342,"Proteinase, Streptomyces griseus",232-909-5,9036-06-0,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,77,H334:77;H319:77;H335:77;H315:77;Not classified:1
119343,5-(2-chloroacetyl)-8-phenylmethoxy-1H-quinolin-2-one,453-270-0,63404-86-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
119345,Methyl 2-chloroacetoacetate,225-286-6,4755-81-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H302:38;H315:38;H319:38;H332:38;H335:38;H312:38;H318:1;H314:1
119346,2-Amino-5-bromo-3-methylpyridine,608-966-0,3430-21-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,136,H319:136;H335:135;H315:136;H302:5;H332:5;H312:5
119347,"Octanoic acid, zirconium salt",242-197-8,18312-04-4,Skin Irrit. 2,Notified C&L,320,H315:233;Not classified:87
119355,"N-(1-oxododecyl)-L-glutamic acid, compound with 2,2',2''-nitrilotrisethanol (1:1)",258-636-1,53576-49-1,Not Classified,Notified C&L,2,Not classified:2
119358,"2,4,5-trimethylaniline",205-282-0,137-17-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H311:0;H411:0;H331:0;H350:0;H301:0
119364,3-[4-(diethylamino)phenyl]-3-(1-ethyl-2-methyl-1H-indol-3-yl)phthalide,278-318-6,75805-17-3,Not Classified,Notified C&L,2,Not classified:2
119366,"β,β-carotene",230-636-6,7235-40-7,Self-heat. 2;Eye Irrit. 2,REACH registration C&L,343,H319:27;H252:1;Not classified:290;H315:25;H412:25;H413:1
119368,"Trisodium 7-hydroxy-8-[[4-[1-[4-[(1-hydroxy-4-sulphonato-2-naphthyl)azo]phenyl]cyclohexyl]phenyl]azo]naphthalene-1,3-disulphonate",229-397-0,6507-78-4,Aquatic Chronic 3,Notified C&L,128,H412:103;Not classified:23;H319:5;H413:2
119369,2-[(2-cyanoethyl)[4-[(6-nitrobenzothiazol-2-yl)azo]phenyl]amino]ethyl acetate,268-697-6,68133-69-7,Aquatic Chronic 3,REACH registration C&L,64,H317:39;H412:44;Not classified:19;H411:1
119370,Citric acid,201-069-1,77-92-9,Not Classified,REACH registration C&L,4233,Not classified:468;H319:3431;H335:363;H318:309;H315:425;H314:5;H302:1
119373,"4-ethyl-1,3-dioxolan-2-one",403-780-4,,Not Classified,Notified C&L,1,Not classified:1
119376,Cyhalofop-butyl,601-817-0,122008-85-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,184,H410:146;H400:184;H302:38;H373:1
119380,Diethoxymethyloctadecylsilane,267-423-2,67859-75-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119381,"Hexa-2,4-dien-1-ol",203-853-9,111-28-4,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,259,H319:258;H311:258;H302:258;H315:259;H318:1;H312:1
119382,"Fatty acids, C16-18, ethoxylated",614-880-4,68989-61-7,Not Classified,Notified C&L,32,Not classified:32
119383,N-benzylethylenediamine,223-984-5,4152-09-4,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,152,H302:84;H314:151;H412:84;H317:106;H318:86;H361:1
119384,"Distillates (petroleum), catalytic cracked heavy tar light;Cracked kerosine;[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 °C to 250 °C (212 °F to 482 °F).]",309-938-8,101631-13-4,Asp. Tox. 1,Harmonised C&L,0,H304:0
119389,"2-(2,2-dimethoxyethoxy)naphthalene",270-883-7,68480-07-9,Not Classified,Notified C&L,88,Not classified:88
119394,"Octadecanoic acid, 12-hydroxy-, reaction products with ethylenediamine",309-629-8,100545-48-0,Skin Sens. 1B,REACH registration C&L,90,H317:59;H412:40;Not classified:31;H413:13
119402,Disodium hexafluorotitanate,241-181-8,17116-13-1,Eye Irrit. 2,Notified C&L,28,H319:27;H335:3;H314:3
119404,"Ethanedioic acid, dihydrate",612-167-2,6153-56-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,467,H302:460;H312:460;H373:85;H318:186;H315:85;Not classified:6;H314:1
119407,"2-(1,1-dimethylpropyl)phenol",221-916-9,3279-27-4,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,17,H302:16;H314:17;H311:12;H411:13;H318:16;H332:13;H410:3;H312:1
119411,Diammonium malate,228-499-2,6283-27-8,Not Classified,Notified C&L,58,Not classified:58
119414,"3,4,4-trimethylpent-2-ene",209-958-6,598-96-9,Flam. Liq. 2,Notified C&L,38,H225:38
119415,Phenanthren-9-ol,207-602-4,484-17-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119429,Tin sulphide,215-248-7,1314-95-0,Not Classified,REACH registration C&L,75,Not classified:45;H319:30;H335:30;H315:30
119431,"Sodium bis[3-[[1-(3-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]-4-hydroxy-N-methylbenzenesulphonamidato(2-)]cobaltate(1-)",275-863-1,71701-14-9,Aquatic Chronic 3,REACH registration C&L,2058,H412:8;H411:2050
119437,p-(difluoromethoxy)benzaldehyde,277-653-5,73960-07-3,,Notified C&L,8,H319:8;H335:7;H315:8
119438,"Acetamide, 2-cyano-N,N-diethyl-",607-929-6,26391-06-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,6,H319:3;H302:3;H361:2;H226:2;H315:1;H332:1;H312:1;Not classified:1
119442,"2,6-dibromopyridin-3-ol",229-548-0,6602-33-1,,Notified C&L,2,H319:2;H302:1;H335:1;H315:2
119449,"reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1)",408-000-6,118658-98-3,Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H373:0;H412:0
119451,N-[2-[(2-cyano-4-nitrophenyl)azo]-5-(diethylamino)phenyl]acetamide,258-020-2,52583-54-7,Skin Sens. 1,Notified C&L,9,H317:9
119452,Zirconium diboride,234-963-5,12045-64-6,Not Classified,REACH registration C&L,53,Not classified:4;H302:45;H332:45;H312:45;H228:4
119453,2-phenylindolizine,246-925-5,25379-20-8,Aquatic Chronic 4,Notified C&L,38,H413:38
119455,"tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II)",404-070-7,116912-62-0,Aquatic Chronic 3,Harmonised C&L,0,H412:0
119457,3-butenyl isothiocyanate,222-209-8,3386-97-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,3,H301:3;H331:1;H315:2;H319:2;H335:2;H314:1;H311:1;H317:1;H330:2;H226:1;H318:1;H334:1;H400:2;H410:1;H310:1
119459,"1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate",419-570-0,,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
119460,"3-Ethoxyestra-3,5-dien-17-one",608-229-3,2863-88-9,Not Classified,Notified C&L,2,Not classified:1;H361:1;H302:1;H351:1;H332:1;H312:1
119461,4-fluoro-2-iodotoluene,236-153-7,13194-67-7,Acute Tox. 3,Notified C&L,44,H301:38;H319:6;H315:6;H302:1;H332:1;H312:1;H335:1
119463,"L-Valine, N-[(1,1-dimethylethoxy)carbonyl]-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester",610-513-7,502421-44-5,Not Classified,Notified C&L,1,Not classified:1
119464,"4'-[2-(4-Chlorphenyl)ethyl]-2-fluor-4-pentyl-1,1'-biphenyl",603-504-4,131739-13-4,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
119466,p-bromophenylacetic acid,217-523-7,1878-68-8,Acute Tox. 4,Notified C&L,49,H302:41;H319:10;H335:9;H315:10
119467,Disodium 6-amino-5-[[4-(benzoylamino)-2-sulphonatophenyl]azo]-4-hydroxynaphthalene-2-sulphonate,263-993-1,63192-51-8,Not Classified,Notified C&L,9,Not classified:9
119469,"Honeysuckle, Lonicera caprifolium, ext.",283-263-6,84603-62-3,Not Classified,Notified C&L,136,Not classified:110;H319:25;H335:25;H226:1
119470,"(17β).-hydroxyandrosta-1,4-dien-3-one acetate",219-112-8,2363-59-9,Carc. 2;STOT RE 2,Notified C&L,38,H373:38;H351:38
119471,"Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;Baseoil - unspecified;[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",292-620-5,90640-97-4,Carc. 1B,Harmonised C&L,0,H350:0
119472,"3-anilino-2-(3,4,5,-trimethoxybenzyl)acrylonitrile",250-033-1,30078-48-9,,Notified C&L,3,H302:1;H319:1;H335:1;H315:1;H317:1;H332:1
119474,3-fluorophenol,206-748-6,372-20-3,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1,Notified C&L,51,H301:42;H318:41;H315:47;H302:6;H314:4;H312:6;H319:3;H332:2;H335:4;H311:2;H331:2
119481,Exo-2-norbornyl formate,255-412-5,41498-71-9,Flam. Liq. 3,Notified C&L,39,H226:39
119482,Disodium dodecanedioate,250-582-7,31352-39-3,Not Classified,Notified C&L,2,Not classified:2
119483,"1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)pentane",459-520-5,132182-92-4,Not Classified,REACH registration C&L,6,Not classified:5;H413:1
119485,"1-Decene, tetramer, mixed with 1-decene trimer, hydrogenated",614-695-9,68649-12-7,Asp. Tox. 1,REACH registration C&L,111,H304:105;Not classified:6;H302:1;H332:1
119486,Lead sulphite,231-196-8,7446-10-8,Not Classified,Notified C&L,1,Not classified:1
119489,"Arctostaphylos uva-ursi, ext.",283-934-3,84776-10-3,Not Classified,Notified C&L,29,Not classified:28;H226:1
119491,"Oils, palm kernel, stearins",295-808-5,92129-07-2,Not Classified,Notified C&L,2,Not classified:2
119492,Midecamycin,252-578-0,35457-80-8,Aquatic Chronic 4,Notified C&L,1,H413:1
119494,"reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol",427-050-1,170016-25-8,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H410:0;H317:0;H315:0;H400:0
119495,Isoxadifen-ethyl,605-330-4,163520-33-0,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,207,H317:207;H302:207;H410:207;H400:207
119496,"Ethanol, 2-butoxy-, phosphate",254-458-3,39454-62-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:5;H335:5;H315:5
119499,6-methylpyridine-2-carbonitrile,216-588-9,1620-75-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40;H311:1;H331:1;H301:1;H302:1;H332:1;H312:1
119500,"Adipic acid, ammonium salt",242-809-3,19090-60-9,Aquatic Chronic 3,REACH registration C&L,36,H412:2;Not classified:34
119503,3-methylbutyl isovalerate,211-536-1,659-70-1,Aquatic Chronic 2,REACH registration C&L,1721,H411:1672;H319:39;H335:38;H315:39;Not classified:10;H400:2
119504,Hexadecyltrimethylammonium toluene-p-sulphonate,205-324-8,138-32-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3;Aquatic Acute 1,REACH registration C&L,42,H302:4;H315:42;H319:40;H335:42;H400:1;Not classified:2;H318:2;H413:1;H332:1;H312:1
119506,"3,5-dimethylisoxazole-4-carboxylic acid",219-724-5,2510-36-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:2
119509,20-[(6-O-α-L-arabinopyranosyl-β-D-glucopyranosyl)oxy]-12β-hydroxydammar-24-en-3β-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside,234-251-4,11021-13-9,Acute Tox. 4,Notified C&L,4,H302:3;Not classified:1
119511,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 3-aminopropyldiethylamine and 2-piperazin-1-ylethylamine",500-230-6,68698-70-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,32,H302:1;H410:1;H320:1;H303:1;H317:1;H315:1;H319:1;H316:1;H400:1;Not classified:31
119512,"Benzene, 1-[(1E)-2-(3,5-dimethoxyphenyl)ethenyl]-2,4-dimethoxy-",607-328-9,24144-92-1,Acute Tox. 4,Notified C&L,38,H302:38
119515,"2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide",403-010-7,106359-94-8,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0
119516,"1,2-diethoxypropane",412-180-1,10221-57-5,Flam. Liq. 2,Harmonised C&L,0,H225:0
119517,Disodium 7-benzamido-4-hydroxy-3-[[4-[(4-sulphonatophenyl)azo]phenyl]azo]naphthalene-2-sulphonate,220-028-9,2610-11-9,Not Classified,REACH registration C&L,158,Not classified:151;H319:5;H312:1;H315:1;H412:1
119520,Lithium tri-sec-butylhydroborate,254-101-1,38721-52-7,Water-react. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,168,H318:41;H314:168;H260:130;H225:100;H335:83;H250:31
119522,N-[3-[(2-cyanoethyl)(2-hydroxyethyl)amino]phenyl]acetamide,259-618-6,55379-84-5,Acute Tox. 4,Notified C&L,38,H302:38
119523,cobalt dichloride,231-589-4,7646-79-9,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1B;Repr. 1B,Harmonised C&L,0,H302:0;H410:0;H341:0;H334:0;H317:0;H350:0;H360:0;H400:0
119524,"3-[3-(pentanoyloxy)-2,2-bis[(pantanoyloxy)methyl]propoxyl]-2,2-bis[(pentanoyloxy)methyl]propyl pentanoate 3-{3-[(3,5,5-trimethylhexanoyl)oxy]-2,2-bis({[(3,5,5-trimethylhexanoyl)oxy]methyl}propoxy)-2,2-bis({[(3,5,5-trimethylhexanoyl)oxy]methyl}propyl 3,5,5-trimethylhexanoate",444-000-2,,Not Classified,REACH registration C&L,2,Not classified:2
119525,Kyanite,215-106-4,1302-76-7,Not Classified,Notified C&L,91,Not classified:47;H319:21;H318:20;H373:3
119526,"Aspidosperma quebracho-blanco, ext.",289-564-9,89957-46-0,Flam. Liq. 2,Notified C&L,1286,H225:1286
119529,"1,2,4-tribromobenzene",210-433-9,615-54-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H410:38;H315:43;H319:43;H335:38;H400:38
119532,"Fatty acids, C6-12, calcium salts",273-780-5,69012-90-4,Not Classified,Notified C&L,7,Not classified:7
119534,2-chlorotoluene-4-sulphonic acid,202-659-1,98-34-0,Skin Corr. 1B;STOT SE 3,Notified C&L,1,H335:1;H314:1
119535,"9-(4-ethoxyphenyl)-2-(3,5-dimethylphenyl)-1,3,8,10-tetraoxoanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline",401-580-1,,Not Classified,Notified C&L,33,Not classified:33
119537,"3-hydroxyoestra-1,3,5(10),6,8-pentaen-17-one",208-230-5,517-09-9,Carc. 2,Notified C&L,39,H351:38;H350:1;H360:1;H372:1
119540,"phorate (ISO);O,O-diethyl ethylthiomethyl phosphorodithioate",206-052-2,298-02-2,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H310:0;H410:0;H300:0;H400:0
119544,phenylmercury acetate,200-532-5,62-38-4,Acute Tox. 3;Skin Corr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H314:0;H372:0;H301:0;H400:0
119545,Levamisole hydrochloride,240-654-6,16595-80-5,Acute Tox. 3,Notified C&L,299,H301:299;H361:39;H373:36;H412:41;H341:10;H317:10;H372:11;H311:3;H331:1;H319:1;H315:1
119546,"S-(2,5-dimethyl-3-furyl) 3-methylbutanethioate",259-802-6,55764-28-8,Acute Tox. 4,Notified C&L,233,H302:233
119547,o-benzyltoluene,211-927-7,713-36-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
119552,"Heptasodium bis[4-hydroxy-5-[(2-hydroxy-1-naphthyl)azo]-3-[(2-hydroxy-3-nitro-5-sulphophenyl)azo]naphthalene-2,7-disulphonato(5-)]cobaltate(7-)",277-761-2,74196-18-2,Not Classified,REACH registration C&L,40,Not classified:40
119553,"Decanedioic acid, calcium salt (1:?)",607-187-3,22999-57-1,Not Classified,Notified C&L,1,Not classified:1
119554,"Trifluoromethanesulphonic acid, compound with diethylamine (1:1)",262-529-5,60933-18-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,20,H302:14;H315:14;H319:14;H332:14;H335:14;H312:14;Not classified:6
119556,S-benzyl-L-cysteine,221-273-4,3054-01-1,Not Classified,Notified C&L,1,Not classified:1
119558,2-bromo-1-[3-(trifluoromethyl)phenyl]ethan-1-one,606-425-3,2003-10-3,,Notified C&L,8,H319:6;H335:6;H315:5;Not classified:1;H314:2
119560,7-sodiooxy-3H-phenoxazin-3-one 10-oxide,263-718-5,62758-13-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H319:52;H335:51;H315:52;Not classified:4;H302:2
119561,2-(ethylthio)benzothiazole,220-418-9,2757-92-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119563,"Amides, C8-18 even numbered, N-[3-(dimethylamino)propyl]",930-947-3,,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,8,H302:8;H410:8;H314:8;H317:8;H411:8;H318:8;H400:8
119564,glyphosate (ISO);N-(phosphonomethyl)glycine,213-997-4,1071-83-6,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0
119565,1-chloro-4-methoxybutane,241-858-8,17913-18-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H302:1;H226:2;H315:2;H319:2;H335:2
119567,"Hydrocarbon waxes (petroleum), oxidized, Me esters, calcium salts",271-638-7,68603-11-2,Not Classified,REACH registration C&L,443,Not classified:443
119568,"Alcohols, C10-16",267-019-6,67762-41-8,Aquatic Acute 1,Notified C&L,855,H400:745;H410:96;H315:121;Not classified:57;H319:21
119569,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-henicosafluorododecane-1-sulphonyl chloride",248-579-0,27619-91-6,,Notified C&L,47,Not classified:47
119575,"[4-[[4-anilino-1-naphthyl][4-(dimethylamino)phenyl]methylene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride",219-943-6,2580-56-5,Acute Tox. 4,Notified C&L,241,H302:201;H319:86;Not classified:27;H410:27;H318:39;H400:26;H341:11;H350:12;H314:1;H411:1;H335:1;H315:1
119577,"Trisodium 4-[[4-chloro-6-[(4-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-[[1-(2,5-dichloro-4-sulphonatophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]benzenesulphonate",256-692-1,50662-99-2,Not Classified,REACH registration C&L,18,Not classified:18
119581,"1,4,6,10-Dodecatetraen-3-ol,3,7,11-trimethyl-,(4E,6E)-",611-799-6,59121-99-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,84,H410:84;H317:84;H315:84;H319:84;H400:84
119582,"2-Propanol, 1,1'-iminobis-, N-tallow alkyl derivs.",273-160-4,68951-72-4,,Notified C&L,1,H302:1;H314:1;H400:1
119585,4-vinylaniline,216-185-8,1520-21-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,45,H302:44;H351:39;H334:39;H373:39;H315:44;H319:44;H332:40;H335:43;H312:40;H311:1;H301:1;H331:1
119586,"6'-(cyclohexylamino)-2'-methylspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",252-800-6,35933-93-8,Not Classified,Notified C&L,1,Not classified:1
119587,2-hydroxybenzophenone,204-226-2,117-99-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
119588,"Pitch, gilsonite",604-409-0,144348-88-9,Not Classified,Notified C&L,73,Not classified:73
119590,"Distillates (petroleum), thermal cracked naphtha and gas oil, extractive;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31°C to 40°C (88°F to 104°F).]",271-634-5,68603-03-2,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
119596,Ethyl cyclopropanecarboxylate,225-010-4,4606-07-9,Flam. Liq. 2,REACH registration C&L,46,H225:46
119599,2-hydroxycyclopentan-1-one,610-343-3,473-84-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
119601,"Glycerides, C16-18 and C18-unsatd. mono- and di-",270-312-1,68424-61-3,Not Classified,Notified C&L,53,Not classified:53
119602,"(2R,2'R)-3,3'-diselane-1,2-diylbis(2-aminopropanoic acid) (non-preferred name)",608-382-6,29621-88-3,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H410:40;H373:40;H331:40;H301:40;H400:40
119603,m-chloro-p-hydroxyphenylacetic acid,251-643-0,33697-81-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
119606,"3-ethyl-2,4-dimethyl-1H-pyrrole",208-234-7,517-22-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
119614,isopropyl chloroacetate,203-301-7,105-48-6,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H335:0;H226:0;H315:0;H319:0;H301:0
119615,tributyltetradecylphosphonium tetrafluoroborate,413-520-1,125792-14-5,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H314:0;H373:0;H317:0;H400:0
119617,"Fatty acids, tall-oil, reaction products with 2-[(2-aminoethyl)amino]ethanol",272-902-4,68919-76-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,92,H319:6;H320:6;H315:11;H410:5;H373:4;H318:5;H400:13;Not classified:72;H317:8;H411:8;H314:9
119618,"5-(1,2-dithiolan-3-yl)valeramide",213-375-2,940-69-2,Acute Tox. 4,Notified C&L,40,H302:40
119619,2-benzhydrylsulfanylacetamide,614-564-6,68524-30-1,Not Classified,REACH registration C&L,42,Not classified:4;H302:38;H410:38;H400:38
119622,"(6R,7R)-7-Amino-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4,2,0]oct-2-ene-2-carboxylic acid",438-350-5,79349-82-9,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,3,H334:3;H317:3
119623,2-chlorobutyric acid,224-029-5,4170-24-5,Skin Corr. 1B,Notified C&L,44,H314:44;H341:1;H290:1;H318:1
119624,"Butanimidamide, 3-methyl-, hydrochloride (1:1)",611-494-8,57297-27-5,,Notified C&L,1,H319:1;H335:1;H315:1
119625,"2,7-dimethylquinoline",202-242-4,93-37-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119628,N-(4-bromobenzyl)-N-pentanoyl-L-valine,700-139-3,867022-57-9,Not Classified,Notified C&L,1,Not classified:1
119631,"S-[2-[(4-chlorophenyl)(isopropyl)amino]-2-oxoethyl] O,O-dimethyl dithiophosphate",264-756-5,64249-01-0,Acute Tox. 4,Notified C&L,38,H302:38
119633,"Silica, hydrate",600-358-3,10279-57-9,Not Classified,Notified C&L,4,Not classified:4
119634,"Fatty acids, C6-12, barium salts",272-530-2,68876-86-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,177,H302:176;H332:93;Not classified:1
119637,"1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-C8-22 acyl derivs., hydroxides, inner salts",281-991-9,84082-44-0,Eye Dam. 1,Notified C&L,5,H318:5;H315:2
119641,"Formic acid, compound with α-methyl-1H-imidazole-1-ethanol (1:1)",269-347-5,68227-32-7,Not Classified,Notified C&L,22,Not classified:22
119642,"2,3-Difluoro-4-[4-(trans-4-ethylcyclohexyl)-cyclohexen-1-yl]- toluene",928-215-3,,Not Classified,Notified C&L,1,Not classified:1
119648,D-menthol,239-388-3,15356-70-4,Skin Irrit. 2,Notified C&L,1448,H315:1447;H319:85;H335:38;H318:38;Not classified:1
119651,Octyl dihydrogen phosphate,223-638-3,3991-73-9,,Notified C&L,59,Not classified:33;H314:26
119652,"(3β)-olean-12-ene-3,28-diol",208-890-4,545-48-2,Not Classified,Notified C&L,1,Not classified:1
119653,Disodium epoxysuccinate,255-004-7,40618-18-6,Not Classified,Notified C&L,2,Not classified:2
119656,"5-chloro-1,3-dihydro-2H-benzimidazole-2-thione",246-903-5,25369-78-2,,Notified C&L,6,H301:6;H319:1;H315:1
119657,Di-2-thienylglycolic acid methyl ester,607-936-4,26447-85-8,,Notified C&L,8,H319:5;H335:5;H315:5;H302:5;Not classified:1;H371:1;H312:1
119661,m-cresol purple,218-960-6,2303-01-7,Not Classified,Notified C&L,2,Not classified:2
119666,"Benzenesulfonic acid, 3-[2-[4-[2-[5-cyano-6-[(2-hydroxyethyl)amino]-4-methyl-2-[[2-(4-sulfophenyl)ethyl]amino]-3-pyridinyl]diazenyl]-2,5-dimethylphenyl]diazenyl]-, sodium salt (1:2)",616-103-4,74499-55-1,Not Classified,Notified C&L,31,Not classified:31
119671,diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate,426-790-0,162208-27-7,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H317:0;H373:0;H400:0;H312:0
119674,"Residues (petroleum), catalytic reformer fractionator;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C",265-069-3,64741-67-9,Carc. 1B,Harmonised C&L,0,H350:0
119676,Calix[4]arene (contains ca. 8% Chloroform),616-117-0,74568-07-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H361:1;H351:1;H412:1;H341:1;H372:1;H370:1
119687,"3,6-bis(ethylamino)-9-[2-(methoxycarbonyl)phenyl]-2,7-dimethylxanthylium chloride",221-326-1,3068-39-1,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,314,H302:313;H410:147;H317:147;H330:148;H318:310;H400:147;H411:111;Not classified:1;H319:1
119688,"Isobutyric acid, monoester with 2,2,4-trimethylpentane-1,3-diol",246-771-9,25265-77-4,Not Classified,REACH registration C&L,889,Not classified:883;H319:4;H412:4;H335:1;H315:1
119693,"Phosphoric acid, isotridecyl ester",258-261-3,52933-07-0,Eye Dam. 1,Notified C&L,1164,H318:1140;H411:84;H315:163;H314:36;H319:16;H335:16;Not classified:1;H360:1
119698,"2,6-Difluor-4-(4-trans-propylcyclohexyl)benzonitrile",605-474-8,167306-96-9,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
119699,"ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate",404-520-2,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
119700,"2,2'-[[3-acetamido-4-[(2-chloro-4-nitrophenyl)azo]phenyl]imino]diethyl diacetate",216-251-6,1533-78-4,Not Classified,REACH registration C&L,83,Not classified:83
119702,4-hydroxy-2-methylacetophenone,212-874-2,875-59-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
119704,Carbazole,201-696-0,86-74-8,Muta. 2;Aquatic Chronic 2,Notified C&L,265,H341:164;H411:157;H351:54;H413:50;Not classified:32;H410:20;H315:21;H319:13;H335:11;H400:32;H302:16;H311:9;H331:9;H332:8;H412:2;H301:1
119705,Hexadecanedioic acid,208-013-5,505-54-4,Eye Irrit. 2,REACH registration C&L,4,H319:4;H315:2;H335:1
119707,Gitoxin,224-934-5,4562-36-1,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,40,H330:38;H310:38;H300:38;H373:2;H301:2;H331:2;H410:1;H319:1;H400:1
119709,"Cellulose, acetate",618-380-7,9004-35-7,,Notified C&L,42,Not classified:42
119710,"reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate;2-ethylhexyl epoxyoleate;2-ethylhexyl diepoxylinoleate;2-ethylhexyl triepoxylinolenate",414-890-7,71302-79-9,Skin Sens. 1,Harmonised C&L,0,H317:0
119712,dodecyl-ω-(C,410-630-1,104051-92-5,Aquatic Chronic 4,Harmonised C&L,0,H413:0
119714,2-thienylacetyl chloride,254-290-0,39098-97-0,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1;STOT SE 3;STOT SE 3,REACH registration C&L,103,H290:2;H318:2;H314:103;H335:40;H302:4;Not classified:1
119716,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with oligo(oxypropylene)diamine",500-217-5,68511-33-1,Not Classified,Notified C&L,83,Not classified:56;H302:24;H314:27;H412:24;H312:23;H311:1;H318:1;H335:1;H317:2;H411:1
119717,EUDESMOL,610-334-4,473-15-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,99,H319:99;H315:99
119719,"Erythromycin, 2'-propanoate, dodecyl sulfate (salt)",222-532-4,3521-62-8,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,117,H334:117;H317:117;H302:117
119720,Harmine,207-131-4,442-51-3,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,45,H319:44;H302:45;H332:45;H312:41;H370:1
119721,N-(3-hydroxyphenyl)benzenesulphonamide,261-627-5,59149-19-8,Acute Tox. 4,Notified C&L,39,H302:39;H319:1;H335:1;H315:1
119722,"(15Z)-12-Hydroxy-13,19-didehydrosenecionan-11,16-dione",610-407-0,480-81-9,Acute Tox. 3,Notified C&L,195,H301:195;H311:1;H331:1
119727,2-methylbenzimidazole,210-411-9,615-15-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H302:41;H335:43;H318:39;H315:43;H319:4;H332:1;H312:1
119728,"Soybean meal, protein extn. residue",293-693-6,91081-84-4,Not Classified,REACH registration C&L,3,Not classified:3
119731,"Fatty acids, C14-18-branched and linear, esters with neopentyl glycol",286-059-5,85186-74-9,Not Classified,Notified C&L,6,Not classified:6
119732,"N,N-dibenzylaniline",202-093-5,91-73-6,,Notified C&L,5,H302:4;H312:4;H319:1;H315:1
119734,Ethyl 4-chloroacetoacetate,211-317-0,638-07-3,Acute Tox. 3;Acute Tox. 2;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,68,H314:68;H317:22;H310:15;H411:24;H301:68;H311:8;H318:6
119736,"cyproconazole (ISO);(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol",619-020-1,94361-06-5,Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H410:0;H360:0;H373:0;H301:0;H400:0
119740,[(1-methylpropan-1-yl-3-ylidene)tris[2-tert-butyl-5-methyl-p-phenylene]]tris[di(tridecyl)phosphine],273-383-7,68958-97-4,Not Classified,Notified C&L,1,Not classified:1
119743,Cyclopropylboronic acid,609-890-0,411235-57-9,,Notified C&L,14,H319:11;H335:11;H315:11;H302:5;H242:3;H332:1;H318:1;H360:1
119744,N-[3-(trimethoxysilyl)propyl]-N'-(4-vinylbenzyl)ethylenediamine monohydrochloride,251-499-9,33401-49-9,,Notified C&L,38,Not classified:38
119746,"Alcohols, C13-15-branched",297-789-9,93762-73-3,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,34,H410:32;H400:32;H315:32;Not classified:2
119747,2-naphthonitrile,210-344-5,613-46-7,Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H335:38;H318:38;H300:38;H315:39;H311:5;H302:4;H332:4;H331:1;H319:1;H301:1
119751,Ethyl γ-cyano-γ-methylbenzenebutyrate,219-921-6,2572-92-1,Acute Tox. 4,Notified C&L,38,H302:38
119752,"Copper, 4-[[]2-[[]2,4-dihydroxy-3-[[]2-(2-hydroxy-3,5-dinitrophenyl)diazenyl]phenyl]diazenyl]benzenesulfonate sodium complexes",600-867-0,108347-99-5,Not Classified,Notified C&L,2,Not classified:2
119753,"Poly[oxy(methyl-1,2-ethanediyl)], α,α'-(2,2-dimethyl-1,3-propanediyl)bis[ω-[(1-oxo-2-propen-1-yl)oxy]-",617-546-6,84170-74-1,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,587,H317:248;H411:180;Not classified:256;H319:144;H315:144;H335:45
119755,"2,6-dimethyloct-7-en-4-one",217-532-6,1879-00-1,Skin Sens. 1B,Notified C&L,26,H317:25;Not classified:1
119758,Ammonium benzoate,217-468-9,1863-63-4,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,656,H319:249;H302:528;Not classified:139;H335:206;H315:212;H301:4
119759,"1,3-Difluor-2-difluormethoxy-5-(4-trans-propyl-[1,1-bicyclohexyl]-4-trans-yl)-benzene",604-038-4,137784-79-3,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
119761,"Bis(4-(1,1,3,3-tetramethylbutyl)phenyl)amine",239-816-9,15721-78-5,Not Classified,REACH registration C&L,168,Not classified:164;H412:3;H413:1
119763,N-1-naphthylaniline,201-983-0,90-30-2,Acute Tox. 4;Skin Sens. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1624,H302:1463;H410:1430;H317:1611;H373:1146;H400:1201;H411:125;H370:156;H319:8;H335:7;H315:8;Not classified:5;H334:1;H371:1;H361:1
119766,"Heptadecafluorooctane-1-sulphonamide, compound with triethylamine (1:1)",278-541-9,76752-82-4,,Notified C&L,49,H319:49;H302:49;H301:49;H412:49
119767,Diperodon hydrochloride,208-659-8,537-12-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119768,5-nitrofuroyl chloride,246-607-6,25084-14-4,Skin Corr. 1B,Notified C&L,42,H314:42
119772,2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one,400-600-6,71868-10-5,Acute Tox. 4;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0,H302:0;H411:0;H360:0
119773,Nigrosine spirit soluble oleate,269-897-6,68389-53-7,Not Classified,Notified C&L,23,Not classified:23
119778,"AMINES, POLYETHYLENEPOLY-, REACTION PRODUCTS WITH 1,3-DIOXOLAN-2-ONE AND SUCCINIC ANHYDRIDE MONOPOLYISOBUTENYL DERIVS.",604-611-9,147880-09-9,Not Classified,Notified C&L,44,Not classified:36;H413:8
119781,Tin tetrabromide,232-184-5,7789-67-5,Skin Corr. 1B;STOT SE 3,Notified C&L,42,H335:38;H314:42
119783,Pholedrine sulphate,228-083-0,6114-26-7,Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H300:38;H315:38
119785,2-phenyloxazol-5(4H)-one,214-840-2,1199-01-5,Acute Tox. 4,Notified C&L,38,H302:38
119789,1-(4-cyclohexylphenyl)ethan-1-one,242-432-4,18594-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:38;H315:39;Not classified:1
119793,"2,7-Naphthalenedisulfonic acid, 5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[2-[4-(phenylamino)-3-sulfophenyl]diazenyl]-, sodium salt (1:3)",616-179-9,75030-18-1,Not Classified,Notified C&L,3,Not classified:3
119794,Methyl 2-bromo-2-butenoate,241-627-1,17642-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119795,3-pyridylacrylic acid,214-424-0,1126-74-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H302:1;H312:1
119796,5-[1-hydroxy-2-[[2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]resorcinol hydrobromide,217-742-8,1944-12-3,Acute Tox. 4,Notified C&L,41,H302:41;H412:1;H411:1;H372:1
119797,heptan-4-one;di-n-propyl ketone,204-608-9,123-19-3,Flam. Liq. 3;Acute Tox. 4,Harmonised C&L,0,H226:0;H332:0
119799,"Oils, currant, Ribes nigrum",619-285-3,97676-19-2,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,131,H302:106;H226:131;H412:131
119802,4-(2-hydroxyethyl)piperazin-1-ylethanesulphonic acid,230-907-9,7365-45-9,Not Classified,REACH registration C&L,88,Not classified:81;H319:7;H315:7;H335:4;H302:1;H332:1;H312:1
119803,1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthol,238-908-6,14847-54-2,Not Classified,Notified C&L,2037,Not classified:2037
119804,tri-Potassium phosphate 3-hydrate,607-154-3,22763-03-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,65,H318:39;H315:65;H319:26
119805,"Fatty acids, C14-18 and C16-26-unsatd., potassium salts",270-281-4,68424-21-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
119807,"3,5,5-trimethylhexanoic acid, iron salt",269-263-9,68213-78-5,,Notified C&L,1,H319:1;H302:1;H315:1
119809,Pyrrole-2-carboxylic acid,211-221-9,634-97-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
119810,"2,5-bis(1,1,3,3-tetramethylbutyl)hydroquinone",212-990-3,903-19-5,Skin Sens. 1,REACH registration C&L,10,H317:3;H373:2;Not classified:3;H302:2;H413:1;H315:3;H319:3;H335:1
119814,"Fatty acids, tall-oil, Bu esters",267-028-5,67762-63-4,Not Classified,REACH registration C&L,97,Not classified:97
119815,"1-Propanamine, N-ethyl-2-methyl-3-(trimethoxysilyl)-",607-140-7,227085-51-0,Eye Dam. 1,Notified C&L,84,H318:84
119816,2-fluorotoluene,202-428-5,95-52-3,Flam. Liq. 2;Acute Tox. 4;Repr. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,270,H361:4;H225:270;H226:4;H411:4;H332:160;H400:4;H315:199;H319:199;H335:261;H301:41;H302:1;Not classified:1
119822,ethyl (3R)-4-cyano-3-hydroxybutanoate,430-220-6,141942-85-0,Eye Irrit. 2,Harmonised C&L,0,H319:0
119823,"Fatty acids, coco, reaction products with N,N-dimethyl-1,3-propanediamine",263-152-9,61790-62-3,Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,53,H319:33;H410:33;H314:20;H400:20;H302:7;H317:7;H318:7
119837,Tridecyl salicylate,243-214-1,19666-16-1,Not Classified,Notified C&L,3,Not classified:3
119838,"4,4'-isopropylidenedi-2,6-xylol",227-033-5,5613-46-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:39;H335:38;H315:39;Not classified:1;H410:1;H400:1
119841,"2',3-bis[[3-[3,5-di-tert-butyl-4-hydroxyphenyl]propionyl]]propionohydrazide",251-156-3,32687-78-8,Not Classified,REACH registration C&L,415,Not classified:231;H412:181;H300:1;H400:2;H413:1;H302:1;H315:1;H319:1;H332:1;H335:1;H312:1
119845,4-[cyano(hydroxyimino)methyl]-1-methylpyridinium iodide,252-317-0,35013-90-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H311:38;H301:38;H331:38
119850,"3,5-dimethylpiperidine",252-730-6,35794-11-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50,H319:48;H226:50;H335:47;H315:48;H302:2;H314:2;H413:2;H318:2;H332:2;H312:2
119851,"Tetrasodium N,N'-[3H-2,1-benzoxathiol-3-ylidenebis[[6-hydroxy-5-isopropyl-2-methylphen-3,1-ylene]methylene]]bis[N-(carboxylatomethyl)aminoacetate] S,S-dioxide",217-743-3,1945-77-3,Not Classified,Notified C&L,3,Not classified:3
119854,Diytterbium tricarbonate,227-585-7,5895-52-3,Not Classified,Notified C&L,3,Not classified:3
119857,3-aminobenzonitrile,218-800-5,2237-30-1,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,Notified C&L,48,H317:45;H302:44;H332:40;H312:40;H311:8;H319:5;H331:3;H315:3;H301:4;H335:1
119862,Sucrose trilaurate,301-728-4,94031-23-9,Not Classified,Notified C&L,1,Not classified:1
119866,"1,3-Dihydro-7,8-dimethoxy-2H-3-benzazepin-2-one",616-033-4,73942-87-7,Aquatic Chronic 3,Notified C&L,37,H412:35;Not classified:1;H319:1;H335:1;H315:1
119869,Sodium iminodiacetate dibasic hydrate,606-617-7,207398-95-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119874,"1,1,1,3,5,5,5-heptamethyl-3-[3-(oxiranylmethoxy)propyl]trisiloxane",231-045-6,7422-52-8,,REACH registration C&L,2,H319:2;H315:2;H335:1
119876,"3,4-bis(4-hydroxyphenyl)hexane-3,4-diol",231-363-5,7507-01-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H335:38;H318:38;H400:38;H315:38
119883,"Soybean oil, epoxidized, Me ester, reaction products with propylene glycol",306-246-8,96690-51-6,Not Classified,REACH registration C&L,93,Not classified:93
119884,"Leach residues, molybdenum roasted ore, ammonium",282-210-4,84144-89-8,Not Classified,REACH registration C&L,1,Not classified:1
119885,Zoxazolamine,200-519-4,61-80-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,129,H302:128;H315:128;H319:128;H332:128;H335:128;H312:128;H311:1;H301:1;H331:1
119886,"4,4'-dithiodibutyric acid",220-818-3,2906-60-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H319:52;H335:51;H315:52
119887,Aluminium nitride,246-140-8,24304-00-5,STOT RE 1;Aquatic Chronic 1,REACH registration C&L,289,H410:6;H372:6;H319:231;H335:263;H315:231;H314:32;H411:14;Not classified:5;H261:3
119889,"2-(3-chlorophenyl)-2,4-dihydro-5-methyl-3H-pyrazol-3-one",201-984-6,90-31-3,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,2126,H317:84;H412:1;H411:2122;Not classified:3
119891,5-nitroacenaphthene,210-025-0,602-87-9,Carc. 1B,Harmonised C&L,0,H350:0
119893,"Estra-1,3,5(10),7-tetraene-3,17α-diol",211-482-9,651-55-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H315:38
119895,"2,3,4,5,6-pentabromoethylbenzene",201-593-0,85-22-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:41;H315:41
119898,"Soybean oil, oxidized",293-694-1,91081-85-5,Not Classified,Notified C&L,13,Not classified:13
119901,"tris(η5-cyclopenta-2,4-dien-1-yl)terbium",215-051-6,1272-25-9,Flam. Sol. 2;Water-react. 2,Notified C&L,42,H261:38;H228:42
119908,4-(phenoxymethyl)piperidinium chloride,264-363-9,63608-13-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
119909,2-morpholinoethanol,210-734-5,622-40-2,Eye Irrit. 2,REACH registration C&L,198,H319:166;Not classified:16;H335:84;H315:94;H318:14;H332:2;H312:2;H350:1;H371:1;H302:1;H317:1
119910,"4-chloro-2,5-dimethylbenzenethiol",261-996-2,59962-29-7,,Notified C&L,4,H302:4;H315:4;H319:4;H332:4;H335:4;H312:4
119911,"2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol",430-810-3,154825-62-4,Aquatic Chronic 3,Harmonised C&L,0,H412:0
119912,"9-Octadecenoic acid (Z)-, reaction products with triethylenetetramine",270-165-3,68412-09-9,Skin Corr. 1B;Skin Sens. 1;STOT SE 3,Notified C&L,3,H317:3;H335:3;H314:3
119915,N-ethyl-5-sulphoanthranilic acid,204-307-2,119-22-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
119917,"1-(2,4-dimethylthiazol-5-yl)ethan-1-one",253-826-0,38205-60-6,Acute Tox. 4,Notified C&L,1591,H302:1546;H334:39;H319:44;H335:39;H315:44;H301:1
119919,"Oils, vegetable, Me esters, sulfated",271-991-7,68648-42-0,Not Classified,Notified C&L,2,Not classified:2
119925,Retinol,200-683-7,68-26-8,Skin Sens. 1;Eye Irrit. 2;Repr. 1B;Aquatic Chronic 4,REACH registration C&L,284,H317:206;H319:208;H360:279;H413:206;H302:49;H315:4;Not classified:1;H361:2
119927,Methyl 2-Bromo-5-fluorobenzoate,614-965-6,6942-39-8,,Notified C&L,2,H319:2;H335:1;H315:2
119928,Antazoline,202-094-0,91-75-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H302:40;H315:38;H319:38;H335:38;H312:39;H304:1;H332:1
119932,Isopropyl cyanoacetate,236-421-3,13361-30-3,,Notified C&L,5,H319:5;H335:4;H315:5
119933,4-chloro-5-methyl-o-anisidine,228-943-5,6376-14-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H302:1;H332:1;H312:1
119938,N-methyl-o-toluidine,210-260-9,611-21-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H311:0;H412:0;H373:0;H331:0;H301:0
119939,Cefotaxime,264-299-1,63527-52-6,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,17,H334:17;H317:17;H315:10;H319:10;H335:10;H314:1
119941,Lithium trifluoromethanesulphonate,251-528-5,33454-82-9,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,497,H319:54;H302:444;H335:49;H315:52;H318:2;H314:1
119942,Triallyl phosphate,216-606-5,1623-19-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38
119943,2-chloro-6-(1-piperazinyl)pyrazine monohydrochloride,262-883-0,61655-58-1,Acute Tox. 3,Notified C&L,38,H301:38
119944,2-benzoylbenzoic acid,201-612-2,85-52-9,Not Classified,REACH registration C&L,116,Not classified:59;H319:55;H335:55;H315:56;H302:2;H332:1;H317:1
119949,"Hydroxytris(hydroxyacetato-O1,O2)zirconium",276-247-5,71975-59-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
119950,"Naphtho[2,3-c]furan-1,3-dione",211-936-6,716-39-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
119952,"(E,E)-hexa-2,4-dien-1-ol",241-173-4,17102-64-6,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1,Notified C&L,44,H311:39;H302:44;H318:44;H315:44;H335:5
119954,"N,N-dimethylhexylamine",224-491-8,4385-04-0,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,42,H226:42;H314:42
119955,"Octanoic acid, chromium salt",243-579-7,20195-23-7,Not Classified,Notified C&L,71,Not classified:71
119961,"Ethanol, 2-(2-ethoxyethoxy)-, 2''-[(C12-15-branched and linear alkyl)oxy] derivs., hydrogen sulfates, sodium salts",293-918-8,91648-56-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,40,H318:39;H412:36;H315:39;Not classified:1
119962,p-octylbenzoic acid,222-692-5,3575-31-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
119963,"Fatty acids, animal, unsatd., 1-methyl-1,2-ethanediyl esters, chlorosulfurized",288-118-0,85665-27-6,Not Classified,Notified C&L,1,Not classified:1
119973,Thorium tetraiodide,232-211-0,7790-49-0,Not Classified,Notified C&L,2,Not classified:2
119974,"N'1-quinoxalin-2-ylsulphanilamide, sodium salt",213-526-2,967-80-6,Acute Tox. 4;Skin Sens. 1,Notified C&L,43,H317:40;H302:40;Not classified:2;H334:1
119975,Catalase,232-577-1,9001-05-2,Resp. Sens. 1,REACH registration C&L,251,H334:249;Not classified:2
119976,Methyl thioacetate,216-252-1,1534-08-3,Flam. Liq. 3;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1486,H311:1478;H319:1478;H226:1287;H331:1427;H225:196;H332:55;H302:5;Not classified:3;H318:1;H315:1
119978,"Decyl alcohol, ethoxylated, phosphated, potassium salt",614-254-0,68070-99-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,25,H318:17;H315:25;H319:8
119981,Cresolsulphonic acid,247-831-7,26590-31-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;STOT SE 3;STOT RE 2,Notified C&L,1,H302:1;H314:1;H373:1;H318:1;H335:1;H312:1
119984,"Fatty acids, C14-18-branched and linear",273-088-3,68937-77-9,Not Classified,Notified C&L,1,Not classified:1
119988,Dimethyl 5-hydroxyisophthalate,235-899-0,13036-02-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
119990,"1-Naphthalenesulfonic acid, 4(or 5)-amino-, diazotized, coupled with diazotized 7-amino-4-hydroxy-2-naphthalenesulfonic acid and resorcinol, coupled with diazotized 4(or 5)-amino-1-naphthalenesulfonic acid and diazotized 4-nitrobenzenamine",291-653-2,90459-12-4,Not Classified,Notified C&L,1,Not classified:1
119993,"5-methylhexane-2,3-dione",237-241-8,13706-86-0,Skin Sens. 1,Notified C&L,1401,H317:1286;H226:115
119998,5-nonylsalicylaldehyde,264-443-3,63753-10-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1,Notified C&L,1,H302:1;H334:1;H317:1;H318:1;H315:1
120000,Homatropine methylbromide,201-284-0,80-49-9,Acute Tox. 4,Notified C&L,65,H302:64;H332:1;Not classified:1
120002,bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate,444-360-0,191617-13-7,Aquatic Chronic 3,Harmonised C&L,0,H412:0
120004,Methenamine 3-chloroallylochloride,223-805-0,4080-31-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,905,H311:622;H319:589;H301:568;H315:682;Not classified:88;H317:138;H302:249;H412:74;H400:45;H310:20;H312:5;H334:3
120005,Lonidamine,256-510-0,50264-69-2,Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,40,H302:40;H360:38;H351:38
120008,N-cyclohexyl-N-ethylcyclohexylamine,230-534-1,7175-49-7,Skin Corr. 1B,Notified C&L,38,H314:38
120010,"1,1,1,3,3,3-Hexafluoropropane",614-909-0,690-39-1,Press. Gas (Liq.),Notified C&L,6,H280:5;Not classified:1;H336:1
120011,(-)-tartaric acid,205-695-6,147-71-7,Eye Dam. 1,REACH registration C&L,318,H318:14;H319:296;H335:62;H315:68;Not classified:4
120012,"Reaction product of oxoacetic acid, ethylene diamine, phenol, sodium hydroxide and potassium hydroxide",928-813-4,,Not Classified,Notified C&L,83,Not classified:83
120015,Ethyl 3-(triethoxysilyl)propylcarbamate,241-872-4,17945-05-0,Not Classified,REACH registration C&L,10,Not classified:8;H335:2;H318:1;H315:2;H319:1
120016,Gallium trichloride,236-610-0,13450-90-3,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,59,H290:9;H318:10;H314:58;H302:5;H332:5;H312:5;H311:1;H301:1;H331:1
120019,Bicuculline,207-619-7,485-49-4,Acute Tox. 1;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1,Notified C&L,195,H311:195;H331:195;H300:194;H400:194;H301:1
120020,"1,1'-ethylenedipiperidine",217-692-7,1932-04-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H302:39;H315:38;H319:38;H332:38;H335:38;H312:38
120021,Benzimidazole-2-thiol,209-502-6,583-39-1,Acute Tox. 3;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,250,H317:136;H301:199;H373:53;H412:101;H319:186;H372:90;H311:51;H315:97;H332:91;H335:40;H312:43;H302:51;H361:6;H370:6;H413:2;H360:2
120026,"Guanidine, cyano-, polymer with ammonium chloride ((NH4)Cl), 1,2-ethanediamine and formaldehyde",613-818-3,65545-83-7,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,85,H302:83;H412:85
120033,2-chloro-4-nitroanisole,225-547-4,4920-79-0,,Notified C&L,3,H311:1;H301:1;H331:1;H319:2;H335:1;H315:1;H302:1
120034,"Boric acid (H3BO3), reaction products with 2,2'-[(C16-18 and C16-18-unsaturated alkyl)imino]bis[ethanol]",300-288-0,93924-91-5,Skin Corr. 1C;Eye Dam. 1,Notified C&L,837,H318:837;H314:837
120036,"Amides, C8-22, N-[3-(dimethylamino)propyl]",281-990-3,84082-43-9,Not Classified,Notified C&L,6,Not classified:2;H319:3;H335:1;H315:3;H317:1;H302:1;H400:1
120038,Decyltriphenylphosphonium bromide,250-996-8,32339-43-8,,Notified C&L,4,H319:4;H335:4;H315:4
120043,4-(2-hydroxyethyl)-1-piperazinepropanesulphonic acid,240-198-8,16052-06-5,,Notified C&L,67,Not classified:63;H319:2;H335:1;H315:2;H302:1;H312:1;H311:1;H301:1
120046,2-Bromo-5-chlorobenzotrifluoride,608-994-3,344-65-0,,Notified C&L,5,H319:5;H335:4;H315:5
120048,2-vinylpyridine,202-879-8,100-69-6,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,174,H302:47;H314:114;H311:112;H317:50;H226:116;H318:69;H411:50;H331:60;H301:70;Not classified:57;H330:7;H335:3;H315:3;H319:3;H341:1;H310:1;H370:1
120055,tetrahydro-4-methylphthalic anhydride,251-823-9,34090-76-1,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H334:0;H317:0;H318:0
120057,"(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate",430-510-2,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
120059,"Aluminum, hydroxy[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, chloro sulfo derivs., sodium salts",307-259-1,97592-62-6,Not Classified,Notified C&L,83,Not classified:83
120060,α-acetyl-γ-butyrolactone,208-235-2,517-23-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,327,H319:325;H315:321;H335:314;H317:3;Not classified:1
120061,p-nitrocinnamaldehyde,217-076-8,1734-79-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,43,H319:43;H315:43;H335:4
120064,"3,3'-[m-phenylenebis(oxy)]dianiline",234-082-6,10526-07-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:1;H332:1;H312:1;H317:1;H411:1
120065,"Amines, C12-14-alkyldimethyl, acetates",306-994-5,97488-58-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H302:1;H318:1;H314:1;H400:1
120068,"Oxirane, 2-methyl-, polymer with oxirane, ether with β-D-fructofuranosyl α-D-glucopyranoside",607-907-6,26301-10-0,Not Classified,Notified C&L,84,Not classified:84
120069,"Benzenesulfonic acid, hydroxy-, reaction products with formaldehyde, ammonium salts",296-101-4,92257-14-2,Not Classified,Notified C&L,1,Not classified:1
120072,"simazine (ISO);6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine",204-535-2,122-34-9,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H351:0;H410:0;H400:0
120075,4-isopropylphenylacetaldehyde,224-522-5,4395-92-0,Not Classified,Notified C&L,233,Not classified:233
120078,Trimipramine,212-008-3,739-71-9,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,43,H410:4;H317:4;H318:4;H315:4;H336:4;H301:42;H400:4;H302:1
120083,1-amino-4-(phenylamino)anthraquinone,224-520-4,4395-65-7,Aquatic Chronic 4,Notified C&L,119,H413:90;Not classified:27;H317:2
120087,Methyl phenyl sulphide,202-878-2,100-68-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,145,H302:144;H317:87;H411:87;H315:127;H319:127;H335:38;H226:4
120101,sec-butyl acetate,203-300-1,105-46-4,Flam. Liq. 2,Harmonised C&L,0,H225:0
120102,"Glycerides, C16-22 and C18-unsatd.",270-311-6,68424-60-2,Not Classified,Notified C&L,98,Not classified:98
120103,"Fatty acids, tall-oil, iso-Bu esters",272-901-9,68919-55-1,Not Classified,Notified C&L,1,Not classified:1
120106,"5H-indeno[1,2-b]pyridin-5-one",223-414-5,3882-46-0,Acute Tox. 4,Notified C&L,38,H302:38
120116,crotoxyphos (ISO);1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate,231-720-5,7700-17-6,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H311:0;H410:0;H301:0;H400:0
120119,Vinyl butyrate,204-609-4,123-20-6,Flam. Liq. 2;Acute Tox. 4,Notified C&L,40,H225:40;H332:38
120120,Quinuclidine hydrochloride,254-682-1,39896-06-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H312:1
120121,2-phenylethyl 2-methylbutyrate,246-476-5,24817-51-4,Not Classified,Notified C&L,261,Not classified:261
120123,Beryl (Al2Be3(SiO3)6),215-101-7,1302-52-9,,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H335:1;H312:1
120125,Tetraamminepalladium(2+) dichloride,237-489-7,13815-17-3,Met. Corr. 1;Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,16,H302:15;H410:15;H290:14;H317:15;H319:16;H400:15;H315:1;H335:1
120127,Sodium 1-methyl 9(or 10)-(sulphonatooxy)octadecanoate,268-479-0,68109-63-7,Not Classified,Notified C&L,36,Not classified:36
120129,Diiron tris(sulphate),233-072-9,10028-22-5,Met. Corr. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,344,H290:190;H302:301;H318:246;H315:276;H317:53;H319:82;H335:88;H412:38;H314:16;Not classified:2
120131,2-chloro-2'-ethyl-N-(2-methoxy-1-methylethyl)-6'-methylacetanilide,257-060-8,51218-45-2,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,197,H317:194;H410:156;H400:156;H330:38;Not classified:3
120133,Aspartic acid,200-291-6,56-84-8,Not Classified,REACH registration C&L,365,Not classified:346;H319:19;H315:1
120135,"3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride",616-309-4,762240-92-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,93,H319:93;H335:92;H315:92;H302:1;H332:1;H312:1
120137,methyl 3-(acetylthio)-2-methyl-propanoate,411-040-7,97101-46-7,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H302:0;H410:0;H400:0
120138,Dimethyl octadecylphosphonate,246-904-0,25371-54-4,Aquatic Chronic 4,REACH registration C&L,30,H413:27;H319:3;H332:2;H335:3;H315:3
120140,(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride,433-010-2,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H302:0;H412:0
120144,1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide,600-462-9,103628-46-2,Repr. 2;Aquatic Chronic 3,Notified C&L,5,H361:3;H412:4;H319:2
120145,Methyl 4-chloro-2-nitrobenzoate,255-654-1,42087-80-9,Not Classified,REACH registration C&L,1,Not classified:1
120148,N-(tri(hydroxymethyl)methyl)glycine,227-193-6,5704-04-1,Not Classified,REACH registration C&L,124,Not classified:121;H319:3;H335:3;H315:3
120149,"1,2,3,3a,4,5,6,8a-octahydro-2-isopropylidene-4,8-dimethylazulen-6-yl acetate",204-225-7,117-98-6,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,319,H317:319;H411:319
120153,"4-(4-trans-Ethylcyclohexyl)-3,4-difluor-[1,1-biphenyl]",603-821-8,134412-18-3,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
120154,3-bromoanisole,219-264-5,2398-37-0,Aquatic Chronic 3,REACH registration C&L,48,H412:39;H319:10;H315:10;Not classified:5;H335:4
120155,"Naphtha (petroleum), light alkylate;Low boiling point modified naphtha;[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C",265-068-8,64741-66-8,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
120157,"Naphtha (petroleum), arom.-contg.;Low boiling point naphtha - unspecified",271-635-0,68603-08-7,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
120158,3-methyl-1-vinyl-1H-imidazolium methyl sulphate,247-832-2,26591-72-0,Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,84,H402:1;H412:84
120160,Boron triiodide,236-857-4,13517-10-7,Skin Corr. 1B,Notified C&L,42,H314:42
120164,"Hydrocarbons, C",297-852-0,93763-33-8,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
120165,Dipotassium tin hexahydroxide,234-721-9,12027-61-1,Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,47,H318:4;H314:42;H412:4;H319:5;H335:5;H315:5
120167,"Butanedinitrile, 2,3-diethyl-2,3-dimethyl-",603-307-3,128903-20-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 1;Aquatic Chronic 3,Notified C&L,47,H330:25;H310:25;H300:25;H412:25;H302:22
120170,"1,2-ethanediyl diacrylate",218-886-4,2274-11-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,703,H311:583;H317:582;H318:458;H315:680;H301:500;H302:139;H330:122;H411:239;H319:240;H335:239;H332:56;H312:56;Not classified:5
120173,N-(1-oxooctyl)glycine,238-122-3,14246-53-8,Eye Dam. 1,REACH registration C&L,21,H318:19;Not classified:1;H319:1;H315:1;H335:1
120175,Tripropylsilane,213-649-1,998-29-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H226:42;H335:42;H315:42
120179,"2,2,4,4,6,6-hexachloro-1,3,5-triaza-2,4,6-triphosphorine",213-376-8,940-71-6,Skin Corr. 1B,Notified C&L,48,H314:48;H318:4;H261:1
120182,"1,2,4,5-tetrafluoro-3,6-diiodobenzene",206-877-8,392-57-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40
120183,"Alcohols, C10-12",288-117-5,85665-26-5,Eye Irrit. 2,Notified C&L,7,H319:6;Not classified:1
120184,Tetrapropylenebenzene,246-772-4,25265-78-5,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,434,H319:326;H411:325;H304:106;H413:106;Not classified:2;H361:2
120188,Quinine hydrochloride,231-437-7,7549-43-1,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,8,H334:4;H317:6;H302:8;H332:4
120190,"1-(3,4-diethoxybenzylidene)-6,7-diethoxy-1,2,3,4-tetrahydro-isoquinolin",619-357-4,985-12-6,Acute Tox. 4,Notified C&L,72,H302:70;Not classified:2;H319:5;H335:5;H315:5;H413:1
120192,tert-Butyl 5-Norbornene-2-carboxylate,604-985-3,154970-45-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
120198,toluene-α-sulphonamide,224-935-0,4563-33-1,Acute Tox. 4,Notified C&L,200,H302:195;H319:5;H335:4;H315:5
120203,Dinitramine,249-419-2,29091-05-2,Acute Tox. 4;Aquatic Acute 1,Notified C&L,41,H400:41;H312:41;H410:3
120207,17β-hydroxyandrost-4-en-3-one cyclopentylpropionate,200-368-4,58-20-8,Carc. 1B;Repr. 2,Notified C&L,80,H361:38;H350:38;H362:24;H351:42;H360:41;H302:18;H332:18;H312:18;H373:1
120208,4-nitrobenzenesulphonic acid,205-329-5,138-42-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H318:1;H314:2
120209,(+)-menthol,239-387-8,15356-60-2,Skin Irrit. 2,REACH registration C&L,333,H315:300;H319:43;H335:44;H318:44;H302:33;H410:33;H314:33;H373:33;H400:33
120213,"N,N'-(2,5-dichloro-1,4-phenylene)bis[4-[(2,5-dichlorophenyl)azo]-3-hydroxynaphthalene-2-carboxamide]",255-005-2,40618-31-3,Not Classified,REACH registration C&L,257,Not classified:257
120214,"Fatty acids, C8-10",273-086-2,68937-75-7,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,294,H318:221;H314:238;H412:61;Not classified:56;H411:33;H319:2
120215,"Fatty acids, C12-20 and C12-20-unsatd., reaction products with diethanolamine",292-852-7,91001-79-5,Aquatic Chronic 3,Notified C&L,33,H412:28;Not classified:4;H318:1;H315:1
120218,"Propanoic acid, 3,3',3-''-[(octylstannylidyne)tris(thio)]tris-, tri-C12-22-alkyl esters",292-024-5,90529-88-7,Repr. 2;STOT RE 2;Aquatic Chronic 4,Notified C&L,1,H361:1;H373:1;H413:1
120221,"Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-hydro-.omega.-hydroxy-, ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1), 2-hydroxy-3-mercaptopropyl ether",615-735-8,72244-98-5,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,75,H317:51;H412:42;Not classified:23;H319:3;H302:2;H315:3
120226,Titanium tetrabromide,232-185-0,7789-68-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,67,H318:62;H314:67
120227,Indan-2-one,210-410-3,615-13-4,Not Classified,Notified C&L,91,Not classified:90;H319:1;H335:1;H315:1
120232,Diamminediiodopalladium,238-080-6,14219-60-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
120237,"reaction product of 2,2'-iminodiethanol, boric acid and fatty acids, soya",921-288-2,,Not Classified,Notified C&L,1,Not classified:1
120239,2-(2-chloroethoxy)acetyl chloride,609-623-8,39229-33-9,Skin Corr. 1A,Notified C&L,2,H314:2;H335:1
120240,"3-[3-formamidosalicylamido]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl butyrate",248-342-1,27220-57-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H311:38;H301:38;H331:38
120241,Stearic anhydride,211-318-6,638-08-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,61,H319:59;H335:58;H315:59;H314:2;H318:1
120243,2-(tris(hydroxymethyl)methylamino)ethane-1-sulphonic acid,230-906-3,7365-44-8,Not Classified,Notified C&L,27,Not classified:24;H319:3;H335:3;H315:3
120245,"Anthra[9,1,2-cde]benzo[rst]pentaphene-5,10-dione, nitro derivatives",228-873-5,6369-65-9,Not Classified,Notified C&L,21,Not classified:21
120248,"Carbonic acid, 2-hydroxy-1-methylethyl 5-methyl-2-(1-methylethyl)cyclohexyl ester",605-068-0,156679-38-8,Not Classified,Notified C&L,25,Not classified:25
120249,"7-[2-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]ethyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione monohydrochloride",219-920-0,2572-61-4,Acute Tox. 4;Acute Tox. 4;Resp. Sens. 1,Notified C&L,2,H334:2;H302:2;H332:1
120253,cadmium sulphate hydrate (3:8),616-572-5,7790-84-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,105,H302:93;H410:105;H332:93;H400:100;H312:93;H340:46;H360:50;H330:50;H372:46;H350:50;H301:50;H272:4
120254,"Shrimp, ext.",307-897-0,97766-35-3,Not Classified,Notified C&L,10,Not classified:10
120255,N-butylaniline,214-425-6,1126-78-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,157,H319:136;H302:157;H335:134;H315:136;H372:1;H370:1;H311:1
120257,"5-Amino-1-methyl-2,3-dihydro-benzimidazol-2-one",611-192-6,54732-89-7,Acute Tox. 4;Skin Sens. 1,Notified C&L,31,H317:31;H302:31
120258,3-(p-cumenyl)-2-methylpropanol,225-289-2,4756-19-8,Skin Sens. 1,Notified C&L,126,H317:126
120262,"Methanone, [4-(butylthio)phenyl]phenyl-",615-936-0,73242-21-4,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H317:38;H410:38;H400:38
120264,"6-tert-butyl-2,4-xylenol",217-533-1,1879-09-0,Acute Tox. 4;Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,757,H302:668;H373:136;H310:89;H411:638;H315:640;H319:624;H301:453;H410:52;H317:52;H400:53;H311:44;H331:44;H314:38;Not classified:22;H335:7
120266,"(Z,Z)-di-9-octadecenyl phosphonate",246-608-1,25088-57-7,Muta. 2,REACH registration C&L,1,H341:1
120271,Methylprednisolone,201-476-4,83-43-2,Repr. 1A;STOT RE 2,REACH registration C&L,55,H373:8;H360:33;H372:25;H361:19;H302:17;H312:16;Not classified:2;H301:1
120272,"[4-[(2-chlorophenyl)[4-(dimethylamino)phenyl]methylene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride",222-531-9,3521-06-0,Not Classified,Notified C&L,2,Not classified:2
120275,"Quinoxaline-2,3-dithiol",214-841-8,1199-03-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H318:1;H315:1;H332:1;H335:1;H312:1
120279,Etynodiol di(acetate),206-044-9,297-76-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,57,H302:55;H332:55;H351:57;H312:55;H360:17;H361:2
120285,"Dimethyl 2-[[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]azo]terephthalate",252-650-1,35636-63-6,Not Classified,REACH registration C&L,48,Not classified:48
120286,6-(chloromethyl)uracil,242-431-9,18592-13-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
120287,"1,4-dioxane-[2LH8]",241-628-7,17647-74-4,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,47,H225:47;H319:44;H335:44;H351:44;H332:3
120292,"Juniper, Juniperus mexicana, ext.",294-461-7,91722-61-1,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1473,H410:1431;H317:18;H315:18;H304:1472;H400:1397;H316:1;Not classified:1
120295,"Formic acid, compound with 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine (1:1)",257-122-4,51301-55-4,Not Classified,Notified C&L,50,Not classified:34;H302:16;H314:16
120296,"2,3,4,5,6-pentafluorobenzhydryl alcohol",217-741-2,1944-05-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
120301,"1,1-diethylurea",211-220-3,634-95-7,Acute Tox. 4,Notified C&L,38,H302:38
120311,2-[2-(allyloxy)ethoxy]ethanol,239-131-5,15075-50-0,Eye Irrit. 2,Notified C&L,38,H319:38
120312,4-methyl-2-phenyl-1H-imidazole,212-571-5,827-43-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,81,H319:81;H335:80;H315:81
120316,"Lead, dross",273-796-2,69029-52-3,Acute Tox. 2;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 3;Muta. 2;Carc. 1A;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,18,H410:18;H314:17;H341:17;H317:18;H362:17;H331:18;H318:18;H300:17;H372:17;H350:18;H360:18;H400:18;H302:1;H340:1;H373:1;H315:1;H301:1
120317,7-aminoheptanoic acid,213-197-5,929-17-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:3;H335:3;H315:3;Not classified:1
120318,"Formaldehyde polymer with phenol, cyanate",618-010-4,87397-54-4,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,26,H317:26;H410:16;H400:16;H411:10
120319,"(2,5-dioxopyrrolidin-1-yl) 9H-fluoren-9-ylmethyl carbonate (Fmoc-onsu)",617-400-1,82911-69-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,167,H317:165;H302:165;H411:165;Not classified:2;H319:2;H335:2;H315:2
120322,5-chloro-2-hydroxybenzophenone,201-592-5,85-19-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,45,H319:45;H335:44;H315:45;H302:1
120323,"2,3,6,7-tetrahydro-3,7-dimethyl-2,6-dioxo-1H-purine-1-acetic acid",227-034-0,5614-56-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
120324,"3,4,5,6-tetrafluorophthalic acid",211-483-4,652-03-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
120326,"Benzenesulfonamide, 4-methyl-N-(methyl-d3)-N-nitroso-",610-021-2,42366-72-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H317:38;H319:38;H335:38;H315:38
120328,ALKYLAMINOPOLYETHOXY-POLYPROPOXYPROPANOL,614-636-7,68603-58-7,Acute Tox. 4,Notified C&L,108,H302:108;H319:1
120329,β-methyl-3-phenyl-DL-alanine hydrochloride,279-646-2,80997-87-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
120330,"4-aminopyrazolo[3,4-d]pyrimidine",245-872-5,23771-52-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
120333,Iron di(acetate),221-441-7,3094-87-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
120337,Dirhodium trisulphide,235-075-0,12067-06-0,,Notified C&L,33,Not classified:33
120338,Copper(2+) tetrafluoroborate(1-),253-959-4,38465-60-0,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H410:4;H314:5;H290:5;H303:4;H318:5;H400:4;H302:1;H341:1;H317:1;H372:1;H370:1;H319:1;H315:1
120341,N-(dichloromethylene)aniline,210-735-0,622-44-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,40,H302:39;H331:40;H315:40;H319:40;H335:39;H301:1;H227:1
120344,Cobalt lithium dioxide,235-362-0,12190-79-3,Repr. 1B,REACH registration C&L,62,H360:7;H317:52;H350:44;H351:5;H302:3;H412:1;H334:2;Not classified:1;H361:1;H341:1;H411:1;H372:1
120349,4-Propylphenylboronium acid,603-797-9,134150-01-9,Aquatic Chronic 4,REACH registration C&L,5,H413:2;H319:3;H335:3;H315:3
120357,Noretynodrel,200-682-1,68-23-5,Carc. 1B;Repr. 1B,Notified C&L,38,H350:38;H360:38
120358,6-methylpyridazin-3-amine,242-430-3,18591-82-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,158,H319:158;H335:158;H315:158
120362,"Chenopodium ambrosioides, ext.",289-682-0,89997-47-7,Acute Tox. 3;Asp. Tox. 1;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,181,H311:181;H301:181;H317:181;H411:181;H315:181;H304:181
120363,Strontium chloride hexahydrate,600-046-7,10025-70-4,Not Classified,Notified C&L,171,Not classified:117;H318:45;H319:6;H335:6;H315:6;H302:3;H332:1;H312:1
120377,"9-Octadecenoic acid (Z)-, reaction products with tetraethylenepentamine",270-166-9,68412-10-2,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,5,H317:3;H410:3;H314:3;H318:2
120380,4-aminohippuric acid,200-518-9,61-78-9,Acute Tox. 3;Acute Tox. 3,Notified C&L,2,H311:1;H301:1;Not classified:1
120385,"Reaction mass of disodium 7-[(4-chloro-6-{ethyl[4-(vinylsulfonyl)phenyl]amino}-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(4-methoxy-2-sulfonatophenyl)diazenyl]naphthalene-2-sulfonate and trisodium 7-({4-chloro-6-[ethyl(4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)amino]-1,3,5-triazin-2-yl}amino)-4-hydroxy-3-[(4-methoxy-2-sulfonatophenyl)diazenyl]naphthalene-2-sulfonate",444-410-1,,Eye Dam. 1,Notified C&L,1,H318:1
120386,"trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)",423-100-1,,Eye Dam. 1,Harmonised C&L,0,H318:0
120387,"N-butyl-2,2,6,6-tetramethylpiperidin-4-amine",252-899-6,36177-92-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,89,H302:89;H314:86;H412:89;H318:86;H312:86;H319:2;H315:2
120388,Metacycline hydrochloride,223-568-3,3963-95-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
120389,"2,6,7-Trioxa-1-phosphabicyclo-2.2.2-octane-4-methanol,1-oxide",610-937-2,5301-78-0,Aquatic Chronic 4,Notified C&L,47,H413:47
120391,Pentafluorobenzoic acid,210-026-6,602-94-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,57,H319:57;H335:56;H301:39;H315:57;H302:11
120392,Norborn-2-ylacetic acid,213-747-4,1007-01-8,Acute Tox. 5;Acute Tox. 5,Notified C&L,1,H303:1;H313:1
120393,"oxadiazon (ISO);3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one",243-215-7,19666-30-9,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
120397,Esters of rosin oligomers with glycerol,614-523-2,68475-37-6,Not Classified,REACH registration C&L,129,Not classified:129
120400,"(S,S)-(+)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine",603-924-8,135616-36-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
120403,"tris(η5-2,4-cyclopentadien-1-yl)thulium",215-052-1,1272-26-0,Flam. Sol. 2;Water-react. 2,Notified C&L,42,H261:38;H228:42
120405,(E)-ethyl N-4-nitrophenoxyacetimidate,617-436-8,83077-00-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,2,H311:2;H411:2;H301:2;H331:2
120409,Indobufen,264-364-4,63610-08-2,Acute Tox. 4,Notified C&L,31,H302:31
120413,Butyl diphenylphosphinite,236-420-8,13360-94-6,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38
120414,"Alcohols, C12-15",264-118-6,63393-82-8,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,323,H319:182;H400:292;H410:68;Not classified:31;H315:20
120415,"1,4-diethoxy-2-nitrobenzene",204-308-8,119-23-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
120417,"Aluminum, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium benzoate complexes",272-217-0,68784-03-2,Not Classified,Notified C&L,1,Not classified:1
120420,Diisotridecyl phosphonate,275-063-2,70955-74-7,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,2,H317:2;H413:2
120425,"4'-(nonyloxy)[1,1'-biphenyl]-4-carbonitrile",261-503-0,58932-13-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H312:1
120427,Ethyl 3-methylcrotonate,211-319-1,638-10-8,Flam. Liq. 3,Notified C&L,40,H226:40
120428,"2,2',5,5'-tetrachloro[1,1'-biphenyl]-4,4'-diamine",239-815-3,15721-02-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
120429,Trimethyl phosphonoacetate,227-663-0,5927-18-4,Not Classified,Notified C&L,63,Not classified:56;H319:7;H335:6;H315:7
120433,"8-butyl-3-(3-formamido-2-hydroxybenzamido)-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl butyrate",248-343-7,27220-59-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H311:38;H301:38;H331:38
120435,5-nitrobenzimidazole,202-341-2,94-52-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:40;H335:40;H315:40;H351:5;H412:5;H341:2;H302:3;H332:3;H312:3
120437,"Fatty acids, tall-oil, esters with pentaerythritol",269-148-3,68188-27-2,Not Classified,Notified C&L,5,Not classified:5
120441,"Indan-1,2,3-trione",207-618-1,485-47-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,175,H319:172;H302:170;H335:167;H315:171;H317:15;Not classified:4;H334:1;H332:1;H312:1;H301:1;H225:1
120446,"p-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolyl)ethyl]benzenesulphonamide",251-529-0,33456-68-7,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
120448,"Sodium 4-[[4-chloro-6-(methylanilino)-1,3,5-triazin-2-yl]amino]-2-[[1-(2-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]benzenesulphonate",277-419-2,73384-78-8,Not Classified,Notified C&L,27,Not classified:26;H334:1;H317:1;H412:1
120450,"N6-[(4-fluorophenyl)methyl]-3-nitropyridine-2,6-diamine",251-498-3,33400-49-6,Eye Irrit. 2,REACH registration C&L,41,H319:41
120452,Ammonium docosanoate,238-593-5,14548-84-6,Not Classified,Notified C&L,1,Not classified:1
120453,Storax (balsam),232-458-4,8046-19-3,Aquatic Chronic 4,REACH registration C&L,807,H413:27;H317:803;H412:419;Not classified:2;H227:1
120457,Quinoline-8-sulphonic acid,201-611-7,85-48-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:38;H302:38;H314:4
120461,9-chloroanthracene,211-937-1,716-53-0,Acute Tox. 4,Notified C&L,42,H302:38;H341:4;H319:4;H335:4;H315:4
120462,4-[2-(dimethylamino)ethyl]morpholine,224-492-3,4385-05-1,Eye Dam. 1,Notified C&L,61,H318:38;H319:23;H315:23
120465,"2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-glucopyranosyl chloride",221-325-6,3068-34-6,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H335:1;H315:1
120467,2-bromophenetole,209-501-0,583-19-7,,Notified C&L,1,H319:1;H335:1;H315:1
120469,2-nitro-m-cresol,225-546-9,4920-77-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H302:41;H315:42;H319:42;H332:40;H335:41;H312:40;H311:1;H331:1;H301:1
120471,"N,N'-(2,5-dimethyl-1,4-phenylene)bis[3-oxobutyramide]",246-141-3,24304-50-5,Not Classified,REACH registration C&L,98,Not classified:98
120475,"Sulfuric acid, mono-C16-20-alkyl esters, sodium salts",293-917-2,91648-55-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,105,H335:83;H318:83;H412:83;H315:83;H319:22
120476,Molybdenum hexafluoride,232-026-5,7783-77-9,Skin Corr. 1B,Notified C&L,100,H314:100;H302:22;H330:22;H318:22;H312:22;H290:1;H311:2;H331:3;H301:2;H261:1
120480,D-(-)-α-phenylglycine,212-876-3,875-74-1,Not Classified,REACH registration C&L,4,Not classified:2;H319:2;H335:2;H315:2
120481,"Dehydratase, carbonate",232-576-6,9001-03-0,Resp. Sens. 1,Notified C&L,1,H334:1
120484,"3,5-DIFLUOROBENZOIC ACID",610-261-8,455-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
120485,"Tetrakis(diethyldithiocarbamato-S,S')tellurium",244-121-9,20941-65-5,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,72,H410:4;H400:4;Not classified:49;H331:19
120486,2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene,404-830-8,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
120487,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, aminosulfonyl sulfo derivs., ammonium sodium salts, compds. with 2,2',2''-[nitrilotris(2,1-ethanediyloxy)]tris[ethanol]",290-999-1,90295-09-3,Not Classified,Notified C&L,1,Not classified:1
120489,4-mesyl- N-methyl-2-nitroaniline,250-171-2,30388-44-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:2;H315:2;H319:2;H332:2;H335:2;H312:2
120497,o-nitrosotoluene,210-261-4,611-23-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H315:38;H319:38;H332:38;H335:38;H312:38
120502,"1,2,3,5-tetraacetyl-beta-D-ribofuranose",235-898-5,13035-61-5,Not Classified,REACH registration C&L,10,Not classified:8;H319:2;H335:2;H315:2
120505,"Benzene, poly(propene) derivatives",614-264-5,68081-77-6,Asp. Tox. 1;Aquatic Chronic 4,Notified C&L,36,H304:36;H413:36
120511,Tetrapentylgermanium,222-850-3,3634-47-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
120512,(2-Methylpropyl)boronic acid,617-531-4,84110-40-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,13,H319:13;H335:12;H315:13
120516,Ethyl (methylthio)acetate,224-700-2,4455-13-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,133,H319:133;H226:133;H335:132;H315:128
120519,"1,2,3-propanetriyl trioleate",204-534-7,122-32-7,Not Classified,REACH registration C&L,252,Not classified:252
120521,Mesotartaric acid,205-696-1,147-73-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
120528,"Fatty acids, coco, reaction products with diethylenetriamine",263-151-3,61790-61-2,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,3,H317:3;H410:3;H314:3
120529,"reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate;trans-1,4-dimethylcyclohexyl dibenzoate",416-230-3,35541-81-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
120531,"Distillates (petroleum), hydrotreated light;Kerosine - unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-149-8,64742-47-8,Asp. Tox. 1,Harmonised C&L,0,H304:0
120536,"[1R-(1α,2β,5α)]-2-(isopropyl)-5-methylcyclohexanecarboxylic acid",240-199-3,16052-40-7,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,14,H319:12;H302:14;H332:2;H331:10;H318:2
120537,"1-[4-(1,1-dimethylethyl)phenyl]-2-hydroxy-2-methylpropan-1-one",270-044-5,68400-54-4,Not Classified,Notified C&L,5,Not classified:5
120539,3-methoxy-α-methylbenzyl alcohol,245-575-0,23308-82-9,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H335:1;H315:1
120540,4-tert-butylbenzylamine,254-681-6,39895-55-1,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,47,H318:4;H314:9;H412:2;H319:38
120541,Tellurium tetraiodide,232-210-5,7790-48-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,42,H302:42;H314:42;H318:38;H332:38;H312:38
120542,methyl (2S)-(2-chlorophenyl){[2-(thiophen-2-yl)ethyl]amino}acetate hydrochloride (1:1),604-219-8,141109-19-5,Aquatic Chronic 4,REACH registration C&L,1,H413:1
120544,Diholmium tricarbonate,227-584-1,5895-51-2,Not Classified,Notified C&L,3,Not classified:3
120545,2-(4-fluorophenyl)thiophene,611-756-1,58861-48-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1
120546,"Diammonium 4,4'-[1,3-phenylenebis[azo(4,6-diamino-3,1-phenylene)azo]]bis(benzenesulphonate)",287-894-8,85587-35-5,Not Classified,Notified C&L,85,Not classified:85
120552,Methyl cyclohex-3-enecarboxylate,229-376-6,6493-77-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H226:3;H335:2;H315:2
120557,[2H12]cyclohexane,217-077-3,1735-17-7,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,47,H410:47;H225:47;H315:47;H336:47;H304:47;H400:47;Not classified:1
120559,Methyl toluene-4-sulphonate,201-283-5,80-48-8,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,215,H317:205;H302:215;H318:71;H314:125;H315:89;H319:50;H335:17;H332:6;H312:6;H341:7;H311:1;H351:2;H331:1
120561,"2,2-dichloro-1,1,1-trifluoroethane",206-190-3,306-83-2,STOT SE 2;STOT RE 2;Ozone 1,REACH registration C&L,235,H373:131;H371:131;H420:208;H336:79;H059:24;Not classified:25;H335:1
120562,"N,N-diethyl-2-propynylamine",223-804-5,4079-68-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,217,H302:217;H314:203;H225:145;H311:156;H412:154;H318:87;H331:111;H332:64;H312:61;H226:14;H315:14;H319:14;H301:14
120565,Ammonium 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonate,421-680-9,58374-69-9,Not Classified,Notified C&L,441,Not classified:441
120573,"Benzenesulfonic acid, hydroxy-, reaction products with formaldehyde",296-100-9,92257-13-1,Not Classified,Notified C&L,2,Not classified:2
120575,"Urea, phosphate (2:1)",611-993-0,60583-37-1,Not Classified,Notified C&L,1,Not classified:1
120578,Potassium hydroxyacetate,217-693-2,1932-50-9,Not Classified,Notified C&L,1,Not classified:1
120581,"4,4'-thiodiethylene hydrogen -2-octadecenylsuccinate",299-434-3,93882-40-7,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,31,H317:3;H319:31;H411:3;H413:28
120583,[No public or meaningful name is available],457-410-1,,Not Classified,Notified C&L,24,Not classified:24
120584,"2-ethylhexyl 2-([1,1'-biphenyl]-4-ylcarbonyl)benzoate",278-051-5,75005-95-7,Aquatic Chronic 4,REACH registration C&L,1,H413:1
120585,Oxiniacic acid,219-265-0,2398-81-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H332:1;H312:1
120586,"1,2,3,4,6-Penta-O-acetyl-α-D-mannopyranose",609-945-9,4163-65-9,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H319:1
120591,Diisononylamine,249-029-2,28454-70-8,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H302:2;H410:1;H314:2;H318:1;H400:1
120595,"4,5-dibromo-2-phenyl-1H-imidazole",260-119-0,56338-00-2,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H301:38;H318:38;H315:38
120599,"3,4-Difluor-4-(4-trans-pentylcyclohexyl)-[1,1-biphenyl]",603-820-2,134412-17-2,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
120601,2-phenoxypropanol,224-027-4,4169-04-4,Eye Dam. 1,Notified C&L,161,H318:157;Not classified:4
120602,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, aminosulfonyl sulfo derivs., sodium salts",291-001-7,90295-11-7,Not Classified,REACH registration C&L,2268,Not classified:2170;H412:84;H319:14;H318:1
120605,"Vanadium yttrium oxide (VYO4), europium-doped",271-590-7,68585-81-9,Acute Tox. 4,Notified C&L,2,H332:1;Not classified:1
120608,Aluminium sodium dioxide,215-100-1,1302-42-7,Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,348,H290:172;H318:209;H314:342;H271:59;Not classified:1
120609,Diaveridine,226-333-3,5355-16-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:45;H315:45
120611,"2,4-dimethoxybenzaldehyde",210-342-4,613-45-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
120616,"Xanthylium, 3,6-bis(ethylamino)-9-[2-(methoxycarbonyl)phenyl]-2,7-dimethyl-, molybdatesilicate",278-270-6,75627-12-2,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,195,H317:24;H413:24;H410:109;H400:109;Not classified:62;H318:5
120618,"Silane, triethoxy[2-(methylphenyl)ethyl]-, sulfurized",267-443-1,67873-85-2,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,58,H319:31;H226:31;Not classified:27
120620,Methyl hydrogen octadecylphosphonate,246-905-6,25371-55-5,Aquatic Chronic 4,REACH registration C&L,1,H413:1
120623,"Poly(oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-(t ridecyloxy)-, branched, sodium salt",614-754-9,68891-17-8,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,35,H319:35;H412:34;H315:35
120626,"Oxyacanthan-12'-ol, 6,6',7-trimethoxy-2,2'-dimethyl-, hydrochloride",239-386-2,15352-74-6,Acute Tox. 3,Notified C&L,1,H301:1
120629,1-Methyl-3-(trifluoromethyl)pyrazole-4-carboxylic Acid,601-232-0,113100-53-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:1;H315:2;H319:2;H332:1;H335:1;H312:1
120643,"5-Nonanol, 5-methyl-",608-919-4,33933-78-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H335:38;H318:38;H315:38
120644,3-[(4-aminobenzoyl)amino]propanoic acid,616-017-7,7377-08-4,,Notified C&L,5,H319:4;H335:4;H315:4;Not classified:1
120648,benzyldimethylamine,203-149-1,103-83-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H314:0;H412:0;H226:0;H332:0;H312:0
120650,"1-Octadecanol, reaction products with hexakis(methoxymethyl)melamine and triethanolamine, di-Et sulfate-quaternized",615-313-3,71608-59-8,Not Classified,Notified C&L,1,Not classified:1
120652,"2,3,4-trimethylpentane",209-292-6,565-75-3,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H225:0;H315:0;H336:0;H304:0;H400:0
120654,Alprenolol hydrochloride,237-244-4,13707-88-5,Acute Tox. 4,Notified C&L,41,H302:41
120655,N-[3-(trimethoxysilyl)propyl]aniline,221-328-2,3068-76-6,Acute Tox. 4,REACH registration C&L,82,H302:29;H314:43;H373:5;H319:8;H351:8;H315:10;H317:2;H318:4;H370:2;H335:3;H412:2
120662,Methyl trichloroacetate,209-960-7,598-99-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:50;H335:49;H315:50;H311:1;H331:1;H301:2
120663,"1,3-dimethylindole",212-872-1,875-30-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
120671,"4-Chlor-2',2''-difluor-4''-pentyl-[1,1':4',1''-terphenyl]",604-798-7,151359-01-2,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
120673,"1,1-Ethenediamine, 2,2-dinitro- ; 1,1-diamino-2,2-dinitroethylene",604-466-1,145250-81-3,Expl. 1.1;Flam. Sol. 2;Acute Tox. 4,Notified C&L,2,H302:1;H228:1;H201:2
120675,"N,N,N',N',N''-pentakis(methoxymethyl)-N''-[(octadecyloxy)methyl]-1,3,5-triazine-2,4,6-triamine",251-949-4,34346-37-7,Aquatic Chronic 4,Notified C&L,83,H413:83
120676,2-MERCAPTOTHIAZOLE,617-322-8,82358-09-6,,Notified C&L,7,H319:7;H302:7;H335:6;H315:7
120678,"Rosin, oligomeric reaction products with isophthalic acid and pentaerythritol",500-219-6,68515-02-6,Skin Sens. 1;Eye Irrit. 2,Notified C&L,4,H317:4;H319:3
120686,nickel difluoride,233-071-3,10028-18-9,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H410:0;H341:0;H334:0;H317:0;H372:0;H350:0;H360:0;H400:0
120687,"Slags, coal",270-708-4,68476-96-0,Not Classified,Notified C&L,3,Not classified:3
120688,3-methyladipic acid,221-293-3,3058-01-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
120691,2-ethyl-N-(2-methoxyisopropyl)-6-methylaniline,257-061-3,51219-00-2,Aquatic Chronic 2,Notified C&L,90,H411:89;H412:90;H302:1;H318:1;H315:1;H402:1;H335:1
120692,"1,3-dioxepane",208-015-6,505-65-7,Flam. Liq. 2;Eye Irrit. 2,Notified C&L,86,H225:83;H319:83;Not classified:3
120695,"2,2'-[[4-[(2-hydroxyethyl)amino]-3-nitrophenyl]imino]bisethanol",251-410-3,33229-34-4,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,110,H317:44;H412:5;H319:67;H335:66;H315:67;H302:8;H332:8;Not classified:1
120696,"[1,2-phenylenebis(methylene)]bis[triphenylphosphonium] dibromide",216-183-7,1519-46-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
120697,[No public or meaningful name is available],482-010-9,762300-77-6,Skin Irrit. 2,Notified C&L,25,H315:25
120698,Ethyl 2-methyl-4-oxo-6-pentylcyclohex-2-ene-1-carboxylate,261-629-6,59151-19-8,Aquatic Chronic 3,REACH registration C&L,1523,H412:1289;Not classified:234
120703,Propyl phenylacetate,225-012-5,4606-15-9,Not Classified,Notified C&L,90,Not classified:90
120704,Methyl 3-chloro-p-anisate,253-709-4,37908-98-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
120706,Tetramethylenebis[triphenylphosphonium] dibromide,239-598-5,15546-42-6,,Notified C&L,4,H319:4;H335:4;H315:4
120707,Dichlorodivinylsilane,217-118-5,1745-72-8,,Notified C&L,1,H225:1;H314:1
120711,"tert-butyl (2S)-2-carbamoyl-2,3-dihydropyrrole-1-carboxylate",615-204-0,709031-38-9,Not Classified,Notified C&L,1,Not classified:1
120714,"reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate",403-030-6,137398-54-0,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H302:0;H410:0;H400:0
120716,Trichloro(octadecyl)silane,203-930-7,112-04-9,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,79,H318:4;H314:78;H335:29;H228:2;Not classified:2;H290:1
120719,Methyl L-asparaginate monohydrochloride,260-748-0,57461-34-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
120721,"1,1',3,3'-tetramethyldibutylamine",203-303-8,105-51-1,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H302:38;H226:38;H314:38
120723,Octadecamethyloctasiloxane,209-138-8,556-69-4,Not Classified,Notified C&L,5,Not classified:5
120725,Zirconium tetranitrate,237-324-9,13746-89-9,Ox. Sol. 2;Eye Dam. 1,Notified C&L,126,H272:126;H318:86;H314:39
120726,"Calcium bis(9,10-dihydroxystearate)",277-772-2,74220-13-6,Not Classified,Notified C&L,2,Not classified:2
120732,"(11-Oxo-6,11-dihydro-dibenzo[b,e]oxepin-2-yl)-acetic acid",611-268-9,55453-87-7,Acute Tox. 3,Notified C&L,5,H301:4;H319:3;H335:3;H315:3
120736,Levoglutamide,200-292-1,56-85-9,Not Classified,REACH registration C&L,242,Not classified:240;H319:1;H335:1;H315:1;H252:1
120740,"4-(2-chlorophenyl)-N-cyclohexyl-N-ethyl-5-oxo-4,5-dihydro-1H-tetrazole-1-carboxamide",605-140-1,158237-07-1,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,129,H373:91;H410:91;H400:129
120746,Triethyl 2-phosphonopropionate,223-033-4,3699-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
120753,"3-[(2,2-dimethoxyethyl)thio]propene",283-030-9,84522-35-0,Not Classified,REACH registration C&L,8,Not classified:7;H319:1;H335:1;H315:1
120754,"N-(1,3-dimethylbutylidene)-5-[(1,3-dimethylbutylidene)amino]-1,3,3-trimethylcyclohexanemethylamine",266-267-2,66230-21-5,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,44,H317:1;H318:44;H314:44;H412:44
120756,Dexamethasone 21-(3-phenylpropionate),217-534-7,1879-72-7,Acute Tox. 4;Repr. 1B;STOT RE 2;Aquatic Chronic 1,Notified C&L,17,H373:17;H410:17;H332:17;H360:17
120763,"5,7-dihydroxy-2-phenyl-4H-benzo[b]pyran-4-one",207-549-7,480-40-0,Not Classified,Notified C&L,8,Not classified:8
120764,"Fats and Glyceridic oils, brazil nut",609-151-2,356065-50-4,Not Classified,Notified C&L,1,Not classified:1
120765,Phosphorus pentabromide,232-186-6,7789-69-7,Skin Corr. 1B,Notified C&L,43,H314:43
120772,2-chloro-6-nitrotoluene,201-475-9,83-42-1,Acute Tox. 4,Notified C&L,50,H302:44;H373:7;H411:7;H315:7;H319:7;H332:4;H312:4;H311:4;H301:4;H330:3;H331:1
120773,4-(chloroacetyl)morpholine,215-880-3,1440-61-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,45,H319:39;H302:40;H314:4;Not classified:1;H315:2;H332:1;H335:2;H312:1;H318:1
120776,"Naphtha (petroleum), heavy alkylate;Low boiling point modified naphtha;[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C",265-067-2,64741-65-7,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
120778,Methyl 1-methyl-4-[(methylphenylhydrazono)methyl]pyridinium sulphate,269-503-2,68259-00-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,178,H302:177;H410:8;H400:63;H411:102;H319:75;H315:58;H412:8;H332:4;H335:4
120779,N-[4-cyano-3-trifluoromethylphenyl]methacrylamide,427-880-2,90357-53-2,STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H411:0
120780,(α-D-glucopyranosylthio)gold,235-365-7,12192-57-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,49,H334:38;H317:38;H361:10;Not classified:1
120784,Econazole,248-341-6,27220-47-9,Acute Tox. 4,Notified C&L,99,H302:98;H319:2;H335:1;H315:2;Not classified:1
120785,"Oleic acid, ester with hydroxypropanediyl diacetate",248-807-9,28060-90-4,Not Classified,Notified C&L,1,Not classified:1
120788,"Hydrocarbons, C",297-853-6,93763-34-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
120790,1-phenylnonan-1-one,227-861-7,6008-36-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
120791,"1,2,3-Trifluor-5-(4-trans-ethyl-[1,1-bicyclohexyl]-4-trans-yl)-benzene",604-115-2,139215-80-8,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
120792,Bromomethyl 2-methoxyphenyl ketone,250-870-2,31949-21-0,Skin Corr. 1B,Notified C&L,44,H314:44;H302:1
120793,Bis(2-ethylhexyl) fumarate,205-448-2,141-02-6,Aquatic Chronic 2,REACH registration C&L,562,H411:77;Not classified:306;H315:179;H319:2;H335:1
120794,(tert-butoxymethyl)oxirane,231-640-0,7665-72-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;STOT SE 3;Muta. 2;Carc. 2;Aquatic Chronic 3,REACH registration C&L,150,H302:98;H351:4;H412:59;H341:4;H317:98;H226:98;H318:3;H315:112;H335:111;H334:56;H319:147;H332:108;H224:52;H312:52
120795,tert-butyl 8-quinolyl carbonate,242-434-5,18595-55-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
120802,Sodium 2-(p-aminoanilino)-5-nitrobenzenesulphonate,238-906-5,14846-08-3,Not Classified,REACH registration C&L,3,Not classified:3
120803,"Bis(2,8,9-Trioxa-5-aza-1-silabicyclo(3.3.3)undecane-1-propane-)disulfide",477-700-1,,Aquatic Chronic 3,REACH registration C&L,2,H412:2
120804,Tetraboron silicide,234-518-5,12007-81-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
120809,"1-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tryptophan",604-383-0,143824-78-6,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,43,H317:39;H411:39;Not classified:3;H302:1;H319:1;H332:1;H335:1;H312:1
120812,"1,2-dihydro-6-nitro-3H-indazol-3-one",230-905-8,7364-33-2,Acute Tox. 3,Notified C&L,38,H301:38
120813,Dibenzofuran-2-ol,201-698-1,86-77-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
120816,"Benzyl (2S, 3aR, 7aS)-octahydro-1H-indol-2-carboxylatehydrochloride",474-170-3,145641-35-6,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H317:3;H410:3;H318:3;H400:2
120819,"9-Octadecenoic acid (Z)-, C12-15-alkyl esters",270-163-2,68412-06-6,Not Classified,Notified C&L,9,Not classified:9
120821,"Hydrogen bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-)",257-789-1,52256-37-8,Aquatic Chronic 2,REACH registration C&L,2505,H411:6;Not classified:2497;H302:2
120822,Sulfadiazine,200-685-8,68-35-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,169,H302:166;H317:127;H334:160;H315:163;H319:163;H335:162;H410:36;H400:36;H361:11;H412:9;Not classified:2;H341:1;H362:1;H411:1
120823,"Dinonylphenol, Ethoxylate, Phosphate",609-688-2,39464-64-7,Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,152,H318:152;H314:133;H412:152;H315:19
120825,"4-benzoylbenzene-1,2,3-triyl tris(6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulphonate)",227-030-9,5610-94-6,Flam. Sol. 2;Self-react. D;Skin Irrit. 2;Aquatic Chronic 4,REACH registration C&L,2,H242:2;H228:1;H413:1;H315:1
120829,Clefamide,222-694-6,3576-64-5,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H301:38;H400:38
120832,"Capsicum annuum, ext.",283-403-6,84625-29-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1478,H319:1348;H315:1396;H302:1389;Not classified:80;H318:50;H226:2;H335:1;H301:2
120833,"2,3-dimethyl-2,3-dinitrobutane",223-569-9,3964-18-9,Acute Tox. 2,REACH registration C&L,50,H300:44;H301:6;H330:1;H411:1;H312:1;H228:1
120834,"Lead, antimonial, dross",273-795-7,69029-51-2,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H410:3;H360:3;H318:3;H372:3;H315:3;H350:3;H332:3;H301:3;H400:3
120837,"1,1'-(methylenedi-4,1-phenylene)bis(3-butylurea)",416-600-4,,Aquatic Chronic 4,REACH registration C&L,8,H413:6;Not classified:2
120838,Allyl propyl disulphide,218-550-7,2179-59-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,94,H319:93;H335:93;H315:91;H226:4;H317:3
120839,"o-[[(2-ethylhexyl)methylamino]carbonyl]benzoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",302-456-9,94109-18-9,Eye Dam. 1,Notified C&L,83,H318:83
120841,Ethyl 2-bromooctanoate,226-647-0,5445-29-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:38;H315:43
120843,3-oxobutyronitrile,219-590-8,2469-99-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:39;H311:1;H315:1;H332:1
120844,Penicillamine hydrochloride,218-727-9,2219-30-9,,Notified C&L,1,H334:1;H315:1
120845,"Bis[1-[4-(dimethylamino)phenyl]-2-phenylethylene-1,2-dithiolato(2-)-S,S']nickel",253-958-9,38465-55-3,Skin Sens. 1;Resp. Sens. 1;Carc. 1A;STOT RE 1,Notified C&L,1,H334:1;H317:1;H350:1;H372:1
120846,sec-butyl propionate,611-802-0,591-34-4,Flam. Liq. 3,Harmonised C&L,0,H226:0
120852,"2,4-Hexadienoic acid, potassium salt (1:1)",611-771-3,590-00-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,361,H319:273;H315:254;Not classified:88;H335:23
120855,"1,2-dihydro-3H-indazol-3-one",230-904-2,7364-25-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
120857,2'-deoxyadenosine 5'-(disodium dihydrogen triphosphate),277-809-2,74299-50-6,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
120859,Dyer’s mulberry (Chlorophora tinctoria) extract,287-897-4,85595-40-0,Not Classified,Notified C&L,2,Not classified:2
120860,"Isononylphenol, ethoxylated",609-346-2,37205-87-1,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1534,H302:935;H411:963;H318:1336;H412:504;H315:125;Not classified:61;H319:127;H413:8;H410:1;H301:1;H400:1
120863,N-(4-chlorophenyl)-N-(1-isopropyl-4-piperidyl)phenylacetamide monohydrochloride,261-504-6,58934-46-6,Acute Tox. 4,Notified C&L,38,H302:38
120866,Z-84,482-090-5,,Eye Dam. 1,Notified C&L,441,H318:441
120867,Chromium dichloride hydroxide,239-063-6,14982-80-0,Not Classified,Notified C&L,2,Not classified:1;H315:1;H302:1;H318:1;H312:1
120869,Pentachlorodisilane,250-620-2,31411-98-0,Skin Corr. 1B,Notified C&L,1,H314:1
120871,(R)-2-tert-butoxycarbonylamino-3-hydroxy propionic acid,613-313-8,6368-20-3,Eye Dam. 1,REACH registration C&L,6,H318:3;Not classified:2;H319:1;H335:1;H315:1
120875,"Slags, tellurium",273-828-5,69029-86-3,Acute Tox. 3;Skin Corr. 1A;Skin Sens. 1;Acute Tox. 4;Carc. 1A;Repr. 1A;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,2,H314:2;H360:2;H317:2;H373:2;H411:2;H350:2;H332:2;H301:2
120876,8-b-D-Glucopyranosyl-7-hydroxy-3-(4-hydroxy-phenyl)-4H-1-benzopyran-4-one,609-296-1,3681-99-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
120877,4-Chloro-3-methylaniline,615-298-3,7149-75-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:45;H335:39;H315:45;H302:7;H373:6;H332:7;H312:7;H311:2;H331:2;H372:1;H370:1;H301:2
120878,"2,2'-[1,6-hexanediylbis(nitrilomethylidyne)]bisphenol",223-807-1,4081-35-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
120880,"4,4'-oxydi(benzenesulphonohydrazide)",201-286-1,80-51-3,Self-react. D;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,336,H302:165;H410:82;H341:153;H317:100;H242:60;H373:82;H315:261;H319:263;H411:86;H335:171;H228:153;H332:66;H334:30;Not classified:13;H412:1;H371:1;H225:1;H200:1;H400:1
120881,Decylcyclopentane,206-040-7,295-48-7,Asp. Tox. 1,Notified C&L,10,H304:10
120885,"1,4-Dihydro-6-methoxy-7-nitroquinoxaline-2,3-dione",614-960-9,69399-57-1,Not Classified,Notified C&L,34,Not classified:34
120887,2-ethoxy-N-hydroxybenzenecarboximidamide,618-095-8,879-57-2,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1
120888,"N,N,N',N'-tetrakis(2-hydroxypropyl)adipamide",260-982-3,57843-53-5,Not Classified,REACH registration C&L,145,Not classified:145
120890,"Sunflower oil, ester with sorbitol",306-248-9,96690-53-8,Not Classified,REACH registration C&L,35,Not classified:35
120895,4-Chlorobutyl 3-chloropropanoate,617-343-2,82530-64-1,Skin Corr. 1B,Notified C&L,2,H314:1;H361:1;H317:1;H411:1;H401:1
120896,"Octadecanoic acid, ester with 2,2-bis(hydroxymethyl)-1,3-propanediol",232-457-9,8045-34-9,Not Classified,Notified C&L,2,Not classified:2
120898,"Bis(12-hydroxyoctadecanoic) acid, diester with glycerol",278-954-4,78616-19-0,Not Classified,Notified C&L,1,Not classified:1
120907,Cyclohexylbenzene,212-572-0,827-52-1,Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,67,H410:53;H304:6;H400:53;H302:40;H315:49;H319:46;Not classified:14;H373:3
120910,"2,2-bis(hydroxymethyl)-1,3-propanediyl dioctanoate",259-750-4,55680-37-0,,Notified C&L,1,Not classified:1
120913,"3-[(dimethylsilyl)oxy]-1,1,5,5-tetramethyl-3-phenyltrisiloxane",241-940-3,18027-45-7,Flam. Liq. 3,REACH registration C&L,91,H226:1;H319:41;H335:40;H315:41;H413:36;H318:13
120914,Zinc isooctadecanoate,261-998-3,59963-29-0,Not Classified,Notified C&L,1,Not classified:1
120919,"5-fluoro-1,3-dimethyl-1H-pyrazole-4-carbonyl fluoride",619-796-1,191614-02-5,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Acute Tox. 3,REACH registration C&L,3,H311:3;H331:3;H301:3;H314:3
120920,(piperidin-4-yl)methanol,613-624-9,6457-49-4,Skin Corr. 1B,Notified C&L,48,H314:48;H302:1;H318:2
120921,vanadyl pyrophosphate,406-260-5,58834-75-6,Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H319:0;H412:0
120925,p-benzyloxypropiophenone,224-788-2,4495-66-3,Not Classified,Notified C&L,1,Not classified:1
120927,"sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate",405-510-0,121216-78-2,Skin Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H315:0
120929,"2-Propenoic acid, 3-(4-bromo-2-fluorophenyl)-",604-711-2,149947-19-3,,Notified C&L,5,H319:5;H335:5;H315:5
120932,Diphenyl phosphonate,225-202-8,4712-55-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,655,H302:634;H410:7;H341:8;H317:8;H373:8;H411:8;H315:613;H319:571;H400:8;H318:63;H335:39;H314:37;H370:18;Not classified:2;H340:1;H372:1;H360:1
120933,"2,4-bis[N'-(4-methylphenyl)ureido]toluene",411-790-5,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
120935,"Diallyl(4,6-diamino-1,3,5-triazin-2-yl)amine",202-096-1,91-77-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
120941,1-(2-aminoethyl)pyrrolidin-2-one,246-539-7,24935-08-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:40;H315:40;H318:1
120942,"Hydrogen [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']ferrate(1-)",241-171-3,17099-81-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
120948,"sodium 4-{[4-(diethylamino)phenyl][4-(diethyliminio)cyclohexa-2,5-dien-1-ylidene]methyl}naphthalene-2,7-disulfonate",603-214-8,12768-78-4,Not Classified,Notified C&L,2042,Not classified:2040;H317:2;H319:2
120952,nickel dibromate,238-596-1,14550-87-9,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H410:0;H341:0;H334:0;H317:0;H372:0;H350:0;H360:0;H400:0
120953,"Amines, C12-14-alkyldimethyl, lactates",306-996-6,97488-60-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,33,H302:33;H314:33;H400:33
120956,2-styrylpyridine,211-934-5,714-08-9,Eye Dam. 1,Notified C&L,41,H318:38;H319:3;H302:3;H335:3;H315:3
120961,Naphthalene-1-sulphonic acid,201-610-1,85-47-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H318:39;H314:42;Not classified:2;H290:1
120967,Zinc bis(hydroxymethanesulphinate),246-515-6,24887-06-7,Acute Tox. 4;Eye Irrit. 2;Muta. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,145,H361:13;H302:142;H410:5;H341:139;H319:142;H400:3;H412:136;H315:12
120968,"Perhydro-1,4-diazepine",208-016-1,505-66-8,Acute Tox. 3;Skin Corr. 1B,Notified C&L,52,H311:45;H314:52;H312:6;H318:1;H227:1
120971,"Amines, tallow alkyl, acetates",263-150-8,61790-60-1,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,135,H318:81;H314:119;H412:60;H302:58;H400:74;H410:16;H315:16;H335:1;H319:1
120976,Triphenylmethyl hydroperoxide,609-978-9,4198-93-0,Ox. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H271:38;H315:38
120980,2-ethylphenylhydrazine hydrochloride,421-460-2,19398-06-2,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H351:0;H317:0;H318:0;H372:0;H400:0
120982,"Phosphoric acid, butyl ester, compd. with 2,2'-iminobis[ethanol]",284-937-2,84989-46-8,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
120988,Digadolinium tricarbonate,227-583-6,5895-49-8,Not Classified,Notified C&L,6,Not classified:6
120990,"2-(3,4-dihydroxyphenyl)-3-(β-D-glucofuranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one",244-488-5,21637-25-2,Not Classified,Notified C&L,2,Not classified:2
120992,"Distillates (petroleum), thermal cracked naphtha and gas oil, C",271-632-4,68603-01-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
120994,Octylphosphonic dichloride,221-444-3,3095-94-1,,Notified C&L,4,H314:4
120995,"Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs., compds. with 2-propanamine",284-664-9,84961-74-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,211,H319:211;H412:211;H315:211
120996,"2,4-dinitrosoresorcinol",204-228-3,118-02-5,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1,Notified C&L,39,H317:38;H301:38;H318:38;H319:1;H201:1;H315:1
120997,2-METHYL-3-METHYLTHIO-FURAN,613-135-0,63012-97-5,Acute Tox. 4,Notified C&L,1443,H302:1365;H319:106;H226:157;H315:106
120998,[No public or meaningful name is available],476-170-9,922525-38-0,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,25,H302:25;H318:25;H314:25
121001,Diisononyl adipate,251-646-7,33703-08-1,Not Classified,REACH registration C&L,161,Not classified:161
121003,2-[(2-hydroxyethyl)(methyl)amino]-1-phenylpropan-1-ol,618-782-2,91688-17-4,Not Classified,REACH registration C&L,1,Not classified:1
121009,"Tetrasodium 3-[[4-[[4-[(6-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]-7-sulphonato-1-naphthyl]azo]-1-naphthyl]azo]naphthalene-1,5-disulphonate",289-317-5,87440-96-8,Not Classified,Notified C&L,7,Not classified:7
121011,Potassium 2-biphenylate,237-243-9,13707-65-8,Acute Tox. 4;Skin Corr. 1B,Notified C&L,36,H302:33;H314:33;Not classified:3
121012,"Copper, complexes with diazotized 3-amino-4-methoxybenzenesulfonic acid monosodium salt coupled with diazotized 4-nitro-1,3-benzenediamine and resorcinol, sodium salts",280-007-5,82640-07-1,Not Classified,REACH registration C&L,10,Not classified:10
121013,Gold stannate purple,215-720-2,1345-24-0,Not Classified,Notified C&L,2,Not classified:2
121016,Dicopper tetraiodomercurate,237-634-4,13876-85-2,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H373:38;H330:38;H310:38;H300:38;H400:38
121020,1-aminopropan-2-ol;isopropanolamine,201-162-7,78-96-6,Skin Corr. 1B,Harmonised C&L,0,H314:0
121022,"1-ethyl-2-[3-(1-ethylnaphtho[1,2-d]thiazol-2(1H)-ylidene)-2-methyl-1-propenyl]naphtho[1,2-d]thiazolium bromide",231-047-7,7423-31-6,,Notified C&L,4,H319:4;H335:4;H315:4
121023,7-hydroxycoumarin,202-240-3,93-35-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,136,H319:134;H335:133;H315:134;Not classified:2
121024,"Iris germanica florentina, ext.",289-954-9,90045-89-9,Aquatic Chronic 3,Notified C&L,88,H412:52;Not classified:36
121025,3-Fluor-4'-propylbiphenyl,923-509-8,,Aquatic Chronic 4,REACH registration C&L,2,H413:2
121026,"N,N-dimethylbenzene-1,4-diammonium sulphate",262-092-0,60160-75-0,,Notified C&L,3,Not classified:1;H311:2;H301:2;H317:1;H330:1;H331:1
121029,Germanium tetrabromide,236-612-1,13450-92-5,Skin Corr. 1B,Notified C&L,42,H314:42
121032,"rac-3-(2,3-Diacetoxypropylcarbamoyl)-2,4,6-triiodo-5-methoxyacetylaminobenzoyl chloride",604-759-4,150928-21-5,Not Classified,Notified C&L,1,Not classified:1
121034,3-Chloro-4-fluorobenzaldehyde,608-972-3,34328-61-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
121035,3-Bromo-5-fluorotoluene,606-501-6,202865-83-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H335:1;H312:1
121044,"Formic acid, compound with 1,4-diazabicyclo[2.2.2]octane",269-344-9,68227-30-5,Not Classified,Notified C&L,27,Not classified:27
121047,"3-hydroxymethylpentane-1,5-diol",213-648-6,998-12-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
121048,Dimethylhydrogenpolydimethylsiloxane,615-197-4,70900-21-9,Not Classified,Notified C&L,138,Not classified:61;H319:60;H335:53;H315:60;H226:15;H225:1;H361:1
121049,"2,4,6-trinitro-m-cresol",210-027-1,602-99-3,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H332:0;H201:0;H312:0
121051,4-ethoxyphenylacetic acid,225-545-3,4919-33-9,,Notified C&L,5,H319:5;H335:5;H315:5;H302:1
121053,Cellulose Acetate Phthalate,618-382-8,9004-38-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:2;H335:2;H315:2;Not classified:1;H252:1
121054,"Distillates (petroleum), hydrotreated middle;Gasoil - unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-148-2,64742-46-7,Carc. 1B,Harmonised C&L,0,H350:0
121059,"carbonic acid, nickel salt",240-408-8,16337-84-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H302:0;H410:0;H341:0;H334:0;H317:0;H372:0;H315:0;H350:0;H332:0;H360:0;H400:0
121060,Arpezine,604-300-8,142-63-2,Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1;Repr. 2,Notified C&L,47,H334:45;H317:45;H361:43;H314:45;H412:3;H318:4;Not classified:1
121061,Dodeclonium bromide,239-779-9,15687-13-5,,Notified C&L,2,H302:2
121062,"Sodium 2-[[3-[(3-amino-4-nitrophenyl)azo]-2,4-dihydroxyphenyl]azo]-5-nitrobenzenesulphonate",282-079-3,84099-99-0,Not Classified,Notified C&L,2,Not classified:1;H319:1
121063,(3-Acryloxypropyl)trimethoxysilane,610-134-7,4369-14-6,Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,79,H314:66;H412:66;H317:79;H332:79;H335:38
121064,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, aminosulfonyl sulfo derivs., ammonium sodium salts",290-998-6,90295-08-2,Not Classified,REACH registration C&L,110,Not classified:110
121068,2-propylpyridine,210-732-4,622-39-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H226:40;H335:38;H315:39
121075,3-methylcyclopent-2-enone,220-421-5,2758-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
121076,"Silicic acid (H4SiO4), tetraethyl ester, reaction products with chlorodimethylsilane",273-531-0,68988-57-8,Not Classified,Notified C&L,35,Not classified:30;H319:5;H315:5
121077,Haematoxylin,208-237-3,517-28-2,Eye Irrit. 2,REACH registration C&L,57,H319:52;H302:42;H335:50;H315:51;Not classified:3;H332:2;H312:1;H311:1
121080,6-anilino-4-hydroxynaphthalene-2-sulphonic acid,204-305-1,119-19-7,Skin Corr. 1B,Notified C&L,38,H314:38
121083,"Octanoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",245-327-1,22919-56-8,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,78,H318:2;H314:2;H319:76;H335:48;H315:76
121087,potassium bromate,231-829-8,7758-01-2,Ox. Sol. 1;Acute Tox. 3;Carc. 1B,Harmonised C&L,0,H301:0;H350:0;H271:0
121089,"Tricarbonyl[(1,2,3,4,5,6-η)-1,3,5-trimethylbenzene]tungsten",235-206-1,12129-69-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H302:38;H315:42;H319:42;H332:38;H335:42;H312:38;H301:4
121091,"4-[(2-arsonophenyl)azo]-3-hydroxynaphthalene-2,7-disulphonic acid",205-058-2,132-33-2,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:39;H301:39;H331:39;H400:39
121092,1-ethynylcyclohexylamine,250-172-8,30389-18-5,Skin Corr. 1B,Notified C&L,98,H314:98;H226:42
121093,Trimethoprim,212-006-2,738-70-5,Acute Tox. 4,Notified C&L,135,H302:116;H361:43;H411:37;H372:37;Not classified:10;H332:6;H341:3;H312:3;H412:4;H360:4;H334:2;H317:2;H301:1;H319:1;H335:1;H315:1
121094,Butyl dihydrogen phosphate,216-604-4,1623-15-0,Skin Corr. 1C;Eye Dam. 1,Notified C&L,768,H318:478;H314:717;H290:35;Not classified:51;H413:2
121100,Ethyl crotonate,210-808-7,623-70-1,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,168,H319:161;H226:122;H225:46;H314:5;H318:2;H315:3;H335:1
121101,"Bis (acetato-κO)[7-chloro-1-cyclopropyl-6-fluoro-4-(oxo-κO)-1,4-dihydroquinoline-3-carboxylato-κO] boron",700-382-5,119618-67-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H315:2;H319:2;H335:2;H312:2
121104,5-(2-(2-iodoacetamido)ethylamino)-1-naphthalenesulphonic acid,253-277-7,36930-63-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
121106,"1,1,3,3-tetraethoxypropane",204-533-1,122-31-6,Acute Tox. 4,Notified C&L,39,H302:39;H226:1
121110,"C8-10 Alkyl alcohol ethoxylate (4EO), -phosphate ester",614-291-2,68130-47-2,Skin Corr. 1C;Eye Dam. 1,Notified C&L,697,H318:643;H314:663;H315:32;H335:3;H411:2;Not classified:1
121112,"Amines, coco alkyl, ethoxylated, compds. with polyethylene glycol monooleyl ether phosphate",601-749-1,120968-16-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,27,H319:22;H315:22;Not classified:5
121113,"2-[[(4-methoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium sulphate (2:1)",281-459-6,83950-02-1,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,7,H302:5;H411:5;H318:7;H410:2;H301:2;H400:2
121115,"[nitrilotris(methylene)]trisphosphonic acid, potassium salt",248-660-0,27794-93-0,Not Classified,REACH registration C&L,95,Not classified:48;H290:3;H319:46;H315:42;H335:14
121116,Anisole,202-876-1,100-66-3,Flam. Liq. 3,REACH registration C&L,2014,H226:2012;H336:180;H341:1;H318:1;H314:2;H319:1594;H315:1536;H331:12;H332:1;Not classified:2;H335:2;H302:1;H225:1;H311:1
121117,2-methylisothiazol-3(2H)-one,220-239-6,2682-20-4,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Skin Sens. 1A;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H314:0;H311:0;H317:0;H330:0;H318:0;H301:0;H400:0
121120,"3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione",412-190-6,168900-02-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
121121,(5-cyanothiophen-2-yl)boronic acid,608-502-7,305832-67-1,,Notified C&L,7,H319:6;H302:6;H335:6;H315:6;H311:1;H301:1;H331:1;H332:1;H312:1
121122,3-methoxybenzylamine,225-779-6,5071-96-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:39;H302:40;H335:39;H315:39;H314:7;H318:2;H332:1;H312:1
121123,(ethoxy)diphenylvinylsilane,241-870-3,17933-85-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
121126,Calcium fluorophosphate,232-187-1,7789-74-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
121131,"6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-hydroxyphenyl)-1H-3-benzazepinium bromide",266-634-7,67287-54-1,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,38,H319:38;H317:38;H302:38;H334:38
121132,2-bromo-5-methoxybenzoic acid,245-329-2,22921-68-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 1,REACH registration C&L,18,H302:10;H318:10;H372:9;H315:18;H319:16;H335:8
121133,"Benzenepropanoic acid, 3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxy-, methyl ester",400-820-2,84268-33-7,Aquatic Chronic 4,REACH registration C&L,91,H413:90;Not classified:1
121137,"4,5-dihydrothiazol-2-amine monohydrochloride",223-416-6,3882-98-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
121138,"2-Oxiranecarboxylic acid, 3-[[[(1S)-1-[[[4-[(aminoiminomethyl)amino]butyl]amino]carbonyl]-3-methylbutyl]amino]carbonyl]-, (2S,3S)-",613-978-4,66701-25-5,Not Classified,Notified C&L,3,Not classified:2;H371:1
121141,2-benzylaniline,248-806-3,28059-64-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
121145,"3'-Cytidylic acid, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 2-chlorophenyl 2-cyanoethyl ester",279-563-1,80817-35-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,38,H302:38;H351:38;H315:38;H319:38;H332:38;H335:38;H312:38
121148,"2,6-dichloro-4-methylnicotinonitrile",212-873-7,875-35-4,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,45,H335:43;H317:38;H318:39;H315:44;H332:43;H301:40;H312:43;H302:4;H319:5;H412:1;H311:1;H331:1
121152,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, aminosulfonyl [[3-[[4-chloro-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-4-sulfophenyl]amino]sulfonyl sulfo derivs., sodium salts",290-996-5,90295-06-0,,Notified C&L,8,Not classified:8
121153,"(2E)-3-(5,5-dimethyl-1,3-dioxan-2-yl)-2-methylprop-2-enal",610-698-4,51575-61-2,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,84,H317:84;H412:84;H315:84
121156,3'-nitroacetanilide,204-532-6,122-28-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H317:38;H319:42;H335:42;H315:42;H302:1;H332:1;H312:1
121159,Ethyl (methylsulphonyl)acetate,224-702-3,4455-15-6,,Notified C&L,7,H319:7;H315:7;H335:3
121161,"Distillates (petroleum), clay-treated heavy naphthenic;Baseoil - unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-146-1,64742-44-5,Carc. 1B,Harmonised C&L,0,H350:0
121162,Cabufocon A,618-381-2,9004-36-8,Not Classified,Notified C&L,559,Not classified:477;H312:57;H319:25;H302:25;H335:25;H315:25
121163,"4-chloro-α,α-dicyclopropylbenzyl alcohol",263-616-0,62586-97-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38
121164,Dodecyltrimethylammonium hydrogen sulfate,600-511-4,103999-25-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
121169,"2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-dipropiononitrile",221-294-9,3058-04-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H302:2;H315:2
121175,"Formic acid, compound with 2,2'-iminobis[ethanol] (1:1)",269-962-9,68391-54-8,Not Classified,Notified C&L,2,Not classified:2
121176,Guanosine,204-227-8,118-00-3,Acute Tox. 3,Notified C&L,56,H301:45;Not classified:10;H341:1;H302:1;H311:1;H331:1
121177,[p-phenylenebis(methylene)]bis[triphenylphosphonium] dichloride,216-184-2,1519-47-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H302:1;H312:1
121181,"1,2,4-trifluoro-3-nitrobenzene",255-656-2,42096-74-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H335:1;H312:1
121182,"N-(2-Diethylamino-ethyl)-2-[2-(4-fluoro-benzylsulfanyl)-4-oxo-4,5,6,7-tetrahydro-cyclopentapyrimidin-1-yl]-N-(4'-trifluoromethyl-biphenyl-4-ylmethyl)-acetamide",619-937-7,356057-34-6,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H410:3;H318:3;H400:3
121183,"Ethyl N,N-dimethylglycinate",251-411-9,33229-89-9,Flam. Liq. 3;Skin Irrit. 2,Notified C&L,39,H226:39;H315:39
121184,Butenone,201-160-6,78-94-4,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 1;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,150,H410:66;H314:146;H225:148;H317:64;H310:66;H330:146;H318:42;H300:150;H373:3;H400:66;H331:4;H315:4;H319:4;Not classified:1;H224:2;H372:1;H370:1
121185,2-bromo-3-methylbutyric acid,209-291-0,565-74-2,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,47,H302:47;H314:47;H312:44;H318:1;H332:2
121186,POLYHEXAMETHYLENE ADIPAMIDE,608-706-6,32131-17-2,Not Classified,Notified C&L,173,Not classified:152;H315:21
121191,Bis[hydrogen 3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(2-)]cobaltate(1-),248-109-4,26921-01-7,Not Classified,Notified C&L,1,Not classified:1
121192,Trimethyl[3-(oleoylamino)propyl]ammonium methyl methylphosphonate,274-294-6,70055-71-9,Eye Irrit. 2,Notified C&L,1,H319:1
121196,Nicotine salicylate,249-852-7,29790-52-1,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Chronic 2,Notified C&L,2,H330:2;H310:2;H411:2;H300:2
121197,4-aminobutyramide monohydrochloride,235-895-9,13031-62-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
121198,Phenylacetic acid,203-148-6,103-82-2,Eye Irrit. 2,REACH registration C&L,1807,H319:1510;H318:295;H335:52;H315:82;H412:33;Not classified:3;H332:1;H312:1;H302:1
121208,Acrylic fibers,613-184-8,63231-45-8,Not Classified,Notified C&L,1,Not classified:1
121209,2-propynyl propionate,217-695-3,1932-92-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H226:42;H335:38;H315:38;H302:4
121212,"4-Chlor-2',2''-difluor-4''-propyl-1,1':4',1''-terphenyl",604-797-1,151359-00-1,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
121213,7-amino-2-naphthol,202-241-9,93-36-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H302:1;H410:1;H315:1;H319:1;H335:1;H400:1
121219,Hex-2-enal,208-014-0,505-57-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,157,H302:156;H311:156;H317:156;H226:156;H411:131;H315:25;H319:38;Not classified:1
121221,Benfluralin,217-465-2,1861-40-1,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,98,H410:98;H317:57;H315:57;H319:57;H400:97
121223,LR-147,413-130-1,114803-11-1,Not Classified,Notified C&L,11,Not classified:11
121226,1-(2-hydroxyethyl)imidazolidin-2-one,223-032-9,3699-54-5,Not Classified,REACH registration C&L,398,Not classified:164;H319:234;H335:234;H315:234
121227,L-(-)-3-phenyllactic acid,243-726-5,20312-36-1,Not Classified,Notified C&L,2,Not classified:1;H319:1
121229,"Benzene, (1-methylethyl)-, oxidized, cumene residues, acetophenone fraction",309-849-4,101316-44-3,Not Classified,REACH registration C&L,2,Not classified:2
121230,"Propanoic acid, 2-[4-[4,6-bis([1,1'-biphenyl]-4-yl)-1,3,5-triazin-2-yl]-3-hydroxyphenoxy]-, isooctyl ester",444-090-3,,Not Classified,REACH registration C&L,85,Not classified:85
121232,Hydrogen sodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-),271-483-5,68556-27-4,Aquatic Chronic 2,Notified C&L,43,H411:40;H319:7;Not classified:2
121234,"Acetamide, N-(2,4-dinitrophenyl)-, reaction products with 1-methyl-2,4-dinitrobenzene and sodium sulfide (Na2(Sx)), thiosulfonated",269-896-0,68389-52-6,Not Classified,Notified C&L,31,Not classified:31
121236,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with N-Methylaniline",920-392-5,,Not Classified,Notified C&L,14,Not classified:14
121237,"N,N,N',N'-tetraphenyl[1,1'-biphenyl]-4,4'-diamine",239-599-0,15546-43-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
121243,4-(chlorodimethylsilyl)butyronitrile,242-039-8,18156-15-5,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,50,H318:3;H314:50;H226:39;H335:42;H290:1;H301:1
121244,[2-[(2-methyl-1-oxoallyl)oxy]ethyl] hydrogen succinate,244-096-4,20882-04-6,Skin Sens. 1;Eye Dam. 1,REACH registration C&L,318,H317:216;H318:204;H315:312;H319:114;H335:2
121246,"3-[1-(4-{Methyl-[2-(4-methyl-piperazin-1-yl)-acetyl]-amino}-phenylamino)-1-phenyl-meth-(Z)-ylidene]-2-oxo-2,3-dihydro-1H-indole-6-ca",922-049-5,,Repr. 1B;STOT RE 2,REACH registration C&L,2,H373:2;H360:2
121249,Piperidin-3-ylmethanol,225-013-0,4606-65-9,Skin Corr. 1B,Notified C&L,46,H314:46;H318:2
121251,"cis-1,3-dimethylcyclohexane",211-316-5,638-04-0,Flam. Liq. 2,Notified C&L,64,H225:64;H304:23
121253,Sucrose myristate,248-340-0,27216-47-3,Not Classified,Notified C&L,1,Not classified:1
121254,2-vinylnaphthalene,212-573-6,827-54-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1,H302:1;H371:1;H315:1;H319:1;H332:1;H335:1;H312:1
121256,Diethyl 3-oxoglutarate,203-302-2,105-50-0,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
121257,4-amino-3-fluorobenzoic acid,207-250-1,455-87-8,,Notified C&L,9,H319:9;H335:8;H315:9
121258,"Fatty acids, C14-18 and C18-unsatd., branched and linear, esters with pentaerythritol",286-056-9,85186-72-7,Not Classified,REACH registration C&L,8,Not classified:8
121260,Dilithium fumarate,246-478-6,24820-18-6,Not Classified,Notified C&L,1,Not classified:1
121264,Hexahydro-2H-azocine-1-ethylamine,214-423-5,1126-67-6,Skin Corr. 1B,Notified C&L,1,H314:1
121265,Carbazol-2-ol,201-699-7,86-79-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43;H302:1
121270,9-cyclohexylbicyclo[3.3.1]nonan-9-ol,244-659-4,21915-40-2,Aquatic Chronic 4,Notified C&L,38,H413:38
121271,Disodium hydroxy[3-hydroxy-4-[(1-hydroxy-8-sulpho-2-naphthyl)azo]naphthalene-1-sulphonato(4-)]chromate(2-),228-875-6,6370-08-7,Skin Irrit. 2,Notified C&L,2114,H315:2044;H319:42;H411:37;Not classified:21;H334:5;H317:2
121272,Tripotassium hexacyanoferrate,237-323-3,13746-66-2,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,178,H319:72;H411:22;H361:42;H302:72;Not classified:54;H335:29;H315:30;H332:9;H312:9;H311:1
121275,"Pentaerythritol, ethoxylated and propoxylated",500-069-1,30374-35-7,Not Classified,Notified C&L,19,Not classified:19
121276,"1H-Imidazole, copper(2+) salt",439-800-3,,Acute Tox. 4;Eye Dam. 1,Notified C&L,1,H302:1;H318:1
121279,Glutamic acid,200-293-7,56-86-0,Not Classified,REACH registration C&L,193,Not classified:191;H319:2;H335:2;H315:2;H302:1
121282,o-toluidine;2-aminotoluene,202-429-0,95-53-4,Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;Carc. 1B;Aquatic Acute 1,Harmonised C&L,0,H331:0;H350:0;H319:0;H301:0;H400:0
121287,Ethyl hydrogen maleate,223-635-7,3990-03-2,Not Classified,Notified C&L,65,Not classified:32;H319:33;H335:32;H315:33
121288,"Sunflower oil, interesterified",307-366-3,97593-60-7,Not Classified,Notified C&L,1,Not classified:1
121290,Triamcinolone hexacetonide,227-031-4,5611-51-8,,Notified C&L,4,H341:1;H302:3;H334:1;H317:1;H332:1;H312:1;H361:2;H372:1
121292,"Ethanol, 2-amino-, reaction products with ammonia, by-products from, distn. residues",282-508-4,84238-53-9,Not Classified,Notified C&L,77,Not classified:55;H317:22;H314:22
121293,N-formyl-L-leucine,228-080-4,6113-61-7,Not Classified,REACH registration C&L,6,Not classified:4;H319:2;H412:1
121297,Carbomer,611-106-7,54182-57-9,Not Classified,Notified C&L,2,Not classified:2
121298,1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]- N-methyl-methanesulfonamide succinate,600-463-4,103628-48-4,Eye Dam. 1,Notified C&L,52,H318:41;H361:8;H412:7;H411:1;H360:1;H362:1;H371:1;H319:2;H334:1;H317:1;H315:1
121299,Sodium tetrahydridoaluminate,237-400-1,13770-96-2,Water-react. 2;Acute Tox. 4;Skin Corr. 1B,Notified C&L,65,H261:38;H302:39;H314:65;H260:27
121303,"1,4,7,10,13,16-hexaazacyclooctadecane",206-042-8,296-35-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39,H319:39;H315:39
121306,"Naphtha (petroleum), full-range alkylate;Low boiling point modified naphtha;[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C",265-066-7,64741-64-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
121307,3-nitro-o-xylene,201-474-3,83-41-0,Aquatic Chronic 2,REACH registration C&L,131,H411:88;Not classified:38;H332:6;H312:6;H330:1;H310:1;H300:1;H302:1
121308,2-allylphenol,217-119-0,1745-81-9,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,68,H314:67;H311:51;H411:8;H318:9;H301:51;H302:2;H312:2;H319:1;H335:1;H315:1
121310,Tolnaftate,219-266-6,2398-96-1,Not Classified,Notified C&L,77,Not classified:38;H319:36;H410:35;H411:35;H400:35;H302:3;H332:3;H335:1;H315:1
121311,1-methyl-4-phenylpiperidin-4-ol,225-619-5,4972-68-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1;H332:1;H312:1
121313,"Hydrocarbons, C",297-854-1,93763-35-0,Asp. Tox. 1,Harmonised C&L,0,H304:0
121318,"1-bromo-3,5-dimethyltricyclo[3.3.1.13,7]decane",213-378-9,941-37-7,Not Classified,REACH registration C&L,26,Not classified:24;H319:2;H335:1;H315:2
121319,"2,2,6,6-tetramethyl-4-piperidone oxime",224-026-9,4168-79-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
121320,Dibutyl succinate,205-449-8,141-03-7,Not Classified,Notified C&L,89,Not classified:88;H411:1
121321,"Guanosine cyclic 3',5'-(hydrogen phosphate)",231-641-6,7665-99-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
121322,"2-bromo-α,α,α-trifluorotoluene",206-879-9,392-83-6,Flam. Liq. 3,Notified C&L,47,H226:43;H319:8;H335:6;H315:6
121324,Indol-5-yl methyl ether,213-745-3,1006-94-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:49;H335:48;H315:49;Not classified:2
121326,Oxydipropanol,246-770-3,25265-71-8,Not Classified,REACH registration C&L,3289,Not classified:3276;H319:13;H315:13;H335:2
121328,Mesylacetonitrile,218-888-5,2274-42-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,47,H302:44;H332:44;H312:44;H311:3;H301:3;H331:3;H335:1;H315:1;H319:1
121329,"7-[[2-[(aminocarbonyl)amino]-4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]phenyl]azo]naphthalene-1,3,6-trisulphonic acid",252-652-2,35642-64-9,Skin Sens. 1;Expl. 1.6,REACH registration C&L,8,H317:3;Not classified:7;H334:1
121331,4-chloro-3-nitrobenzophenone,259-995-7,56107-02-9,,Notified C&L,5,H319:5;H335:4;H315:5
121334,"1,1'-{(phenylmethanediyl)bis[(3-substituted benzene-4,1-diyl)diazene-2,1-diyl{1-[3-(dimethylamino)propyl]-2-hydroxy-4-methyl-6-oxo-1,6-dihydropyridine-5,3-diyl}]}dipyridinium chloride lactate salts",700-136-7,,Acute Tox. 3;Skin Sens. 1;STOT RE 2;Aquatic Chronic 1,Notified C&L,38,H317:38;H410:38;H301:38;H373:38
121336,"Sunflower oil, polymd.",614-611-0,68555-10-2,Not Classified,Notified C&L,7,Not classified:7
121339,(Z)-hept-3-en-1-ol,216-964-2,1708-81-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:38;H335:38;H315:38;Not classified:10
121340,4-phenylpiperidine-4-carbonitrile hydrochloride,257-124-5,51304-58-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H302:46;H315:43;H319:43;H332:45;H335:43;H312:46;H311:1;H331:1;H301:1
121345,"Phenol, 3-(4-morpholinyl)-",608-075-7,27292-49-5,,Notified C&L,4,H319:4;H335:4;H315:4
121347,Strontium sulphide,215-249-2,1314-96-1,Met. Corr. 1;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,216,H314:212;H290:174;H318:174;H301:2;H400:174;H302:172;H261:4;H319:4;H335:4;H315:4
121350,4-(diethylamino)-2-butyn-1-ol,234-163-6,10575-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,60,H319:59;H335:58;H315:59;H302:16
121352,2-phenylbutyric acid,201-982-5,90-27-7,Acute Tox. 4,REACH registration C&L,69,H302:69;H319:6;H335:5;H315:6
121356,"Alcohols, C6-10, ethoxylated",615-189-0,70879-83-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,483,H302:461;H318:483;H315:469;H412:19;H400:20;H410:1
121365,Sulfametoxydiazine,211-480-8,651-06-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,127,H319:127;H335:127;H315:127
121367,Diisopropyl succinate,213-110-0,924-88-9,Not Classified,REACH registration C&L,38,Not classified:38
121370,"Silkworm, ext.",293-402-2,91079-16-2,Not Classified,Notified C&L,2,Not classified:2
121373,4-(trifluoromethoxy)benzylamine,300-040-1,93919-56-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:38;H335:39;H315:38;H314:6;H227:1
121375,"N,N-dimethylbenzene-1,3-diamine dihydrochloride",222-693-0,3575-32-4,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H301:44;H317:38;H315:44;H319:44;H335:44;H311:6;H330:4;H331:1
121378,7-formylheptanoic acid,213-199-6,929-48-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
121379,"Ash (Fraxinus), F. excelsior, ext.",283-402-0,84625-28-5,Flam. Liq. 3,Notified C&L,3,H226:3;H319:1
121380,"Indium, cake",273-794-1,69029-48-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1;Muta. 2;Carc. 1B;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,8,H302:4;H410:8;H341:8;H317:4;H330:4;H334:4;H318:4;H372:8;H315:4;H350:8;H360:8;H400:8;H331:4
121381,[No public or meaningful name is available],451-010-0,,,,0,No data
121384,"α,2,2-trimethyl-6-methylenecyclohexylpropyl acetate",270-879-5,68479-99-2,Not Classified,Notified C&L,88,Not classified:88
121385,"2,2'-thiodisuccinic acid",225-544-8,4917-76-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,62,H319:62;H315:62;H335:4
121387,"Bis[O,O-bis(2-ethylhexyl) dithiophosphorato-S,S']dioxodi-μ-thioxodimolybdenum",273-381-6,68958-92-9,Not Classified,REACH registration C&L,48,Not classified:48
121388,1-bromobut-2-yne,608-891-3,3355-28-0,Flam. Liq. 3,Notified C&L,53,H226:53;H319:8;H335:7;H315:9;H301:1
121389,"Methyl (2E,4Z)-2,4-decadienoate",224-787-7,4493-42-9,Not Classified,Notified C&L,88,Not classified:88
121392,p-tert-butylethylbenzene,230-903-7,7364-19-4,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H319:38;H410:38;H400:38;H225:4
121394,Flubendiamide,608-064-7,272451-65-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,196,H410:156;H400:194;Not classified:2
121396,Canavanine sulphate,218-728-4,2219-31-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
121400,"Poly[(1,1-dimethylpiperidinium-3,5-diyl)methylene chloride (1:1)]",608-712-9,32168-43-7,,Notified C&L,1,H319:1;H302:1;H411:1
121401,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-henicosafluorododecene",250-173-3,30389-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
121407,Hex-3-enyl acetate,216-965-8,1708-82-3,Flam. Liq. 3,Notified C&L,1558,H226:1533;Not classified:25
121408,"3,4-diethoxyphenylacetic acid",253-957-3,38464-04-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,4,H319:3;H335:2;H315:3;Not classified:1
121409,"Beta-cyclodextrin sulfobutyl ether, sodium salt",605-965-7,182410-00-0,Not Classified,Notified C&L,18,Not classified:11;H317:7
121410,Toluene-4-sulphonanilide,200-684-2,68-34-8,Acute Tox. 4,Notified C&L,40,H302:40;H319:1;H335:1;H315:1
121414,"6-phenyl-1,3,5-triazine-2,4-diyldiamine;6-phenyl-1,3,5-triazine-2,4-diamine;benzoguanamine",202-095-6,91-76-9,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
121415,"6-(5-chloro-2-pyridyl)-5H-pyrrolo[3,4-b]pyrazine-5,7(6H)-dione",256-141-5,43200-82-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,3,H302:3;H317:2;H315:2;H319:2;H335:2
121417,7-amino-3-(diethylamino)-2-methylphenoxazin-5-ium chloride,225-203-3,4712-70-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
121421,"1-Propanesulfonic acid, 2,3-dimercapto-, sodium salt, hydrate (1:1:1)",606-614-0,207233-91-8,,Notified C&L,1,H319:1;H335:1;H315:1
121422,(phenylethyl)benzene,254-179-7,38888-98-1,Asp. Tox. 1;Skin Irrit. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H410:1;H315:1;H332:1;H304:1;H400:1;Not classified:5
121424,Cobalt monosulfate heptahydrate,600-050-9,10026-24-1,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Muta. 2;Carc. 1B;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,185,H302:165;H410:165;H341:180;H334:185;H317:185;H350:185;H360:181;H400:185;H413:20;H301:20
121426,"chlormephos (ISO);S-chloromethyl O,O-diethyl phosphorodithioate",246-538-1,24934-91-6,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H310:0;H410:0;H300:0;H400:0
121427,"9-Octadecenoic acid (Z)-, sulfurized",270-164-8,68412-07-7,Not Classified,Notified C&L,34,Not classified:34
121429,"3-methylcyclopentanol, mixed isomers",242-540-1,18729-48-1,Flam. Liq. 3,Notified C&L,39,H226:39
121435,"[N,N',N''-tris[3-[(2-ethylhexyl)oxy]propyl]-29H,31H-phthalocyaninetrisulphonamidato(2-)-N29,N30,N31,N32]copper",262-882-5,61641-50-7,Not Classified,Notified C&L,2,Not classified:2
121440,"Diethyl cyclopropane-1,1-dicarboxylate",216-321-6,1559-02-0,Flam. Sol. 2;Acute Tox. 1;Acute Tox. 1;Acute Tox. 2,Notified C&L,2,H330:1;H310:1;H228:1;H300:1;Not classified:1
121442,"alachlor (ISO);2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide",240-110-8,15972-60-8,Acute Tox. 4;Skin Sens. 1;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H351:0;H317:0;H400:0
121445,Methyl cyanoformate,241-626-6,17640-15-2,Flam. Liq. 3;Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1,Notified C&L,39,H330:39;H310:39;H226:39;H300:39;H315:39;H319:39
121449,"2-(1,1-dimethylethyl)-4-methylcyclohexan-1-ol",266-815-0,67634-11-1,Not Classified,Notified C&L,128,Not classified:128
121451,"1,1,1,2,3,4,4,4-octafluorobut-2-ene",206-640-9,360-89-4,Press. Gas (Liq.);Acute Tox. 4,Notified C&L,115,H332:115;H280:115
121456,Sodium aluminosilicate violet,235-811-0,12769-96-9,Not Classified,Notified C&L,242,Not classified:242
121457,"Hexanedioic acid, polymer with 1-piperazineethanamine",608-345-4,29316-68-5,Not Classified,Notified C&L,3,Not classified:1;H319:2;H315:2;H317:1
121461,Samarium phosphate,236-698-0,13465-57-1,,Notified C&L,4,H319:4;H335:4;H315:4
121465,"Grape, ext.",287-896-9,85594-37-2,Not Classified,Notified C&L,211,Not classified:174;H226:36;H411:1
121467,Ethyl o-fluorobenzoate,207-134-0,443-26-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
121469,Ethylestrenol,213-523-6,965-90-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,17,H302:17;H351:17;H332:17;H360:17;H312:17
121470,"2,2'-methylenedibenzothiazole",217-744-9,1945-78-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
121471,1-amino-4-(benzothiazol-2-ylthio)anthraquinone,223-191-4,3767-68-8,Not Classified,Notified C&L,2,Not classified:2
121473,"3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionohydrazide",251-155-8,32687-77-7,Not Classified,Notified C&L,83,Not classified:83
121475,"Sulfurous acid, monosodium salt, reaction products with formaldehyde and (1-methylethylidene)bis[phenol], sodium salts",300-349-1,93925-46-3,Not Classified,Notified C&L,1,Not classified:1
121478,"Dimethyl 2,5-dioxocyclohexane-1,4-dicarboxylate",228-528-9,6289-46-9,Aquatic Chronic 3,REACH registration C&L,118,H412:33;Not classified:85
121485,Ethyl O-methylsulphonylacetohydroxamate,253-825-5,38202-27-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;Not classified:1
121487,"Disodium 4,4'-bis(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-ylazo)-1,1'-biphenyl-2,6'-disulphonate",228-940-9,6375-55-9,Skin Sens. 1B,REACH registration C&L,262,H317:145;Not classified:113;H319:86;H335:2;H315:2;H412:1
121488,N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide,416-860-9,777891-21-1,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H317:0;H410:0;H400:0
121492,"4,4'-thiobis[2-methylresorcinol]",248-977-4,28341-66-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
121494,1-Bromo-2-hexyldecane,610-928-3,52997-43-0,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,37,H317:35;H318:35;H413:35;H319:3;H302:1;H315:2
121509,3-[(2-hydroxyethyl)[4-[(6-methoxybenzothiazol-2-yl)azo]-3-methylphenyl]amino]propiononitrile,277-417-1,73384-74-4,Not Classified,Notified C&L,3,Not classified:3
121512,"2,5-dichlorobenzonitrile",244-518-7,21663-61-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H302:5;H332:4;H312:5;H311:1;H331:1;H301:1
121515,Cytisine,207-616-0,485-35-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:40;H335:39;H301:45;H315:40;H311:4;H330:2;H331:2
121516,"Trisodium 7-[[4-chloro-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2-sulphonate",245-719-2,23532-29-8,Not Classified,Notified C&L,4,Not classified:4
121517,Tris[di(2H3)methylamido]phosphorus,257-063-4,51219-90-0,Carc. 1B,Notified C&L,1,H350:1
121519,"Rare earth metals, silicides",270-706-3,68476-89-1,Not Classified,Notified C&L,3,Not classified:3
121524,(E)-3-(3-Hydroxyphenyl)-2-propenoic acid,604-589-0,14755-02-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
121529,N-(2-Aminoethyl)glycine,607-325-2,24123-14-6,Eye Irrit. 2,Notified C&L,40,H319:39;Not classified:1;H315:1
121531,8-chlorotheophylline,201-590-4,85-18-7,Acute Tox. 4,REACH registration C&L,48,H302:48
121536,"Fats and Glyceridic oils, Carapa guianensis",609-104-6,352458-32-3,Not Classified,Notified C&L,1,Not classified:1
121539,"Phosphoric acid, octyl ester, compd. with 2-aminoethanol",284-938-8,84989-47-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
121545,"Amines, (C16-18 and C18-unsatd. alkyl)dimethyl",268-220-1,68037-96-7,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,34,H302:34;H410:34;H314:34;H400:34
121546,Hexakis(bromomethyl)benzene,221-443-8,3095-73-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H318:39;H314:44;H290:1
121548,1-methyl-4-nitrosopiperazine,240-409-3,16339-07-4,Acute Tox. 3;Skin Corr. 1B;Carc. 1B,Notified C&L,1,H350:1;H301:1;H314:1
121549,"Tricarbonyl[(1,2,3,4,5,6-η)-1,3,5-trimethylbenzene]chromium",235-205-6,12129-67-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
121551,"2,2-dimethylpropane-1,3-diyl dilaurate",234-081-0,10525-39-0,Not Classified,Notified C&L,2,Not classified:2
121553,"Silicic acid, sodium salt, reaction products with chlorotrimethylsilane and iso-Pr alc.",273-530-5,68988-56-7,Not Classified,Notified C&L,325,Not classified:202;H319:114;H226:34;H335:34;H332:34;H318:9;H315:9
121558,o-(methylamino)phenol,210-263-5,611-24-5,Acute Tox. 4,Notified C&L,38,H302:38
121560,2-phenylacetamide,203-147-0,103-81-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:41;H302:41;H335:1;H315:1
121562,"1-Naphthalenesulfonic acid, 4-amino-, diazotized, coupled with diazotized 5(or 8)-amino-2-naphthalenesulfonic acid, diazotized 4-nitrobenzenamine and resorcinol",291-652-7,90459-11-3,Eye Irrit. 2,REACH registration C&L,2,H319:2
121564,"Aniba parviflora, ext.",294-913-3,91771-23-2,,Notified C&L,1,H317:1;H319:1;H412:1;H315:1
121570,Chloroacetone,201-161-1,78-95-5,Flam. Liq. 1;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,365,H410:283;H335:360;H311:282;H330:362;H226:240;H315:360;H319:360;H301:365;H400:283;H310:83;H314:5;Not classified:1;H224:1;H318:1;H370:1
121575,Ethyl dihydrogen phosphate,216-603-9,1623-14-9,Not Classified,Notified C&L,44,Not classified:44
121576,"Oxybis(ethane-2,1-diyloxyethane-2,1-diyl) bis[3-(dodecylthio)propionate]",264-757-0,64253-30-1,Not Classified,Notified C&L,103,Not classified:83;H410:17;H400:20
121577,5-Bromo-2-methoxynicotinic acid,611-211-8,54916-66-4,,Notified C&L,6,H319:6;H335:6;H315:6
121581,2-(2-(2-aminoethylamino)ethylamino)ethanol,217-811-2,1965-29-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,70,H318:59;H315:60;Not classified:5;H317:5;H302:5;H314:5;H312:5;H319:1;H335:1
121582,"5H-Dibenz[b,f]azepine-5-carbonyl chloride",608-925-7,33948-22-0,Skin Corr. 1B,Notified C&L,39,H314:39
121585,Gallium triiodide,236-611-6,13450-91-4,Skin Corr. 1B;Skin Sens. 1;Repr. 2,Notified C&L,45,H361:39;H317:44;H314:45;H334:5;H335:1
121591,"Fatty acids, animal, unsatd., 1-methyl-1,2-ethanediyl esters, sulfurized",288-119-6,85665-28-7,Not Classified,Notified C&L,1,Not classified:1
121594,"Distillates (petroleum), clay-treated light naphthenic;Baseoil - unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-147-7,64742-45-6,Carc. 1B,Harmonised C&L,0,H350:0
121595,2-chloro-5-nitrobenzenesulphinic acid,263-283-1,61886-18-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H317:38;H319:38
121596,"Benzoic acid, 2-[2-(phenylmethylene)hydrazinyl]-4-sulfo-, sodium salt (1:?)",603-529-0,131887-77-9,Not Classified,Notified C&L,9,Not classified:9
121599,"2,6-dichlorobenzyl alcohol",239-300-3,15258-73-8,,Notified C&L,4,H319:4;H335:4;H315:4
121601,Proxyphylline,210-028-7,603-00-9,Acute Tox. 4,Notified C&L,41,H302:41
121602,"Fatty acids, C16-20 and C18-unsatd.",273-089-9,68937-78-0,Not Classified,Notified C&L,1,Not classified:1
121603,Dieuropium tricarbonate,227-582-0,5895-48-7,Not Classified,Notified C&L,6,Not classified:6
121605,"1,1,1-Trifluoro-2-(trifluoromethyl)-4-penten-2-ol",613-651-6,646-97-9,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,88,H225:85;H314:47;H318:38;H319:2;H335:2;H315:2;H226:1
121606,Magnesium di(hexanolate),244-489-0,21643-32-3,,Notified C&L,2,Not classified:1;H319:1;H315:1
121608,4-methoxyphenylacetaldehyde,227-191-5,5703-26-4,,Notified C&L,1,H319:1;H335:1;H315:1
121611,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, aminosulfonyl sulfo derivs., lithium salts",291-000-1,90295-10-6,,Notified C&L,34,Not classified:34
121612,"1,2,3,6-tetrahydromethylphthalic anhydride",247-830-1,26590-20-5,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H334:0;H317:0;H318:0
121615,Isosorbide mononitrate,240-197-2,16051-77-7,Flam. Sol. 2;Repr. 2,Notified C&L,40,H361:29;H228:36;H302:6;H242:3;H315:4;H319:3;H335:3;H241:1
121616,"Silicones and Siloxanes, dimethyl reaction products with silica",924-588-1,,Not Classified,Notified C&L,441,Not classified:441
121619,Octatropine methylbromide,201-285-6,80-50-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1,Notified C&L,40,H302:40;H332:39;H400:38;H312:39;H319:1
121620,"1-chloro-2,4-dimethoxy-5-nitrobenzene",204-306-7,119-21-1,Eye Irrit. 2,Notified C&L,38,H319:38
121622,"2,3,4,5,6,7-hexahydro-1,1,2,3,3-pentamethyl-1H-indene",251-647-2,33704-59-5,Not Classified,Notified C&L,11,Not classified:11
121625,Tris(2-methylpropan-1-olato)oxovanadium,242-825-0,19120-62-8,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,27,H314:27;H226:27;H318:25;H301:27;H312:27
121626,4-isopropylcyclohexenecarbaldehyde,244-355-1,21391-98-0,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H227:1;H319:1;H335:1;H315:1
121627,"5,5'-bis(β-C-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo[9,9'-bianthracene]-2,2'-dicarboxylic acid",208-238-9,517-43-1,Skin Sens. 1B;Resp. Sens. 1B,Notified C&L,4,H334:3;H317:3;H411:1
121630,3-amino-9-ethyl carbazole;9-ethylcarbazol-3-ylamine,205-057-7,132-32-1,Carc. 1B,Harmonised C&L,0,H350:0
121634,"2-{5-[(dichlorophosphoryl)amino]-1,2,4-thiadiazol-3-yl}-(Z)-2-(ethoxyimino)acetyl chloride",448-000-3,,,Notified C&L,1,H314:1
121636,(3-bromopropyl)cyclohexane,251-824-4,34094-21-8,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:39;H301:39;H400:38
121637,"2',4'-dihydroxypropiophenone oxime",245-328-7,22919-58-0,Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H317:38;H319:38
121639,Methyltestosterone,200-366-3,58-18-4,Carc. 1B;Repr. 2,Notified C&L,58,H361:39;H350:39;H302:17;H351:17;H332:17;H360:19;H312:17
121641,Gallium selenide,234-689-6,12024-11-2,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 1,Notified C&L,170,H410:170;H373:170;H331:170;H301:170;H400:170
121642,2-ethylhexyl hydrogen maleate,231-048-2,7423-42-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Resp. Sens. 1;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,137,H302:5;H334:5;H317:114;H373:2;H318:89;H411:2;H315:89;Not classified:23;H335:3
121643,Lithium bromide,231-439-8,7550-35-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,158,H319:145;H317:100;H302:153;H315:143;H335:4;H332:3;H312:3;Not classified:1
121644,"Alcohols, C8-10, ethoxylated",615-247-5,71060-57-6,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,124,H411:59;H318:124;H302:57;H315:7;H319:3;H412:1;H400:1
121645,Ethyl 3-chloropropionate,210-809-2,623-71-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H226:2
121650,"Dimethyl dihydrogen 4,4'-carbonylbisphthalate",253-276-1,36928-64-0,Aquatic Acute 1,Notified C&L,52,H400:38;H334:14;H317:14
121656,Diethyl malonate,203-305-9,105-53-3,Eye Irrit. 2,REACH registration C&L,2454,H319:2304;H335:209;H315:214;Not classified:149;H412:2;H318:1;H227:1;H402:1
121657,Potassium phenyl sulphate,217-071-0,1733-88-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
121658,Chlorotrifluoroethylene,201-201-8,79-38-9,Flam. Gas 1;Press. Gas (Liq.);Acute Tox. 3;STOT RE 1,REACH registration C&L,140,H220:125;H331:140;H372:14;H280:126;H301:41;H221:1
121663,"(±)-2,3-dihydroxypropyl palmitate",243-218-3,19670-51-0,Not Classified,Notified C&L,1,Not classified:1
121664,"Fatty acids, montan-wax, lithium salts",297-076-2,93334-04-4,Not Classified,Notified C&L,2,Not classified:2
121668,"Resin acids and Rosin acids, compds. with triethanolamine",263-156-0,61790-65-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,7,H319:4;H315:4;Not classified:3
121672,Magnesium dioxide,238-438-1,14452-57-4,Ox. Liq. 1;Skin Corr. 1B,Notified C&L,120,H271:59;H314:98;H272:61
121673,Trihexylphosphine,224-025-3,4168-73-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
121675,Dichloro-(3-hydroxy-adamantan-1-yl)-acetic acid,615-203-5,709031-36-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 2;Aquatic Chronic 2,REACH registration C&L,1,H302:1;H341:1;H411:1;H332:1;H312:1
121676,Sodium heptafluorobutyrate,218-721-6,2218-54-4,,Notified C&L,5,H319:5;H335:5;H315:5
121679,"2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium sulphate (2:1)",281-458-0,83950-01-0,Not Classified,Notified C&L,2,Not classified:2
121680,"4-amino-6-chlorobenzene-1,3-disulphonamide",204-463-1,121-30-2,Not Classified,REACH registration C&L,29,Not classified:19;H319:6;H335:5;H315:6;H311:2;H331:2;H373:4;H332:2;H312:2;H361:1;H301:1
121685,Zirconium bis(hydrogen phosphate),237-401-7,13772-29-7,Skin Sens. 1,REACH registration C&L,173,H317:130;Not classified:43
121687,Tiratricol,200-086-1,51-24-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,41,H302:40;H332:40;H312:40;H319:1;H315:1
121690,ethyl 5-amino-2-chlorobenzoate,613-585-8,64401-55-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H302:1;H335:2;H315:2
121692,2-methylpentyl 2-methylvalerate,291-418-4,90397-38-9,Acute Tox. 4,REACH registration C&L,1560,H302:17;Not classified:1543
121694,"4-bromo-1,2-difluorobenzene",206-481-5,348-61-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73,H319:46;H226:73;H335:45;H315:73;H302:27;H317:27;H411:27;H332:27;Not classified:1
121695,"1-(2,5-dichloro-3-thienyl)ethan-1-one",252-893-3,36157-40-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,47,H302:46;H315:46;H319:46;H332:41;H335:45;H312:41;H301:1
121696,9-phenylacridine,210-020-3,602-56-2,Acute Tox. 4,Notified C&L,89,H302:57;Not classified:32;H410:1;H400:1
121697,"2-ethyl-4,4-dimethylcyclohexan-1-one",451-230-7,,STOT SE 3;Aquatic Chronic 3,REACH registration C&L,2,H336:2;H412:2
121699,4-Propylcyclohexylacetaldehyde,926-261-9,,Not Classified,Notified C&L,1,Not classified:1
121703,"Kumquat, Fortunella japonica, ext.",294-464-3,91722-64-4,Flam. Liq. 3,Notified C&L,1,H226:1
121706,Fenproporex,239-772-0,15686-61-0,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H335:1;H331:1;H315:1;H319:2;H301:2;H312:2
121707,"2,6-bis(trifluoromethyl)benzoic acid",246-479-1,24821-22-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
121708,"β,1,1,2,3,3-hexamethylindan-5-ethanol",214-934-3,1217-08-9,Not Classified,Notified C&L,233,Not classified:233
121710,"Propylidynetrimethanol, ethoxylated, esters with acrylic acid",500-066-5,28961-43-5,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,3508,H317:3153;H319:3445;H315:73;Not classified:58;H412:26;H335:5;H411:1;H318:1
121712,"Hydrogen hydroxy[2-hydroxy-3-[(2-hydroxy-3-nitrobenzylidene)amino]-5-nitrobenzenesulphonato(3-)]chromate(1-), compound with 3-[(2-ethylhexyl)oxy]propylamine (1:1)",287-267-9,85455-32-9,Self-heat. 2;Aquatic Chronic 2,REACH registration C&L,2375,H411:94;H252:11;H319:2273;H412:2273;Not classified:8
121715,6-methoxyquinoline-4-carboxylic acid,617-906-2,86-68-0,,Notified C&L,2,H319:2;H302:2;H335:2;H315:2
121719,"reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1)",411-830-1,114765-88-7,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H318:0;H412:0
121721,"Tetrahydro-α,α,5-trimethyl-5-vinylfuran-2-methanol",252-312-3,34995-77-2,Acute Tox. 4;Skin Irrit. 2,Notified C&L,114,H302:114;H315:113;H319:26
121727,p-tolylurea,210-739-2,622-51-5,Acute Tox. 3,Notified C&L,39,H301:38;H302:1
121731,"2,6-diethylphenol",213-744-8,1006-59-3,,Notified C&L,1,H302:1
121732,Tetrabutylammonium bromide,216-699-2,1643-19-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,625,H319:555;H302:164;H412:338;H315:547;H373:4;H411:100;H335:198;Not classified:70;H332:8;H312:12
121733,Reaction mass of diammonium sulfate and L-norvaline,930-119-1,,Not Classified,REACH registration C&L,1,Not classified:1
121736,Hafnium dihydride,235-812-6,12770-26-2,Not Classified,Notified C&L,27,Not classified:25;H260:1;H302:1;H315:1;H261:1;H319:1;H332:1;H228:1;H312:1
121737,"Glycerides, C16-22",268-083-8,68002-70-0,Not Classified,REACH registration C&L,10,Not classified:10
121738,"2(1H)-Naphthalenone, octahydro-4,4a-dimethyl-6-(1-methylethenyl)-, (4R,4aS,6R,8aS)-",606-567-6,20489-53-6,Not Classified,Notified C&L,88,Not classified:77;H317:11;H302:11
121739,"1,4,7,10,13,16-hexaoxacyclooctadecane-2-methanol",274-299-3,70069-04-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43;H302:4
121743,Disodium tin hexahydroxide,234-724-5,12027-70-2,Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,64,H318:10;H314:10;H412:10;H319:52;H335:51;H315:52;Not classified:2
121744,Methyl [3-(trimethoxysilyl)propyl]carbamate,245-659-7,23432-62-4,STOT RE 2,REACH registration C&L,7,H373:2;Not classified:5
121746,"(2S,3S,3aR,9aS)-3-hydroxy-2-(hydroxymethyl)-7-methyl-2,3,3a,9a-tertryhydro-6H-furo[2’,3’:4,5][1,3]oxazolo [3,2-a]pyrimidin-6-one",700-330-1,433733-92-7,Not Classified,Notified C&L,12,Not classified:11;H361:1
121747,"trans-4'-cyano[1,1'-biphenyl]-4-yl 4-ethylcyclohexanecarboxylate",266-631-0,67284-56-4,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
121753,"Naphtha (petroleum), light catalytic reformed;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-065-1,64741-63-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
121754,(4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-),422-960-3,178233-72-2,Acute Tox. 4;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H373:0;H400:0;H312:0
121758,"1,3-dimethyl-3-butenyl salicylate",279-400-4,80118-10-1,Not Classified,Notified C&L,89,Not classified:89
121763,Isopulegyl acetate,260-820-1,57576-09-7,Not Classified,Notified C&L,1521,Not classified:1520;H302:1;H315:1
121767,"3,5-dichlorobenzoyl chloride",220-813-6,2905-62-6,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,110,H302:109;H314:110;H318:57;H335:42;H319:2;H332:1;H312:1;H290:1
121770,"N-butyl-2,2,6,6-tetramethylpiperidin-4-amine, oligomeric reaction products with N,N'-bis(3-aminopropyl)ethylenediamine and 2,4,6-trichloro-1,3,5-triazine",500-311-6,120498-03-5,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,3,H317:3;H411:2;H319:1;H400:1
121771,DL-4-aminoisoxazolidin-3-one,200-687-9,68-39-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,90,H319:90;H302:90;H335:90;H315:90
121774,Isoxsuprine hydrochloride,209-443-6,579-56-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,47,H302:47;H410:38;H400:38;H335:4;H317:1;H315:2;H319:2
121775,gamma-hexabromocyclododecane,603-804-5,134237-52-8,Repr. 2;Lact.;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H361:38;H410:38;H400:38;H362:38
121776,mandipropamid (ISO);2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide,609-434-0,374726-62-2,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
121781,"Benzenamine, 2-bromo-4,6-dimethyl-",609-959-5,41825-73-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:39;H315:44;H302:6;H373:4;H332:6;H312:6;H311:1;H301:1;H331:1
121784,6-cyclohexyl-4-methyl-2H-pyran-2-one,404-220-1,14818-35-0,Aquatic Chronic 3,REACH registration C&L,4,H412:4
121787,Heptyl acetate,203-932-8,112-06-1,Not Classified,Notified C&L,318,Not classified:316;H319:1;H315:1;H411:1
121790,Calcium hydrogenorthophosphate,231-826-1,7757-93-9,Not Classified,REACH registration C&L,436,Not classified:425;H319:11;H335:10;H315:10
121792,"hydrocarbons, C7-C8, n-alkanes",922-214-1,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,56,H410:55;H225:56;H315:56;H336:56;H304:56;H400:55;H411:1
121794,"5-methyl-s-triazolo[1,5-a]pyrimidin-7-ol",219-706-7,2503-56-2,Not Classified,REACH registration C&L,43,Not classified:3;H319:40;H335:39;H315:40
121795,8-chloroquinoline,210-265-6,611-33-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
121798,3-[(4-fluorophenyl)thio]-2-hydroxy-2-methylpropanoic acid,608-927-8,339530-91-5,Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1
121801,"Poly(oxy-1,2-ethanediyl), .alpha.-isodecyl-.omega.-hydroxy-, phosphate",600-882-2,108818-88-8,Not Classified,Notified C&L,49,Not classified:42;H314:5;H302:2;H318:1;H315:2;H319:1;H335:1
121802,Alpha-chloro-3-methyl-4-nitrotoluene,242-392-8,18515-14-5,Skin Corr. 1B,Notified C&L,38,H314:38
121805,"cis-2,3-dimethylthiirane",227-721-5,5954-71-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,10,H225:10;H319:10;H335:10;H315:10
121806,nickel bis(phosphinate),238-511-8,14507-36-9,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H410:0;H334:0;H317:0;H372:0;H350:0;H400:0
121808,2-{[(4-chloro-3-methylpyridin-2-yl)methyl]thio}-1H-benzimidazole,600-417-3,103312-62-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,39,H319:39;H335:39;H413:38;H315:39
121811,4-(phenylmethoxy)-1H-indole,243-690-0,20289-26-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
121812,8-(BENZYLOXY)-5-(1-OXOETHYL)-1H-QUINOLIN-2-ONE,618-957-3,93609-84-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
121816,3-amino-4-cyclobutyl-2-hydroxybutanamide hydrochloride,609-699-2,394735-23-0,Skin Irrit. 2,Notified C&L,29,H315:27;Not classified:1;H228:1;H252:1
121818,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, chromium (3+) salt",614-626-2,685853-81-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2,H412:2;H317:2;H411:2;H315:2;H319:2
121825,Abies sibirica oil,617-005-4,8021-29-2,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,105,H410:66;H317:66;H226:105;H319:105;H304:66;H400:64;H315:42
121827,1-[(2-Chlorophenyl)(diphenyl)methyl]-1H-imidazole nitrate,807-571-2,37594-64-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 1,REACH registration C&L,2,H319:2;H302:2;H410:2;H315:2
121828,octamethylcyclotetrasiloxane; [D4],209-136-7,556-67-2,Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H410:0
121830,"3,5-diisopropylsalicylic acid",218-677-8,2215-21-6,Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:5
121836,"2,4-Pyrimidinediamine, 5-[(2-cyclopropyl-7,8-dimethoxy-2H-1-benzopyran-5-yl)methyl]-",606-269-6,192314-93-5,Repr. 2,REACH registration C&L,1,H361:1
121839,"3,7-bis(ethylamino)-2,8-dimethylphenothiazin-5-ium chloride",217-696-9,1934-16-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
121841,"2,3,4,4'-Tetrahydroxybenzophenone",608-581-8,31127-54-5,Not Classified,Notified C&L,56,Not classified:55;H319:1;H315:1
121846,Arabinose,205-699-8,147-81-9,Not Classified,Notified C&L,5,Not classified:5
121847,Sodium 4-chloro-3-[[4-[(4-ethoxyphenyl)azo]phenyl]azo]benzenesulphonate,273-387-9,68959-01-3,Aquatic Chronic 3,Notified C&L,20,H412:11;Not classified:9
121848,"2,6-bis[[3-(tert-butyl)-2-hydroxy-5-tolyl]methyl]-4-methylphenol",202-011-8,90-68-6,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38
121852,Boc-3-(3-pyridyl)-D-Ala-OH,619-331-2,98266-33-2,Skin Sens. 1,Notified C&L,42,H317:42
121863,"3-hydroxy-4-[[4-[[4-[(2-hydroxy-6-sulpho-1-naphthyl)azo]-o-tolyl]methyl]-m-tolyl]azo]naphthalene-2,7-disulphonic acid, sodium salt",285-155-4,85030-31-5,Eye Irrit. 2,Notified C&L,97,H319:83;Not classified:14
121871,"2,6-DIMETHYL-2'-DIETHYLAMINOACETANILIDE HYDROCHLORIDE",612-079-4,6108-05-0,Acute Tox. 3,Notified C&L,182,H301:149;H302:33;H317:3;H334:4;H315:6;H319:7;H335:5;H412:1;H311:1;H331:1
121873,Hexakis[μ-(acetato-O:O')]-μ4-oxotetraberyllium,242-785-4,19049-40-2,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 1B;STOT RE 1;Aquatic Chronic 2,Notified C&L,40,H335:40;H317:40;H330:40;H411:40;H372:40;H315:40;H350:40;H319:40;H301:40
121874,p-(methylsulphonyl)toluene,221-682-8,3185-99-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H302:38;H335:38;H318:38;H315:38;Not classified:5
121878,1-Methyl-cyclopropene,608-567-1,3100-04-7,Not Classified,Notified C&L,57,Not classified:55;H220:1;H280:1;H330:1
121882,N-methyl-3-oxobutyramide,243-723-9,20306-75-6,Not Classified,Notified C&L,117,Not classified:79;H312:38
121887,Potassium mercaptoacetate,252-038-4,34452-51-2,Met. Corr. 1;Acute Tox. 3;Acute Tox. 4;Skin Sens. 1,REACH registration C&L,132,H290:94;H301:95;H317:95;H312:95;Not classified:36;H302:1;H315:1
121888,Lead bis(tetrafluoroborate),237-486-0,13814-96-5,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,44,H302:44;H410:44;H373:44;H332:44;H360:44;H314:38;H335:38;H400:42
121893,Octanoic anhydride,210-806-6,623-66-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,41,H318:39;H314:41;H290:1
121894,Methyl 4-chlorobenzoate,214-420-9,1126-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
121895,"(R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)",605-782-2,176763-62-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,76,H302:75;H332:75;H312:75;Not classified:1;H315:1;H319:1;H335:1
121897,Tetrallylstannane,230-987-5,7393-43-3,,Notified C&L,6,H410:4;H311:6;H330:4;H315:4;H319:4;H301:6;H400:4;H331:2
121899,"Cashew, nutshell liq.,glycidyl ethers",605-602-2,171263-25-5,Skin Sens. 1,Notified C&L,30,H317:24;Not classified:6
121901,3-methylbutyraldehyde oxime,210-970-9,626-90-4,Flam. Liq. 4;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H227:1;H315:1;H319:1;H332:1;H335:1;H312:1
121902,Trifluoro(methanol)boron,206-766-4,373-57-9,Flam. Liq. 3;Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Repr. 1B;STOT SE 1;STOT RE 1,Notified C&L,249,H314:245;H290:120;H226:120;H318:122;H372:242;H370:122;H332:242;H360:120;H302:122;H225:41;Not classified:4;H311:2;H331:3;H301:3
121904,potassium mu-fluoro-bis(triethylaluminium),400-040-2,12091-08-6,Flam. Sol. 1;Water-react. 1;Skin Corr. 1A;Acute Tox. 4,Harmonised C&L,0,H332:0;H228:0;H314:0;H260:0
121908,Diethylammonium chloride,211-541-9,660-68-4,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,65,H302:2;H314:2;H311:2;H317:2;H318:2;H332:2;H335:63;H319:62;H315:62;Not classified:1
121912,3-(chloromethyl)-p-anisaldehyde,258-015-5,52577-09-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
121917,"1,2-Benzenedicarboxylic acid, mixed hexyl and oleyl and stearyl diesters",284-662-8,84961-72-8,Not Classified,Notified C&L,23,Not classified:23
121918,2-amino-4-hydroxythiophene-3-carbonitrile,619-446-8,99580-50-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H335:1;H312:1
121921,(Z)-hexadec-9-enoic acid,206-765-9,373-49-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,151,H319:110;H335:109;H315:110;Not classified:41
121925,1-phenylethanol,202-707-1,98-85-1,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,1827,H319:1387;H302:1790;H318:66;H315:69;Not classified:37;H335:28
121928,3-ethyl-5-[(3-methylthiazolidin-2-ylidene)ethylidene]-2-thioxooxazolidin-4-one,252-734-8,35795-44-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40
121929,Methionine S-oxide,221-758-0,3226-65-1,,Notified C&L,38,Not classified:38
121931,Calcium tetrafluoroborate(1-),237-485-5,13814-93-2,Acute Tox. 4;Skin Corr. 1,Notified C&L,1,H302:1;H314:1
121933,Trichloro(2-phenylethyl)silane,213-371-0,940-41-0,Acute Tox. 3;Skin Corr. 1B,Notified C&L,39,H311:38;H314:39
121934,"2-heptadecyl-4,5-dihydro-1H-imidazole-1-ethylamine monoacetate",302-990-2,94138-74-6,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H318:1;H412:1;H315:1
121935,"Ethyl 2,6,6-trimethyl-4-oxocyclohex-2-ene-1-carboxylate",245-410-2,23068-96-4,Not Classified,REACH registration C&L,2,Not classified:2
121937,"Trisodium 7-[[4-chloro-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]methylamino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2-sulphonate",274-418-9,70210-21-8,Not Classified,REACH registration C&L,21,Not classified:21
121939,"Cinchonan-9-ol, (8α,9S)-",611-224-9,550-54-9,Acute Tox. 4,Notified C&L,38,H302:38
121940,"Pentane-1,5-dithiol",213-194-9,928-98-3,,Notified C&L,6,H302:5;H332:5;H315:1;H319:1;H312:1;Not classified:1
121941,Bis(lauroyloxy)dimethylstannane,218-552-8,2179-99-9,Repr. 2;STOT RE 1;Aquatic Chronic 4,Notified C&L,56,H361:56;H413:56;H372:56
121942,Methylaminoacetonitrile,227-037-7,5616-32-0,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:40;H302:40;H226:40;H315:40
121945,"N,N'-dinitroethylenediamine",208-018-2,505-71-5,Expl. 1.1;Acute Tox. 4,Notified C&L,1,H302:1;H201:1
121960,"2-[[4-(dimethylamino)phenyl]azo]-1,3-dimethyl-1H-imidazolium chloride",278-601-4,77061-58-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,178,H302:177;H410:111;H315:70;H319:76;H400:173;Not classified:1;H332:1;H312:1
121961,"Glycerides, C4-22 mono- and di-, lactates",309-065-2,99811-74-2,Not Classified,Notified C&L,1,Not classified:1
121965,"2,3,5-tribromo-4-methylthiophene",267-441-0,67869-13-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
121967,"3,5-dipropoxyphenol",248-974-8,28334-99-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
121969,4-hydroxyanilinium chloride,200-122-6,51-78-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H317:39;H319:39;H335:38;H315:39;H302:4;H410:3;H341:3;H332:4;H400:3
121970,Isopropyl N-4-chlorophenylcarbamate,218-804-7,2239-92-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
121971,"[S-(R*,S*)]-α-(1-aminoethyl)benzyl alcohol hydrochloride",255-008-9,40626-29-7,Acute Tox. 4,Notified C&L,39,H302:39
121972,"Bis(2,6-difluoro-3-(1-hydropyrrol-1-yl)phenyl)titanocene",603-024-5,125051-32-3,Flam. Sol. 2;Repr. 2;Aquatic Chronic 2,Notified C&L,1,H361:1;H411:1;H228:1
121973,Sodium 2-butyloctyl sulphate,303-553-9,94200-74-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,2,H302:2;H412:2;H318:2;H315:2;H332:1;H335:1
121974,"2',4'-dimethoxypropiophenone",212-601-7,831-00-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
121975,"2,3,5,6-tetrachloroaniline",222-461-9,3481-20-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:39;H311:41;H373:41;H331:38;H301:41;H400:39;H330:3;H302:1;H315:1;H319:1;H332:1;H312:1
121979,Sodium 4-oxovalerate,243-378-4,19856-23-6,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,28,H302:21;H318:8;H319:13;H335:13;H315:13;Not classified:7
121983,"(8[?],9R)-6'-methoxycinchonan-9-ol monohydrochloride",612-097-2,6119-47-7,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,215,H334:160;H317:213;H302:214;H332:53;H413:1;H315:1;H319:1;H312:1
121986,4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide dihydrochloride,219-926-3,2576-84-3,,Notified C&L,1,H302:1
121988,5-phenyl-4-thiohydantoic acid,218-676-2,2215-20-5,Acute Tox. 3,Notified C&L,38,H301:38
121989,"6-[2-(2-undecyl-1H-imidazol-1-yl)ethyl]-1,3,5-triazine-2,4-diamine",256-742-2,50729-75-4,Not Classified,Notified C&L,40,Not classified:26;H319:14;H335:13;H315:14
121990,Osmocene,215-055-8,1273-81-0,,Notified C&L,4,H319:4;H335:4;H315:4
121996,"Carbamic acid, N-[3-amino-1-(cyclobutylmethyl)-2-hydroxy-3-oxopropyl]-, 1,1-dimethylethyl ester",609-698-7,394735-22-9,Not Classified,Notified C&L,1,Not classified:1
121997,"N,N'-(dithiodi-2,1-ethanediyl)bis(acrylamide)",262-546-8,60984-57-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
121998,Sparteine,201-988-8,90-39-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H302:40;H332:39;H312:39;H319:1;H315:1
121999,Methylthioninium chloride,200-515-2,61-73-4,Acute Tox. 4,Notified C&L,266,H302:244;H318:69;Not classified:22;H412:13;H315:15;H319:5;H335:4;H361:1;H341:1;H373:2;H301:1
122000,4-aminoimidazole-5-carboxamide,206-641-4,360-97-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H319:50;H335:50;H315:50;Not classified:1;H302:1
122002,"(D)-p-hydroxyphenylglycine-2-hydroxyethylester, hydrochloride",433-310-3,,Skin Sens. 1,Notified C&L,1,H317:1
122003,"2,4-dimethylpentan-3-one;di-isopropyl ketone",209-294-7,565-80-0,Flam. Liq. 2;Acute Tox. 4,Harmonised C&L,0,H225:0;H332:0
122005,Methyl DL-alaninate hydrochloride,236-854-8,13515-97-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
122006,"β-D-Galactopyranose, 1-thio-, 2,3,4,6-tetraacetate 1-carbamimidate, hydrobromide (1:1)",610-634-5,51224-13-6,Not Classified,Notified C&L,7,Not classified:7
122008,"D-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-",616-484-7,7764-95-6,Not Classified,Notified C&L,2,Not classified:2
122010,"5,5-dimethyl-2-phenoxy-1,3,2-dioxaphosphorinane",221-291-2,3057-08-7,Aquatic Chronic 3,Notified C&L,16,H413:16;H412:16
122015,Gallium sulphide,234-688-0,12024-10-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
122019,"Octadecanoic acid, reaction products with diethylenetriamine",270-169-5,68412-13-5,,Notified C&L,55,Not classified:36;H412:17;H319:1;H315:2;H318:1
122024,N-propylbutylamine,243-575-5,20193-21-9,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38,H226:38;H314:38
122025,"Methyl 2-[[(2,4-dimethyl-3-cyclohexen-1-yl)methylene]amino]benzoate",272-449-2,68845-02-3,Not Classified,Notified C&L,126,Not classified:112;H315:13;H317:1
122030,Dibenzyl hydrogen phosphate,216-602-3,1623-08-1,Eye Dam. 1,REACH registration C&L,4,Not classified:1;H319:3;H335:2;H315:3
122031,Dodecan-5-olide,211-932-4,713-95-1,Not Classified,REACH registration C&L,1699,Not classified:1648;H319:50;H335:43;H315:50;H224:1
122035,Thenyldiamine,202-098-2,91-79-2,Acute Tox. 4,Notified C&L,1,H302:1
122036,4-[[4-(dimethylamino)phenyl]imino]naphthalen-1(4H)-one,205-056-1,132-31-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
122037,Tributylmethylammonium hydroxide,251-152-1,32680-30-1,Skin Corr. 1B,Notified C&L,38,H314:38
122039,"2,2',2""-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine",225-208-0,4719-04-4,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0,H317:0;H302:0
122041,nickel(II) sulfite,231-827-7,7757-95-1,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H410:0;H334:0;H317:0;H372:0;H350:0;H400:0
122042,4'-bromo-4-chlorobutyrophenone,224-930-3,4559-96-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
122044,8-methylquinoline,210-264-0,611-32-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:38;H315:45;H341:5
122045,Methyl 2-fluoro-4-nitrobenzoate,206-873-6,392-09-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
122049,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [[2-[(4-chloro-6-methoxy-1,3,5-triazin-2-yl)amino]ethyl]amino]sulfonyl sulfo derivs., sodium salts",275-060-6,70955-64-5,Not Classified,REACH registration C&L,45,Not classified:45
122050,"m-(4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzenesulphonic acid",204-303-0,119-17-5,Not Classified,REACH registration C&L,167,Not classified:128;H317:39
122053,"Alkanes, C12-14-iso-",271-369-5,68551-19-9,Asp. Tox. 1,REACH registration C&L,79,H304:78;H336:3;H373:1;H372:1;H413:1
122055,"Alcohols, C12-14, ethoxylated",500-213-3,68439-50-9,Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1622,H412:613;H400:1375;H319:527;H318:759;H410:212;H302:328;H315:133;Not classified:38;H301:1;H413:1
122056,"Reaction mass of 3,6-Bis(3-chlorophenyl)-2,5-dihydro-pyrrolo[3,4-c]pyrrole-1,4-dione, 3-(3-Chlorophenyl)-6-(4-chlorophenyl)-2,5-dihydro- pyrrolo[3,4-c]pyrrole-1,4-dione and 3,6-Bis(4-chlorophenyl)-2,5-dihydro-pyrrolo[3,4-c]pyrrole-1,4-dione",465-080-5,,Acute Tox. 4,REACH registration C&L,85,H332:85
122062,Xylazine,230-902-1,7361-61-7,Acute Tox. 3,Notified C&L,50,H301:49;H319:3;H335:3;H315:3;H311:2;H331:1;H302:1;H332:1;H312:1;H330:1
122067,Nifuroxazide,213-522-0,965-52-6,Not Classified,Notified C&L,6,Not classified:4;H302:2;H332:1;H312:1
122068,"Butyl (Z,Z)-6,6-dibutyl-4,8,11-trioxo-5,7,12-trioxa-6-stannahexadeca-2,9-dienoate",239-596-4,15546-16-4,Acute Tox. 4;Skin Corr. 1B;STOT RE 2;Aquatic Chronic 2,Notified C&L,12,H373:10;H302:11;H411:9;H314:9;H410:2;H400:2;H341:1;H372:1;H315:1;H319:1;H360:1
122069,2-chlorobenzothiazole,210-415-0,615-20-3,Acute Tox. 3;Eye Irrit. 2;Acute Tox. 2;Aquatic Chronic 2,REACH registration C&L,43,H330:35;H319:38;H411:35;H301:36;H302:6;H335:3;H315:3
122070,2-chloro-6-fluorobenzaldehyde oxime,207-135-6,443-33-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:42;H302:38;H335:4;H315:4
122071,"Oils, camellia",614-787-9,68916-73-4,Not Classified,Notified C&L,88,Not classified:88
122072,2-ethoxyethyl acrylate,203-429-3,106-74-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
122074,"3,4-dichloro-α-methylbenzyl alcohol",216-017-3,1475-11-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H335:38;H318:38;H315:38
122078,Dipotassium wolframate,232-215-2,7790-60-5,Not Classified,REACH registration C&L,120,Not classified:29;H314:2;H302:83;H319:6;H335:6;H315:1
122083,"5,6,7,7a-tetrahydro-3,6-dimethyl-(4H)-benzofuran-2-one",236-390-6,13341-72-5,Acute Tox. 4,Notified C&L,1549,H302:1549
122084,C.I. Reactive Orange 107,618-590-9,90597-79-8,Not Classified,Notified C&L,17,Not classified:15;H317:2
122086,"2-[2-[4-[(2-cyanoethyl)ethylamino]-o-tolyl]vinyl]-1,3,3-trimethyl-3H-indolium acetate",281-691-8,84012-51-1,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,4,H318:3;H412:3;Not classified:1
122087,Cefaloglycin,222-696-7,3577-01-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,38,H334:38;H317:38
122089,"Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride, trihydrate",615-731-6,7220-79-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,76,H319:65;H302:69;H335:42;H315:44;H373:21;Not classified:7
122091,Hydroxy[(1-oxoallyl)amino]acetic acid,229-790-7,6737-24-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:38;H335:38;H315:38;H318:1;H314:2
122094,3-(benzothiazol-2-yl)-7-(diethylamino)-2-oxo-2H-1-benzopyran-4-carbonitrile,274-668-9,70546-25-7,Aquatic Chronic 4,REACH registration C&L,3,H413:2;Not classified:1
122096,Triethyloxonium hexafluorophosphate(1-),241-876-6,17950-40-2,Flam. Sol. 1;Skin Corr. 1A,Notified C&L,38,H228:38;H314:38
122097,"2-[2,4-bis(tert-pentyl)phenoxy]-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)butyramide",300-634-0,93951-12-3,Aquatic Chronic 4,Notified C&L,38,H413:34;Not classified:3;H317:1;H319:1;H315:1
122102,"tetramethylene diacrylate;1,4-butyleneglycol diacrylate",213-979-6,1070-70-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Harmonised C&L,0,H317:0;H314:0;H312:0
122104,"Glucuronidase, β-",232-606-8,9001-45-0,Skin Sens. 1;Resp. Sens. 1,Notified C&L,38,H334:38;H317:38
122105,4-(phenylthio)pyridine,251-495-7,33399-48-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H315:1;H319:1;H332:1;H335:1;H312:1
122106,Triphenylsulphonium hexafluoroantimonate(1-),260-980-2,57840-38-7,Not Classified,Notified C&L,5,Not classified:5
122107,"Benzenesulfonic acid, mono-C10-13-alkyl derivs., ammonium salts",287-334-2,85480-54-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:2;H315:2;Not classified:1
122110,"N,N-hydrazinodiacetic acid",403-510-5,19247-05-3,Acute Tox. 3;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H301:0;H373:0;H412:0
122111,Natural iron oxide,215-722-3,1345-27-3,Not Classified,Notified C&L,47,Not classified:47
122114,Dicerium tricarbonate,208-655-6,537-01-9,Not Classified,REACH registration C&L,109,Not classified:101;H413:4;H319:3;H335:3;H315:3;H302:1
122115,"(R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one",421-830-3,49805-30-3,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0,H317:0;H302:0
122119,"p-menthane-1,8-diol",201-288-2,80-53-5,Not Classified,Notified C&L,90,Not classified:90
122120,1-isopropyl-2-methylpropylamine,223-809-2,4083-57-2,Flam. Liq. 2;Skin Corr. 1C,Notified C&L,2,H225:1;H314:2
122130,Polypropylenglykoldioleat~,607-962-6,26571-49-3,Aquatic Chronic 3,Notified C&L,69,H412:69
122132,Tungsten hexafluoride,232-029-1,7783-82-6,Press. Gas (Liq.);Skin Corr. 1A;Eye Dam. 1;Acute Tox. 2,REACH registration C&L,143,H330:104;H318:16;H314:143;H280:143;H311:38;H301:38;H413:1;H373:1;H331:1
122133,"Pentasodium 4-amino-6-[[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-2-sulphonatophenyl]azo]-3-[(2,5-disulphonatophenyl)azo]-5-hydroxynaphthalene-2,7-disulphonate",269-505-3,68259-02-9,Skin Sens. 1B;Eye Irrit. 2;STOT RE 2,REACH registration C&L,94,H317:46;H319:48;H373:43;Not classified:43;H334:3
122140,DIGLYCIDYL ETHER OF POLY PROPYLENE GLYCOL,607-873-2,26142-30-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,296,H317:252;H319:203;H315:204;H412:38;Not classified:37;H350:6;H302:1
122142,1-(butylamino)-4-(methylamino)anthraquinone,269-342-8,68227-28-1,Not Classified,Notified C&L,1,Not classified:1
122143,Iridium tetrabromide,232-180-3,7789-64-2,,Notified C&L,4,H319:4;H335:4;H315:4
122153,"Phosphorodithioic acid, 2-ethylhexyl 2-methylpropyl ester",269-892-9,68389-47-9,Not Classified,Notified C&L,441,Not classified:441
122155,"2H-1-Benzopyran-2-methanol, alpha,alpha'-[[(phenylmethyl)imino]bis(methylene)]bis[6-fluoro-3,4-dihydro-, (alphaR,alpha'R,2R,2'S)-rel-",618-043-4,876666-07-8,Aquatic Chronic 4,REACH registration C&L,2,H413:2
122157,"(2E,4E)-dodeca-2,4-dienal",244-517-1,21662-16-8,Skin Irrit. 2,Notified C&L,1440,H315:1328;Not classified:112;H319:42;H335:38
122158,Aluminium hydroxide hydrate,603-699-6,1330-44-5,Eye Irrit. 2,Notified C&L,38,H319:38
122159,"3,6,9,12-tetraoxahexadecan-1-ol",216-322-1,1559-34-8,Eye Irrit. 2,REACH registration C&L,407,H319:217;Not classified:190
122162,"cis,trans-4-methoxycinnamonitrile",249-022-4,28446-68-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:42;H332:38;H312:38;H319:4;H315:4;H311:1;H301:1;H331:1
122167,"Amides, from C18-24 fatty acids and triethylenetetramine, reaction products with 1,6-diisocyanatohexane",307-732-2,97721-85-2,Not Classified,Notified C&L,1,Not classified:1
122169,(Z)-5-(3-hexenyl)dihydrofuran-2(3H)-one,263-852-4,63095-33-0,Not Classified,Notified C&L,88,Not classified:88
122171,1-benzylpiperazine,220-423-6,2759-28-6,Skin Corr. 1B,REACH registration C&L,48,H314:48
122172,"(R*,S*)-9,9',10,10'-tetrahydro-4,4',5,5'-tetrahydroxy-10,10'-dioxo[9,9'-bianthracene]-2,2'-dicarboxylic acid",208-239-4,517-44-2,Acute Tox. 4,Notified C&L,1,H302:1
122173,Reaktiv Rot F02-0037,445-800-4,,Not Classified,REACH registration C&L,1,Not classified:1
122174,"Phosphoric acid, C16-18-branched and linear alkyl esters, potassium salts",307-075-1,97489-33-3,Not Classified,REACH registration C&L,11,Not classified:10;H319:1;H315:1
122178,"chloroprene (stabilised);2-chlorobuta-1,3-diene (stabilised)",204-818-0,126-99-8,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 1B;STOT RE 2,Harmonised C&L,0,H302:0;H225:0;H373:0;H315:0;H350:0;H319:0;H332:0;H335:0
122179,"Oils, herring, oleins",297-484-0,93572-52-2,Not Classified,Notified C&L,1,Not classified:1
122180,"Glycerides, C16-18",268-084-3,68002-71-1,Not Classified,REACH registration C&L,85,Not classified:85
122182,"Bis(1,3-dimethylbutyl) maleate",203-304-3,105-52-2,Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,75,H317:4;H315:4;Not classified:71
122183,"Fatty acids, montan-wax, sodium salts",297-077-8,93334-05-5,Not Classified,Notified C&L,35,Not classified:35
122184,Sodium D-glucuronate,239-065-7,14984-34-0,Not Classified,Notified C&L,5,Not classified:5
122185,"2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one",429-460-4,7078-98-0,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
122186,"1,3-Propanediol, 2-(aminomethyl)-2-(hydroxymethyl)-",615-965-9,7332-39-0,Not Classified,Notified C&L,1,Not classified:1
122189,"2-chloro-3,4-dimethoxyphenethylamine",266-632-6,67287-36-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H318:1;H315:1;H332:1;H335:1;H312:1
122190,"Lanolin, hydroxylated",270-315-8,68424-66-8,Not Classified,REACH registration C&L,15,Not classified:15
122193,diethylmethylbenzenediamine,270-877-4,68479-98-1,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H373:0;H319:0;H400:0;H312:0
122194,"Diborane (4)Tetramine,octamethyl",605-312-6,1630-79-1,Flam. Liq. 2;Repr. 2;Aquatic Chronic 3,Notified C&L,124,H361:85;H225:84;H412:84;H319:40;H335:39;H315:41;H373:1;H226:1;H411:1;H336:1;H304:1
122197,Trilead diarsenate,222-979-5,3687-31-8,,Notified C&L,4,H410:4;H360:4;H331:4;H350:4;H301:4;H400:4
122199,"(2E,6Z)-dodeca-2,6-dienal",244-515-0,21662-13-5,Not Classified,Notified C&L,150,Not classified:112;H319:38;H335:38;H315:38
122200,"Bis(pentane-2,4-dionato-O,O')strontium",235-366-2,12193-47-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,38,H302:38;H351:38;H315:38;H319:38;H332:38;H335:38;H312:38
122202,"α-D-glucose 1,6-bis(dihydrogen phosphate), compound with cyclohexylamine (1:4)",275-777-4,71662-13-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H315:38
122203,"N,N-dimethylacrylamide",220-237-5,2680-03-7,Acute Tox. 3;Acute Tox. 3;Eye Dam. 1,REACH registration C&L,400,H311:353;H301:336;H318:276;H317:53;H330:81;H319:79;H302:59;H315:39;H335:17;H312:21;Not classified:5;H341:5;H332:7;H331:5;H412:2
122204,Cloral betaine,218-722-1,2218-68-0,Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H315:1
122205,"L-Glutamine, N-(triphenylmethyl)-",600-344-7,102747-84-2,Not Classified,Notified C&L,1,Not classified:1
122210,"(S)-2,3-dihydro-5-hydroxy-7-methoxy-2-phenyl-4-benzopyrone",207-548-1,480-37-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
122212,"4,4'-methylenebis(2-isopropyl-6-methylaniline)",415-150-6,16298-38-7,STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H411:0
122214,Fluorouracil,200-085-6,51-21-8,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 1B;Repr. 1B,REACH registration C&L,166,H340:61;H360:65;H301:109;H315:62;H319:62;H335:60;H312:59;Not classified:55;H412:40;H341:4;H373:5;H332:2;H351:1;H350:2;H400:1;H302:2;H311:1;H331:1;H334:1;H317:1
122216,"1,4-bis(trichloromethyl)benzene",200-686-3,68-36-0,,Notified C&L,3,H311:1;H331:1;H301:1;H314:3;H318:1
122220,7-(β-D-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one,209-430-5,578-74-5,Not Classified,Notified C&L,2,Not classified:2
122224,"2-(1-oxonaphtho[2,1-b]thien-2(1H)-ylidene)naphtho[2,1-b]thiophen-1(2H)-one",223-633-6,3989-75-1,Not Classified,Notified C&L,1,Not classified:1
122225,"6,6'-bis(diazo-5,5',6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)",441-550-5,,Self-react. C;Carc. 2,Harmonised C&L,0,H242:0;H351:0
122228,"Protein hydrolyzates, reaction products with 10-undecenoyl chloride, potassium salts",614-832-2,68951-92-8,,Notified C&L,1,Not classified:1
122229,3-Bromo-2-chlorotoluene,619-267-5,97329-43-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
122232,"Phosphoric acid, C16-20-branched and linear alkyl esters, potassium salts",307-076-7,97489-34-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
122233,Cobalt (II) Nitrate – hexahydrate,600-049-3,10026-22-9,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1;Muta. 2;Carc. 1B;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,172,H302:165;H410:158;H341:154;H334:164;H317:172;H318:108;H350:154;H360:154;H400:159;H272:76;H332:26;H351:17;H315:10;H319:10;H335:10;H314:1;H371:1
122236,"Hydrocarbons, C7-C8, cyclics",927-033-1,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,2,H225:2;H411:2;H315:2;H336:2;H304:2
122237,"Yttrium oxide (Y2O3), europium-doped",271-591-2,68585-82-0,Aquatic Chronic 4,REACH registration C&L,15,H413:8;Not classified:7
122238,"Decahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan-2(1H)-one",214-933-8,1216-84-8,Not Classified,Notified C&L,10,Not classified:10
122242,"Hexamethylene diisocyanate, oligomerisation product, blocked with N-butyl-1-butanamine",924-903-2,,Not Classified,REACH registration C&L,85,Not classified:85
122244,2-cyclohexylidene-2-phenylacetonitrile,423-740-1,10461-98-0,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
122245,"2,2-bis[[(1-oxoisooctadecyl)oxy]methyl]-1,3-propanediyl bis(isooctadecanoate)",263-423-1,62125-22-8,Not Classified,REACH registration C&L,92,Not classified:92
122246,"Amides, C14-18 and C16-22-unsatd., N,N-bis(hydroxyethyl)",287-965-3,85631-17-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:3;H315:3
122247,2-[(2-ethylhexyl)oxy]ethanol,216-323-7,1559-35-9,Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,404,H319:304;H315:304;Not classified:62;H318:38;H314:38;H312:38;H412:15
122248,Thallium trinitrate,237-325-4,13746-98-0,Ox. Sol. 3;Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H272:1;H373:1;H330:1;H411:1;H300:1
122251,"Silicic acid (H4SiO4), tetraethyl ester, reaction products with bis(acetyloxy)dioctylstannane",300-346-5,93925-43-0,Flam. Liq. 3;STOT RE 1;STOT RE 1,REACH registration C&L,62,H226:7;H372:5;H373:55;H413:56;H412:1;H225:1;H371:1;H318:1;H361:1;H302:1;H319:1
122252,"Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs., compds. with 3-methoxy-1-propanamine",285-993-0,85186-10-3,Not Classified,Notified C&L,1,Not classified:1
122253,"7,7,9-trimethyl-4,13-dioxo-3,14-dioxa-5,12-diazahexadecane-1,16-diyl bismethacrylate",255-239-5,41137-60-4,Aquatic Chronic 3,Notified C&L,2,H412:2
122255,ethyl 2-(3-benzoylphenyl)propanoate,414-920-9,60658-04-0,Acute Tox. 3;Skin Sens. 1;STOT RE 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0;H301:0;H372:0
122259,nonanoic acid,203-931-2,112-05-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H319:0;H412:0;H315:0
122261,Indan-1-yl methyl ether,213-743-2,1006-27-5,Not Classified,Notified C&L,88,Not classified:88
122263,"Diethyl 1,1-cyclopentanedicarboxylate",224-024-8,4167-77-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
122264,β-oxo-γ-butyrolactone,225-617-4,4971-56-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
122267,Dibutylammonium chloride,228-521-0,6287-40-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,40,H302:39;H315:39;H319:39;H332:40;H312:40;H301:1;H335:1
122269,4-Methoxyphenylmagnesium bromide,603-481-0,13139-86-1,Skin Corr. 1B,Notified C&L,69,H314:68;H225:30;Not classified:1
122270,Tetrahydrofurfuryl acrylate,219-268-7,2399-48-6,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1B;Eye Dam. 1;Repr. 1B;Aquatic Chronic 2,REACH registration C&L,292,H302:68;H314:84;H317:90;H411:19;H318:71;H360:32;H319:192;H315:192;H361:32;Not classified:16;H335:5
122274,Methyl 2-(dimethoxyphosphinyl)acrylate,259-508-8,55168-74-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
122277,"2,5-dichloro-α-methylbenzyl alcohol",216-018-9,1475-12-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H302:39;H335:39;H318:39;H315:39
122278,"Clarified oils (petroleum), catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C",265-064-6,64741-62-4,Carc. 1B,Harmonised C&L,0,H350:0
122279,"2-Propen-1-aminium, N,N-dimethyl-N-2-propen-1-yl-, chloride (1:1), homopolymer",607-855-4,26062-79-3,Aquatic Chronic 3,Notified C&L,942,H412:695;H410:158;H400:119;H411:50;Not classified:39;H319:1;H315:1;H413:1
122281,3-ethoxy-4-hydroxybenzaldehyde,204-464-7,121-32-4,Eye Irrit. 2,REACH registration C&L,1942,H319:319;Not classified:1610;H302:67;H335:56;H315:56;H317:3
122286,"Hydrogen-9-[(4-aminophenyl)amino]-7-phenyl-5-(phenylamino)-4,10-disulphonatobenzo[a]phenazinium, sodium salt",273-417-0,68959-44-4,Not Classified,Notified C&L,31,Not classified:31
122289,"Oils, palm, stearins",293-400-1,91079-14-0,Not Classified,Notified C&L,34,Not classified:34
122290,"3-Pyridinemethanol, 5-hydroxy-6-methyl-4-[[(2-methylphenyl)imino]methyl]-, .alpha.-(dihydrogen phosphate)",927-752-0,401629-24-1,Not Classified,REACH registration C&L,2,Not classified:2
122293,"Carboxylic acids, C6-18 and C8-15-di-",273-082-0,68937-70-2,Not Classified,Notified C&L,1,Not classified:1
122297,"reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate",417-110-3,,Flam. Liq. 2;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H225:0;H411:0;H318:0;H315:0
122299,"Sulfonic acids, petroleum, calcium salts, overbased",272-213-9,68783-96-0,Aquatic Chronic 4,Notified C&L,1106,H413:527;H317:461;Not classified:95;H319:24;H315:25;H350:2
122300,"ε-Caprolactone, oligomers, esters with 2-hydroxyethyl methacrylate, phosphate",500-310-0,120145-72-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:39;H335:39;H315:39;Not classified:9
122306,"1,3-oxazolidin-2-one",207-840-9,497-25-6,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,76,H319:40;H317:40;H302:39;Not classified:36;H315:1
122308,2-ethylanthracene,257-788-6,52251-71-5,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H410:38;H318:38;H400:38;Not classified:3
122313,Tetraiodoethylene,208-176-2,513-92-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H315:38;H319:38;H332:38;H335:38;H312:38
122317,Ammonium methacrylate,240-402-5,16325-47-6,Not Classified,Notified C&L,2,Not classified:2
122318,Permanganic acid,236-695-4,13465-41-3,Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,3,H318:2;H314:3;H400:3;H410:1
122320,2-naphthyl benzoate,202-247-1,93-44-7,,Notified C&L,50,Not classified:39;H413:11
122324,Cefalexin,239-773-6,15686-71-2,Skin Sens. 1;Resp. Sens. 1,Notified C&L,75,H334:75;H317:75;H302:2;H315:2;H319:2;H332:1;H335:2;H312:1
122326,Lobeline,202-012-3,90-69-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,194,H311:194;H301:194;H331:194
122327,carbendazim (ISO);methyl benzimidazol-2-ylcarbamate,234-232-0,10605-21-7,Muta. 1B;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H410:0;H340:0;H400:0;H360:0
122328,"sodium 2-oxo-1,2,3,4-tetrahydroquinolin-6-olate",617-946-0,87032-92-6,Not Classified,REACH registration C&L,2,Not classified:2
122330,4-dodecylresorcinol,246-145-5,24305-56-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
122334,N-[3-(trimethoxysilyl)propylcyclohexylamine],221-329-8,3068-78-8,Eye Dam. 1,REACH registration C&L,7,H318:3;Not classified:4;H315:1
122336,"4,4'-Methylenebis(2,6-dimethylphenyl cyanate)",600-230-7,101657-77-6,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,25,H317:25;H412:25
122337,5-aminoquinoline,210-266-1,611-34-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45,H319:41;H315:41;H302:6;H332:5;H312:5;H335:2
122338,"1,4-Dihydroxy-2,2,6,6-tetramethylpiperidine",434-880-6,,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,4,H302:4;H412:4;H373:1
122339,2-[bis(2-hydroxyethyl)amino]ethanol;sulfuric acid,601-497-2,117875-77-1,Eye Irrit. 2,Notified C&L,529,H319:481;H311:48;H302:48;H318:48;H314:48
122340,"Serine, hydrazide",613-642-7,64616-76-8,Not Classified,Notified C&L,1,Not classified:1
122343,"2-butyl-6-(butylamino)-1H-benz[de]isoquinoline-1,3(2H)-dione",242-828-7,19125-99-6,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,45,H410:4;H400:4;Not classified:41
122344,3-hydroxy-2-(hydroxymethyl)-2-methylpropionaldehyde,242-393-3,18516-18-2,,Notified C&L,38,Not classified:33;H319:5;H315:5
122345,"Alpha-dodecyl-omega-hydroxy-poly[oxy(hydroxymethyl)-1,2-ethanediyl]",470-470-3,9022-75-7,Skin Corr. 1C;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H314:2;H400:2
122346,"Tallow, hydrogenated, reaction products with 2-[(2-aminoethyl)amino]ethanol",269-659-1,68308-55-4,Eye Dam. 1;Repr. 1B;Aquatic Chronic 2,Notified C&L,70,H411:67;H318:66;H360:27;Not classified:2;H317:2;H319:1;H315:1;H412:1
122348,"1,1,1,2,2,3,3-heptafluoro-3-[(trifluorovinyl)oxy]propane",216-600-2,1623-05-8,Eye Irrit. 2,REACH registration C&L,44,H319:24;Not classified:17;H224:2;H302:3;H335:1;H315:1;H332:1;H312:1
122350,"1H-Naphtho[2,1-b]pyran-1-one, 6-(acetyloxy)-3-ethenyldodecahydro-5,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-",613-649-5,64657-21-2,,Notified C&L,39,Not classified:38;H312:1
122352,2-chloro-3-phenyl-DL-alanine,237-939-2,14091-11-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38;H315:38
122356,"(13S-cis)-13-ethyl-7,11,12,13,16,17-hexahydro-3-methoxy-6H-cyclopenta[a]phenantren-17-ol",238-512-3,14507-45-0,Not Classified,Notified C&L,2,Not classified:2
122357,Pentamethylbenzonitrile,225-912-8,5144-10-5,,Notified C&L,4,H302:4;H315:4;H319:4;H332:4;H335:4;H312:4
122361,"Amines, di-C14-18-alkyl",268-222-2,68037-98-9,Skin Irrit. 2,Notified C&L,74,H315:72;H318:5;H412:4;Not classified:1;H410:1;H400:2;H314:1
122365,"reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate;sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate;sodium [bis(2-hydroxyethyl)amino]methylsulfonate;N,N-bis(2-hydroxyethyl)stearamide",401-230-8,55349-70-7,Aquatic Chronic 3,Harmonised C&L,0,H412:0
122366,4-tert-butyl hydrogen L-aspartate,221-292-8,3057-74-7,Not Classified,Notified C&L,1,Not classified:1
122368,Abies balsamea,617-004-9,8021-28-1,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,154,H317:90;H226:129;H304:90;H411:89;Not classified:25;H410:1;H319:1;H400:1
122371,Nα-acetyl-DL-tryptophan,201-739-3,87-32-1,Not Classified,REACH registration C&L,42,Not classified:41;H319:1;H335:1;H315:1
122373,Mefenamic acid,200-513-1,61-68-7,Acute Tox. 4,Notified C&L,125,H302:124;H361:30;Not classified:1;H319:1;H335:1;H315:1
122377,9-DECENYL (E)-3-(2-HYDROXYPHENYL)-2-PROPENOATE,471-970-4,,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1286,H317:1286;H410:1286;H400:1286
122379,"Phenol, sulfonated, condensed, sodium salts",274-507-2,70247-95-9,Not Classified,Notified C&L,3,Not classified:2;H317:1
122380,Hexadecamethylcyclooctasiloxane,209-137-2,556-68-3,Not Classified,Notified C&L,14,Not classified:13;H319:1
122381,2-bromoethylammonium bromide,219-924-2,2576-47-8,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,70,H302:26;H412:25;H319:61;H335:60;H315:61;H317:22;H301:5;H332:1;H312:1;H341:1
122384,1-(hydrazinocarbonylmethyl)pyridinium chloride,214-421-4,1126-58-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
122386,6-allylguaicol,209-444-1,579-60-2,Acute Tox. 4,Notified C&L,126,H302:88;H334:38;H317:38;H315:38;H319:38;H335:38
122390,Poly(vinyl chloride-co-acrylic acid),607-779-1,25702-80-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,38,H319:38;H335:38;H412:38;H315:38
122391,"edifenphos (ISO);O-ethyl S,S-diphenyl phosphorodithioate",241-178-1,17109-49-8,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H331:0;H301:0;H400:0;H312:0
122392,"3-methylcyclohexylamine, mixed isomers",229-940-1,6850-35-7,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1,Notified C&L,3,H225:3;H318:3;H314:3
122394,"4,4',4''-(ethan-1,1,1-triyl)triphenol",405-800-7,27955-94-8,Aquatic Chronic 2,Harmonised C&L,0,H411:0
122404,Methacrylamide,201-202-3,79-39-0,Acute Tox. 4;Eye Irrit. 2;STOT SE 3;STOT SE 2;STOT RE 2,REACH registration C&L,778,H371:182;H302:771;H373:182;H319:666;H335:139;H315:40;H332:56;Not classified:7;H350:1;H361:1
122406,"Nonanoic acid, sulfophenyl ester, sodium salt",618-704-7,91125-43-8,Skin Sens. 1;Eye Dam. 1,Notified C&L,36,H317:36;H318:36
122409,"Benzenesulfonic acid, C10-60-alkyl derivs., magnesium salts",296-721-5,93028-29-6,Aquatic Chronic 4,Notified C&L,1017,H413:873;Not classified:144;H350:2
122411,Potassium 2-naphthylsulphate,217-072-6,1733-89-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
122412,Hexacontane,231-643-7,7667-80-3,Not Classified,Notified C&L,3,Not classified:3
122414,But-2-en-1-ol,228-086-7,6117-91-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,131,H302:131;H226:131;H312:121;H311:10
